data_1tih_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tih _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 121.445 0.64 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.07 136.84 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.985 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -142.71 35.84 1.43 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.246 1.022 . . . . 0.0 111.851 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.32 158.42 26.1 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 113.432 -1.713 . . . . 0.0 107.538 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -147.92 161.81 40.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 124.552 1.158 . . . . 0.0 110.831 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.21 -18.35 35.92 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.765 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 1.1 t -58.61 -59.2 5.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.2 -100.22 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.628 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.37 -99.13 0.56 Allowed Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.383 -0.823 . . . . 0.0 114.634 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 173.82 112.72 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HB2' ' N ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -61.3 107.53 0.78 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.432 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 131.2 -19.6 4.85 Favored Glycine 0 N--CA 1.493 2.441 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.3 m -103.65 143.34 32.9 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.019 0.437 . . . . 0.0 111.353 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -89.3 96.35 10.68 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.546 ' CZ ' ' HA2' ' A' ' 27' ' ' GLY . 3.5 m-85 -55.54 127.85 31.71 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.033 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.55 158.57 43.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.143 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 t -109.21 128.2 54.85 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 113.316 -1.766 . . . . 0.0 110.918 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -41.89 -24.13 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 112.636 -2.075 . . . . 0.0 114.86 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -53.03 -31.94 44.03 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.923 0.764 . . . . 0.0 111.237 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.98 31.31 1.21 Allowed Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 m -143.88 143.31 31.23 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.869 0.842 . . . . 0.0 111.755 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -72.61 144.98 47.64 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.584 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.6 t -102.19 -54.93 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.173 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.485 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -174.59 168.27 3.77 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 123.992 0.808 . . . . 0.0 110.036 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -90.07 156.39 18.41 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.546 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -47.57 115.03 1.96 Allowed Glycine 0 N--CA 1.494 2.566 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.84 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -12.98 4.51 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 t -142.96 120.81 11.95 Favored 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 118.86 0.755 . . . . 0.0 110.659 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' N ' ' HB2' ' A' ' 12' ' ' LYS . 5.5 t70 -79.6 143.01 58.23 Favored Pre-proline 0 N--CA 1.49 1.545 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.091 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.19 -33.68 55.55 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.699 1.599 . . . . 0.0 111.87 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.57 -29.76 41.42 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.789 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -89.72 138.78 27.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.05 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -74.83 79.95 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.647 2.232 . . . . 0.0 110.331 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -138.68 38.58 2.21 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.857 0.837 . . . . 0.0 109.84 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.46 164.61 11.74 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 113.984 -1.462 . . . . 0.0 111.683 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.9 m -142.66 79.53 15.04 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.29 78.9 1.49 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.362 2.041 . . . . 0.0 110.026 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -149.09 -54.32 0.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.027 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -76.54 174.4 10.38 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.711 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.5 m -148.78 122.94 9.52 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.781 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -117.26 78.02 10.18 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 124.113 0.883 . . . . 0.0 112.569 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.4 -19.99 38.13 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.192 1.928 . . . . 0.0 113.478 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -71.08 -40.63 71.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 123.742 0.651 . . . . 0.0 110.912 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 tt -54.82 148.32 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 123.679 0.612 . . . . 0.0 110.421 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.11 -40.55 1.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 124.172 0.92 . . . . 0.0 110.598 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -172.92 -172.06 0.81 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.154 0.909 . . . . 0.0 109.985 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.43 116.33 3.0 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.9 mm -79.1 90.82 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.64 154.8 68.56 Favored Pre-proline 0 N--CA 1.493 1.675 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.536 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.489 1.259 0 C-N-CA 122.076 1.851 . . . . 0.0 110.446 173.904 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.895 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 tp -84.74 61.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.06 36.35 0.77 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 114.336 -1.302 . . . . 0.0 113.089 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -90.71 174.2 7.61 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.345 -1.752 . . . . 0.0 108.749 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -161.44 166.0 27.93 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 124.217 0.948 . . . . 0.0 111.129 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.1 t -57.73 -9.84 1.39 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.567 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.4 t -89.09 -64.75 1.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.287 -1.324 . . . . 0.0 113.665 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.75 73.44 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 120.104 3.372 . . . . 0.0 120.104 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -20.93 -105.0 0.0 OUTLIER Glycine 0 N--CA 1.514 3.869 0 N-CA-C 119.398 2.519 . . . . 0.0 119.398 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -178.24 114.77 0.07 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 123.747 0.322 . . . . 0.0 111.681 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -45.16 111.93 0.38 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 124.19 0.931 . . . . 0.0 110.388 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.25 -35.7 2.77 Favored Glycine 0 N--CA 1.494 2.53 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.771 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.5 m -79.34 -178.38 6.21 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -137.71 106.8 6.01 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.594 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.536 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 61.7 m-85 -56.85 129.73 42.7 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.392 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.45 157.13 44.07 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.198 0.999 . . . . 0.0 111.294 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.8 t -109.04 126.15 52.84 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.175 -1.829 . . . . 0.0 110.866 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -38.49 -33.08 0.09 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.03 -26.67 60.71 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.917 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.92 34.71 0.72 Allowed Glycine 0 N--CA 1.493 2.499 0 O-C-N 124.233 0.958 . . . . 0.0 111.777 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.4 m -141.49 137.58 32.19 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.657 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -71.92 140.18 49.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.7 -51.96 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 123.723 0.639 . . . . 0.0 111.152 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.27 178.97 4.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 123.81 0.694 . . . . 0.0 110.839 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -104.44 150.05 24.89 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.55 111.77 1.54 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -118.22 -15.18 9.82 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.414 ' HG ' ' N ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -66.74 105.32 1.53 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.47 129.63 46.53 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 124.233 0.958 . . . . 0.0 109.341 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -73.63 60.02 4.2 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.489 2.126 . . . . 0.0 111.731 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.82 -27.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.43 155.07 46.53 Favored Pre-proline 0 N--CA 1.498 1.961 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.415 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -75.76 72.99 4.9 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.342 2.028 . . . . 0.0 111.065 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.19 98.51 0.11 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.225 0.536 . . . . 0.0 110.121 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.59 131.61 36.05 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.913 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.79 79.83 10.31 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 124.428 1.08 . . . . 0.0 112.311 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.82 0.58 6.23 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.685 2.256 . . . . 0.0 111.748 168.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -25.3 41.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.736 0.648 . . . . 0.0 110.819 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 54.45 -160.15 0.16 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.157 0.911 . . . . 0.0 111.59 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.3 m -55.4 127.69 30.75 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.704 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -127.24 75.16 77.15 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 124.055 0.847 . . . . 0.0 112.056 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.67 -18.48 33.43 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.962 1.775 . . . . 0.0 112.617 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ttp-105 -59.29 -44.97 92.45 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mt -68.56 154.01 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.36 -46.6 3.53 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.627 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -172.44 -173.4 1.04 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.524 1.14 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.56 115.69 3.09 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.4 mm -78.8 104.65 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 36.6 m -93.51 122.65 62.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.489 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.2 0 C-N-CA 121.762 1.641 . . . . 0.0 108.77 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 54.9 mtt85 . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.7 tp -72.29 84.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 124.73 1.269 . . . . 0.0 107.625 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -92.89 47.47 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.385 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 p -89.83 176.66 6.74 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.743 -1.571 . . . . 0.0 108.441 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -157.77 154.65 28.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.168 0.918 . . . . 0.0 113.309 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 t -61.07 -31.25 70.92 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.778 -2.01 . . . . 0.0 112.418 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.7 t -63.33 -56.3 17.5 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.376 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.74 27.63 0.62 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 113.895 -1.502 . . . . 0.0 112.571 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.66 -135.71 0.06 OUTLIER Glycine 0 N--CA 1.497 2.731 0 O-C-N 124.129 0.893 . . . . 0.0 113.722 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.416 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 10.9 p -149.96 114.71 5.31 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 123.92 0.424 . . . . 0.0 112.052 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.12 103.46 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.821 0.701 . . . . 0.0 112.35 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.87 -31.72 3.64 Favored Glycine 0 N--CA 1.496 2.655 0 CA-C-N 114.336 -1.302 . . . . 0.0 113.86 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.9 m -85.91 158.77 19.84 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.968 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -112.31 91.68 3.74 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.471 1.107 . . . . 0.0 108.904 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -57.54 124.93 20.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.451 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.14 157.26 46.26 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.517 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.7 p -101.8 130.18 48.17 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.314 -1.766 . . . . 0.0 111.941 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -38.73 -32.27 0.08 Allowed 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -57.31 -28.76 63.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 123.687 0.617 . . . . 0.0 112.1 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.1 34.28 0.79 Allowed Glycine 0 N--CA 1.492 2.408 0 O-C-N 124.156 0.91 . . . . 0.0 111.0 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.2 m -140.43 137.46 33.97 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.19 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -70.81 142.84 51.29 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.39 -49.87 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 123.649 0.593 . . . . 0.0 110.481 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -175.74 -178.97 1.14 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.102 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -114.31 128.04 56.16 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -50.1 112.55 1.53 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 1.28 54.8 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.4 m -64.37 102.86 0.58 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.354 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.2 136.33 57.22 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 124.651 1.22 . . . . 0.0 112.104 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -67.39 87.46 0.33 Allowed 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 122.495 2.13 . . . . 0.0 110.002 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mtm105 166.85 -46.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.628 -1.623 . . . . 0.0 106.881 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -86.46 132.49 42.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.11 65.3 7.85 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.51 2.14 . . . . 0.0 110.621 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt 26.6 86.61 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 O-C-N 124.503 1.127 . . . . 0.0 113.806 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.04 87.91 4.81 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.619 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.0 m -148.86 147.88 25.73 Favored Pre-proline 0 N--CA 1.496 1.842 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.355 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.89 -75.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.167 0 C-N-CA 121.591 1.527 . . . . 0.0 109.683 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -161.15 -64.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.8 m120 56.54 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 125.411 1.694 . . . . 0.0 112.898 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.2 m -94.02 125.75 38.83 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.113 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -123.57 77.0 55.32 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 124.021 0.826 . . . . 0.0 110.725 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.91 -30.32 57.77 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 122.309 2.006 . . . . 0.0 112.707 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -64.24 -43.75 93.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.162 0.914 . . . . 0.0 111.332 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.88 137.12 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 124.152 0.908 . . . . 0.0 109.316 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.42 -42.8 2.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.748 1.28 . . . . 0.0 109.085 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -170.13 -175.84 2.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.544 1.153 . . . . 0.0 109.92 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.22 114.58 2.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.4 mm -78.81 94.34 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.3 m -89.87 143.3 29.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.127 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 C-N-CA 122.0 1.8 . . . . 0.0 110.715 176.256 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 tp -81.3 70.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.7 m -90.75 36.04 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.869 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 p -86.93 166.38 15.17 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 112.967 -1.924 . . . . 0.0 107.427 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -153.85 154.94 34.84 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 124.674 1.233 . . . . 0.0 109.046 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -59.34 -14.68 12.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 124.065 0.853 . . . . 0.0 112.257 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.0 t -90.39 -64.43 1.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.041 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.89 50.93 1.96 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.07 -88.21 2.04 Favored Glycine 0 N--CA 1.503 3.121 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.582 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.5 ' H ' ' HH ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -169.08 108.68 0.45 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 124.641 0.848 . . . . 0.0 110.564 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HA ' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -50.8 112.14 0.66 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 123.763 0.664 . . . . 0.0 109.997 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 124.79 -30.51 4.62 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 124.483 1.114 . . . . 0.0 111.82 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.5 m -87.27 122.99 31.79 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -73.86 102.05 3.95 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.82 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.54 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 99.4 m-85 -51.66 126.49 17.8 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.53 153.61 41.3 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.429 1.109 . . . . 0.0 111.665 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.5 t -103.43 132.71 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.705 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.404 ' H ' ' HB1' ' A' ' 46' ' ' ALA . 2.5 p30 -46.4 -23.58 0.38 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 113.111 -1.859 . . . . 0.0 114.449 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -58.99 -19.4 43.06 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.122 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.97 33.25 3.29 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.5 m -139.81 137.74 35.23 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.497 0.665 . . . . 0.0 112.232 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -72.26 142.47 48.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.2 t -102.56 -52.94 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.186 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.75 -179.77 3.42 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.823 0.702 . . . . 0.0 110.608 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -102.46 143.65 31.92 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.501 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -47.01 116.13 2.35 Favored Glycine 0 N--CA 1.498 2.819 0 O-C-N 125.353 1.658 . . . . 0.0 110.115 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.43 -29.81 5.03 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 p -68.43 100.16 1.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -101.74 129.12 27.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.61 -27.16 31.96 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.17 1.913 . . . . 0.0 113.219 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -38.86 51.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.721 0.638 . . . . 0.0 112.015 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.51 148.43 55.23 Favored Pre-proline 0 N--CA 1.495 1.796 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.082 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.14 76.88 4.0 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.502 2.135 . . . . 0.0 111.209 171.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.84 94.7 0.63 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.445 0.64 . . . . 0.0 109.637 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.7 83.12 5.7 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.43 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.9 m -102.56 151.31 38.22 Favored Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.327 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -67.5 153.77 75.58 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.118 1.879 . . . . 0.0 110.387 166.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -88.47 33.96 0.76 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.593 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -72.09 173.94 7.79 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.532 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 98.0 m -125.11 132.4 53.13 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.218 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -113.79 84.38 8.38 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 123.747 0.654 . . . . 0.0 112.674 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -55.47 -21.88 32.14 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.352 2.035 . . . . 0.0 113.262 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -40.38 96.89 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.797 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.4 tt -77.78 163.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 123.794 0.683 . . . . 0.0 110.667 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB1' ' H ' ' A' ' 19' ' ' ASP . . . -121.67 -43.67 2.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 124.388 1.055 . . . . 0.0 108.289 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -171.75 -167.7 0.53 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 124.41 1.069 . . . . 0.0 109.758 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -128.01 120.61 3.48 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.6 100.75 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.4 m -92.51 145.63 30.88 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.147 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.487 1.108 0 C-N-CA 122.064 1.842 . . . . 0.0 109.943 176.604 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -72.46 80.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.841 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.49 43.25 1.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.649 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 t -75.93 167.63 21.52 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.407 -1.724 . . . . 0.0 108.199 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -148.43 141.81 25.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 123.869 0.73 . . . . 0.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -23.63 49.12 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.024 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.12 -62.77 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.759 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.29 63.44 7.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 124.455 1.097 . . . . 0.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.48 -144.08 16.31 Favored Glycine 0 N--CA 1.494 2.563 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.292 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 p -136.68 107.23 6.51 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 123.905 0.415 . . . . 0.0 111.674 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -50.07 95.94 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.755 1.284 . . . . 0.0 110.661 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.86 -27.81 1.74 Allowed Glycine 0 N--CA 1.493 2.466 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.82 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.0 m -111.68 140.08 46.6 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.429 0.633 . . . . 0.0 112.4 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -89.79 97.96 11.49 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.209 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -56.43 125.34 21.58 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 156.98 48.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.807 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 t -104.51 130.31 52.47 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.993 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -39.84 -28.32 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 117.691 2.478 . . . . 0.0 117.691 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -55.99 -27.7 54.01 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.812 -0.755 . . . . 0.0 112.2 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.98 34.22 1.17 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 107.684 -2.166 . . . . 0.0 107.684 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.9 m -143.01 137.89 29.63 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.812 0.815 . . . . 0.0 111.172 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -70.12 152.41 44.35 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.699 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.7 -59.09 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 123.748 0.655 . . . . 0.0 111.677 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -176.19 177.96 1.47 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.868 0.73 . . . . 0.0 111.07 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.551 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -99.27 130.18 45.55 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.36 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.79 107.01 1.97 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.72 12.89 28.3 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.491 ' HG ' ' HZ3' ' A' ' 35' ' ' LYS . 4.4 m -106.14 132.44 52.2 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.19 137.66 56.5 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.99 67.86 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.237 1.958 . . . . 0.0 111.924 169.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 170.09 -21.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.449 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -90.35 143.62 29.72 Favored Pre-proline 0 N--CA 1.493 1.716 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.072 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.3 55.44 5.66 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.528 2.152 . . . . 0.0 111.439 169.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HZ3' ' HG ' ' A' ' 29' ' ' SER . 0.7 OUTLIER -59.29 132.33 53.7 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.728 -1.189 . . . . 0.0 110.862 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.66 127.51 32.27 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.518 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.0 m -150.84 145.78 18.63 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 124.174 0.921 . . . . 0.0 110.54 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.65 151.09 83.43 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.721 1.614 . . . . 0.0 109.704 163.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.3 tpp85 -84.66 59.88 5.78 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.996 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -73.91 93.34 2.18 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.195 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.6 m -59.23 120.84 9.98 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.91 78.4 7.32 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.48 -21.97 25.92 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 C-N-CA 122.554 2.169 . . . . 0.0 112.803 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -48.84 77.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.125 0.891 . . . . 0.0 109.136 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 mt -58.18 143.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 123.931 0.769 . . . . 0.0 109.737 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.76 -37.38 0.82 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 112.607 -2.088 . . . . 0.0 111.036 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.01 178.19 9.42 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.196 0.935 . . . . 0.0 110.481 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.34 109.83 1.33 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.17 88.86 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -86.85 128.49 55.98 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.49 1.31 0 C-N-CA 122.069 1.846 . . . . 0.0 110.979 -179.033 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.1 ttt85 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 121.642 0.734 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 tp -87.44 45.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.329 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -84.56 46.68 1.26 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.478 1.132 . . . . 0.0 112.577 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.16 150.08 22.16 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.898 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -113.27 -165.76 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.752 1.283 . . . . 0.0 107.868 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 1.2 t -116.31 -29.39 6.23 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.376 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 t -56.32 -56.14 24.74 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.126 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.59 33.77 0.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.764 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.69 -113.88 0.14 Allowed Glycine 0 N--CA 1.494 2.556 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.457 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -154.88 111.82 3.31 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 123.933 0.431 . . . . 0.0 110.537 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -46.12 99.31 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.9 -23.57 5.88 Favored Glycine 0 N--CA 1.499 2.892 0 CA-C-N 114.99 -1.005 . . . . 0.0 114.902 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.1 m -86.31 143.14 28.04 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.837 0.818 . . . . 0.0 110.747 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -97.63 97.19 8.83 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.449 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 17.4 m-85 -62.24 122.39 15.5 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.97 162.85 31.27 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.023 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.8 t -108.84 131.44 54.99 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.462 -1.699 . . . . 0.0 111.5 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.421 ' H ' ' HB3' ' A' ' 46' ' ' ALA . 4.4 p30 -45.14 -21.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 112.596 -2.093 . . . . 0.0 114.895 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -53.62 -30.33 42.25 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.896 0.747 . . . . 0.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.28 30.29 1.6 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.8 m -146.13 147.24 31.33 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.774 0.797 . . . . 0.0 112.124 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -69.86 158.68 35.06 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.04 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.98 -48.94 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 28.4 p -164.24 -175.85 4.16 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.143 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -130.48 137.01 49.56 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.239 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.32 115.41 5.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -114.49 26.12 10.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 109.63 21.14 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -88.16 137.19 31.25 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 124.379 1.049 . . . . 0.0 110.247 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -69.91 70.95 1.63 Allowed 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 121.969 1.779 . . . . 0.0 110.121 167.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 169.43 -30.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.682 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -90.08 141.47 27.92 Favored Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.215 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -75.12 68.29 5.88 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 122.734 2.289 . . . . 0.0 110.671 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.65 86.38 3.95 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.502 0.668 . . . . 0.0 110.061 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.43 103.07 9.1 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.198 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.3 m -104.82 150.62 38.86 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.25 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.87 158.18 57.68 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 122.317 2.012 . . . . 0.0 110.522 157.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.454 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.3 60.87 6.35 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.626 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -63.47 110.09 1.84 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.652 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 99.2 m -74.38 116.19 14.77 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.746 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -121.35 74.67 31.34 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.89 -25.77 78.44 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.413 2.076 . . . . 0.0 111.305 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.3 ttp-105 -59.99 -31.13 69.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.991 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.12 156.96 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB3' ' H ' ' A' ' 19' ' ' ASP . . . -116.83 -44.37 2.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.588 1.18 . . . . 0.0 109.687 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -173.92 178.93 2.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.305 1.003 . . . . 0.0 111.098 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.66 111.64 3.33 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.3 mt -79.24 89.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.0 m -86.27 134.65 38.06 Favored Pre-proline 0 N--CA 1.495 1.813 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.617 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 C-N-CA 121.954 1.769 . . . . 0.0 110.931 175.782 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 121.574 0.702 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.6 tp -45.11 131.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.746 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -135.26 48.28 2.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.195 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -78.81 170.35 16.81 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.382 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -150.59 148.17 28.32 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 41.6 t -78.14 -20.98 50.99 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.181 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -60.57 -58.3 9.07 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.36 36.91 0.89 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.648 -1.615 . . . . 0.0 108.229 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.48 -110.13 0.07 OUTLIER Glycine 0 N--CA 1.495 2.601 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.646 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.432 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 5.3 t -162.35 123.96 2.68 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -65.3 91.94 0.12 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.073 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.83 -21.64 0.79 Allowed Glycine 0 N--CA 1.489 2.194 0 CA-C-N 113.443 -1.708 . . . . 0.0 111.779 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.5 m -127.02 138.23 53.21 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 119.301 -0.96 . . . . 0.0 113.069 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -83.48 102.3 12.0 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 113.548 -1.66 . . . . 0.0 108.501 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.594 ' HB2' ' SG ' ' A' ' 7' ' ' CYS . 6.5 m-85 -62.52 122.81 16.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.7 159.88 38.35 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.045 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 t -108.21 131.28 54.84 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.161 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -39.63 -28.3 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -56.54 -28.53 60.3 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.829 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.07 34.14 0.92 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.3 m -143.61 138.8 29.29 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.886 0.85 . . . . 0.0 112.079 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -71.9 138.91 48.5 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.001 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.32 -57.19 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.909 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -175.84 174.89 2.09 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.556 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.484 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 1.4 mt-10 -99.19 131.11 45.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.315 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.432 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -65.43 112.94 5.38 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -103.45 7.8 37.94 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.383 0.696 . . . . 0.0 112.733 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -80.87 100.04 8.64 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.559 -0.857 . . . . 0.0 112.583 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -90.44 133.43 32.99 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.91 -26.01 23.39 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.974 1.783 . . . . 0.0 112.134 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -86.41 -37.64 18.17 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.725 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -83.74 143.59 43.94 Favored Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.119 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -76.23 74.58 4.56 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 122.445 2.097 . . . . 0.0 109.91 167.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HE2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -64.55 97.89 0.23 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.78 127.2 31.93 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.529 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.42 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 60.8 m -147.09 149.2 34.64 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 124.266 0.979 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.37 142.85 67.66 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 N-CA-C 107.729 -1.681 . . . . 0.0 107.729 153.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -85.31 62.03 7.23 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.092 0.948 . . . . 0.0 108.878 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -61.09 107.7 0.77 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.625 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.2 m -55.63 118.14 4.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 124.193 0.933 . . . . 0.0 110.587 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -128.76 74.05 80.85 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 124.311 1.007 . . . . 0.0 113.061 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.45 -22.44 66.1 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 121.888 1.726 . . . . 0.0 110.627 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.434 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -55.64 -38.22 69.26 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 124.314 1.009 . . . . 0.0 110.099 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mt -66.67 146.52 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.02 -42.56 1.38 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.143 -1.39 . . . . 0.0 111.87 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.87 175.68 12.22 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 124.111 0.882 . . . . 0.0 110.571 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.18 108.81 1.5 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.353 -2.299 . . . . 0.0 107.353 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.5 mt -79.12 94.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.07 152.32 46.02 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.887 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 C--N 1.316 -1.144 0 C-N-CA 121.785 1.656 . . . . 0.0 108.814 -179.727 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 tp -57.03 133.4 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.611 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -146.9 49.22 1.13 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.784 1.278 . . . . 0.0 110.546 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.427 ' H ' ' HG1' ' A' ' 5' ' ' THR . 2.2 p -72.99 167.11 21.76 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 112.997 -1.91 . . . . 0.0 109.562 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -161.19 162.04 31.13 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.946 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.7 t -65.72 -23.48 66.76 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.932 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -58.32 -60.4 3.84 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.8 -106.6 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 112.899 -1.955 . . . . 0.0 105.738 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 16' ' ' TYR . . . 79.09 -107.93 2.6 Favored Glycine 0 CA--C 1.549 2.174 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -179.13 97.61 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 123.291 0.636 . . . . 0.0 111.055 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.8 133.93 42.37 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.937 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.7 -28.6 12.77 Favored Glycine 0 N--CA 1.488 2.136 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.924 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.6 m -106.63 143.38 34.82 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.412 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.68 106.19 18.17 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.68 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 2.6 m-30 -55.59 131.33 46.04 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.09 159.41 43.32 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 124.669 1.231 . . . . 0.0 112.188 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 t -108.12 129.32 55.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 112.735 -2.029 . . . . 0.0 111.113 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -43.37 -25.15 0.12 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-N 113.092 -1.867 . . . . 0.0 115.321 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -54.14 -30.2 48.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 123.897 0.748 . . . . 0.0 111.592 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.41 32.72 1.2 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 m -143.56 143.96 31.74 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.901 0.857 . . . . 0.0 111.759 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -72.86 149.16 43.76 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.435 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.2 t -110.5 -52.38 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.53 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -170.05 -173.01 1.44 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 123.53 0.519 . . . . 0.0 110.252 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.557 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 mt-10 -112.43 158.66 19.58 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.78 110.55 2.88 Favored Glycine 0 N--CA 1.494 2.561 0 CA-C-N 112.812 -1.994 . . . . 0.0 110.897 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -121.13 -39.06 2.73 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 p -72.11 102.42 3.01 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.54 133.42 59.57 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.63 -29.83 20.36 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.975 1.783 . . . . 0.0 113.102 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.6 mtt180 -84.77 -34.86 22.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 123.863 0.727 . . . . 0.0 112.093 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -81.16 142.88 51.72 Favored Pre-proline 0 N--CA 1.495 1.808 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.574 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.84 47.3 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.365 2.71 . . . . 0.0 112.37 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -96.1 95.16 7.98 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.498 0.666 . . . . 0.0 110.584 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.49 140.22 16.07 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.473 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.61 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.8 m -133.2 94.29 20.56 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -71.61 79.17 1.57 Allowed 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.099 1.866 . . . . 0.0 109.364 172.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -144.82 -59.41 0.36 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.263 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -77.69 136.01 38.14 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.004 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.1 m -112.13 126.36 55.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.972 1.42 . . . . 0.0 108.217 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -126.24 71.74 70.88 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 123.893 0.745 . . . . 0.0 112.497 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.15 -28.54 73.58 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.486 2.124 . . . . 0.0 112.643 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -63.15 -17.51 62.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.026 0.829 . . . . 0.0 112.147 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 tt -69.65 158.82 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 123.694 0.621 . . . . 0.0 109.671 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.16 -45.18 1.99 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.946 0.778 . . . . 0.0 109.47 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -173.94 -169.73 0.5 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 124.343 1.027 . . . . 0.0 110.181 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.52 116.06 3.11 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.9 mt -80.79 91.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.216 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.24 127.06 77.74 Favored Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 N--CA 1.489 1.245 0 C-N-CA 121.901 1.734 . . . . 0.0 109.365 177.009 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mtm105 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 121.703 0.763 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.7 tp -86.63 46.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.687 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 m -85.48 46.35 1.29 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.549 1.166 . . . . 0.0 112.513 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -90.21 174.12 7.78 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 112.961 -1.927 . . . . 0.0 108.45 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -161.39 165.58 28.67 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.028 0.83 . . . . 0.0 110.373 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.7 t -67.49 -3.28 8.15 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.7 t -91.12 -57.77 2.69 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -42.13 -69.26 0.14 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 4.43 -112.93 0.01 OUTLIER Glycine 0 N--CA 1.508 3.465 0 N-CA-C 117.556 1.782 . . . . 0.0 117.556 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 173.65 126.82 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -49.62 110.55 0.39 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 124.148 0.905 . . . . 0.0 110.01 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.94 -28.38 4.39 Favored Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.536 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.6 m -79.59 -176.48 5.34 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.199 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -139.22 101.39 4.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.857 0.723 . . . . 0.0 109.683 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.589 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 85.6 m-85 -57.45 131.92 51.57 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.42 155.86 44.5 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.222 1.01 . . . . 0.0 110.94 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.475 ' HG ' HH21 ' A' ' 44' ' ' ARG . 9.8 t -106.86 135.74 47.88 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.382 -2.19 . . . . 0.0 113.485 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -47.27 -24.47 0.74 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 111.575 -2.557 . . . . 0.0 113.573 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -56.0 -25.76 45.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 124.098 0.874 . . . . 0.0 111.797 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.27 32.17 2.43 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.7 m -145.66 148.34 32.96 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 112.449 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -70.98 153.49 42.61 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.339 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.7 t -115.99 -56.75 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.213 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.589 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -162.5 -178.92 6.56 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.702 0.626 . . . . 0.0 110.56 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.418 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -112.77 150.64 31.34 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.48 110.49 1.41 Allowed Glycine 0 N--CA 1.492 2.419 0 CA-C-N 112.951 -1.931 . . . . 0.0 109.653 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -114.03 -6.61 13.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.897 0.998 . . . . 0.0 113.437 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.97 89.66 4.14 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.95 130.39 44.85 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.28 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.0 74.49 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.609 2.206 . . . . 0.0 110.993 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 170.57 -39.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.591 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -80.95 155.99 72.52 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.104 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.86 78.51 2.47 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 122.128 1.885 . . . . 0.0 111.163 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.09 99.4 0.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.07 92.92 5.06 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.6 m -111.71 98.93 43.15 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.115 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.9 169.45 13.26 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 121.97 1.78 . . . . 0.0 110.452 168.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -83.69 25.51 0.77 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.352 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -63.95 134.85 55.85 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.644 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.22 136.66 34.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 125.501 1.75 . . . . 0.0 110.887 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -129.82 81.0 70.31 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 124.054 0.846 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -54.96 -27.92 56.67 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 122.189 1.926 . . . . 0.0 113.238 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.475 HH21 ' HG ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -59.36 -46.9 87.36 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mt -64.77 148.46 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.97 -42.13 2.97 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.209 -1.814 . . . . 0.0 108.604 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -173.7 -168.74 0.45 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.638 1.211 . . . . 0.0 109.676 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.11 113.8 1.92 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 mm -79.5 111.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.6 m -102.71 157.44 33.72 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 123.557 0.536 . . . . 0.0 110.459 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.486 1.073 0 C-N-CA 121.909 1.739 . . . . 0.0 108.094 173.091 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.4 mmt-85 . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 tp -72.72 89.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.599 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -97.05 55.8 1.34 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.693 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.429 ' HG1' ' H ' ' A' ' 6' ' ' ASN . 9.7 t -87.72 179.49 6.49 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.507 -1.678 . . . . 0.0 107.993 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.429 ' H ' ' HG1' ' A' ' 5' ' ' THR . 51.1 p-10 -160.27 -171.19 3.09 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 t -98.73 -30.95 12.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.043 0.84 . . . . 0.0 111.944 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.2 t -67.18 -60.82 2.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 123.995 0.81 . . . . 0.0 109.761 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.19 63.86 8.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 125.119 1.512 . . . . 0.0 108.772 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.65 -136.35 7.74 Favored Glycine 0 N--CA 1.491 2.348 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.812 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -144.25 108.63 4.83 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.86 94.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.346 1.029 . . . . 0.0 111.888 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.01 -26.2 2.5 Favored Glycine 0 N--CA 1.495 2.582 0 CA-C-N 113.754 -1.566 . . . . 0.0 113.169 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.7 m -87.66 158.88 18.73 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.005 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -116.18 95.66 5.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.515 1.134 . . . . 0.0 109.834 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -52.27 129.8 29.08 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.927 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.88 158.99 43.6 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.521 0.677 . . . . 0.0 111.76 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -107.38 132.71 52.86 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.473 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -44.58 -24.39 0.19 Allowed 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 112.887 -1.96 . . . . 0.0 114.997 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -54.42 -27.67 38.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.07 0.856 . . . . 0.0 111.45 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.06 32.84 1.77 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.6 m -144.93 140.78 28.5 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.505 0.669 . . . . 0.0 111.539 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.16 159.52 28.77 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.754 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.3 t -127.68 -46.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.72 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -167.38 -173.96 2.41 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.838 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.72 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -128.15 124.81 37.8 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.23 117.87 12.74 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 107.481 -2.248 . . . . 0.0 107.481 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.63 13.79 24.95 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.35 109.89 20.98 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.408 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.41 132.45 62.29 Favored Pre-proline 0 N--CA 1.494 1.725 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.21 75.66 0.48 Allowed 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.859 1.706 . . . . 0.0 110.149 173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 164.58 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.96 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -90.43 144.64 31.1 Favored Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.478 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.12 69.01 8.1 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.513 2.142 . . . . 0.0 111.309 168.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -71.08 89.41 0.82 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.91 121.63 25.67 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.715 -1.129 . . . . 0.0 113.675 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.4 m -160.42 162.47 23.51 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.079 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.62 159.77 35.31 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.692 1.594 . . . . 0.0 110.682 165.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.5 ttm105 -87.31 63.3 7.68 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -57.36 149.98 19.31 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.601 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.7 m -109.97 128.72 55.56 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.1 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -123.66 75.51 55.26 Favored Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 124.059 0.849 . . . . 0.0 113.202 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.07 -21.47 65.58 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.485 2.123 . . . . 0.0 112.068 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -63.73 -39.07 93.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.039 0.837 . . . . 0.0 110.009 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -69.29 154.31 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.42 1.075 . . . . 0.0 109.537 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.25 -44.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.354 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.49 -177.6 6.32 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 124.308 1.005 . . . . 0.0 110.212 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.68 110.57 1.26 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 107.169 -2.372 . . . . 0.0 107.169 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.1 mt -79.07 90.6 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -92.51 149.71 38.65 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.921 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.374 0 C-N-CA 122.206 1.938 . . . . 0.0 112.35 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 . . . . . 0 N--CA 1.497 1.908 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 tp -69.31 87.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 124.22 0.95 . . . . 0.0 109.863 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.68 37.55 1.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.552 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 p -89.03 171.95 9.47 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 113.727 -1.578 . . . . 0.0 107.385 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -158.0 155.71 29.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.142 0.901 . . . . 0.0 111.883 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.42 -16.66 38.11 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.96 -1.473 . . . . 0.0 112.284 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -90.25 -69.27 0.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.472 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.82 58.85 3.97 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.94 -83.77 1.21 Allowed Glycine 0 N--CA 1.497 2.749 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.909 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.24 111.78 0.16 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.83 119.72 4.14 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.072 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.9 -31.11 7.25 Favored Glycine 0 N--CA 1.495 2.63 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.416 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -90.06 120.56 31.35 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.766 -1.173 . . . . 0.0 111.124 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -67.53 100.11 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.371 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.533 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 91.8 m-85 -48.96 131.03 18.84 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.29 156.37 42.45 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 122.147 0.975 . . . . 0.0 110.985 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.4 t -107.19 130.08 54.77 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 112.438 -2.165 . . . . 0.0 110.704 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -39.04 -28.83 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 118.402 2.741 . . . . 0.0 118.402 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.43 -28.59 65.39 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.521 -0.872 . . . . 0.0 112.37 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.93 35.01 0.75 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 m -142.93 140.21 31.05 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.668 0.747 . . . . 0.0 111.845 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -70.63 153.37 42.92 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.081 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t -115.52 -57.91 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.114 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.533 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -162.08 -178.66 6.55 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 123.523 0.514 . . . . 0.0 110.717 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -97.42 138.62 34.59 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.525 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -54.47 113.8 3.75 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.14 -23.46 5.35 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.65 98.49 0.52 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 118.9 0.773 . . . . 0.0 111.504 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.73 127.23 30.63 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.482 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.53 -22.65 44.0 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.453 2.102 . . . . 0.0 113.772 -168.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.02 -41.71 18.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 123.895 0.747 . . . . 0.0 110.511 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.33 147.39 87.59 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -73.2 77.87 2.36 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.184 1.922 . . . . 0.0 110.607 174.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 81.43 2.29 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.045 0.926 . . . . 0.0 109.184 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.53 127.93 32.75 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.518 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -147.95 148.93 31.52 Favored Pre-proline 0 N--CA 1.495 1.783 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.07 161.26 37.82 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.818 1.679 . . . . 0.0 109.735 165.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -86.54 61.81 7.04 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.25 1.024 . . . . 0.0 109.367 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -76.69 -177.88 4.49 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.258 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 93.8 m -146.77 122.61 10.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -112.74 83.15 5.51 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 123.775 0.672 . . . . 0.0 112.724 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -51.95 -31.44 43.55 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.573 2.182 . . . . 0.0 112.213 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -59.88 -50.69 72.79 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 124.406 1.066 . . . . 0.0 108.477 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.02 148.1 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.031 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.64 -43.19 2.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 124.527 1.142 . . . . 0.0 108.021 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -173.06 -167.75 0.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.719 1.262 . . . . 0.0 109.308 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.81 121.06 4.02 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.5 mt -83.0 95.03 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 123.947 0.44 . . . . 0.0 111.607 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 m -82.57 145.56 51.42 Favored Pre-proline 0 N--CA 1.503 2.2 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 C-N-CA 122.274 1.983 . . . . 0.0 110.77 177.216 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tp -56.73 119.45 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.122 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -124.49 47.33 2.12 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.58 140.48 29.51 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 40' ' ' ASN . 14.6 p-10 -160.35 163.04 33.55 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 124.028 0.83 . . . . 0.0 111.052 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.447 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 10.1 t -60.81 -16.8 44.75 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.437 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 1.9 t -91.55 -43.87 9.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.419 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -88.59 43.66 1.15 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -102.45 -118.18 4.39 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.066 -1.064 . . . . 0.0 114.056 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.5 m -160.6 126.4 3.97 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.86 103.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 123.706 0.629 . . . . 0.0 109.575 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.411 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 132.41 -25.31 3.84 Favored Glycine 0 N--CA 1.498 2.777 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.776 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.8 m -88.25 122.97 32.39 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 117.362 0.581 . . . . 0.0 110.174 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -76.75 99.43 5.11 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.491 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.59 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 82.7 m-85 -54.95 127.98 31.34 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.09 157.74 44.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.197 0.999 . . . . 0.0 110.839 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.8 t -103.99 131.32 51.36 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 112.592 -2.094 . . . . 0.0 110.97 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -44.55 -24.87 0.22 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 125.519 1.762 . . . . 0.0 114.892 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -58.2 -20.95 45.47 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.766 0.666 . . . . 0.0 112.469 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.08 33.27 2.82 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.3 m -139.82 136.2 33.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.122 0.542 . . . . 0.0 112.119 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -70.89 148.66 47.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t -111.88 -50.88 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 123.779 0.674 . . . . 0.0 110.583 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.59 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -168.48 173.3 7.62 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 123.823 0.702 . . . . 0.0 109.778 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -96.99 152.19 18.97 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.624 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.454 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -48.02 118.46 4.46 Favored Glycine 0 N--CA 1.507 3.378 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -132.53 39.78 3.34 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.3 t -162.82 94.93 0.87 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.521 ' H ' HD22 ' A' ' 33' ' ' ASN . 16.3 t70 -79.23 133.16 61.03 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -60.94 86.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 121.916 1.744 . . . . 0.0 109.419 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.62 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.219 -1.809 . . . . 0.0 106.961 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.521 HD22 ' H ' ' A' ' 30' ' ' ASP . 1.8 p30 -90.76 135.49 28.93 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 124.154 0.909 . . . . 0.0 109.307 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -75.08 66.62 6.09 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.185 1.923 . . . . 0.0 109.439 167.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -53.03 127.36 23.7 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.81 135.8 37.17 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.371 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.3 m -145.74 155.89 52.29 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 124.526 1.141 . . . . 0.0 111.944 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.91 -46.07 3.64 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 122.193 1.929 . . . . 0.0 112.26 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -158.15 -2.0 0.09 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.509 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 58.1 m-20 51.79 48.32 23.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.002 0.814 . . . . 0.0 113.111 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 98.1 m -153.41 131.41 11.78 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.186 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -157.98 101.35 1.77 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 123.938 0.774 . . . . 0.0 110.93 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.59 -18.6 60.86 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 122.02 1.814 . . . . 0.0 112.652 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 ttm105 -66.53 -33.12 74.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 123.651 0.594 . . . . 0.0 110.351 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.74 157.11 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.03 -46.49 3.0 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.01 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -172.47 -172.93 0.97 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.327 1.017 . . . . 0.0 109.683 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -121.06 118.01 3.66 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.2 mm -79.03 95.47 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.54 142.35 29.41 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.291 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo . . . . . 0 N--CA 1.489 1.219 0 C-N-CA 122.062 1.841 . . . . 0.0 111.525 177.288 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.5 tp -60.67 125.36 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 123.992 0.808 . . . . 0.0 110.517 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.13 47.59 2.46 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.23 143.95 36.68 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.42 HD21 ' H ' ' A' ' 8' ' ' CYS . 3.8 t30 -150.76 178.13 9.42 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.491 1.139 . . . . 0.0 113.35 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.0 t -94.48 -45.02 7.61 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.262 -2.245 . . . . 0.0 108.589 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.42 ' H ' HD21 ' A' ' 6' ' ' ASN . 37.5 t -60.24 -56.57 19.91 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.03 41.48 1.03 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.454 -1.703 . . . . 0.0 108.856 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.428 ' N ' ' HB3' ' A' ' 29' ' ' SER . . . -78.7 -155.91 9.05 Favored Glycine 0 N--CA 1.491 2.348 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.518 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.446 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.1 m -141.02 96.17 2.96 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 115.697 -0.252 . . . . 0.0 110.566 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -26.05 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 124.86 -34.89 3.3 Favored Glycine 0 N--CA 1.501 3.03 0 CA-C-N 114.932 -1.031 . . . . 0.0 114.822 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.3 m -84.4 120.61 26.48 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 101.7 5.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.375 1.047 . . . . 0.0 110.746 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -58.99 122.57 14.04 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.65 157.47 46.56 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.404 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 t -103.18 130.61 50.43 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.64 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -46.2 -20.32 0.1 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 113.168 -1.833 . . . . 0.0 114.903 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -55.27 -28.65 54.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 123.638 0.586 . . . . 0.0 110.747 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.24 30.95 1.79 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.8 m -144.94 142.61 29.99 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.816 0.817 . . . . 0.0 112.09 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -69.35 149.69 48.15 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.808 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.5 t -112.38 -52.77 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 123.783 0.677 . . . . 0.0 110.986 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -168.21 176.9 5.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.083 0.864 . . . . 0.0 110.528 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.634 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -99.91 123.36 44.08 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -59.52 103.39 0.41 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -93.7 -8.23 41.45 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 118.075 2.62 . . . . 0.0 118.075 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.428 ' HB3' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -79.37 131.71 36.19 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.574 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.53 134.58 23.17 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.5 -27.5 19.08 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.034 1.823 . . . . 0.0 112.712 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -85.9 -34.17 21.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.957 0.786 . . . . 0.0 112.805 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -90.14 152.88 46.52 Favored Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.791 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -79.85 51.93 4.09 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.1 2.533 . . . . 0.0 112.978 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -74.05 94.65 2.42 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.795 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.48 155.57 48.31 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.765 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.3 m -145.05 160.44 46.31 Favored Pre-proline 0 N--CA 1.499 1.989 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.11 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.02 -13.03 17.24 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.872 1.715 . . . . 0.0 113.241 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.12 75.32 1.44 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 124.035 0.834 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -104.48 42.44 1.2 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.605 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.0 m -147.52 134.54 20.32 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.132 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -159.05 98.8 1.63 Allowed Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.24 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.22 -17.47 32.7 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.585 2.19 . . . . 0.0 113.677 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.6 ttp-105 -61.06 -35.28 76.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 123.705 0.628 . . . . 0.0 110.949 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -77.54 155.18 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.714 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.17 -41.44 1.77 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 112.414 -2.176 . . . . 0.0 110.064 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.17 177.94 10.0 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 124.162 0.913 . . . . 0.0 110.909 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.63 108.18 1.15 Allowed Glycine 0 N--CA 1.495 2.605 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.41 93.98 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.47 148.39 38.72 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-N 114.843 -1.072 . . . . 0.0 108.752 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo . . . . . 0 N--CA 1.488 1.201 0 C-N-CA 121.806 1.671 . . . . 0.0 110.32 176.65 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 120.908 0.385 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 tp -86.42 49.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.643 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.4 45.45 1.12 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.668 1.223 . . . . 0.0 112.504 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.14 170.1 14.17 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 113.056 -1.884 . . . . 0.0 108.146 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -160.58 145.23 14.25 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.201 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.488 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 1.7 t -55.9 -19.9 13.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.554 1.159 . . . . 0.0 113.329 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -73.71 -67.82 0.56 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.182 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.45 -86.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA3' ' CE2' ' A' ' 16' ' ' TYR . . . 33.22 -108.04 0.03 OUTLIER Glycine 0 N--CA 1.506 3.363 0 N-CA-C 115.208 0.843 . . . . 0.0 115.208 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 177.28 121.74 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 124.912 1.007 . . . . 0.0 109.251 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.27 104.7 0.15 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 123.965 0.79 . . . . 0.0 109.863 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.02 -30.09 2.38 Favored Glycine 0 N--CA 1.491 2.313 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.076 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.45 125.57 41.03 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -82.74 113.81 20.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.345 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.603 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 92.2 m-85 -55.73 131.32 46.37 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.64 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.71 155.41 42.39 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.067 0.937 . . . . 0.0 111.204 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.5 t -107.92 133.51 52.15 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 112.683 -2.053 . . . . 0.0 112.851 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -38.96 -31.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 111.245 -2.707 . . . . 0.0 118.053 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.21 -28.15 66.39 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.362 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.82 37.17 0.68 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 m -144.56 142.06 29.92 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -69.89 152.12 44.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.677 -1.147 . . . . 0.0 107.951 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.7 -47.43 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 123.835 0.709 . . . . 0.0 110.541 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.603 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.04 -176.85 2.74 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 123.703 0.627 . . . . 0.0 110.683 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.5 mm-40 -111.15 147.54 34.69 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.52 113.7 1.91 Allowed Glycine 0 N--CA 1.491 2.33 0 O-C-N 125.652 1.845 . . . . 0.0 109.303 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -108.22 -37.21 6.08 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 t -77.9 95.48 4.77 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.46 ' H ' HD22 ' A' ' 33' ' ' ASN . 16.5 t70 -85.55 123.06 73.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.98 86.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.326 2.017 . . . . 0.0 111.628 -167.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 30' ' ' ASP . 4.6 mtm-85 169.41 -34.89 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.671 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.46 HD22 ' H ' ' A' ' 30' ' ' ASP . 55.7 p30 -87.91 152.33 50.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 123.958 0.786 . . . . 0.0 112.62 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -79.52 42.64 1.34 Allowed 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 123.301 2.668 . . . . 0.0 112.929 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.96 38.16 1.25 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.55 132.36 56.21 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.255 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.457 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 4.5 m -137.06 68.99 57.12 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.96 -21.49 41.6 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.193 1.929 . . . . 0.0 112.338 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -83.37 19.9 1.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.791 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -118.93 118.33 31.23 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.741 0.651 . . . . 0.0 109.805 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.7 m -105.89 129.05 54.12 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.53 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -130.97 78.81 72.76 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 123.86 0.725 . . . . 0.0 110.938 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.42 -22.19 57.45 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.086 1.857 . . . . 0.0 113.78 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -43.12 83.44 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.15 155.92 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.16 -43.18 2.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.099 0.875 . . . . 0.0 109.408 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -175.64 -165.07 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.36 1.038 . . . . 0.0 109.264 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -128.35 119.26 3.03 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.4 mm -79.0 110.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -99.3 151.52 37.45 Favored Pre-proline 0 N--CA 1.495 1.818 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.89 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.486 1.049 0 C-N-CA 121.944 1.763 . . . . 0.0 109.323 168.502 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.798 0.809 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.3 mm -76.14 89.65 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.94 27.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.03 164.78 13.84 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -160.87 150.6 17.32 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.585 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.3 t -65.37 -21.5 66.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.753 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -77.76 -68.6 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.162 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.32 52.8 2.31 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.556 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.74 -121.76 0.18 Allowed Glycine 0 N--CA 1.491 2.336 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.809 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.416 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -158.88 103.0 1.68 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -42.46 105.42 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.18 -30.06 4.42 Favored Glycine 0 N--CA 1.496 2.651 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.832 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.6 m -82.4 157.2 23.8 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.908 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -111.73 95.35 5.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.258 0.974 . . . . 0.0 111.703 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.6 129.0 34.84 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.639 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.12 160.39 41.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.024 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.4 t -109.6 129.8 55.56 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.408 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -42.95 -24.35 0.06 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 112.962 -1.926 . . . . 0.0 115.366 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -53.24 -30.69 39.53 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.876 0.735 . . . . 0.0 111.292 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.16 31.78 1.25 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -144.86 144.43 31.11 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.759 0.79 . . . . 0.0 111.92 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -71.19 154.37 41.74 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.325 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.4 t -118.56 -52.43 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 123.613 0.57 . . . . 0.0 111.229 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -173.34 -169.51 0.53 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.027 0.829 . . . . 0.0 109.443 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.68 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -124.78 134.72 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -51.9 111.39 1.44 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.32 11.72 37.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.61 0.83 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.9 p -77.69 92.45 4.14 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.973 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -82.57 137.8 44.54 Favored Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.547 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.14 77.92 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 122.19 1.927 . . . . 0.0 111.309 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 161.58 -37.24 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.097 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -82.04 143.18 48.96 Favored Pre-proline 0 N--CA 1.498 1.954 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.333 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.97 91.22 0.53 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.847 1.698 . . . . 0.0 108.87 170.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 66.7 3.6 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.031 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.77 135.08 54.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.524 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 2.8 m -153.78 167.77 12.99 Favored Pre-proline 0 N--CA 1.497 1.918 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.083 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -68.99 70.08 1.19 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.073 1.848 . . . . 0.0 109.007 159.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.409 HH11 HH12 ' A' ' 44' ' ' ARG . 4.6 tpm_? -160.41 73.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -107.01 114.03 27.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.565 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.8 m 59.64 108.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 124.967 1.417 . . . . 0.0 111.615 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.15 88.31 5.65 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -47.1 -35.2 18.76 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 123.375 2.717 . . . . 0.0 114.434 170.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.409 HH12 HH11 ' A' ' 39' ' ' ARG . 0.5 OUTLIER -56.28 -43.74 79.11 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 124.223 0.952 . . . . 0.0 110.211 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 mt -75.41 161.43 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.782 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.71 -44.6 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.0 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -173.52 -169.76 0.54 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 124.303 1.002 . . . . 0.0 109.754 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.84 117.07 2.92 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.8 mm -78.86 95.15 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.5 m -85.19 133.32 43.0 Favored Pre-proline 0 N--CA 1.493 1.713 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.301 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.488 1.151 0 C-N-CA 122.133 1.889 . . . . 0.0 110.522 178.02 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.028 0.442 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.4 tp -89.99 38.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.646 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.8 m -94.21 43.15 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.985 -1.461 . . . . 0.0 112.299 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.72 176.01 7.6 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.675 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -158.86 141.17 14.0 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.469 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -65.28 -24.99 67.45 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.58 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -63.64 -54.2 39.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 124.249 0.968 . . . . 0.0 112.056 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.82 -77.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 113.811 -1.541 . . . . 0.0 115.135 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.43 -98.32 0.01 OUTLIER Glycine 0 N--CA 1.501 2.971 0 N-CA-C 115.433 0.933 . . . . 0.0 115.433 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.628 ' H ' ' HH ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER 179.46 119.41 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 O-C-N 124.509 0.77 . . . . 0.0 111.575 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.23 130.25 8.02 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 123.669 0.605 . . . . 0.0 111.514 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.68 -29.66 10.65 Favored Glycine 0 N--CA 1.493 2.49 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.58 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.9 m -80.21 121.46 25.63 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.33 107.2 11.92 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.584 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.628 ' HH ' ' H ' ' A' ' 11' ' ' THR . 95.5 m-85 -58.43 129.01 40.02 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.76 156.99 43.96 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 124.229 0.956 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 t -106.04 136.05 46.42 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.572 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -47.06 -23.48 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 112.074 -2.33 . . . . 0.0 113.503 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -58.11 -19.85 35.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 123.798 0.686 . . . . 0.0 111.849 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.66 33.24 3.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.6 m -143.88 139.93 29.49 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.687 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -68.65 154.93 41.01 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.443 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.25 -53.39 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.126 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -161.96 -178.32 6.37 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 123.567 0.542 . . . . 0.0 110.927 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.419 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 17.0 mm-40 -112.63 150.75 30.99 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.02 110.45 0.35 Allowed Glycine 0 N--CA 1.499 2.861 0 O-C-N 125.779 1.924 . . . . 0.0 112.459 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 -42.75 7.32 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 118.39 2.737 . . . . 0.0 118.39 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 t -57.86 102.81 0.11 Allowed 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 119.756 1.162 . . . . 0.0 113.883 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.55 139.9 22.98 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 124.931 1.395 . . . . 0.0 107.45 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -45.75 -30.61 6.75 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.627 2.218 . . . . 0.0 115.942 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -65.21 -36.93 85.69 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.634 HD21 ' H ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -81.61 142.49 49.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 119.226 -0.989 . . . . 0.0 108.561 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -75.52 40.52 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.147 1.898 . . . . 0.0 110.933 166.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.634 ' H ' HD21 ' A' ' 33' ' ' ASN . 2.6 mptp? 48.81 71.6 0.36 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.633 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.32 86.36 5.07 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.302 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.1 m -153.66 141.54 13.81 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.99 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.53 -166.28 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 121.936 1.757 . . . . 0.0 110.753 168.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -79.54 -76.56 0.21 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 m120 50.5 86.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 124.62 1.2 . . . . 0.0 113.052 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.8 m -66.95 128.37 36.09 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -113.71 80.97 5.32 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.59 -30.63 83.87 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 122.367 2.045 . . . . 0.0 112.603 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -44.58 96.84 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.49 144.3 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.21 -46.74 3.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.959 0.787 . . . . 0.0 109.22 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -173.21 -170.08 0.6 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.118 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -127.73 115.22 2.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.6 mm -79.4 110.55 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.23 160.53 28.02 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.487 1.116 0 C-N-CA 121.633 1.556 . . . . 0.0 108.961 173.837 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 tp -79.19 76.23 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.322 1.058 . . . . 0.0 108.711 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.1 m -90.32 36.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.218 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.24 -171.55 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.727 -2.033 . . . . 0.0 106.843 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -160.4 167.8 26.57 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.406 1.066 . . . . 0.0 111.122 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -61.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.344 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -59.69 5.06 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.101 -1.408 . . . . 0.0 109.013 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.05 31.8 0.21 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.137 -2.301 . . . . 0.0 111.351 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.03 -130.09 0.65 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -142.58 109.64 5.56 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 123.97 0.453 . . . . 0.0 111.294 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -48.37 106.61 0.1 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.443 1.089 . . . . 0.0 111.225 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.28 -27.23 4.27 Favored Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.567 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.4 m -110.29 134.45 52.26 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.919 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -80.2 101.15 8.66 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.529 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -62.42 119.24 8.74 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.96 158.68 38.88 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.222 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 t -103.59 129.76 50.91 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.323 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -46.0 -20.84 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 125.855 1.972 . . . . 0.0 114.765 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -55.17 -29.81 58.58 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 123.859 0.724 . . . . 0.0 110.785 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.55 31.57 1.48 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.8 m -144.03 140.68 29.69 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.732 0.777 . . . . 0.0 111.574 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -74.49 135.74 42.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.374 -1.284 . . . . 0.0 107.682 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -91.14 -63.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.356 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -176.25 171.91 2.39 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.17 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.3 mt-10 -90.45 150.25 21.89 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 120.174 -0.611 . . . . 0.0 112.433 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.11 124.61 11.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.65 -5.0 15.12 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.8 t -85.39 123.45 30.87 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.545 ' H ' HD22 ' A' ' 33' ' ' ASN . 13.0 t70 -80.11 127.06 78.06 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.85 83.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.93 1.753 . . . . 0.0 110.155 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 30' ' ' ASP . 1.4 mmt-85 176.16 -39.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.966 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.545 HD22 ' H ' ' A' ' 30' ' ' ASP . 14.9 p30 -91.28 148.91 38.76 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 124.167 0.917 . . . . 0.0 110.945 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.14 47.29 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.58 2.187 . . . . 0.0 110.183 162.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -72.88 111.55 8.1 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -155.08 109.12 2.9 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.784 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 2.2 m -79.48 -42.66 1.59 Allowed Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 37' ' ' CYS . 10.0 Cg_endo -72.79 -176.32 2.28 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 C-N-CA 122.42 2.08 . . . . 0.0 110.643 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.11 -1.23 1.77 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.575 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -125.49 -168.02 1.78 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.213 0.946 . . . . 0.0 113.023 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 89.0 m -91.18 152.91 20.37 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.132 -1.395 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -113.8 76.36 3.11 Favored Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 123.652 0.595 . . . . 0.0 110.996 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.66 -26.98 81.58 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.447 2.098 . . . . 0.0 111.423 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 mtm-85 -60.51 -45.09 95.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.22 0.95 . . . . 0.0 109.744 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -66.55 155.36 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 124.347 1.03 . . . . 0.0 108.614 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.34 -45.38 0.83 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.93 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.18 175.02 12.56 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 124.059 0.849 . . . . 0.0 111.16 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.01 108.96 1.63 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.27 90.49 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.25 156.6 59.85 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 N--CA 1.49 1.267 0 C-N-CA 122.116 1.877 . . . . 0.0 110.057 173.196 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tp -70.4 105.11 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.29 26.81 9.49 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -91.32 158.89 16.29 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 112.663 -2.062 . . . . 0.0 106.143 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -140.13 161.53 37.41 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.437 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -57.62 -34.95 69.84 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.124 0.964 . . . . 0.0 109.548 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' SG ' ' C ' ' A' ' 36' ' ' ALA . 8.1 t -75.61 -62.36 1.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.47 67.78 6.63 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 113.854 -1.521 . . . . 0.0 106.912 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.76 -109.45 2.88 Favored Glycine 0 N--CA 1.497 2.723 0 CA-C-N 114.259 -1.337 . . . . 0.0 115.066 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 m -167.07 107.46 0.62 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 124.648 0.852 . . . . 0.0 109.95 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.18 132.19 1.41 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.609 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.46 -24.02 6.81 Favored Glycine 0 N--CA 1.493 2.457 0 CA-C-O 118.603 -1.11 . . . . 0.0 114.473 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.4 m -79.97 127.74 32.63 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.781 1.29 . . . . 0.0 109.921 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -77.76 91.56 4.1 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.523 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 16.4 m-85 -54.48 132.27 44.27 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.52 156.5 43.75 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.721 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.6 t -105.51 128.15 53.41 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 112.295 -2.23 . . . . 0.0 109.775 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -39.16 -27.52 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.71 -29.22 64.52 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.199 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.93 36.27 0.73 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.1 m -141.36 133.78 28.25 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.489 0.662 . . . . 0.0 111.552 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -71.51 147.61 47.57 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.156 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.23 -72.56 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.053 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.523 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -154.57 176.67 12.11 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.73 156.83 16.38 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.506 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -52.23 104.4 0.17 Allowed Glycine 0 N--CA 1.489 2.208 0 CA-C-N 112.909 -1.95 . . . . 0.0 109.657 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.49 -19.59 10.01 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.552 -0.824 . . . . 0.0 112.983 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.65 116.41 11.99 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.174 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.07 122.17 84.11 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -70.76 72.12 1.96 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 123.062 2.508 . . . . 0.0 112.342 -173.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -177.51 -48.02 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -87.5 144.43 35.56 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 124.135 0.897 . . . . 0.0 109.416 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.13 82.46 1.8 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.966 1.777 . . . . 0.0 109.085 167.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -69.39 91.67 0.56 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.482 ' C ' ' SG ' ' A' ' 8' ' ' CYS . . . -109.12 148.06 31.45 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.882 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 m -159.25 -51.24 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.88 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.322 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 18.7 Cg_endo -80.94 -158.66 0.1 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.997 2.465 . . . . 0.0 109.489 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -79.72 -94.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -160.5 135.49 7.75 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.2 m 60.12 126.3 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.716 1.26 . . . . 0.0 114.103 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.81 83.61 11.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.716 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -53.46 -24.8 29.5 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.568 2.178 . . . . 0.0 113.122 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.06 -48.01 79.6 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mt -74.12 150.3 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.932 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.03 -44.52 3.58 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.532 -1.667 . . . . 0.0 107.211 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -171.36 -171.23 0.91 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.718 1.261 . . . . 0.0 109.161 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.45 120.74 3.98 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.91 85.84 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.3 m -80.29 132.49 59.15 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.378 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.201 0 C-N-CA 121.945 1.764 . . . . 0.0 111.707 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tp -86.34 45.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 114.231 -1.349 . . . . 0.0 110.591 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.6 m -87.24 39.91 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.589 1.185 . . . . 0.0 111.495 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -79.76 171.09 15.59 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 112.931 -1.94 . . . . 0.0 107.92 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -157.95 172.94 17.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.53 1.144 . . . . 0.0 111.079 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 t -72.2 -22.86 61.21 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.069 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 9.1 t -74.42 -59.23 2.82 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.111 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.55 62.01 3.82 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.045 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.12 -95.64 1.22 Allowed Glycine 0 N--CA 1.502 3.051 0 N-CA-C 118.513 2.165 . . . . 0.0 118.513 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.505 ' H ' ' HH ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -175.35 113.42 0.13 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 123.827 0.369 . . . . 0.0 111.69 -179.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HA ' ' C ' ' A' ' 27' ' ' GLY . 13.4 ttpt -71.62 93.49 1.24 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.321 1.057 . . . . 0.0 109.005 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.418 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 165.03 -39.26 0.29 Allowed Glycine 0 N--CA 1.485 1.962 0 CA-C-N 112.944 -1.935 . . . . 0.0 108.471 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.2 m -97.36 137.47 36.3 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.571 0.7 . . . . 0.0 112.451 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -85.07 105.17 15.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.64 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.791 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 56.9 m-85 -48.74 128.69 15.86 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.569 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.42 152.22 37.77 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.514 1.149 . . . . 0.0 111.959 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.2 t -104.53 130.37 52.49 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 112.082 -2.326 . . . . 0.0 111.955 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.93 -30.89 0.05 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 119.072 2.989 . . . . 0.0 119.072 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.07 -26.51 66.22 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.839 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.9 37.46 0.71 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 m -141.96 136.91 30.83 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.95 0.881 . . . . 0.0 111.862 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -70.49 150.05 46.56 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.975 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.7 t -112.11 -51.38 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.591 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.791 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -166.43 176.7 7.22 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 123.672 0.608 . . . . 0.0 109.942 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -106.03 142.68 35.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA3' ' H ' ' A' ' 13' ' ' GLY . . . -39.99 111.96 0.26 Allowed Glycine 0 N--CA 1.5 2.916 0 O-C-N 125.131 1.52 . . . . 0.0 111.434 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -126.31 -21.18 4.28 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' A' ' 11' ' ' THR . 15.2 m -65.71 84.4 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -83.03 133.86 47.46 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -50.76 -31.08 31.58 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.027 1.818 . . . . 0.0 112.937 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -75.06 -40.79 59.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 123.943 0.777 . . . . 0.0 110.713 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -83.18 150.7 61.59 Favored Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.593 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.83 90.7 0.36 Allowed 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.165 1.91 . . . . 0.0 110.952 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 66.02 8.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.837 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.36 123.58 4.37 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.87 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.7 m -146.72 67.96 11.59 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.95 112.26 1.61 Allowed 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 121.972 1.782 . . . . 0.0 111.033 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -160.54 -37.02 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 123.79 0.681 . . . . 0.0 112.51 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -142.76 175.79 9.55 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.853 0.721 . . . . 0.0 112.075 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 68.7 m -119.8 145.48 46.56 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.569 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -118.09 70.48 7.97 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.86 -23.41 76.78 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 C-N-CA 122.192 1.928 . . . . 0.0 112.217 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -42.62 99.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 124.405 1.066 . . . . 0.0 110.581 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tt -60.04 148.79 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.281 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.52 -40.37 3.06 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.035 -1.439 . . . . 0.0 107.678 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -174.46 -165.04 0.2 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.797 1.311 . . . . 0.0 109.102 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.39 122.93 4.78 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -79.12 102.85 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.2 m -91.06 125.32 59.06 Favored Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.097 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo . . . . . 0 N--CA 1.488 1.191 0 C-N-CA 122.03 1.82 . . . . 0.0 110.911 177.495 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 . . . . . 0 N--CA 1.502 2.126 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 tp -87.59 60.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 122.409 1.099 . . . . 0.0 109.487 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.98 52.53 2.5 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.654 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.35 166.6 23.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.248 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -161.04 148.83 15.59 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.459 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -7.38 5.3 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.121 -1.399 . . . . 0.0 113.714 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 4.4 t -78.58 -63.31 1.44 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.97 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.2 -79.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 37.31 -103.51 0.02 OUTLIER Glycine 0 N--CA 1.503 3.112 0 O-C-N 123.658 0.599 . . . . 0.0 113.675 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -179.25 118.45 0.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -45.48 115.48 0.95 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 123.883 0.74 . . . . 0.0 111.509 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.8 -23.26 20.0 Favored Glycine 0 N--CA 1.499 2.835 0 O-C-N 124.393 1.058 . . . . 0.0 114.155 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -79.32 -176.96 5.47 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 118.014 0.907 . . . . 0.0 109.607 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -137.46 104.18 5.28 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.164 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.503 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 63.6 m-85 -57.82 131.26 49.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.24 154.49 42.44 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.238 1.018 . . . . 0.0 110.684 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 t -106.16 124.77 50.11 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 112.565 -2.107 . . . . 0.0 109.491 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.426 ' H ' ' HB3' ' A' ' 46' ' ' ALA . 20.6 p-10 -39.04 -28.86 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.0 -28.17 64.17 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.218 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.33 35.22 0.72 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.2 m -140.01 135.45 32.7 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.615 0.721 . . . . 0.0 112.498 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -72.97 138.06 45.85 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.83 -52.73 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.422 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -173.03 -174.05 1.02 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 123.622 0.576 . . . . 0.0 111.007 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -114.17 142.6 46.04 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.65 110.06 1.7 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.45 14.02 23.79 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.7 t -145.45 115.65 7.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.556 0.693 . . . . 0.0 110.801 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.554 ' H ' HD22 ' A' ' 33' ' ' ASN . 10.6 t70 -79.68 141.36 55.84 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 113.569 -1.651 . . . . 0.0 106.716 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -44.25 -34.94 7.57 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 122.155 1.903 . . . . 0.0 113.152 173.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 tpp180 -73.98 -39.86 63.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 123.881 0.738 . . . . 0.0 112.593 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.554 HD22 ' H ' ' A' ' 30' ' ' ASP . 27.1 p30 -88.0 143.55 33.32 Favored Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.484 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.88 47.65 2.54 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 123.161 2.574 . . . . 0.0 112.881 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -98.51 27.17 4.95 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.139 0.971 . . . . 0.0 110.139 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.91 157.72 16.21 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.083 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.561 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.3 m -136.91 83.12 29.51 Favored Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.463 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.9 76.41 1.2 Allowed 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.219 1.946 . . . . 0.0 108.859 166.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -160.31 -30.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.644 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -94.96 132.27 39.98 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.985 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.0 m -113.84 131.44 56.25 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.836 1.335 . . . . 0.0 108.489 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -137.58 82.7 26.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 123.736 0.648 . . . . 0.0 111.087 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.51 -28.31 87.15 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.251 1.968 . . . . 0.0 112.751 168.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 mtm105 -64.18 -19.07 65.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.784 0.678 . . . . 0.0 111.91 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.13 144.07 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.426 ' HB3' ' H ' ' A' ' 19' ' ' ASP . . . -103.04 -50.12 3.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.522 1.138 . . . . 0.0 108.46 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -169.44 -173.76 1.77 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.935 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.9 110.6 2.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.3 mm -79.07 102.21 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.8 m -95.45 133.63 25.56 Favored Pre-proline 0 N--CA 1.493 1.724 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.322 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 C-N-CA 122.052 1.834 . . . . 0.0 110.214 174.329 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 50.65 29.5 4.2 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 124.488 1.117 . . . . 0.0 111.643 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.07 136.84 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.985 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -142.71 35.84 1.43 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.246 1.022 . . . . 0.0 111.851 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.32 158.42 26.1 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 113.432 -1.713 . . . . 0.0 107.538 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -147.92 161.81 40.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 124.552 1.158 . . . . 0.0 110.831 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.21 -18.35 35.92 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.765 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 1.1 t -58.61 -59.2 5.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.2 -100.22 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.628 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.37 -99.13 0.56 Allowed Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.383 -0.823 . . . . 0.0 114.634 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 173.82 112.72 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HB2' ' N ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -61.3 107.53 0.78 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 131.2 -19.6 4.85 Favored Glycine 0 N--CA 1.493 2.441 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.3 m -103.65 143.34 32.9 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.019 0.437 . . . . 0.0 111.353 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -89.3 96.35 10.68 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.546 ' CZ ' ' HA2' ' A' ' 27' ' ' GLY . 3.5 m-85 -55.54 127.85 31.71 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.033 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.55 158.57 43.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.143 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 t -109.21 128.2 54.85 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 113.316 -1.766 . . . . 0.0 110.918 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -41.89 -24.13 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 112.636 -2.075 . . . . 0.0 114.86 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -53.03 -31.94 44.03 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.923 0.764 . . . . 0.0 111.237 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.98 31.31 1.21 Allowed Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 m -143.88 143.31 31.23 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.869 0.842 . . . . 0.0 111.755 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -72.61 144.98 47.64 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.584 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.6 t -102.19 -54.93 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.173 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.485 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -174.59 168.27 3.77 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 123.992 0.808 . . . . 0.0 110.036 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -90.07 156.39 18.41 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.546 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -47.57 115.03 1.96 Allowed Glycine 0 N--CA 1.494 2.566 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.84 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -12.98 4.51 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 t -142.96 120.81 11.95 Favored 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 118.86 0.755 . . . . 0.0 110.659 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' N ' ' HB2' ' A' ' 12' ' ' LYS . 5.5 t70 -79.6 143.01 58.23 Favored Pre-proline 0 N--CA 1.49 1.545 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.091 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.19 -33.68 55.55 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.699 1.599 . . . . 0.0 111.87 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.57 -29.76 41.42 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.789 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -89.72 138.78 27.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.05 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -74.83 79.95 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.647 2.232 . . . . 0.0 110.331 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -138.68 38.58 2.21 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.857 0.837 . . . . 0.0 109.84 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.46 164.61 11.74 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 113.984 -1.462 . . . . 0.0 111.683 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.538 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.9 m -142.66 79.53 15.04 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.29 78.9 1.49 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.362 2.041 . . . . 0.0 110.026 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -149.09 -54.32 0.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.027 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -76.54 174.4 10.38 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.711 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.5 m -148.78 122.94 9.52 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.781 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -117.26 78.02 10.18 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 124.113 0.883 . . . . 0.0 112.569 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.4 -19.99 38.13 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.192 1.928 . . . . 0.0 113.478 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -71.08 -40.63 71.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 123.742 0.651 . . . . 0.0 110.912 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 tt -54.82 148.32 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 123.679 0.612 . . . . 0.0 110.421 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.11 -40.55 1.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 124.172 0.92 . . . . 0.0 110.598 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -172.92 -172.06 0.81 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.154 0.909 . . . . 0.0 109.985 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.43 116.33 3.0 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.9 mm -79.1 90.82 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.64 154.8 68.56 Favored Pre-proline 0 N--CA 1.493 1.675 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.536 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.56 -29.66 89.01 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.076 1.851 . . . . 0.0 110.446 173.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.76 -32.27 35.6 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.888 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 116.266 -1.826 . . . . 0.0 109.325 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.048 0.452 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.51 -28.02 1.02 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.049 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 tp -84.74 61.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.06 36.35 0.77 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 114.336 -1.302 . . . . 0.0 113.089 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -90.71 174.2 7.61 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.345 -1.752 . . . . 0.0 108.749 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -161.44 166.0 27.93 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 124.217 0.948 . . . . 0.0 111.129 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.1 t -57.73 -9.84 1.39 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.567 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.4 t -89.09 -64.75 1.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.287 -1.324 . . . . 0.0 113.665 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.75 73.44 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 120.104 3.372 . . . . 0.0 120.104 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -20.93 -105.0 0.0 OUTLIER Glycine 0 N--CA 1.514 3.869 0 N-CA-C 119.398 2.519 . . . . 0.0 119.398 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -178.24 114.77 0.07 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 123.747 0.322 . . . . 0.0 111.681 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -45.16 111.93 0.38 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 124.19 0.931 . . . . 0.0 110.388 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.25 -35.7 2.77 Favored Glycine 0 N--CA 1.494 2.53 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.771 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.5 m -79.34 -178.38 6.21 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -137.71 106.8 6.01 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.594 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.536 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 61.7 m-85 -56.85 129.73 42.7 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.392 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.45 157.13 44.07 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.198 0.999 . . . . 0.0 111.294 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.8 t -109.04 126.15 52.84 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.175 -1.829 . . . . 0.0 110.866 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -38.49 -33.08 0.09 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.03 -26.67 60.71 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.917 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.92 34.71 0.72 Allowed Glycine 0 N--CA 1.493 2.499 0 O-C-N 124.233 0.958 . . . . 0.0 111.777 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.4 m -141.49 137.58 32.19 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.657 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -71.92 140.18 49.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.7 -51.96 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 123.723 0.639 . . . . 0.0 111.152 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.27 178.97 4.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 123.81 0.694 . . . . 0.0 110.839 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -104.44 150.05 24.89 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.55 111.77 1.54 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -118.22 -15.18 9.82 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.414 ' HG ' ' N ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -66.74 105.32 1.53 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.47 129.63 46.53 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 124.233 0.958 . . . . 0.0 109.341 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -73.63 60.02 4.2 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.489 2.126 . . . . 0.0 111.731 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.82 -27.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.43 155.07 46.53 Favored Pre-proline 0 N--CA 1.498 1.961 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.415 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -75.76 72.99 4.9 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.342 2.028 . . . . 0.0 111.065 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.19 98.51 0.11 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.225 0.536 . . . . 0.0 110.121 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.59 131.61 36.05 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.913 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.79 79.83 10.31 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 124.428 1.08 . . . . 0.0 112.311 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.82 0.58 6.23 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.685 2.256 . . . . 0.0 111.748 168.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -25.3 41.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.736 0.648 . . . . 0.0 110.819 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 54.45 -160.15 0.16 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.157 0.911 . . . . 0.0 111.59 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.3 m -55.4 127.69 30.75 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.704 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -127.24 75.16 77.15 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 124.055 0.847 . . . . 0.0 112.056 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.67 -18.48 33.43 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.962 1.775 . . . . 0.0 112.617 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ttp-105 -59.29 -44.97 92.45 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mt -68.56 154.01 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.36 -46.6 3.53 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.627 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -172.44 -173.4 1.04 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.524 1.14 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.56 115.69 3.09 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.4 mm -78.8 104.65 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 36.6 m -93.51 122.65 62.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.489 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.1 -61.24 0.16 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.762 1.641 . . . . 0.0 108.77 172.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.66 -51.3 1.94 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.898 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.715 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 54.9 mtt85 -136.78 -54.14 0.72 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.7 tp -72.29 84.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 124.73 1.269 . . . . 0.0 107.625 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -92.89 47.47 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.385 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 p -89.83 176.66 6.74 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.743 -1.571 . . . . 0.0 108.441 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -157.77 154.65 28.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.168 0.918 . . . . 0.0 113.309 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 t -61.07 -31.25 70.92 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.778 -2.01 . . . . 0.0 112.418 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.7 t -63.33 -56.3 17.5 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.376 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.74 27.63 0.62 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 113.895 -1.502 . . . . 0.0 112.571 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.66 -135.71 0.06 OUTLIER Glycine 0 N--CA 1.497 2.731 0 O-C-N 124.129 0.893 . . . . 0.0 113.722 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.416 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 10.9 p -149.96 114.71 5.31 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 123.92 0.424 . . . . 0.0 112.052 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.12 103.46 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.821 0.701 . . . . 0.0 112.35 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.87 -31.72 3.64 Favored Glycine 0 N--CA 1.496 2.655 0 CA-C-N 114.336 -1.302 . . . . 0.0 113.86 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.9 m -85.91 158.77 19.84 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.968 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -112.31 91.68 3.74 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.471 1.107 . . . . 0.0 108.904 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -57.54 124.93 20.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.451 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.14 157.26 46.26 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.517 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.7 p -101.8 130.18 48.17 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.314 -1.766 . . . . 0.0 111.941 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -38.73 -32.27 0.08 Allowed 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -57.31 -28.76 63.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 123.687 0.617 . . . . 0.0 112.1 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.1 34.28 0.79 Allowed Glycine 0 N--CA 1.492 2.408 0 O-C-N 124.156 0.91 . . . . 0.0 111.0 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.2 m -140.43 137.46 33.97 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.19 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -70.81 142.84 51.29 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.39 -49.87 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 123.649 0.593 . . . . 0.0 110.481 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -175.74 -178.97 1.14 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.102 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -114.31 128.04 56.16 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -50.1 112.55 1.53 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 1.28 54.8 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.4 m -64.37 102.86 0.58 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.354 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.2 136.33 57.22 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 124.651 1.22 . . . . 0.0 112.104 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -67.39 87.46 0.33 Allowed 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 122.495 2.13 . . . . 0.0 110.002 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mtm105 166.85 -46.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.628 -1.623 . . . . 0.0 106.881 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -86.46 132.49 42.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.11 65.3 7.85 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.51 2.14 . . . . 0.0 110.621 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt 26.6 86.61 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 O-C-N 124.503 1.127 . . . . 0.0 113.806 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.04 87.91 4.81 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.619 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.0 m -148.86 147.88 25.73 Favored Pre-proline 0 N--CA 1.496 1.842 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.355 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.89 -75.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.167 0 C-N-CA 121.591 1.527 . . . . 0.0 109.683 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -161.15 -64.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.8 m120 56.54 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 125.411 1.694 . . . . 0.0 112.898 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.2 m -94.02 125.75 38.83 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.113 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -123.57 77.0 55.32 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 124.021 0.826 . . . . 0.0 110.725 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.91 -30.32 57.77 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 122.309 2.006 . . . . 0.0 112.707 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -64.24 -43.75 93.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.162 0.914 . . . . 0.0 111.332 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.88 137.12 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 124.152 0.908 . . . . 0.0 109.316 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.42 -42.8 2.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.748 1.28 . . . . 0.0 109.085 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -170.13 -175.84 2.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.544 1.153 . . . . 0.0 109.92 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.22 114.58 2.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.4 mm -78.81 94.34 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.3 m -89.87 143.3 29.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.127 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.27 132.07 37.09 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 122.0 1.8 . . . . 0.0 110.715 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.63 -4.6 10.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 124.285 0.991 . . . . 0.0 111.262 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 116.683 -1.627 . . . . 0.0 111.369 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -72.34 -22.82 61.11 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.362 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 tp -81.3 70.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.7 m -90.75 36.04 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.869 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 p -86.93 166.38 15.17 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 112.967 -1.924 . . . . 0.0 107.427 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -153.85 154.94 34.84 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 124.674 1.233 . . . . 0.0 109.046 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -59.34 -14.68 12.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 124.065 0.853 . . . . 0.0 112.257 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.0 t -90.39 -64.43 1.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.041 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.89 50.93 1.96 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.07 -88.21 2.04 Favored Glycine 0 N--CA 1.503 3.121 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.582 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.5 ' H ' ' HH ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -169.08 108.68 0.45 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 124.641 0.848 . . . . 0.0 110.564 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HA ' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -50.8 112.14 0.66 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 123.763 0.664 . . . . 0.0 109.997 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 124.79 -30.51 4.62 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 124.483 1.114 . . . . 0.0 111.82 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.5 m -87.27 122.99 31.79 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -73.86 102.05 3.95 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.82 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.54 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 99.4 m-85 -51.66 126.49 17.8 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.53 153.61 41.3 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.429 1.109 . . . . 0.0 111.665 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.5 t -103.43 132.71 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.705 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' H ' ' HB1' ' A' ' 46' ' ' ALA . 2.5 p30 -46.4 -23.58 0.38 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 113.111 -1.859 . . . . 0.0 114.449 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -58.99 -19.4 43.06 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.122 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.97 33.25 3.29 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.5 m -139.81 137.74 35.23 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.497 0.665 . . . . 0.0 112.232 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -72.26 142.47 48.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.2 t -102.56 -52.94 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.186 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.75 -179.77 3.42 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.823 0.702 . . . . 0.0 110.608 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -102.46 143.65 31.92 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.501 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -47.01 116.13 2.35 Favored Glycine 0 N--CA 1.498 2.819 0 O-C-N 125.353 1.658 . . . . 0.0 110.115 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.43 -29.81 5.03 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 p -68.43 100.16 1.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -101.74 129.12 27.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.61 -27.16 31.96 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.17 1.913 . . . . 0.0 113.219 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -38.86 51.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.721 0.638 . . . . 0.0 112.015 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.51 148.43 55.23 Favored Pre-proline 0 N--CA 1.495 1.796 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.082 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.14 76.88 4.0 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.502 2.135 . . . . 0.0 111.209 171.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.84 94.7 0.63 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.445 0.64 . . . . 0.0 109.637 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.7 83.12 5.7 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.43 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.9 m -102.56 151.31 38.22 Favored Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.327 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -67.5 153.77 75.58 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.118 1.879 . . . . 0.0 110.387 166.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -88.47 33.96 0.76 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.593 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -72.09 173.94 7.79 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.532 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 98.0 m -125.11 132.4 53.13 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.218 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -113.79 84.38 8.38 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 123.747 0.654 . . . . 0.0 112.674 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -55.47 -21.88 32.14 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.352 2.035 . . . . 0.0 113.262 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -40.38 96.89 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.797 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.4 tt -77.78 163.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 123.794 0.683 . . . . 0.0 110.667 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB1' ' H ' ' A' ' 19' ' ' ASP . . . -121.67 -43.67 2.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 124.388 1.055 . . . . 0.0 108.289 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -171.75 -167.7 0.53 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 124.41 1.069 . . . . 0.0 109.758 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -128.01 120.61 3.48 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.6 100.75 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.4 m -92.51 145.63 30.88 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.147 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.59 112.0 2.04 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 122.064 1.842 . . . . 0.0 109.943 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 mt -137.41 -50.98 0.63 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 124.153 0.908 . . . . 0.0 109.743 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.171 0 O-C-N 124.421 1.076 . . . . 0.0 113.552 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.08 163.26 30.31 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 123.838 0.711 . . . . 0.0 110.001 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -72.46 80.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.841 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.49 43.25 1.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.649 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 t -75.93 167.63 21.52 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.407 -1.724 . . . . 0.0 108.199 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -148.43 141.81 25.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 123.869 0.73 . . . . 0.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -23.63 49.12 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.024 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.12 -62.77 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.759 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.29 63.44 7.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 124.455 1.097 . . . . 0.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.48 -144.08 16.31 Favored Glycine 0 N--CA 1.494 2.563 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.292 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 p -136.68 107.23 6.51 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 123.905 0.415 . . . . 0.0 111.674 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -50.07 95.94 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.755 1.284 . . . . 0.0 110.661 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.86 -27.81 1.74 Allowed Glycine 0 N--CA 1.493 2.466 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.82 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.0 m -111.68 140.08 46.6 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.429 0.633 . . . . 0.0 112.4 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -89.79 97.96 11.49 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.209 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -56.43 125.34 21.58 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 156.98 48.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.807 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 t -104.51 130.31 52.47 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.993 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -39.84 -28.32 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 117.691 2.478 . . . . 0.0 117.691 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -55.99 -27.7 54.01 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.812 -0.755 . . . . 0.0 112.2 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.98 34.22 1.17 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 107.684 -2.166 . . . . 0.0 107.684 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.9 m -143.01 137.89 29.63 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.812 0.815 . . . . 0.0 111.172 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -70.12 152.41 44.35 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.699 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.7 -59.09 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 123.748 0.655 . . . . 0.0 111.677 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -176.19 177.96 1.47 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.868 0.73 . . . . 0.0 111.07 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.551 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -99.27 130.18 45.55 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.36 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.79 107.01 1.97 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.72 12.89 28.3 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.491 ' HG ' ' HZ3' ' A' ' 35' ' ' LYS . 4.4 m -106.14 132.44 52.2 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.19 137.66 56.5 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.99 67.86 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.237 1.958 . . . . 0.0 111.924 169.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 170.09 -21.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.449 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -90.35 143.62 29.72 Favored Pre-proline 0 N--CA 1.493 1.716 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.072 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.3 55.44 5.66 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.528 2.152 . . . . 0.0 111.439 169.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HZ3' ' HG ' ' A' ' 29' ' ' SER . 0.7 OUTLIER -59.29 132.33 53.7 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.728 -1.189 . . . . 0.0 110.862 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.66 127.51 32.27 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.518 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.0 m -150.84 145.78 18.63 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 124.174 0.921 . . . . 0.0 110.54 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.65 151.09 83.43 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.721 1.614 . . . . 0.0 109.704 163.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.3 tpp85 -84.66 59.88 5.78 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.996 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -73.91 93.34 2.18 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.195 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.6 m -59.23 120.84 9.98 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.91 78.4 7.32 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.48 -21.97 25.92 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 C-N-CA 122.554 2.169 . . . . 0.0 112.803 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -48.84 77.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.125 0.891 . . . . 0.0 109.136 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 mt -58.18 143.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 123.931 0.769 . . . . 0.0 109.737 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.76 -37.38 0.82 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 112.607 -2.088 . . . . 0.0 111.036 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.01 178.19 9.42 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.196 0.935 . . . . 0.0 110.481 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.34 109.83 1.33 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.17 88.86 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -86.85 128.49 55.98 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -55.39 -30.58 73.72 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.069 1.846 . . . . 0.0 110.979 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.2 mt -124.34 125.1 43.77 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.12 0 O-C-N 124.167 0.917 . . . . 0.0 111.447 -179.851 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.551 0.691 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.1 ttt85 58.02 81.57 0.15 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.034 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 tp -87.44 45.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.329 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -84.56 46.68 1.26 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.478 1.132 . . . . 0.0 112.577 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.16 150.08 22.16 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.898 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -113.27 -165.76 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.752 1.283 . . . . 0.0 107.868 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 1.2 t -116.31 -29.39 6.23 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.376 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 t -56.32 -56.14 24.74 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.126 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.59 33.77 0.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.764 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.69 -113.88 0.14 Allowed Glycine 0 N--CA 1.494 2.556 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.457 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -154.88 111.82 3.31 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 123.933 0.431 . . . . 0.0 110.537 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -46.12 99.31 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.9 -23.57 5.88 Favored Glycine 0 N--CA 1.499 2.892 0 CA-C-N 114.99 -1.005 . . . . 0.0 114.902 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.1 m -86.31 143.14 28.04 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.837 0.818 . . . . 0.0 110.747 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -97.63 97.19 8.83 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.449 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 17.4 m-85 -62.24 122.39 15.5 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.97 162.85 31.27 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.023 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.8 t -108.84 131.44 54.99 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.462 -1.699 . . . . 0.0 111.5 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' H ' ' HB3' ' A' ' 46' ' ' ALA . 4.4 p30 -45.14 -21.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 112.596 -2.093 . . . . 0.0 114.895 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -53.62 -30.33 42.25 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.896 0.747 . . . . 0.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.28 30.29 1.6 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.8 m -146.13 147.24 31.33 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.774 0.797 . . . . 0.0 112.124 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -69.86 158.68 35.06 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.04 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.98 -48.94 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 28.4 p -164.24 -175.85 4.16 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.143 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -130.48 137.01 49.56 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.239 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.32 115.41 5.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -114.49 26.12 10.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 109.63 21.14 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -88.16 137.19 31.25 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 124.379 1.049 . . . . 0.0 110.247 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -69.91 70.95 1.63 Allowed 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 121.969 1.779 . . . . 0.0 110.121 167.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 169.43 -30.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.682 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -90.08 141.47 27.92 Favored Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.215 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -75.12 68.29 5.88 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 122.734 2.289 . . . . 0.0 110.671 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.65 86.38 3.95 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.502 0.668 . . . . 0.0 110.061 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.43 103.07 9.1 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.198 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.3 m -104.82 150.62 38.86 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.25 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.87 158.18 57.68 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 122.317 2.012 . . . . 0.0 110.522 157.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.454 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.3 60.87 6.35 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.626 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -63.47 110.09 1.84 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.652 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 99.2 m -74.38 116.19 14.77 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.746 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -121.35 74.67 31.34 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.89 -25.77 78.44 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.413 2.076 . . . . 0.0 111.305 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.3 ttp-105 -59.99 -31.13 69.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.991 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.12 156.96 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB3' ' H ' ' A' ' 19' ' ' ASP . . . -116.83 -44.37 2.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.588 1.18 . . . . 0.0 109.687 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -173.92 178.93 2.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.305 1.003 . . . . 0.0 111.098 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.66 111.64 3.33 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.3 mt -79.24 89.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.0 m -86.27 134.65 38.06 Favored Pre-proline 0 N--CA 1.495 1.813 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.617 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -64.42 147.09 90.6 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.954 1.769 . . . . 0.0 110.931 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 tp -154.35 116.49 4.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 123.992 0.807 . . . . 0.0 109.362 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 116.734 -1.603 . . . . 0.0 110.196 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -154.79 47.7 0.56 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.332 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.6 tp -45.11 131.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.746 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -135.26 48.28 2.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.195 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -78.81 170.35 16.81 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.382 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -150.59 148.17 28.32 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 41.6 t -78.14 -20.98 50.99 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.181 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -60.57 -58.3 9.07 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.36 36.91 0.89 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.648 -1.615 . . . . 0.0 108.229 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.48 -110.13 0.07 OUTLIER Glycine 0 N--CA 1.495 2.601 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.646 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.432 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 5.3 t -162.35 123.96 2.68 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -65.3 91.94 0.12 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.073 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.83 -21.64 0.79 Allowed Glycine 0 N--CA 1.489 2.194 0 CA-C-N 113.443 -1.708 . . . . 0.0 111.779 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.5 m -127.02 138.23 53.21 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 119.301 -0.96 . . . . 0.0 113.069 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -83.48 102.3 12.0 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 113.548 -1.66 . . . . 0.0 108.501 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.594 ' HB2' ' SG ' ' A' ' 7' ' ' CYS . 6.5 m-85 -62.52 122.81 16.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.7 159.88 38.35 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.045 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 t -108.21 131.28 54.84 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.161 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -39.63 -28.3 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -56.54 -28.53 60.3 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.829 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.07 34.14 0.92 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.3 m -143.61 138.8 29.29 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.886 0.85 . . . . 0.0 112.079 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -71.9 138.91 48.5 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.001 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.32 -57.19 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.909 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -175.84 174.89 2.09 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.556 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.484 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 1.4 mt-10 -99.19 131.11 45.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.315 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.432 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -65.43 112.94 5.38 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -103.45 7.8 37.94 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.383 0.696 . . . . 0.0 112.733 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -80.87 100.04 8.64 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.559 -0.857 . . . . 0.0 112.583 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -90.44 133.43 32.99 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.91 -26.01 23.39 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.974 1.783 . . . . 0.0 112.134 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -86.41 -37.64 18.17 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.725 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -83.74 143.59 43.94 Favored Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.119 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -76.23 74.58 4.56 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 122.445 2.097 . . . . 0.0 109.91 167.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HE2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -64.55 97.89 0.23 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.78 127.2 31.93 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.529 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.42 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 60.8 m -147.09 149.2 34.64 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 124.266 0.979 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.37 142.85 67.66 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 N-CA-C 107.729 -1.681 . . . . 0.0 107.729 153.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -85.31 62.03 7.23 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.092 0.948 . . . . 0.0 108.878 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -61.09 107.7 0.77 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.625 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.2 m -55.63 118.14 4.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 124.193 0.933 . . . . 0.0 110.587 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -128.76 74.05 80.85 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 124.311 1.007 . . . . 0.0 113.061 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.45 -22.44 66.1 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 121.888 1.726 . . . . 0.0 110.627 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.434 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -55.64 -38.22 69.26 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 124.314 1.009 . . . . 0.0 110.099 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mt -66.67 146.52 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.02 -42.56 1.38 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.143 -1.39 . . . . 0.0 111.87 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.87 175.68 12.22 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 124.111 0.882 . . . . 0.0 110.571 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.18 108.81 1.5 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.353 -2.299 . . . . 0.0 107.353 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.5 mt -79.12 94.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.07 152.32 46.02 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.887 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -65.04 -65.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.785 1.656 . . . . 0.0 108.814 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.57 26.19 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.049 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 116.67 -1.633 . . . . 0.0 111.396 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -160.46 33.5 0.16 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.353 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 tp -57.03 133.4 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.611 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -146.9 49.22 1.13 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.784 1.278 . . . . 0.0 110.546 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.427 ' H ' ' HG1' ' A' ' 5' ' ' THR . 2.2 p -72.99 167.11 21.76 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 112.997 -1.91 . . . . 0.0 109.562 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -161.19 162.04 31.13 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.946 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.7 t -65.72 -23.48 66.76 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.932 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -58.32 -60.4 3.84 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.8 -106.6 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 112.899 -1.955 . . . . 0.0 105.738 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 16' ' ' TYR . . . 79.09 -107.93 2.6 Favored Glycine 0 CA--C 1.549 2.174 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -179.13 97.61 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 123.291 0.636 . . . . 0.0 111.055 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.8 133.93 42.37 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.937 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.7 -28.6 12.77 Favored Glycine 0 N--CA 1.488 2.136 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.924 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.6 m -106.63 143.38 34.82 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.412 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.68 106.19 18.17 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.68 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 2.6 m-30 -55.59 131.33 46.04 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.09 159.41 43.32 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 124.669 1.231 . . . . 0.0 112.188 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 t -108.12 129.32 55.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 112.735 -2.029 . . . . 0.0 111.113 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -43.37 -25.15 0.12 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-N 113.092 -1.867 . . . . 0.0 115.321 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -54.14 -30.2 48.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 123.897 0.748 . . . . 0.0 111.592 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.41 32.72 1.2 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 m -143.56 143.96 31.74 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.901 0.857 . . . . 0.0 111.759 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -72.86 149.16 43.76 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.435 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.2 t -110.5 -52.38 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.53 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -170.05 -173.01 1.44 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 123.53 0.519 . . . . 0.0 110.252 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.557 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 mt-10 -112.43 158.66 19.58 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.78 110.55 2.88 Favored Glycine 0 N--CA 1.494 2.561 0 CA-C-N 112.812 -1.994 . . . . 0.0 110.897 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -121.13 -39.06 2.73 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 p -72.11 102.42 3.01 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.54 133.42 59.57 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.63 -29.83 20.36 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.975 1.783 . . . . 0.0 113.102 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.6 mtt180 -84.77 -34.86 22.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 123.863 0.727 . . . . 0.0 112.093 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -81.16 142.88 51.72 Favored Pre-proline 0 N--CA 1.495 1.808 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.574 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.84 47.3 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.365 2.71 . . . . 0.0 112.37 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -96.1 95.16 7.98 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.498 0.666 . . . . 0.0 110.584 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.49 140.22 16.07 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.473 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.61 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.8 m -133.2 94.29 20.56 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -71.61 79.17 1.57 Allowed 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.099 1.866 . . . . 0.0 109.364 172.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -144.82 -59.41 0.36 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.263 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -77.69 136.01 38.14 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.004 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.1 m -112.13 126.36 55.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.972 1.42 . . . . 0.0 108.217 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -126.24 71.74 70.88 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 123.893 0.745 . . . . 0.0 112.497 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.15 -28.54 73.58 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.486 2.124 . . . . 0.0 112.643 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -63.15 -17.51 62.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.026 0.829 . . . . 0.0 112.147 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 tt -69.65 158.82 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 123.694 0.621 . . . . 0.0 109.671 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.16 -45.18 1.99 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.946 0.778 . . . . 0.0 109.47 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -173.94 -169.73 0.5 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 124.343 1.027 . . . . 0.0 110.181 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.52 116.06 3.11 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.9 mt -80.79 91.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.216 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.24 127.06 77.74 Favored Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.49 -30.26 23.8 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.901 1.734 . . . . 0.0 109.365 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.81 42.98 2.04 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.18 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 116.367 -1.778 . . . . 0.0 111.738 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mtm105 57.28 63.71 1.81 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 124.556 1.16 . . . . 0.0 110.987 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.7 tp -86.63 46.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.687 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 m -85.48 46.35 1.29 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.549 1.166 . . . . 0.0 112.513 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -90.21 174.12 7.78 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 112.961 -1.927 . . . . 0.0 108.45 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -161.39 165.58 28.67 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.028 0.83 . . . . 0.0 110.373 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.7 t -67.49 -3.28 8.15 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.7 t -91.12 -57.77 2.69 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -42.13 -69.26 0.14 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 4.43 -112.93 0.01 OUTLIER Glycine 0 N--CA 1.508 3.465 0 N-CA-C 117.556 1.782 . . . . 0.0 117.556 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 173.65 126.82 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -49.62 110.55 0.39 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 124.148 0.905 . . . . 0.0 110.01 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.94 -28.38 4.39 Favored Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.536 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.6 m -79.59 -176.48 5.34 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.199 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -139.22 101.39 4.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.857 0.723 . . . . 0.0 109.683 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.589 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 85.6 m-85 -57.45 131.92 51.57 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.42 155.86 44.5 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.222 1.01 . . . . 0.0 110.94 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.475 ' HG ' HH21 ' A' ' 44' ' ' ARG . 9.8 t -106.86 135.74 47.88 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.382 -2.19 . . . . 0.0 113.485 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -47.27 -24.47 0.74 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 111.575 -2.557 . . . . 0.0 113.573 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -56.0 -25.76 45.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 124.098 0.874 . . . . 0.0 111.797 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.27 32.17 2.43 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.7 m -145.66 148.34 32.96 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 112.449 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -70.98 153.49 42.61 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.339 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.7 t -115.99 -56.75 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.213 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.589 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -162.5 -178.92 6.56 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.702 0.626 . . . . 0.0 110.56 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.418 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -112.77 150.64 31.34 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.48 110.49 1.41 Allowed Glycine 0 N--CA 1.492 2.419 0 CA-C-N 112.951 -1.931 . . . . 0.0 109.653 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -114.03 -6.61 13.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.897 0.998 . . . . 0.0 113.437 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.97 89.66 4.14 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.95 130.39 44.85 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.28 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.0 74.49 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.609 2.206 . . . . 0.0 110.993 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 170.57 -39.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.591 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -80.95 155.99 72.52 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.104 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.86 78.51 2.47 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 122.128 1.885 . . . . 0.0 111.163 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.09 99.4 0.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.07 92.92 5.06 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.6 m -111.71 98.93 43.15 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.115 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.9 169.45 13.26 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 121.97 1.78 . . . . 0.0 110.452 168.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -83.69 25.51 0.77 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.352 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -63.95 134.85 55.85 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.644 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.22 136.66 34.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 125.501 1.75 . . . . 0.0 110.887 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -129.82 81.0 70.31 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 124.054 0.846 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -54.96 -27.92 56.67 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 122.189 1.926 . . . . 0.0 113.238 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.475 HH21 ' HG ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -59.36 -46.9 87.36 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mt -64.77 148.46 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.97 -42.13 2.97 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.209 -1.814 . . . . 0.0 108.604 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -173.7 -168.74 0.45 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.638 1.211 . . . . 0.0 109.676 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.11 113.8 1.92 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 mm -79.5 111.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.6 m -102.71 157.44 33.72 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 123.557 0.536 . . . . 0.0 110.459 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.59 -34.71 41.01 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 121.909 1.739 . . . . 0.0 108.094 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.51 44.94 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.009 -1.451 . . . . 0.0 107.181 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.005 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.826 -179.853 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.4 mmt-85 -143.03 82.2 1.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 124.212 0.945 . . . . 0.0 109.458 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 tp -72.72 89.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.599 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -97.05 55.8 1.34 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.693 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.429 ' HG1' ' H ' ' A' ' 6' ' ' ASN . 9.7 t -87.72 179.49 6.49 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.507 -1.678 . . . . 0.0 107.993 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.429 ' H ' ' HG1' ' A' ' 5' ' ' THR . 51.1 p-10 -160.27 -171.19 3.09 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 t -98.73 -30.95 12.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.043 0.84 . . . . 0.0 111.944 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.2 t -67.18 -60.82 2.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 123.995 0.81 . . . . 0.0 109.761 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.19 63.86 8.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 125.119 1.512 . . . . 0.0 108.772 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.65 -136.35 7.74 Favored Glycine 0 N--CA 1.491 2.348 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.812 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -144.25 108.63 4.83 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.86 94.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.346 1.029 . . . . 0.0 111.888 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.01 -26.2 2.5 Favored Glycine 0 N--CA 1.495 2.582 0 CA-C-N 113.754 -1.566 . . . . 0.0 113.169 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.7 m -87.66 158.88 18.73 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.005 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -116.18 95.66 5.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.515 1.134 . . . . 0.0 109.834 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -52.27 129.8 29.08 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.927 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.88 158.99 43.6 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.521 0.677 . . . . 0.0 111.76 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -107.38 132.71 52.86 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.473 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -44.58 -24.39 0.19 Allowed 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 112.887 -1.96 . . . . 0.0 114.997 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -54.42 -27.67 38.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.07 0.856 . . . . 0.0 111.45 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.06 32.84 1.77 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.6 m -144.93 140.78 28.5 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.505 0.669 . . . . 0.0 111.539 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.16 159.52 28.77 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.754 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.3 t -127.68 -46.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.72 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -167.38 -173.96 2.41 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.838 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.72 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -128.15 124.81 37.8 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.23 117.87 12.74 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 107.481 -2.248 . . . . 0.0 107.481 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.63 13.79 24.95 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.35 109.89 20.98 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.408 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.41 132.45 62.29 Favored Pre-proline 0 N--CA 1.494 1.725 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.21 75.66 0.48 Allowed 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.859 1.706 . . . . 0.0 110.149 173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 164.58 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.96 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -90.43 144.64 31.1 Favored Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.478 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.12 69.01 8.1 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.513 2.142 . . . . 0.0 111.309 168.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -71.08 89.41 0.82 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.91 121.63 25.67 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.715 -1.129 . . . . 0.0 113.675 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.4 m -160.42 162.47 23.51 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.079 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.62 159.77 35.31 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.692 1.594 . . . . 0.0 110.682 165.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.5 ttm105 -87.31 63.3 7.68 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -57.36 149.98 19.31 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.601 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.7 m -109.97 128.72 55.56 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.1 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -123.66 75.51 55.26 Favored Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 124.059 0.849 . . . . 0.0 113.202 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.07 -21.47 65.58 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.485 2.123 . . . . 0.0 112.068 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -63.73 -39.07 93.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.039 0.837 . . . . 0.0 110.009 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -69.29 154.31 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.42 1.075 . . . . 0.0 109.537 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.25 -44.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.354 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.49 -177.6 6.32 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 124.308 1.005 . . . . 0.0 110.212 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.68 110.57 1.26 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 107.169 -2.372 . . . . 0.0 107.169 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.1 mt -79.07 90.6 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -92.51 149.71 38.65 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.921 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.83 -18.89 44.17 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.206 1.938 . . . . 0.0 112.35 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 tp -79.66 138.87 37.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 123.951 0.782 . . . . 0.0 109.567 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 116.703 -1.618 . . . . 0.0 110.686 179.907 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -152.7 151.35 30.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.176 0.922 . . . . 0.0 109.763 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 tp -69.31 87.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 124.22 0.95 . . . . 0.0 109.863 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.68 37.55 1.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.552 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 p -89.03 171.95 9.47 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 113.727 -1.578 . . . . 0.0 107.385 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -158.0 155.71 29.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.142 0.901 . . . . 0.0 111.883 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.42 -16.66 38.11 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.96 -1.473 . . . . 0.0 112.284 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -90.25 -69.27 0.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.472 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.82 58.85 3.97 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.94 -83.77 1.21 Allowed Glycine 0 N--CA 1.497 2.749 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.909 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.24 111.78 0.16 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.83 119.72 4.14 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.072 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.9 -31.11 7.25 Favored Glycine 0 N--CA 1.495 2.63 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.416 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.2 m -90.06 120.56 31.35 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.766 -1.173 . . . . 0.0 111.124 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -67.53 100.11 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.371 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.533 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 91.8 m-85 -48.96 131.03 18.84 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.29 156.37 42.45 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 122.147 0.975 . . . . 0.0 110.985 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.4 t -107.19 130.08 54.77 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 112.438 -2.165 . . . . 0.0 110.704 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -39.04 -28.83 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 118.402 2.741 . . . . 0.0 118.402 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.43 -28.59 65.39 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.521 -0.872 . . . . 0.0 112.37 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.93 35.01 0.75 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 m -142.93 140.21 31.05 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.668 0.747 . . . . 0.0 111.845 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -70.63 153.37 42.92 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.081 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t -115.52 -57.91 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.114 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.533 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -162.08 -178.66 6.55 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 123.523 0.514 . . . . 0.0 110.717 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -97.42 138.62 34.59 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.525 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -54.47 113.8 3.75 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.14 -23.46 5.35 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.65 98.49 0.52 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 118.9 0.773 . . . . 0.0 111.504 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.73 127.23 30.63 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.482 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.53 -22.65 44.0 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.453 2.102 . . . . 0.0 113.772 -168.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.02 -41.71 18.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 123.895 0.747 . . . . 0.0 110.511 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.33 147.39 87.59 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -73.2 77.87 2.36 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.184 1.922 . . . . 0.0 110.607 174.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 81.43 2.29 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.045 0.926 . . . . 0.0 109.184 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.53 127.93 32.75 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.518 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -147.95 148.93 31.52 Favored Pre-proline 0 N--CA 1.495 1.783 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.07 161.26 37.82 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.818 1.679 . . . . 0.0 109.735 165.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -86.54 61.81 7.04 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.25 1.024 . . . . 0.0 109.367 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -76.69 -177.88 4.49 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.258 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 93.8 m -146.77 122.61 10.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -112.74 83.15 5.51 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 123.775 0.672 . . . . 0.0 112.724 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -51.95 -31.44 43.55 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.573 2.182 . . . . 0.0 112.213 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -59.88 -50.69 72.79 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 124.406 1.066 . . . . 0.0 108.477 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.02 148.1 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.031 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.64 -43.19 2.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 124.527 1.142 . . . . 0.0 108.021 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -173.06 -167.75 0.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.719 1.262 . . . . 0.0 109.308 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.81 121.06 4.02 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.5 mt -83.0 95.03 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 123.947 0.44 . . . . 0.0 111.607 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 m -82.57 145.56 51.42 Favored Pre-proline 0 N--CA 1.503 2.2 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.41 86.54 0.34 Allowed 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 122.274 1.983 . . . . 0.0 110.77 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.75 -46.5 0.11 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.368 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 116.271 -1.823 . . . . 0.0 110.242 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.46 179.98 7.88 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.298 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tp -56.73 119.45 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.122 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -124.49 47.33 2.12 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.58 140.48 29.51 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 40' ' ' ASN . 14.6 p-10 -160.35 163.04 33.55 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 124.028 0.83 . . . . 0.0 111.052 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.447 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 10.1 t -60.81 -16.8 44.75 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.437 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 1.9 t -91.55 -43.87 9.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.419 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -88.59 43.66 1.15 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -102.45 -118.18 4.39 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.066 -1.064 . . . . 0.0 114.056 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.5 m -160.6 126.4 3.97 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.86 103.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 123.706 0.629 . . . . 0.0 109.575 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.411 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 132.41 -25.31 3.84 Favored Glycine 0 N--CA 1.498 2.777 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.776 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.8 m -88.25 122.97 32.39 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 117.362 0.581 . . . . 0.0 110.174 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -76.75 99.43 5.11 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.491 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.59 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 82.7 m-85 -54.95 127.98 31.34 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.09 157.74 44.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.197 0.999 . . . . 0.0 110.839 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.8 t -103.99 131.32 51.36 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 112.592 -2.094 . . . . 0.0 110.97 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -44.55 -24.87 0.22 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 125.519 1.762 . . . . 0.0 114.892 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -58.2 -20.95 45.47 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.766 0.666 . . . . 0.0 112.469 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.08 33.27 2.82 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.3 m -139.82 136.2 33.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.122 0.542 . . . . 0.0 112.119 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -70.89 148.66 47.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t -111.88 -50.88 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 123.779 0.674 . . . . 0.0 110.583 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.59 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -168.48 173.3 7.62 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 123.823 0.702 . . . . 0.0 109.778 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -96.99 152.19 18.97 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.624 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.454 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -48.02 118.46 4.46 Favored Glycine 0 N--CA 1.507 3.378 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -132.53 39.78 3.34 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.3 t -162.82 94.93 0.87 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.521 ' H ' HD22 ' A' ' 33' ' ' ASN . 16.3 t70 -79.23 133.16 61.03 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -60.94 86.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 121.916 1.744 . . . . 0.0 109.419 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.62 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.219 -1.809 . . . . 0.0 106.961 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.521 HD22 ' H ' ' A' ' 30' ' ' ASP . 1.8 p30 -90.76 135.49 28.93 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 124.154 0.909 . . . . 0.0 109.307 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -75.08 66.62 6.09 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.185 1.923 . . . . 0.0 109.439 167.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -53.03 127.36 23.7 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.81 135.8 37.17 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.371 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.3 m -145.74 155.89 52.29 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 124.526 1.141 . . . . 0.0 111.944 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.91 -46.07 3.64 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 122.193 1.929 . . . . 0.0 112.26 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -158.15 -2.0 0.09 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.509 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 58.1 m-20 51.79 48.32 23.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.002 0.814 . . . . 0.0 113.111 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 98.1 m -153.41 131.41 11.78 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.186 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -157.98 101.35 1.77 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 123.938 0.774 . . . . 0.0 110.93 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.59 -18.6 60.86 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 122.02 1.814 . . . . 0.0 112.652 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 ttm105 -66.53 -33.12 74.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 123.651 0.594 . . . . 0.0 110.351 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.74 157.11 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.03 -46.49 3.0 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.01 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -172.47 -172.93 0.97 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.327 1.017 . . . . 0.0 109.683 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -121.06 118.01 3.66 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.2 mm -79.03 95.47 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.54 142.35 29.41 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.291 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -65.39 133.55 35.27 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 122.062 1.841 . . . . 0.0 111.525 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mp -117.62 109.2 16.38 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.261 0.976 . . . . 0.0 108.402 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 116.376 -1.773 . . . . 0.0 111.172 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.035 0.445 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -144.34 125.58 14.66 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.403 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.5 tp -60.67 125.36 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 123.992 0.808 . . . . 0.0 110.517 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.13 47.59 2.46 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.23 143.95 36.68 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.42 HD21 ' H ' ' A' ' 8' ' ' CYS . 3.8 t30 -150.76 178.13 9.42 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.491 1.139 . . . . 0.0 113.35 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.0 t -94.48 -45.02 7.61 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.262 -2.245 . . . . 0.0 108.589 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.42 ' H ' HD21 ' A' ' 6' ' ' ASN . 37.5 t -60.24 -56.57 19.91 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.03 41.48 1.03 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.454 -1.703 . . . . 0.0 108.856 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' N ' ' HB3' ' A' ' 29' ' ' SER . . . -78.7 -155.91 9.05 Favored Glycine 0 N--CA 1.491 2.348 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.518 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.446 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.1 m -141.02 96.17 2.96 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 115.697 -0.252 . . . . 0.0 110.566 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -26.05 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 124.86 -34.89 3.3 Favored Glycine 0 N--CA 1.501 3.03 0 CA-C-N 114.932 -1.031 . . . . 0.0 114.822 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.3 m -84.4 120.61 26.48 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 101.7 5.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.375 1.047 . . . . 0.0 110.746 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -58.99 122.57 14.04 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.65 157.47 46.56 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.404 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 t -103.18 130.61 50.43 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.64 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -46.2 -20.32 0.1 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 113.168 -1.833 . . . . 0.0 114.903 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -55.27 -28.65 54.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 123.638 0.586 . . . . 0.0 110.747 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.24 30.95 1.79 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.8 m -144.94 142.61 29.99 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.816 0.817 . . . . 0.0 112.09 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -69.35 149.69 48.15 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.808 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.5 t -112.38 -52.77 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 123.783 0.677 . . . . 0.0 110.986 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -168.21 176.9 5.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.083 0.864 . . . . 0.0 110.528 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.634 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -99.91 123.36 44.08 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -59.52 103.39 0.41 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -93.7 -8.23 41.45 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 118.075 2.62 . . . . 0.0 118.075 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.428 ' HB3' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -79.37 131.71 36.19 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.574 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.53 134.58 23.17 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.5 -27.5 19.08 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.034 1.823 . . . . 0.0 112.712 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -85.9 -34.17 21.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.957 0.786 . . . . 0.0 112.805 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -90.14 152.88 46.52 Favored Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.791 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -79.85 51.93 4.09 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.1 2.533 . . . . 0.0 112.978 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -74.05 94.65 2.42 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.795 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.48 155.57 48.31 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.765 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.3 m -145.05 160.44 46.31 Favored Pre-proline 0 N--CA 1.499 1.989 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.11 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.02 -13.03 17.24 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.872 1.715 . . . . 0.0 113.241 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.12 75.32 1.44 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 124.035 0.834 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -104.48 42.44 1.2 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.605 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.0 m -147.52 134.54 20.32 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.132 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -159.05 98.8 1.63 Allowed Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.24 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.22 -17.47 32.7 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.585 2.19 . . . . 0.0 113.677 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.6 ttp-105 -61.06 -35.28 76.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 123.705 0.628 . . . . 0.0 110.949 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -77.54 155.18 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.714 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.17 -41.44 1.77 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 112.414 -2.176 . . . . 0.0 110.064 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.17 177.94 10.0 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 124.162 0.913 . . . . 0.0 110.909 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.63 108.18 1.15 Allowed Glycine 0 N--CA 1.495 2.605 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.41 93.98 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.47 148.39 38.72 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-N 114.843 -1.072 . . . . 0.0 108.752 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -61.76 -57.68 0.51 Allowed 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.806 1.671 . . . . 0.0 110.32 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.5 pp -160.37 160.55 32.47 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.515 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 116.475 -1.726 . . . . 0.0 110.251 179.963 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 -80.85 25.59 0.44 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 123.996 0.81 . . . . 0.0 111.329 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 tp -86.42 49.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.643 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.4 45.45 1.12 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.668 1.223 . . . . 0.0 112.504 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.14 170.1 14.17 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 113.056 -1.884 . . . . 0.0 108.146 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -160.58 145.23 14.25 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.201 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.488 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 1.7 t -55.9 -19.9 13.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.554 1.159 . . . . 0.0 113.329 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -73.71 -67.82 0.56 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.182 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.45 -86.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA3' ' CE2' ' A' ' 16' ' ' TYR . . . 33.22 -108.04 0.03 OUTLIER Glycine 0 N--CA 1.506 3.363 0 N-CA-C 115.208 0.843 . . . . 0.0 115.208 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 177.28 121.74 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 124.912 1.007 . . . . 0.0 109.251 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.27 104.7 0.15 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 123.965 0.79 . . . . 0.0 109.863 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.02 -30.09 2.38 Favored Glycine 0 N--CA 1.491 2.313 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.076 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.45 125.57 41.03 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -82.74 113.81 20.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.345 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.603 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 92.2 m-85 -55.73 131.32 46.37 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.64 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.71 155.41 42.39 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.067 0.937 . . . . 0.0 111.204 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.5 t -107.92 133.51 52.15 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 112.683 -2.053 . . . . 0.0 112.851 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -38.96 -31.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 111.245 -2.707 . . . . 0.0 118.053 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.21 -28.15 66.39 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.362 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.82 37.17 0.68 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 m -144.56 142.06 29.92 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -69.89 152.12 44.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.677 -1.147 . . . . 0.0 107.951 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.7 -47.43 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 123.835 0.709 . . . . 0.0 110.541 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.603 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.04 -176.85 2.74 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 123.703 0.627 . . . . 0.0 110.683 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.5 mm-40 -111.15 147.54 34.69 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.52 113.7 1.91 Allowed Glycine 0 N--CA 1.491 2.33 0 O-C-N 125.652 1.845 . . . . 0.0 109.303 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -108.22 -37.21 6.08 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 t -77.9 95.48 4.77 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.46 ' H ' HD22 ' A' ' 33' ' ' ASN . 16.5 t70 -85.55 123.06 73.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.98 86.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.326 2.017 . . . . 0.0 111.628 -167.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 30' ' ' ASP . 4.6 mtm-85 169.41 -34.89 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.671 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.46 HD22 ' H ' ' A' ' 30' ' ' ASP . 55.7 p30 -87.91 152.33 50.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 123.958 0.786 . . . . 0.0 112.62 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -79.52 42.64 1.34 Allowed 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 123.301 2.668 . . . . 0.0 112.929 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.96 38.16 1.25 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.55 132.36 56.21 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.255 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.457 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 4.5 m -137.06 68.99 57.12 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.96 -21.49 41.6 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.193 1.929 . . . . 0.0 112.338 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -83.37 19.9 1.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.791 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -118.93 118.33 31.23 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.741 0.651 . . . . 0.0 109.805 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.7 m -105.89 129.05 54.12 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.53 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -130.97 78.81 72.76 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 123.86 0.725 . . . . 0.0 110.938 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.42 -22.19 57.45 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.086 1.857 . . . . 0.0 113.78 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -43.12 83.44 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.15 155.92 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.16 -43.18 2.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.099 0.875 . . . . 0.0 109.408 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -175.64 -165.07 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.36 1.038 . . . . 0.0 109.264 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -128.35 119.26 3.03 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.4 mm -79.0 110.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -99.3 151.52 37.45 Favored Pre-proline 0 N--CA 1.495 1.818 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.89 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.62 88.73 0.35 Allowed 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 121.944 1.763 . . . . 0.0 109.323 168.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.1 -59.4 2.02 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.285 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 116.688 -1.625 . . . . 0.0 110.906 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -91.6 51.0 1.79 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.094 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.3 mm -76.14 89.65 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.94 27.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.03 164.78 13.84 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -160.87 150.6 17.32 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.585 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.3 t -65.37 -21.5 66.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.753 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -77.76 -68.6 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.162 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.32 52.8 2.31 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.556 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.74 -121.76 0.18 Allowed Glycine 0 N--CA 1.491 2.336 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.809 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.416 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -158.88 103.0 1.68 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -42.46 105.42 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.18 -30.06 4.42 Favored Glycine 0 N--CA 1.496 2.651 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.832 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.6 m -82.4 157.2 23.8 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.908 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -111.73 95.35 5.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.258 0.974 . . . . 0.0 111.703 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.6 129.0 34.84 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.639 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.12 160.39 41.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.024 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.4 t -109.6 129.8 55.56 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.408 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -42.95 -24.35 0.06 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 112.962 -1.926 . . . . 0.0 115.366 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -53.24 -30.69 39.53 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.876 0.735 . . . . 0.0 111.292 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.16 31.78 1.25 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -144.86 144.43 31.11 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.759 0.79 . . . . 0.0 111.92 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -71.19 154.37 41.74 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.325 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.4 t -118.56 -52.43 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 123.613 0.57 . . . . 0.0 111.229 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -173.34 -169.51 0.53 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.027 0.829 . . . . 0.0 109.443 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.68 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -124.78 134.72 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -51.9 111.39 1.44 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.32 11.72 37.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.61 0.83 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.9 p -77.69 92.45 4.14 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.973 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -82.57 137.8 44.54 Favored Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.547 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.14 77.92 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 122.19 1.927 . . . . 0.0 111.309 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 161.58 -37.24 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.097 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -82.04 143.18 48.96 Favored Pre-proline 0 N--CA 1.498 1.954 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.333 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.97 91.22 0.53 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.847 1.698 . . . . 0.0 108.87 170.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 66.7 3.6 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.031 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.77 135.08 54.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.524 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 2.8 m -153.78 167.77 12.99 Favored Pre-proline 0 N--CA 1.497 1.918 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.083 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -68.99 70.08 1.19 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.073 1.848 . . . . 0.0 109.007 159.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.409 HH11 HH12 ' A' ' 44' ' ' ARG . 4.6 tpm_? -160.41 73.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -107.01 114.03 27.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.565 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.8 m 59.64 108.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 124.967 1.417 . . . . 0.0 111.615 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.15 88.31 5.65 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -47.1 -35.2 18.76 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 123.375 2.717 . . . . 0.0 114.434 170.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.409 HH12 HH11 ' A' ' 39' ' ' ARG . 0.5 OUTLIER -56.28 -43.74 79.11 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 124.223 0.952 . . . . 0.0 110.211 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 mt -75.41 161.43 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.782 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.71 -44.6 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.0 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -173.52 -169.76 0.54 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 124.303 1.002 . . . . 0.0 109.754 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.84 117.07 2.92 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.8 mm -78.86 95.15 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.5 m -85.19 133.32 43.0 Favored Pre-proline 0 N--CA 1.493 1.713 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.301 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.9 95.9 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 122.133 1.889 . . . . 0.0 110.522 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.5 tp -108.84 57.21 0.61 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.002 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.309 0 CA-C-N 114.288 -1.324 . . . . 0.0 113.512 179.977 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.925 0.393 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -76.42 166.67 23.09 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.968 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.4 tp -89.99 38.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.646 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.8 m -94.21 43.15 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.985 -1.461 . . . . 0.0 112.299 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.72 176.01 7.6 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.675 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -158.86 141.17 14.0 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.469 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -65.28 -24.99 67.45 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.58 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -63.64 -54.2 39.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 124.249 0.968 . . . . 0.0 112.056 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.82 -77.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 113.811 -1.541 . . . . 0.0 115.135 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.43 -98.32 0.01 OUTLIER Glycine 0 N--CA 1.501 2.971 0 N-CA-C 115.433 0.933 . . . . 0.0 115.433 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.628 ' H ' ' HH ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER 179.46 119.41 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 O-C-N 124.509 0.77 . . . . 0.0 111.575 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.23 130.25 8.02 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 123.669 0.605 . . . . 0.0 111.514 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.68 -29.66 10.65 Favored Glycine 0 N--CA 1.493 2.49 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.58 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.9 m -80.21 121.46 25.63 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.33 107.2 11.92 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.584 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.628 ' HH ' ' H ' ' A' ' 11' ' ' THR . 95.5 m-85 -58.43 129.01 40.02 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.76 156.99 43.96 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 124.229 0.956 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 t -106.04 136.05 46.42 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.572 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -47.06 -23.48 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 112.074 -2.33 . . . . 0.0 113.503 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -58.11 -19.85 35.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 123.798 0.686 . . . . 0.0 111.849 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.66 33.24 3.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.6 m -143.88 139.93 29.49 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.687 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -68.65 154.93 41.01 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.443 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.25 -53.39 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.126 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -161.96 -178.32 6.37 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 123.567 0.542 . . . . 0.0 110.927 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 17.0 mm-40 -112.63 150.75 30.99 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.02 110.45 0.35 Allowed Glycine 0 N--CA 1.499 2.861 0 O-C-N 125.779 1.924 . . . . 0.0 112.459 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 -42.75 7.32 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 118.39 2.737 . . . . 0.0 118.39 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 t -57.86 102.81 0.11 Allowed 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 119.756 1.162 . . . . 0.0 113.883 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.55 139.9 22.98 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 124.931 1.395 . . . . 0.0 107.45 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -45.75 -30.61 6.75 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.627 2.218 . . . . 0.0 115.942 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -65.21 -36.93 85.69 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.634 HD21 ' H ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -81.61 142.49 49.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 119.226 -0.989 . . . . 0.0 108.561 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -75.52 40.52 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.147 1.898 . . . . 0.0 110.933 166.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.634 ' H ' HD21 ' A' ' 33' ' ' ASN . 2.6 mptp? 48.81 71.6 0.36 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.633 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.32 86.36 5.07 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.302 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.1 m -153.66 141.54 13.81 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.99 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.53 -166.28 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 121.936 1.757 . . . . 0.0 110.753 168.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -79.54 -76.56 0.21 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 m120 50.5 86.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 124.62 1.2 . . . . 0.0 113.052 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.8 m -66.95 128.37 36.09 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -113.71 80.97 5.32 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.59 -30.63 83.87 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 122.367 2.045 . . . . 0.0 112.603 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -44.58 96.84 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.49 144.3 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.21 -46.74 3.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.959 0.787 . . . . 0.0 109.22 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -173.21 -170.08 0.6 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.118 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -127.73 115.22 2.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.6 mm -79.4 110.55 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.23 160.53 28.02 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.93 -42.85 34.27 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 121.633 1.556 . . . . 0.0 108.961 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.52 79.61 7.58 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 2.229 0 CA-C-O 115.723 -2.084 . . . . 0.0 113.629 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -137.63 -44.43 0.54 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.441 1.088 . . . . 0.0 108.835 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 tp -79.19 76.23 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.322 1.058 . . . . 0.0 108.711 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.1 m -90.32 36.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.218 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.24 -171.55 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.727 -2.033 . . . . 0.0 106.843 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -160.4 167.8 26.57 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.406 1.066 . . . . 0.0 111.122 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -61.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.344 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -59.69 5.06 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.101 -1.408 . . . . 0.0 109.013 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.05 31.8 0.21 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.137 -2.301 . . . . 0.0 111.351 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.03 -130.09 0.65 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -142.58 109.64 5.56 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 123.97 0.453 . . . . 0.0 111.294 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -48.37 106.61 0.1 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.443 1.089 . . . . 0.0 111.225 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.28 -27.23 4.27 Favored Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.567 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.4 m -110.29 134.45 52.26 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.919 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -80.2 101.15 8.66 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.529 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -62.42 119.24 8.74 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.96 158.68 38.88 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.222 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 t -103.59 129.76 50.91 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.323 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -46.0 -20.84 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 125.855 1.972 . . . . 0.0 114.765 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -55.17 -29.81 58.58 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 123.859 0.724 . . . . 0.0 110.785 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.55 31.57 1.48 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.8 m -144.03 140.68 29.69 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.732 0.777 . . . . 0.0 111.574 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -74.49 135.74 42.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.374 -1.284 . . . . 0.0 107.682 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -91.14 -63.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.356 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -176.25 171.91 2.39 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.17 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.3 mt-10 -90.45 150.25 21.89 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 120.174 -0.611 . . . . 0.0 112.433 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.11 124.61 11.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.65 -5.0 15.12 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.8 t -85.39 123.45 30.87 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.545 ' H ' HD22 ' A' ' 33' ' ' ASN . 13.0 t70 -80.11 127.06 78.06 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.85 83.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.93 1.753 . . . . 0.0 110.155 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 30' ' ' ASP . 1.4 mmt-85 176.16 -39.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.966 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.545 HD22 ' H ' ' A' ' 30' ' ' ASP . 14.9 p30 -91.28 148.91 38.76 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 124.167 0.917 . . . . 0.0 110.945 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.14 47.29 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.58 2.187 . . . . 0.0 110.183 162.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -72.88 111.55 8.1 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -155.08 109.12 2.9 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.784 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 2.2 m -79.48 -42.66 1.59 Allowed Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 37' ' ' CYS . 10.0 Cg_endo -72.79 -176.32 2.28 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 C-N-CA 122.42 2.08 . . . . 0.0 110.643 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.11 -1.23 1.77 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.575 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -125.49 -168.02 1.78 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.213 0.946 . . . . 0.0 113.023 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 89.0 m -91.18 152.91 20.37 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.132 -1.395 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -113.8 76.36 3.11 Favored Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 123.652 0.595 . . . . 0.0 110.996 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.66 -26.98 81.58 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.447 2.098 . . . . 0.0 111.423 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 mtm-85 -60.51 -45.09 95.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.22 0.95 . . . . 0.0 109.744 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -66.55 155.36 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 124.347 1.03 . . . . 0.0 108.614 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.34 -45.38 0.83 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.93 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.18 175.02 12.56 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 124.059 0.849 . . . . 0.0 111.16 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.01 108.96 1.63 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.27 90.49 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.25 156.6 59.85 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 53' ' ' ALA . 1.4 Cg_endo -60.62 -30.1 89.82 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.116 1.877 . . . . 0.0 110.057 173.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.6 tp -85.91 30.65 0.65 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.608 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 116.86 -1.543 . . . . 0.0 108.848 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.982 0.42 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.3 131.53 23.43 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.454 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 tp -70.4 105.11 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.29 26.81 9.49 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -91.32 158.89 16.29 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 112.663 -2.062 . . . . 0.0 106.143 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -140.13 161.53 37.41 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.437 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -57.62 -34.95 69.84 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.124 0.964 . . . . 0.0 109.548 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' SG ' ' C ' ' A' ' 36' ' ' ALA . 8.1 t -75.61 -62.36 1.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.47 67.78 6.63 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 113.854 -1.521 . . . . 0.0 106.912 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.76 -109.45 2.88 Favored Glycine 0 N--CA 1.497 2.723 0 CA-C-N 114.259 -1.337 . . . . 0.0 115.066 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 m -167.07 107.46 0.62 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 124.648 0.852 . . . . 0.0 109.95 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.18 132.19 1.41 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.609 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.46 -24.02 6.81 Favored Glycine 0 N--CA 1.493 2.457 0 CA-C-O 118.603 -1.11 . . . . 0.0 114.473 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.4 m -79.97 127.74 32.63 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.781 1.29 . . . . 0.0 109.921 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -77.76 91.56 4.1 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.523 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 16.4 m-85 -54.48 132.27 44.27 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.52 156.5 43.75 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.721 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.6 t -105.51 128.15 53.41 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 112.295 -2.23 . . . . 0.0 109.775 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -39.16 -27.52 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.71 -29.22 64.52 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.199 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.93 36.27 0.73 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.1 m -141.36 133.78 28.25 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.489 0.662 . . . . 0.0 111.552 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -71.51 147.61 47.57 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.156 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.23 -72.56 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.053 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.523 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -154.57 176.67 12.11 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.73 156.83 16.38 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.506 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -52.23 104.4 0.17 Allowed Glycine 0 N--CA 1.489 2.208 0 CA-C-N 112.909 -1.95 . . . . 0.0 109.657 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.49 -19.59 10.01 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.552 -0.824 . . . . 0.0 112.983 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.65 116.41 11.99 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.174 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.07 122.17 84.11 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -70.76 72.12 1.96 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 123.062 2.508 . . . . 0.0 112.342 -173.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -177.51 -48.02 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -87.5 144.43 35.56 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 124.135 0.897 . . . . 0.0 109.416 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.13 82.46 1.8 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.966 1.777 . . . . 0.0 109.085 167.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -69.39 91.67 0.56 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.482 ' C ' ' SG ' ' A' ' 8' ' ' CYS . . . -109.12 148.06 31.45 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.882 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 m -159.25 -51.24 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.88 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.322 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 18.7 Cg_endo -80.94 -158.66 0.1 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.997 2.465 . . . . 0.0 109.489 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -79.72 -94.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -160.5 135.49 7.75 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.2 m 60.12 126.3 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.716 1.26 . . . . 0.0 114.103 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.81 83.61 11.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.716 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -53.46 -24.8 29.5 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.568 2.178 . . . . 0.0 113.122 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.06 -48.01 79.6 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mt -74.12 150.3 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.932 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.03 -44.52 3.58 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.532 -1.667 . . . . 0.0 107.211 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -171.36 -171.23 0.91 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.718 1.261 . . . . 0.0 109.161 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.45 120.74 3.98 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.91 85.84 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.3 m -80.29 132.49 59.15 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.378 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.75 151.65 68.97 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.945 1.764 . . . . 0.0 111.707 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.46 153.83 47.63 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.37 1.044 . . . . 0.0 109.827 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.143 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.129 0.49 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.92 56.29 0.68 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tp -86.34 45.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 114.231 -1.349 . . . . 0.0 110.591 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.6 m -87.24 39.91 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.589 1.185 . . . . 0.0 111.495 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -79.76 171.09 15.59 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 112.931 -1.94 . . . . 0.0 107.92 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -157.95 172.94 17.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.53 1.144 . . . . 0.0 111.079 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 t -72.2 -22.86 61.21 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.069 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 9.1 t -74.42 -59.23 2.82 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.111 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.55 62.01 3.82 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.045 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.12 -95.64 1.22 Allowed Glycine 0 N--CA 1.502 3.051 0 N-CA-C 118.513 2.165 . . . . 0.0 118.513 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.505 ' H ' ' HH ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -175.35 113.42 0.13 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 123.827 0.369 . . . . 0.0 111.69 -179.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HA ' ' C ' ' A' ' 27' ' ' GLY . 13.4 ttpt -71.62 93.49 1.24 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.321 1.057 . . . . 0.0 109.005 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.418 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 165.03 -39.26 0.29 Allowed Glycine 0 N--CA 1.485 1.962 0 CA-C-N 112.944 -1.935 . . . . 0.0 108.471 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.2 m -97.36 137.47 36.3 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.571 0.7 . . . . 0.0 112.451 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -85.07 105.17 15.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.64 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.791 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 56.9 m-85 -48.74 128.69 15.86 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.569 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.42 152.22 37.77 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.514 1.149 . . . . 0.0 111.959 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.2 t -104.53 130.37 52.49 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 112.082 -2.326 . . . . 0.0 111.955 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.93 -30.89 0.05 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 119.072 2.989 . . . . 0.0 119.072 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.07 -26.51 66.22 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.839 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.9 37.46 0.71 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 m -141.96 136.91 30.83 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.95 0.881 . . . . 0.0 111.862 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -70.49 150.05 46.56 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.975 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.7 t -112.11 -51.38 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.591 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.791 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -166.43 176.7 7.22 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 123.672 0.608 . . . . 0.0 109.942 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -106.03 142.68 35.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA3' ' H ' ' A' ' 13' ' ' GLY . . . -39.99 111.96 0.26 Allowed Glycine 0 N--CA 1.5 2.916 0 O-C-N 125.131 1.52 . . . . 0.0 111.434 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -126.31 -21.18 4.28 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' A' ' 11' ' ' THR . 15.2 m -65.71 84.4 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -83.03 133.86 47.46 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -50.76 -31.08 31.58 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.027 1.818 . . . . 0.0 112.937 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -75.06 -40.79 59.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 123.943 0.777 . . . . 0.0 110.713 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -83.18 150.7 61.59 Favored Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.593 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.83 90.7 0.36 Allowed 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.165 1.91 . . . . 0.0 110.952 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 66.02 8.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.837 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.36 123.58 4.37 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.87 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.7 m -146.72 67.96 11.59 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.95 112.26 1.61 Allowed 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 121.972 1.782 . . . . 0.0 111.033 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -160.54 -37.02 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 123.79 0.681 . . . . 0.0 112.51 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -142.76 175.79 9.55 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.853 0.721 . . . . 0.0 112.075 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 68.7 m -119.8 145.48 46.56 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.569 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -118.09 70.48 7.97 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.86 -23.41 76.78 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 C-N-CA 122.192 1.928 . . . . 0.0 112.217 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -42.62 99.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 124.405 1.066 . . . . 0.0 110.581 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tt -60.04 148.79 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.281 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.52 -40.37 3.06 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.035 -1.439 . . . . 0.0 107.678 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -174.46 -165.04 0.2 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.797 1.311 . . . . 0.0 109.102 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.39 122.93 4.78 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -79.12 102.85 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.2 m -91.06 125.32 59.06 Favored Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.097 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -64.18 148.24 91.23 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.03 1.82 . . . . 0.0 110.911 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.7 17.06 2.91 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 114.768 -2.539 . . . . 0.0 111.423 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.732 0.301 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 66.14 121.87 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 124.435 1.084 . . . . 0.0 112.872 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 tp -87.59 60.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 122.409 1.099 . . . . 0.0 109.487 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.98 52.53 2.5 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.654 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.35 166.6 23.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.248 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -161.04 148.83 15.59 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.459 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -7.38 5.3 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.121 -1.399 . . . . 0.0 113.714 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 4.4 t -78.58 -63.31 1.44 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.97 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.2 -79.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 37.31 -103.51 0.02 OUTLIER Glycine 0 N--CA 1.503 3.112 0 O-C-N 123.658 0.599 . . . . 0.0 113.675 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -179.25 118.45 0.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -45.48 115.48 0.95 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 123.883 0.74 . . . . 0.0 111.509 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.8 -23.26 20.0 Favored Glycine 0 N--CA 1.499 2.835 0 O-C-N 124.393 1.058 . . . . 0.0 114.155 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -79.32 -176.96 5.47 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 118.014 0.907 . . . . 0.0 109.607 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -137.46 104.18 5.28 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.164 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.503 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 63.6 m-85 -57.82 131.26 49.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.24 154.49 42.44 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.238 1.018 . . . . 0.0 110.684 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 t -106.16 124.77 50.11 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 112.565 -2.107 . . . . 0.0 109.491 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.426 ' H ' ' HB3' ' A' ' 46' ' ' ALA . 20.6 p-10 -39.04 -28.86 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.0 -28.17 64.17 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.218 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.33 35.22 0.72 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.2 m -140.01 135.45 32.7 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.615 0.721 . . . . 0.0 112.498 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -72.97 138.06 45.85 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.83 -52.73 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.422 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -173.03 -174.05 1.02 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 123.622 0.576 . . . . 0.0 111.007 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -114.17 142.6 46.04 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.65 110.06 1.7 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.45 14.02 23.79 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.7 t -145.45 115.65 7.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.556 0.693 . . . . 0.0 110.801 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.554 ' H ' HD22 ' A' ' 33' ' ' ASN . 10.6 t70 -79.68 141.36 55.84 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 113.569 -1.651 . . . . 0.0 106.716 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -44.25 -34.94 7.57 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 122.155 1.903 . . . . 0.0 113.152 173.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 tpp180 -73.98 -39.86 63.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 123.881 0.738 . . . . 0.0 112.593 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.554 HD22 ' H ' ' A' ' 30' ' ' ASP . 27.1 p30 -88.0 143.55 33.32 Favored Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.484 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.88 47.65 2.54 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 123.161 2.574 . . . . 0.0 112.881 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -98.51 27.17 4.95 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.139 0.971 . . . . 0.0 110.139 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.91 157.72 16.21 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.083 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.561 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.3 m -136.91 83.12 29.51 Favored Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.463 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.9 76.41 1.2 Allowed 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.219 1.946 . . . . 0.0 108.859 166.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -160.31 -30.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.644 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -94.96 132.27 39.98 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.985 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.0 m -113.84 131.44 56.25 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.836 1.335 . . . . 0.0 108.489 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -137.58 82.7 26.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 123.736 0.648 . . . . 0.0 111.087 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.51 -28.31 87.15 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.251 1.968 . . . . 0.0 112.751 168.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 mtm105 -64.18 -19.07 65.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.784 0.678 . . . . 0.0 111.91 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.13 144.07 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.426 ' HB3' ' H ' ' A' ' 19' ' ' ASP . . . -103.04 -50.12 3.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.522 1.138 . . . . 0.0 108.46 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -169.44 -173.76 1.77 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.935 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.9 110.6 2.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.3 mm -79.07 102.21 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.8 m -95.45 133.63 25.56 Favored Pre-proline 0 N--CA 1.493 1.724 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.322 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.0 86.34 0.39 Allowed 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 122.052 1.834 . . . . 0.0 110.214 174.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.16 179.11 8.99 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.045 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 116.958 -1.496 . . . . 0.0 110.103 179.922 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 121.445 0.64 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.07 136.84 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.985 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -142.71 35.84 1.43 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.246 1.022 . . . . 0.0 111.851 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.32 158.42 26.1 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 113.432 -1.713 . . . . 0.0 107.538 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -147.92 161.81 40.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 124.552 1.158 . . . . 0.0 110.831 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.21 -18.35 35.92 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.765 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 1.1 t -58.61 -59.2 5.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.2 -100.22 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.628 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 11' ' ' THR . . . 68.37 -99.13 0.56 Allowed Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.383 -0.823 . . . . 0.0 114.634 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 173.82 112.72 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HB2' ' N ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -61.3 107.53 0.78 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.507 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 131.2 -19.6 4.85 Favored Glycine 0 N--CA 1.493 2.441 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.3 m -103.65 143.34 32.9 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.019 0.437 . . . . 0.0 111.353 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -89.3 96.35 10.68 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.573 ' CZ ' ' HA2' ' A' ' 27' ' ' GLY . 3.5 m-85 -55.54 127.85 31.71 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.033 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.55 158.57 43.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.143 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 t -109.21 128.2 54.85 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 113.316 -1.766 . . . . 0.0 110.918 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.42 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 20.6 p-10 -41.89 -24.13 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 112.636 -2.075 . . . . 0.0 114.86 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -53.03 -31.94 44.03 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.923 0.764 . . . . 0.0 111.237 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.98 31.31 1.21 Allowed Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 m -143.88 143.31 31.23 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.869 0.842 . . . . 0.0 111.755 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -72.61 144.98 47.64 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.584 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.6 t -102.19 -54.93 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.173 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.494 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -174.59 168.27 3.77 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 123.992 0.808 . . . . 0.0 110.036 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -90.07 156.39 18.41 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -47.57 115.03 1.96 Allowed Glycine 0 N--CA 1.494 2.566 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.84 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -12.98 4.51 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 t -142.96 120.81 11.95 Favored 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 118.86 0.755 . . . . 0.0 110.659 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' N ' ' HB2' ' A' ' 12' ' ' LYS . 5.5 t70 -79.6 143.01 58.23 Favored Pre-proline 0 N--CA 1.49 1.545 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.091 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.19 -33.68 55.55 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.699 1.599 . . . . 0.0 111.87 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.57 -29.76 41.42 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.789 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -89.72 138.78 27.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.05 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -74.83 79.95 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.647 2.232 . . . . 0.0 110.331 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -138.68 38.58 2.21 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.857 0.837 . . . . 0.0 109.84 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.46 164.61 11.74 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 113.984 -1.462 . . . . 0.0 111.683 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.9 m -142.66 79.53 15.04 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.29 78.9 1.49 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.362 2.041 . . . . 0.0 110.026 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -149.09 -54.32 0.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.027 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -76.54 174.4 10.38 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.711 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.5 m -148.78 122.94 9.52 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.781 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.604 ' O ' HG22 ' A' ' 45' ' ' ILE . 7.8 t70 -117.26 78.02 10.18 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 124.113 0.883 . . . . 0.0 112.569 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.4 -19.99 38.13 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.192 1.928 . . . . 0.0 113.478 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -71.08 -40.63 71.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 123.742 0.651 . . . . 0.0 110.912 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 42' ' ' ASP . 12.4 tt -54.82 148.32 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 123.679 0.612 . . . . 0.0 110.421 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -126.11 -40.55 1.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 124.172 0.92 . . . . 0.0 110.598 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -172.92 -172.06 0.81 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.154 0.909 . . . . 0.0 109.985 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.43 116.33 3.0 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.9 mm -79.1 90.82 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.64 154.8 68.56 Favored Pre-proline 0 N--CA 1.493 1.675 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.536 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.489 1.259 0 C-N-CA 122.076 1.851 . . . . 0.0 110.446 173.904 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.895 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 tp -84.74 61.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.06 36.35 0.77 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 114.336 -1.302 . . . . 0.0 113.089 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -90.71 174.2 7.61 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.345 -1.752 . . . . 0.0 108.749 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -161.44 166.0 27.93 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 124.217 0.948 . . . . 0.0 111.129 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.42 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 1.1 t -57.73 -9.84 1.39 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.567 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.4 t -89.09 -64.75 1.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.287 -1.324 . . . . 0.0 113.665 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.75 73.44 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 120.104 3.372 . . . . 0.0 120.104 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 11' ' ' THR . . . -20.93 -105.0 0.0 OUTLIER Glycine 0 N--CA 1.514 3.869 0 N-CA-C 119.398 2.519 . . . . 0.0 119.398 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -178.24 114.77 0.07 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 123.747 0.322 . . . . 0.0 111.681 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -45.16 111.93 0.38 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 124.19 0.931 . . . . 0.0 110.388 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.25 -35.7 2.77 Favored Glycine 0 N--CA 1.494 2.53 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.771 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.5 m -79.34 -178.38 6.21 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -137.71 106.8 6.01 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.594 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.536 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 61.7 m-85 -56.85 129.73 42.7 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.392 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.482 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -145.45 157.13 44.07 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.198 0.999 . . . . 0.0 111.294 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.8 t -109.04 126.15 52.84 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.175 -1.829 . . . . 0.0 110.866 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.589 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 20.7 p-10 -38.49 -33.08 0.09 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.03 -26.67 60.71 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.917 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.92 34.71 0.72 Allowed Glycine 0 N--CA 1.493 2.499 0 O-C-N 124.233 0.958 . . . . 0.0 111.777 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.4 m -141.49 137.58 32.19 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.657 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -71.92 140.18 49.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 17' ' ' PHE . 59.2 t -100.7 -51.96 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 123.723 0.639 . . . . 0.0 111.152 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.27 178.97 4.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 123.81 0.694 . . . . 0.0 110.839 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -104.44 150.05 24.89 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.55 111.77 1.54 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -118.22 -15.18 9.82 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.74 105.32 1.53 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.47 129.63 46.53 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 124.233 0.958 . . . . 0.0 109.341 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -73.63 60.02 4.2 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.489 2.126 . . . . 0.0 111.731 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.82 -27.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -90.43 155.07 46.53 Favored Pre-proline 0 N--CA 1.498 1.961 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.415 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -75.76 72.99 4.9 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.342 2.028 . . . . 0.0 111.065 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.19 98.51 0.11 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.225 0.536 . . . . 0.0 110.121 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.59 131.61 36.05 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.913 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.79 79.83 10.31 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 124.428 1.08 . . . . 0.0 112.311 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.82 0.58 6.23 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.685 2.256 . . . . 0.0 111.748 168.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -25.3 41.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.736 0.648 . . . . 0.0 110.819 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 54.45 -160.15 0.16 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.157 0.911 . . . . 0.0 111.59 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.3 m -55.4 127.69 30.75 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.704 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -127.24 75.16 77.15 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 124.055 0.847 . . . . 0.0 112.056 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.67 -18.48 33.43 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.962 1.775 . . . . 0.0 112.617 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ttp-105 -59.29 -44.97 92.45 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mt -68.56 154.01 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -109.36 -46.6 3.53 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.627 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -172.44 -173.4 1.04 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.524 1.14 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.56 115.69 3.09 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.4 mm -78.8 104.65 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 36.6 m -93.51 122.65 62.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.489 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.2 0 C-N-CA 121.762 1.641 . . . . 0.0 108.77 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 54.9 mtt85 . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.701 HG23 ' HA ' ' A' ' 43' ' ' PRO . 4.7 tp -72.29 84.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 124.73 1.269 . . . . 0.0 107.625 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -92.89 47.47 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.385 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 p -89.83 176.66 6.74 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.743 -1.571 . . . . 0.0 108.441 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 9' ' ' ALA . 28.9 p-10 -157.77 154.65 28.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.168 0.918 . . . . 0.0 113.309 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 t -61.07 -31.25 70.92 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.778 -2.01 . . . . 0.0 112.418 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.7 t -63.33 -56.3 17.5 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.376 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.464 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -83.74 27.63 0.62 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 113.895 -1.502 . . . . 0.0 112.571 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.66 -135.71 0.06 OUTLIER Glycine 0 N--CA 1.497 2.731 0 O-C-N 124.129 0.893 . . . . 0.0 113.722 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.519 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 10.9 p -149.96 114.71 5.31 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 123.92 0.424 . . . . 0.0 112.052 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.12 103.46 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.821 0.701 . . . . 0.0 112.35 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.87 -31.72 3.64 Favored Glycine 0 N--CA 1.496 2.655 0 CA-C-N 114.336 -1.302 . . . . 0.0 113.86 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.9 m -85.91 158.77 19.84 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.968 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -112.31 91.68 3.74 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.471 1.107 . . . . 0.0 108.904 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -57.54 124.93 20.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.451 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.14 157.26 46.26 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.517 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.7 p -101.8 130.18 48.17 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.314 -1.766 . . . . 0.0 111.941 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.421 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 1.7 p30 -38.73 -32.27 0.08 Allowed 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -57.31 -28.76 63.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 123.687 0.617 . . . . 0.0 112.1 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.1 34.28 0.79 Allowed Glycine 0 N--CA 1.492 2.408 0 O-C-N 124.156 0.91 . . . . 0.0 111.0 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.2 m -140.43 137.46 33.97 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.19 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -70.81 142.84 51.29 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.39 -49.87 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 123.649 0.593 . . . . 0.0 110.481 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -175.74 -178.97 1.14 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.102 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -114.31 128.04 56.16 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.519 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -50.1 112.55 1.53 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 1.28 54.8 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.4 m -64.37 102.86 0.58 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.354 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.2 136.33 57.22 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 124.651 1.22 . . . . 0.0 112.104 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -67.39 87.46 0.33 Allowed 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 122.495 2.13 . . . . 0.0 110.002 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mtm105 166.85 -46.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.628 -1.623 . . . . 0.0 106.881 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -86.46 132.49 42.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.11 65.3 7.85 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.51 2.14 . . . . 0.0 110.621 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt 26.6 86.61 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 O-C-N 124.503 1.127 . . . . 0.0 113.806 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.04 87.91 4.81 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.619 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.0 m -148.86 147.88 25.73 Favored Pre-proline 0 N--CA 1.496 1.842 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.355 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.89 -75.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.167 0 C-N-CA 121.591 1.527 . . . . 0.0 109.683 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -161.15 -64.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.8 m120 56.54 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 125.411 1.694 . . . . 0.0 112.898 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.2 m -94.02 125.75 38.83 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.113 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -123.57 77.0 55.32 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 124.021 0.826 . . . . 0.0 110.725 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.701 ' HA ' HG23 ' A' ' 3' ' ' ILE . 5.9 Cg_exo -53.91 -30.32 57.77 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 122.309 2.006 . . . . 0.0 112.707 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -64.24 -43.75 93.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.162 0.914 . . . . 0.0 111.332 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.88 137.12 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 124.152 0.908 . . . . 0.0 109.316 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -116.42 -42.8 2.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.748 1.28 . . . . 0.0 109.085 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -170.13 -175.84 2.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.544 1.153 . . . . 0.0 109.92 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.22 114.58 2.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.4 mm -78.81 94.34 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.3 m -89.87 143.3 29.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.127 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 C-N-CA 122.0 1.8 . . . . 0.0 110.715 176.256 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 3' ' ' ILE . 7.0 tp -81.3 70.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.7 m -90.75 36.04 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.869 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 p -86.93 166.38 15.17 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 112.967 -1.924 . . . . 0.0 107.427 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -153.85 154.94 34.84 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 124.674 1.233 . . . . 0.0 109.046 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.471 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -59.34 -14.68 12.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 124.065 0.853 . . . . 0.0 112.257 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.0 t -90.39 -64.43 1.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.041 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.89 50.93 1.96 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 11' ' ' THR . . . -103.07 -88.21 2.04 Favored Glycine 0 N--CA 1.503 3.121 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.582 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.7 OUTLIER -169.08 108.68 0.45 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 124.641 0.848 . . . . 0.0 110.564 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HA ' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -50.8 112.14 0.66 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 123.763 0.664 . . . . 0.0 109.997 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.421 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 124.79 -30.51 4.62 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 124.483 1.114 . . . . 0.0 111.82 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.5 m -87.27 122.99 31.79 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -73.86 102.05 3.95 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.82 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.54 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 99.4 m-85 -51.66 126.49 17.8 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.53 153.61 41.3 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.429 1.109 . . . . 0.0 111.665 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.5 t -103.43 132.71 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.705 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 2.5 p30 -46.4 -23.58 0.38 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 113.111 -1.859 . . . . 0.0 114.449 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -58.99 -19.4 43.06 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.122 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.97 33.25 3.29 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.5 m -139.81 137.74 35.23 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.497 0.665 . . . . 0.0 112.232 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -72.26 142.47 48.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.2 t -102.56 -52.94 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.186 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.75 -179.77 3.42 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.823 0.702 . . . . 0.0 110.608 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -102.46 143.65 31.92 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -47.01 116.13 2.35 Favored Glycine 0 N--CA 1.498 2.819 0 O-C-N 125.353 1.658 . . . . 0.0 110.115 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.43 -29.81 5.03 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 p -68.43 100.16 1.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -101.74 129.12 27.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.61 -27.16 31.96 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.17 1.913 . . . . 0.0 113.219 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -38.86 51.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.721 0.638 . . . . 0.0 112.015 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.51 148.43 55.23 Favored Pre-proline 0 N--CA 1.495 1.796 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.082 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.14 76.88 4.0 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.502 2.135 . . . . 0.0 111.209 171.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.84 94.7 0.63 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.445 0.64 . . . . 0.0 109.637 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.7 83.12 5.7 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.43 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.9 m -102.56 151.31 38.22 Favored Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.327 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -67.5 153.77 75.58 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.118 1.879 . . . . 0.0 110.387 166.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -88.47 33.96 0.76 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.593 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -72.09 173.94 7.79 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.532 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 98.0 m -125.11 132.4 53.13 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.218 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 45' ' ' ILE . 12.6 t70 -113.79 84.38 8.38 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 123.747 0.654 . . . . 0.0 112.674 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -55.47 -21.88 32.14 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.352 2.035 . . . . 0.0 113.262 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -40.38 96.89 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.797 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 42' ' ' ASP . 11.4 tt -77.78 163.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 123.794 0.683 . . . . 0.0 110.667 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -121.67 -43.67 2.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 124.388 1.055 . . . . 0.0 108.289 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -171.75 -167.7 0.53 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 124.41 1.069 . . . . 0.0 109.758 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -128.01 120.61 3.48 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.6 100.75 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.4 m -92.51 145.63 30.88 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.147 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.487 1.108 0 C-N-CA 122.064 1.842 . . . . 0.0 109.943 176.604 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 43' ' ' PRO . 5.0 tp -72.46 80.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.841 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.49 43.25 1.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.649 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.508 HG21 ' CG2' ' A' ' 45' ' ' ILE . 5.0 t -75.93 167.63 21.52 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.407 -1.724 . . . . 0.0 108.199 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' A' ' 9' ' ' ALA . 31.9 p-10 -148.43 141.81 25.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 123.869 0.73 . . . . 0.0 109.433 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -23.63 49.12 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.024 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.12 -62.77 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.759 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.545 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -88.29 63.44 7.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 124.455 1.097 . . . . 0.0 110.497 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.48 -144.08 16.31 Favored Glycine 0 N--CA 1.494 2.563 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.292 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 p -136.68 107.23 6.51 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 123.905 0.415 . . . . 0.0 111.674 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -50.07 95.94 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.755 1.284 . . . . 0.0 110.661 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.86 -27.81 1.74 Allowed Glycine 0 N--CA 1.493 2.466 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.82 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.0 m -111.68 140.08 46.6 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.429 0.633 . . . . 0.0 112.4 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -89.79 97.96 11.49 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.209 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -56.43 125.34 21.58 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 156.98 48.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.807 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 t -104.51 130.31 52.47 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.993 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -39.84 -28.32 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 117.691 2.478 . . . . 0.0 117.691 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -55.99 -27.7 54.01 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.812 -0.755 . . . . 0.0 112.2 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.98 34.22 1.17 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 107.684 -2.166 . . . . 0.0 107.684 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.9 m -143.01 137.89 29.63 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.812 0.815 . . . . 0.0 111.172 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -70.12 152.41 44.35 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.699 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.7 -59.09 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 123.748 0.655 . . . . 0.0 111.677 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -176.19 177.96 1.47 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.868 0.73 . . . . 0.0 111.07 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.551 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -99.27 130.18 45.55 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.36 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.79 107.01 1.97 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.72 12.89 28.3 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -106.14 132.44 52.2 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.411 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -79.19 137.66 56.5 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.99 67.86 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.237 1.958 . . . . 0.0 111.924 169.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 170.09 -21.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.449 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -90.35 143.62 29.72 Favored Pre-proline 0 N--CA 1.493 1.716 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.072 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.3 55.44 5.66 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.528 2.152 . . . . 0.0 111.439 169.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.29 132.33 53.7 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.728 -1.189 . . . . 0.0 110.862 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.66 127.51 32.27 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.518 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.0 m -150.84 145.78 18.63 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 124.174 0.921 . . . . 0.0 110.54 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.65 151.09 83.43 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.721 1.614 . . . . 0.0 109.704 163.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.3 tpp85 -84.66 59.88 5.78 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.996 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -73.91 93.34 2.18 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.195 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.6 m -59.23 120.84 9.98 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.91 78.4 7.32 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.614 ' HA ' HG23 ' A' ' 3' ' ' ILE . 5.9 Cg_exo -54.48 -21.97 25.92 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 C-N-CA 122.554 2.169 . . . . 0.0 112.803 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -48.84 77.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.125 0.891 . . . . 0.0 109.136 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.508 ' CG2' HG21 ' A' ' 5' ' ' THR . 3.6 mt -58.18 143.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 123.931 0.769 . . . . 0.0 109.737 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.76 -37.38 0.82 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 112.607 -2.088 . . . . 0.0 111.036 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.01 178.19 9.42 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.196 0.935 . . . . 0.0 110.481 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.34 109.83 1.33 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.17 88.86 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -86.85 128.49 55.98 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.49 1.31 0 C-N-CA 122.069 1.846 . . . . 0.0 110.979 -179.033 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.1 ttt85 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 121.642 0.734 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 tp -87.44 45.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.329 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -84.56 46.68 1.26 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.478 1.132 . . . . 0.0 112.577 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.16 150.08 22.16 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.898 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -113.27 -165.76 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.752 1.283 . . . . 0.0 107.868 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 1.2 t -116.31 -29.39 6.23 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.376 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 t -56.32 -56.14 24.74 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.126 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.59 33.77 0.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.764 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.69 -113.88 0.14 Allowed Glycine 0 N--CA 1.494 2.556 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.457 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.5 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 1.4 p -154.88 111.82 3.31 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 123.933 0.431 . . . . 0.0 110.537 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -46.12 99.31 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.9 -23.57 5.88 Favored Glycine 0 N--CA 1.499 2.892 0 CA-C-N 114.99 -1.005 . . . . 0.0 114.902 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.1 m -86.31 143.14 28.04 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.837 0.818 . . . . 0.0 110.747 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -97.63 97.19 8.83 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.49 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 17.4 m-85 -62.24 122.39 15.5 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.97 162.85 31.27 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.023 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.8 t -108.84 131.44 54.99 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.462 -1.699 . . . . 0.0 111.5 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.556 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 4.4 p30 -45.14 -21.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 112.596 -2.093 . . . . 0.0 114.895 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -53.62 -30.33 42.25 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.896 0.747 . . . . 0.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.28 30.29 1.6 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.8 m -146.13 147.24 31.33 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.774 0.797 . . . . 0.0 112.124 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -69.86 158.68 35.06 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.04 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.482 HG11 ' NH1' ' A' ' 44' ' ' ARG . 39.2 t -129.98 -48.94 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 28.4 p -164.24 -175.85 4.16 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.143 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -130.48 137.01 49.56 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.239 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.5 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.32 115.41 5.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -114.49 26.12 10.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 109.63 21.14 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -88.16 137.19 31.25 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 124.379 1.049 . . . . 0.0 110.247 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -69.91 70.95 1.63 Allowed 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 121.969 1.779 . . . . 0.0 110.121 167.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 169.43 -30.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.682 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -90.08 141.47 27.92 Favored Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.215 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -75.12 68.29 5.88 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 122.734 2.289 . . . . 0.0 110.671 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.65 86.38 3.95 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.502 0.668 . . . . 0.0 110.061 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.43 103.07 9.1 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.198 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.3 m -104.82 150.62 38.86 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.25 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.87 158.18 57.68 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 122.317 2.012 . . . . 0.0 110.522 157.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.499 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.3 60.87 6.35 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.626 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -63.47 110.09 1.84 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.652 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 99.2 m -74.38 116.19 14.77 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.746 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.494 ' CG ' HD12 ' A' ' 45' ' ' ILE . 6.3 t70 -121.35 74.67 31.34 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.89 -25.77 78.44 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.413 2.076 . . . . 0.0 111.305 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.482 ' NH1' HG11 ' A' ' 24' ' ' VAL . 2.3 ttp-105 -59.99 -31.13 69.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.991 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.494 HD12 ' CG ' ' A' ' 42' ' ' ASP . 1.4 mt -77.12 156.96 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.556 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -116.83 -44.37 2.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.588 1.18 . . . . 0.0 109.687 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -173.92 178.93 2.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.305 1.003 . . . . 0.0 111.098 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.66 111.64 3.33 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.3 mt -79.24 89.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.0 m -86.27 134.65 38.06 Favored Pre-proline 0 N--CA 1.495 1.813 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.617 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 C-N-CA 121.954 1.769 . . . . 0.0 110.931 175.782 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 121.574 0.702 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.6 tp -45.11 131.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.746 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -135.26 48.28 2.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.195 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -78.81 170.35 16.81 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.382 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -150.59 148.17 28.32 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 41.6 t -78.14 -20.98 50.99 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.181 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -60.57 -58.3 9.07 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.36 36.91 0.89 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.648 -1.615 . . . . 0.0 108.229 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.48 -110.13 0.07 OUTLIER Glycine 0 N--CA 1.495 2.601 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.646 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.536 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 5.3 t -162.35 123.96 2.68 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -65.3 91.94 0.12 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.073 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.83 -21.64 0.79 Allowed Glycine 0 N--CA 1.489 2.194 0 CA-C-N 113.443 -1.708 . . . . 0.0 111.779 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.5 m -127.02 138.23 53.21 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 119.301 -0.96 . . . . 0.0 113.069 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -83.48 102.3 12.0 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 113.548 -1.66 . . . . 0.0 108.501 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.613 ' HB2' ' SG ' ' A' ' 7' ' ' CYS . 6.5 m-85 -62.52 122.81 16.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.7 159.88 38.35 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.045 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 t -108.21 131.28 54.84 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.161 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -39.63 -28.3 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -56.54 -28.53 60.3 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.829 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.07 34.14 0.92 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.3 m -143.61 138.8 29.29 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.886 0.85 . . . . 0.0 112.079 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -71.9 138.91 48.5 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.001 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.32 -57.19 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.909 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -175.84 174.89 2.09 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.556 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.484 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 1.4 mt-10 -99.19 131.11 45.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.315 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.536 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -65.43 112.94 5.38 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -103.45 7.8 37.94 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.383 0.696 . . . . 0.0 112.733 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -80.87 100.04 8.64 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.559 -0.857 . . . . 0.0 112.583 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -90.44 133.43 32.99 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.91 -26.01 23.39 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.974 1.783 . . . . 0.0 112.134 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -86.41 -37.64 18.17 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.725 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -83.74 143.59 43.94 Favored Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.119 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -76.23 74.58 4.56 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 122.445 2.097 . . . . 0.0 109.91 167.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HE2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -64.55 97.89 0.23 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.78 127.2 31.93 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.529 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.439 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 60.8 m -147.09 149.2 34.64 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 124.266 0.979 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.37 142.85 67.66 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 N-CA-C 107.729 -1.681 . . . . 0.0 107.729 153.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -85.31 62.03 7.23 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.092 0.948 . . . . 0.0 108.878 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.09 107.7 0.77 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.625 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.2 m -55.63 118.14 4.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 124.193 0.933 . . . . 0.0 110.587 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -128.76 74.05 80.85 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 124.311 1.007 . . . . 0.0 113.061 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.45 -22.44 66.1 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 121.888 1.726 . . . . 0.0 110.627 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.478 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -55.64 -38.22 69.26 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 124.314 1.009 . . . . 0.0 110.099 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mt -66.67 146.52 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.02 -42.56 1.38 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.143 -1.39 . . . . 0.0 111.87 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.87 175.68 12.22 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 124.111 0.882 . . . . 0.0 110.571 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.18 108.81 1.5 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.353 -2.299 . . . . 0.0 107.353 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.5 mt -79.12 94.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.07 152.32 46.02 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.887 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 C--N 1.316 -1.144 0 C-N-CA 121.785 1.656 . . . . 0.0 108.814 -179.727 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 tp -57.03 133.4 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.611 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -146.9 49.22 1.13 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.784 1.278 . . . . 0.0 110.546 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -72.99 167.11 21.76 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 112.997 -1.91 . . . . 0.0 109.562 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -161.19 162.04 31.13 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.946 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.7 t -65.72 -23.48 66.76 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.932 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -58.32 -60.4 3.84 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.8 -106.6 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 112.899 -1.955 . . . . 0.0 105.738 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 11' ' ' THR . . . 79.09 -107.93 2.6 Favored Glycine 0 CA--C 1.549 2.174 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -179.13 97.61 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 123.291 0.636 . . . . 0.0 111.055 -179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.8 133.93 42.37 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.937 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.7 -28.6 12.77 Favored Glycine 0 N--CA 1.488 2.136 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.924 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.6 m -106.63 143.38 34.82 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.412 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.68 106.19 18.17 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.68 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 2.6 m-30 -55.59 131.33 46.04 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.09 159.41 43.32 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 124.669 1.231 . . . . 0.0 112.188 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 t -108.12 129.32 55.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 112.735 -2.029 . . . . 0.0 111.113 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.539 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 6.8 p-10 -43.37 -25.15 0.12 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-N 113.092 -1.867 . . . . 0.0 115.321 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -54.14 -30.2 48.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 123.897 0.748 . . . . 0.0 111.592 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.41 32.72 1.2 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 m -143.56 143.96 31.74 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.901 0.857 . . . . 0.0 111.759 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -72.86 149.16 43.76 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.435 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.2 t -110.5 -52.38 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.53 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -170.05 -173.01 1.44 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 123.53 0.519 . . . . 0.0 110.252 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.557 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 mt-10 -112.43 158.66 19.58 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.41 ' HA2' ' CE1' ' A' ' 16' ' ' TYR . . . -59.78 110.55 2.88 Favored Glycine 0 N--CA 1.494 2.561 0 CA-C-N 112.812 -1.994 . . . . 0.0 110.897 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -121.13 -39.06 2.73 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 p -72.11 102.42 3.01 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.463 ' H ' HD21 ' A' ' 33' ' ' ASN . 10.5 t70 -79.54 133.42 59.57 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.63 -29.83 20.36 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.975 1.783 . . . . 0.0 113.102 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.6 mtt180 -84.77 -34.86 22.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 123.863 0.727 . . . . 0.0 112.093 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.463 HD21 ' H ' ' A' ' 30' ' ' ASP . 32.9 p30 -81.16 142.88 51.72 Favored Pre-proline 0 N--CA 1.495 1.808 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.574 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.84 47.3 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.365 2.71 . . . . 0.0 112.37 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -96.1 95.16 7.98 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.498 0.666 . . . . 0.0 110.584 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.49 140.22 16.07 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.473 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.61 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.8 m -133.2 94.29 20.56 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -71.61 79.17 1.57 Allowed 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.099 1.866 . . . . 0.0 109.364 172.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -144.82 -59.41 0.36 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.263 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -77.69 136.01 38.14 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.004 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.1 m -112.13 126.36 55.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.972 1.42 . . . . 0.0 108.217 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -126.24 71.74 70.88 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 123.893 0.745 . . . . 0.0 112.497 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.15 -28.54 73.58 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.486 2.124 . . . . 0.0 112.643 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -63.15 -17.51 62.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.026 0.829 . . . . 0.0 112.147 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.664 HD11 ' HB3' ' A' ' 16' ' ' TYR . 4.6 tt -69.65 158.82 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 123.694 0.621 . . . . 0.0 109.671 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.539 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -124.16 -45.18 1.99 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.946 0.778 . . . . 0.0 109.47 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -173.94 -169.73 0.5 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 124.343 1.027 . . . . 0.0 110.181 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.52 116.06 3.11 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.9 mt -80.79 91.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.216 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.24 127.06 77.74 Favored Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 N--CA 1.489 1.245 0 C-N-CA 121.901 1.734 . . . . 0.0 109.365 177.009 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mtm105 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 121.703 0.763 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.7 tp -86.63 46.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.687 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 m -85.48 46.35 1.29 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.549 1.166 . . . . 0.0 112.513 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -90.21 174.12 7.78 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 112.961 -1.927 . . . . 0.0 108.45 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -161.39 165.58 28.67 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.028 0.83 . . . . 0.0 110.373 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.7 t -67.49 -3.28 8.15 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.7 t -91.12 -57.77 2.69 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -42.13 -69.26 0.14 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 4.43 -112.93 0.01 OUTLIER Glycine 0 N--CA 1.508 3.465 0 N-CA-C 117.556 1.782 . . . . 0.0 117.556 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 173.65 126.82 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -49.62 110.55 0.39 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 124.148 0.905 . . . . 0.0 110.01 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.94 -28.38 4.39 Favored Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.536 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.6 m -79.59 -176.48 5.34 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.199 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -139.22 101.39 4.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.857 0.723 . . . . 0.0 109.683 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.589 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 85.6 m-85 -57.45 131.92 51.57 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.42 155.86 44.5 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.222 1.01 . . . . 0.0 110.94 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 t -106.86 135.74 47.88 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.382 -2.19 . . . . 0.0 113.485 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -47.27 -24.47 0.74 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 111.575 -2.557 . . . . 0.0 113.573 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -56.0 -25.76 45.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 124.098 0.874 . . . . 0.0 111.797 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.27 32.17 2.43 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.7 m -145.66 148.34 32.96 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 112.449 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -70.98 153.49 42.61 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.339 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.7 t -115.99 -56.75 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.213 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.589 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -162.5 -178.92 6.56 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.702 0.626 . . . . 0.0 110.56 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.418 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -112.77 150.64 31.34 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.48 110.49 1.41 Allowed Glycine 0 N--CA 1.492 2.419 0 CA-C-N 112.951 -1.931 . . . . 0.0 109.653 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -114.03 -6.61 13.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.897 0.998 . . . . 0.0 113.437 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.97 89.66 4.14 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.95 130.39 44.85 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.28 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.0 74.49 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.609 2.206 . . . . 0.0 110.993 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 170.57 -39.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.591 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -80.95 155.99 72.52 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.104 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.86 78.51 2.47 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 122.128 1.885 . . . . 0.0 111.163 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.09 99.4 0.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.07 92.92 5.06 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.6 m -111.71 98.93 43.15 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.115 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.9 169.45 13.26 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 121.97 1.78 . . . . 0.0 110.452 168.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -83.69 25.51 0.77 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.352 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -63.95 134.85 55.85 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.644 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.22 136.66 34.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 125.501 1.75 . . . . 0.0 110.887 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -129.82 81.0 70.31 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 124.054 0.846 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -54.96 -27.92 56.67 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 122.189 1.926 . . . . 0.0 113.238 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -59.36 -46.9 87.36 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mt -64.77 148.46 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.97 -42.13 2.97 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.209 -1.814 . . . . 0.0 108.604 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -173.7 -168.74 0.45 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.638 1.211 . . . . 0.0 109.676 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.11 113.8 1.92 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 mm -79.5 111.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.6 m -102.71 157.44 33.72 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 123.557 0.536 . . . . 0.0 110.459 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.486 1.073 0 C-N-CA 121.909 1.739 . . . . 0.0 108.094 173.091 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.4 mmt-85 . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 3' ' ' ILE . 5.9 tp -72.72 89.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.599 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -97.05 55.8 1.34 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.693 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -87.72 179.49 6.49 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.507 -1.678 . . . . 0.0 107.993 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -160.27 -171.19 3.09 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 t -98.73 -30.95 12.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.043 0.84 . . . . 0.0 111.944 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.2 t -67.18 -60.82 2.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 123.995 0.81 . . . . 0.0 109.761 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.19 63.86 8.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 125.119 1.512 . . . . 0.0 108.772 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.65 -136.35 7.74 Favored Glycine 0 N--CA 1.491 2.348 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.812 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -144.25 108.63 4.83 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.86 94.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.346 1.029 . . . . 0.0 111.888 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.01 -26.2 2.5 Favored Glycine 0 N--CA 1.495 2.582 0 CA-C-N 113.754 -1.566 . . . . 0.0 113.169 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.7 m -87.66 158.88 18.73 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.005 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -116.18 95.66 5.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.515 1.134 . . . . 0.0 109.834 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -52.27 129.8 29.08 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.927 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.88 158.99 43.6 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.521 0.677 . . . . 0.0 111.76 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -107.38 132.71 52.86 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.473 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -44.58 -24.39 0.19 Allowed 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 112.887 -1.96 . . . . 0.0 114.997 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -54.42 -27.67 38.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.07 0.856 . . . . 0.0 111.45 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.06 32.84 1.77 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.6 m -144.93 140.78 28.5 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.505 0.669 . . . . 0.0 111.539 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.16 159.52 28.77 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.754 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.3 t -127.68 -46.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.72 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -167.38 -173.96 2.41 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.838 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.72 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -128.15 124.81 37.8 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.447 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.23 117.87 12.74 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 107.481 -2.248 . . . . 0.0 107.481 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.63 13.79 24.95 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.35 109.89 20.98 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.408 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.41 132.45 62.29 Favored Pre-proline 0 N--CA 1.494 1.725 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.21 75.66 0.48 Allowed 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.859 1.706 . . . . 0.0 110.149 173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 164.58 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.96 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.43 144.64 31.1 Favored Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.478 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.12 69.01 8.1 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.513 2.142 . . . . 0.0 111.309 168.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -71.08 89.41 0.82 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.91 121.63 25.67 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.715 -1.129 . . . . 0.0 113.675 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.4 m -160.42 162.47 23.51 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.079 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.62 159.77 35.31 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.692 1.594 . . . . 0.0 110.682 165.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.5 ttm105 -87.31 63.3 7.68 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -57.36 149.98 19.31 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.601 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.7 m -109.97 128.72 55.56 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.1 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CG ' HD12 ' A' ' 45' ' ' ILE . 5.7 t70 -123.66 75.51 55.26 Favored Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 124.059 0.849 . . . . 0.0 113.202 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.07 -21.47 65.58 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.485 2.123 . . . . 0.0 112.068 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -63.73 -39.07 93.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.039 0.837 . . . . 0.0 110.009 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.587 HD12 ' CG ' ' A' ' 42' ' ' ASP . 1.6 mt -69.29 154.31 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.42 1.075 . . . . 0.0 109.537 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.25 -44.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.354 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.49 -177.6 6.32 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 124.308 1.005 . . . . 0.0 110.212 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.68 110.57 1.26 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 107.169 -2.372 . . . . 0.0 107.169 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.1 mt -79.07 90.6 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -92.51 149.71 38.65 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.921 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.374 0 C-N-CA 122.206 1.938 . . . . 0.0 112.35 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 . . . . . 0 N--CA 1.497 1.908 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 43' ' ' PRO . 5.9 tp -69.31 87.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 124.22 0.95 . . . . 0.0 109.863 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.68 37.55 1.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.552 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 p -89.03 171.95 9.47 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 113.727 -1.578 . . . . 0.0 107.385 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -158.0 155.71 29.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.142 0.901 . . . . 0.0 111.883 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.42 -16.66 38.11 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.96 -1.473 . . . . 0.0 112.284 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -90.25 -69.27 0.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.472 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.82 58.85 3.97 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.94 -83.77 1.21 Allowed Glycine 0 N--CA 1.497 2.749 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.909 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.573 HG23 ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -174.24 111.78 0.16 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.83 119.72 4.14 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.072 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.9 -31.11 7.25 Favored Glycine 0 N--CA 1.495 2.63 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.416 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.573 ' HB2' HG23 ' A' ' 11' ' ' THR . 90.2 m -90.06 120.56 31.35 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.766 -1.173 . . . . 0.0 111.124 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -67.53 100.11 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.371 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.55 ' CE2' ' HA2' ' A' ' 27' ' ' GLY . 91.8 m-85 -48.96 131.03 18.84 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.29 156.37 42.45 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 122.147 0.975 . . . . 0.0 110.985 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.4 t -107.19 130.08 54.77 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 112.438 -2.165 . . . . 0.0 110.704 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 4.0 p-10 -39.04 -28.83 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 118.402 2.741 . . . . 0.0 118.402 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.43 -28.59 65.39 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.521 -0.872 . . . . 0.0 112.37 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.93 35.01 0.75 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 m -142.93 140.21 31.05 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.668 0.747 . . . . 0.0 111.845 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -70.63 153.37 42.92 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.081 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t -115.52 -57.91 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.114 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.533 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -162.08 -178.66 6.55 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 123.523 0.514 . . . . 0.0 110.717 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -97.42 138.62 34.59 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.55 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -54.47 113.8 3.75 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.14 -23.46 5.35 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.65 98.49 0.52 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 118.9 0.773 . . . . 0.0 111.504 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.73 127.23 30.63 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.482 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.53 -22.65 44.0 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.453 2.102 . . . . 0.0 113.772 -168.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.436 ' H ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -83.02 -41.71 18.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 123.895 0.747 . . . . 0.0 110.511 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.33 147.39 87.59 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -73.2 77.87 2.36 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.184 1.922 . . . . 0.0 110.607 174.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 81.43 2.29 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.045 0.926 . . . . 0.0 109.184 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.53 127.93 32.75 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.518 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -147.95 148.93 31.52 Favored Pre-proline 0 N--CA 1.495 1.783 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.07 161.26 37.82 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.818 1.679 . . . . 0.0 109.735 165.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -86.54 61.81 7.04 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.25 1.024 . . . . 0.0 109.367 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -76.69 -177.88 4.49 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.258 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 93.8 m -146.77 122.61 10.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -112.74 83.15 5.51 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 123.775 0.672 . . . . 0.0 112.724 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' HA ' HG23 ' A' ' 3' ' ' ILE . 4.5 Cg_exo -51.95 -31.44 43.55 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.573 2.182 . . . . 0.0 112.213 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -59.88 -50.69 72.79 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 124.406 1.066 . . . . 0.0 108.477 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -63.02 148.1 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.031 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -118.64 -43.19 2.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 124.527 1.142 . . . . 0.0 108.021 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -173.06 -167.75 0.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.719 1.262 . . . . 0.0 109.308 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.81 121.06 4.02 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.5 mt -83.0 95.03 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 123.947 0.44 . . . . 0.0 111.607 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 m -82.57 145.56 51.42 Favored Pre-proline 0 N--CA 1.503 2.2 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 C-N-CA 122.274 1.983 . . . . 0.0 110.77 177.216 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tp -56.73 119.45 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.122 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -124.49 47.33 2.12 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.58 140.48 29.51 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.542 ' ND2' ' HA ' ' A' ' 40' ' ' ASN . 14.6 p-10 -160.35 163.04 33.55 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 124.028 0.83 . . . . 0.0 111.052 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 10.1 t -60.81 -16.8 44.75 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 1.9 t -91.55 -43.87 9.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.455 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -88.59 43.66 1.15 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -102.45 -118.18 4.39 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.066 -1.064 . . . . 0.0 114.056 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.5 m -160.6 126.4 3.97 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.86 103.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 123.706 0.629 . . . . 0.0 109.575 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.434 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 132.41 -25.31 3.84 Favored Glycine 0 N--CA 1.498 2.777 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.776 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.8 m -88.25 122.97 32.39 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 117.362 0.581 . . . . 0.0 110.174 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -76.75 99.43 5.11 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.491 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.59 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 82.7 m-85 -54.95 127.98 31.34 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.501 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -145.09 157.74 44.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.197 0.999 . . . . 0.0 110.839 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.8 t -103.99 131.32 51.36 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 112.592 -2.094 . . . . 0.0 110.97 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.1 p-10 -44.55 -24.87 0.22 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 125.519 1.762 . . . . 0.0 114.892 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -58.2 -20.95 45.47 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.766 0.666 . . . . 0.0 112.469 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.08 33.27 2.82 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.3 m -139.82 136.2 33.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.122 0.542 . . . . 0.0 112.119 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -70.89 148.66 47.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 45' ' ' ILE . 45.7 t -111.88 -50.88 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 123.779 0.674 . . . . 0.0 110.583 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.59 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -168.48 173.3 7.62 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 123.823 0.702 . . . . 0.0 109.778 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -96.99 152.19 18.97 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.624 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -48.02 118.46 4.46 Favored Glycine 0 N--CA 1.507 3.378 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -132.53 39.78 3.34 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.3 t -162.82 94.93 0.87 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.23 133.16 61.03 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -60.94 86.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 121.916 1.744 . . . . 0.0 109.419 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.62 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.219 -1.809 . . . . 0.0 106.961 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.76 135.49 28.93 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 124.154 0.909 . . . . 0.0 109.307 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -75.08 66.62 6.09 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.185 1.923 . . . . 0.0 109.439 167.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -53.03 127.36 23.7 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.81 135.8 37.17 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.371 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.3 m -145.74 155.89 52.29 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 124.526 1.141 . . . . 0.0 111.944 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.91 -46.07 3.64 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 122.193 1.929 . . . . 0.0 112.26 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -158.15 -2.0 0.09 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.542 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 58.1 m-20 51.79 48.32 23.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.002 0.814 . . . . 0.0 113.111 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 98.1 m -153.41 131.41 11.78 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.186 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -157.98 101.35 1.77 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 123.938 0.774 . . . . 0.0 110.93 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.59 -18.6 60.86 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 122.02 1.814 . . . . 0.0 112.652 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 ttm105 -66.53 -33.12 74.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 123.651 0.594 . . . . 0.0 110.351 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.605 HD11 HG11 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -83.74 157.11 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -114.03 -46.49 3.0 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.01 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -172.47 -172.93 0.97 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.327 1.017 . . . . 0.0 109.683 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -121.06 118.01 3.66 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.2 mm -79.03 95.47 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.54 142.35 29.41 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.291 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo . . . . . 0 N--CA 1.489 1.219 0 C-N-CA 122.062 1.841 . . . . 0.0 111.525 177.288 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.5 tp -60.67 125.36 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 123.992 0.808 . . . . 0.0 110.517 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.13 47.59 2.46 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.23 143.95 36.68 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -150.76 178.13 9.42 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.491 1.139 . . . . 0.0 113.35 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.0 t -94.48 -45.02 7.61 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.262 -2.245 . . . . 0.0 108.589 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.24 -56.57 19.91 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.03 41.48 1.03 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.454 -1.703 . . . . 0.0 108.856 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' HB3' ' A' ' 29' ' ' SER . . . -78.7 -155.91 9.05 Favored Glycine 0 N--CA 1.491 2.348 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.518 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.515 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.1 m -141.02 96.17 2.96 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 115.697 -0.252 . . . . 0.0 110.566 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 5.8 mmtm -26.05 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 124.86 -34.89 3.3 Favored Glycine 0 N--CA 1.501 3.03 0 CA-C-N 114.932 -1.031 . . . . 0.0 114.822 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.3 m -84.4 120.61 26.48 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 101.7 5.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.375 1.047 . . . . 0.0 110.746 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.416 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 7.4 m-85 -58.99 122.57 14.04 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.65 157.47 46.56 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.404 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 t -103.18 130.61 50.43 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.64 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -46.2 -20.32 0.1 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 113.168 -1.833 . . . . 0.0 114.903 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -55.27 -28.65 54.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 123.638 0.586 . . . . 0.0 110.747 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.24 30.95 1.79 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.8 m -144.94 142.61 29.99 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.816 0.817 . . . . 0.0 112.09 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -69.35 149.69 48.15 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.808 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.5 t -112.38 -52.77 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 123.783 0.677 . . . . 0.0 110.986 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -168.21 176.9 5.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.083 0.864 . . . . 0.0 110.528 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.634 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -99.91 123.36 44.08 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -59.52 103.39 0.41 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -93.7 -8.23 41.45 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 118.075 2.62 . . . . 0.0 118.075 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.448 ' HB3' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -79.37 131.71 36.19 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.574 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.53 134.58 23.17 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.5 -27.5 19.08 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.034 1.823 . . . . 0.0 112.712 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -85.9 -34.17 21.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.957 0.786 . . . . 0.0 112.805 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -90.14 152.88 46.52 Favored Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.791 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -79.85 51.93 4.09 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.1 2.533 . . . . 0.0 112.978 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -74.05 94.65 2.42 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.795 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.48 155.57 48.31 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.765 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.427 ' H ' HD21 ' A' ' 40' ' ' ASN . 29.3 m -145.05 160.44 46.31 Favored Pre-proline 0 N--CA 1.499 1.989 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.11 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.02 -13.03 17.24 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.872 1.715 . . . . 0.0 113.241 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.12 75.32 1.44 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 124.035 0.834 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.427 HD21 ' H ' ' A' ' 37' ' ' CYS . 5.3 m120 -104.48 42.44 1.2 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.605 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.0 m -147.52 134.54 20.32 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.132 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -159.05 98.8 1.63 Allowed Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.24 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.22 -17.47 32.7 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.585 2.19 . . . . 0.0 113.677 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.6 ttp-105 -61.06 -35.28 76.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 123.705 0.628 . . . . 0.0 110.949 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -77.54 155.18 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.714 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.17 -41.44 1.77 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 112.414 -2.176 . . . . 0.0 110.064 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.17 177.94 10.0 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 124.162 0.913 . . . . 0.0 110.909 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.63 108.18 1.15 Allowed Glycine 0 N--CA 1.495 2.605 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.41 93.98 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.47 148.39 38.72 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-N 114.843 -1.072 . . . . 0.0 108.752 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo . . . . . 0 N--CA 1.488 1.201 0 C-N-CA 121.806 1.671 . . . . 0.0 110.32 176.65 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 120.908 0.385 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 tp -86.42 49.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.643 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.4 45.45 1.12 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.668 1.223 . . . . 0.0 112.504 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.14 170.1 14.17 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 113.056 -1.884 . . . . 0.0 108.146 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -160.58 145.23 14.25 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.201 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 1.7 t -55.9 -19.9 13.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.554 1.159 . . . . 0.0 113.329 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -73.71 -67.82 0.56 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.182 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.45 -86.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 11' ' ' THR . . . 33.22 -108.04 0.03 OUTLIER Glycine 0 N--CA 1.506 3.363 0 N-CA-C 115.208 0.843 . . . . 0.0 115.208 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 177.28 121.74 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 124.912 1.007 . . . . 0.0 109.251 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.27 104.7 0.15 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 123.965 0.79 . . . . 0.0 109.863 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.02 -30.09 2.38 Favored Glycine 0 N--CA 1.491 2.313 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.076 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.45 125.57 41.03 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -82.74 113.81 20.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.345 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.634 ' HB3' HD11 ' A' ' 45' ' ' ILE . 92.2 m-85 -55.73 131.32 46.37 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.64 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.71 155.41 42.39 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.067 0.937 . . . . 0.0 111.204 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.5 t -107.92 133.51 52.15 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 112.683 -2.053 . . . . 0.0 112.851 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -38.96 -31.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 111.245 -2.707 . . . . 0.0 118.053 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.21 -28.15 66.39 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.362 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.82 37.17 0.68 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 m -144.56 142.06 29.92 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -69.89 152.12 44.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.677 -1.147 . . . . 0.0 107.951 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.7 -47.43 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 123.835 0.709 . . . . 0.0 110.541 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.603 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.04 -176.85 2.74 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 123.703 0.627 . . . . 0.0 110.683 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.5 mm-40 -111.15 147.54 34.69 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA2' ' CE1' ' A' ' 16' ' ' TYR . . . -49.52 113.7 1.91 Allowed Glycine 0 N--CA 1.491 2.33 0 O-C-N 125.652 1.845 . . . . 0.0 109.303 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -108.22 -37.21 6.08 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 t -77.9 95.48 4.77 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.509 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.5 t70 -85.55 123.06 73.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.98 86.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.326 2.017 . . . . 0.0 111.628 -167.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 30' ' ' ASP . 4.6 mtm-85 169.41 -34.89 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.671 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.509 HD21 ' H ' ' A' ' 30' ' ' ASP . 55.7 p30 -87.91 152.33 50.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 123.958 0.786 . . . . 0.0 112.62 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -79.52 42.64 1.34 Allowed 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 123.301 2.668 . . . . 0.0 112.929 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.96 38.16 1.25 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.55 132.36 56.21 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.255 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.457 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 4.5 m -137.06 68.99 57.12 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.96 -21.49 41.6 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.193 1.929 . . . . 0.0 112.338 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -83.37 19.9 1.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.791 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -118.93 118.33 31.23 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.741 0.651 . . . . 0.0 109.805 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.7 m -105.89 129.05 54.12 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.53 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -130.97 78.81 72.76 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 123.86 0.725 . . . . 0.0 110.938 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.42 -22.19 57.45 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.086 1.857 . . . . 0.0 113.78 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.495 ' HD3' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -67.07 -43.12 83.44 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -66.15 155.92 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.16 -43.18 2.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.099 0.875 . . . . 0.0 109.408 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -175.64 -165.07 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.36 1.038 . . . . 0.0 109.264 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -128.35 119.26 3.03 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.4 mm -79.0 110.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -99.3 151.52 37.45 Favored Pre-proline 0 N--CA 1.495 1.818 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.89 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.486 1.049 0 C-N-CA 121.944 1.763 . . . . 0.0 109.323 168.502 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.798 0.809 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.601 HG22 ' OG1' ' A' ' 5' ' ' THR . 7.3 mm -76.14 89.65 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -85.94 27.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.601 ' OG1' HG22 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -91.03 164.78 13.84 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 9' ' ' ALA . 39.9 p-10 -160.87 150.6 17.32 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.585 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.3 t -65.37 -21.5 66.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.753 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -77.76 -68.6 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.162 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' A' ' 6' ' ' ASN . . . -90.32 52.8 2.31 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.556 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.74 -121.76 0.18 Allowed Glycine 0 N--CA 1.491 2.336 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.809 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.498 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -158.88 103.0 1.68 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -42.46 105.42 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.18 -30.06 4.42 Favored Glycine 0 N--CA 1.496 2.651 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.832 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.6 m -82.4 157.2 23.8 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.908 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -111.73 95.35 5.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.258 0.974 . . . . 0.0 111.703 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.6 129.0 34.84 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.639 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.12 160.39 41.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.024 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.4 t -109.6 129.8 55.56 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.408 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.559 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 7.2 p-10 -42.95 -24.35 0.06 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 112.962 -1.926 . . . . 0.0 115.366 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -53.24 -30.69 39.53 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.876 0.735 . . . . 0.0 111.292 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.16 31.78 1.25 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -144.86 144.43 31.11 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.759 0.79 . . . . 0.0 111.92 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -71.19 154.37 41.74 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.325 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.4 t -118.56 -52.43 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 123.613 0.57 . . . . 0.0 111.229 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -173.34 -169.51 0.53 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.027 0.829 . . . . 0.0 109.443 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.68 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -124.78 134.72 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.498 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -51.9 111.39 1.44 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.32 11.72 37.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.61 0.83 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.9 p -77.69 92.45 4.14 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.973 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -82.57 137.8 44.54 Favored Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.547 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.14 77.92 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 122.19 1.927 . . . . 0.0 111.309 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 161.58 -37.24 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.097 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -82.04 143.18 48.96 Favored Pre-proline 0 N--CA 1.498 1.954 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.333 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.97 91.22 0.53 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.847 1.698 . . . . 0.0 108.87 170.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 66.7 3.6 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.031 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.77 135.08 54.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.524 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 2.8 m -153.78 167.77 12.99 Favored Pre-proline 0 N--CA 1.497 1.918 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.083 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -68.99 70.08 1.19 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.073 1.848 . . . . 0.0 109.007 159.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.469 HH11 HH12 ' A' ' 44' ' ' ARG . 4.6 tpm_? -160.41 73.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -107.01 114.03 27.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.565 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 84.8 m 59.64 108.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 124.967 1.417 . . . . 0.0 111.615 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.15 88.31 5.65 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -47.1 -35.2 18.76 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 123.375 2.717 . . . . 0.0 114.434 170.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.469 HH12 HH11 ' A' ' 39' ' ' ARG . 0.5 OUTLIER -56.28 -43.74 79.11 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 124.223 0.952 . . . . 0.0 110.211 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.555 ' O ' HG21 ' A' ' 3' ' ' ILE . 2.2 mt -75.41 161.43 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.782 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.559 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -120.71 -44.6 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.0 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -173.52 -169.76 0.54 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 124.303 1.002 . . . . 0.0 109.754 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.84 117.07 2.92 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.8 mm -78.86 95.15 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.5 m -85.19 133.32 43.0 Favored Pre-proline 0 N--CA 1.493 1.713 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.301 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.488 1.151 0 C-N-CA 122.133 1.889 . . . . 0.0 110.522 178.02 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.028 0.442 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.761 HD11 ' HA ' ' A' ' 46' ' ' ALA . 9.4 tp -89.99 38.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.646 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.8 m -94.21 43.15 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.985 -1.461 . . . . 0.0 112.299 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.72 176.01 7.6 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.675 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' A' ' 9' ' ' ALA . 10.4 p30 -158.86 141.17 14.0 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -65.28 -24.99 67.45 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.58 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -63.64 -54.2 39.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 124.249 0.968 . . . . 0.0 112.056 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.55 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -89.82 -77.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 113.811 -1.541 . . . . 0.0 115.135 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 11' ' ' THR . . . 39.43 -98.32 0.01 OUTLIER Glycine 0 N--CA 1.501 2.971 0 N-CA-C 115.433 0.933 . . . . 0.0 115.433 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 179.46 119.41 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 O-C-N 124.509 0.77 . . . . 0.0 111.575 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.23 130.25 8.02 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 123.669 0.605 . . . . 0.0 111.514 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.68 -29.66 10.65 Favored Glycine 0 N--CA 1.493 2.49 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.58 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.9 m -80.21 121.46 25.63 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.33 107.2 11.92 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.584 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 95.5 m-85 -58.43 129.01 40.02 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.76 156.99 43.96 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 124.229 0.956 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 t -106.04 136.05 46.42 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.572 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.608 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 10.8 p-10 -47.06 -23.48 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 112.074 -2.33 . . . . 0.0 113.503 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -58.11 -19.85 35.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 123.798 0.686 . . . . 0.0 111.849 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.66 33.24 3.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.6 m -143.88 139.93 29.49 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.687 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -68.65 154.93 41.01 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.443 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.25 -53.39 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.126 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -161.96 -178.32 6.37 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 123.567 0.542 . . . . 0.0 110.927 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.419 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 17.0 mm-40 -112.63 150.75 30.99 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.02 110.45 0.35 Allowed Glycine 0 N--CA 1.499 2.861 0 O-C-N 125.779 1.924 . . . . 0.0 112.459 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 -42.75 7.32 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 118.39 2.737 . . . . 0.0 118.39 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 t -57.86 102.81 0.11 Allowed 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 119.756 1.162 . . . . 0.0 113.883 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.55 139.9 22.98 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 124.931 1.395 . . . . 0.0 107.45 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -45.75 -30.61 6.75 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.627 2.218 . . . . 0.0 115.942 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -65.21 -36.93 85.69 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.743 HD22 ' H ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -81.61 142.49 49.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 119.226 -0.989 . . . . 0.0 108.561 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -75.52 40.52 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.147 1.898 . . . . 0.0 110.933 166.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.743 ' H ' HD22 ' A' ' 33' ' ' ASN . 2.6 mptp? 48.81 71.6 0.36 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.633 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.32 86.36 5.07 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.302 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.1 m -153.66 141.54 13.81 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.99 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.53 -166.28 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 121.936 1.757 . . . . 0.0 110.753 168.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -79.54 -76.56 0.21 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 m120 50.5 86.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 124.62 1.2 . . . . 0.0 113.052 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.8 m -66.95 128.37 36.09 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -113.71 80.97 5.32 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.59 -30.63 83.87 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 122.367 2.045 . . . . 0.0 112.603 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.481 ' HD3' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -61.48 -44.58 96.84 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.49 144.3 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.761 ' HA ' HD11 ' A' ' 3' ' ' ILE . . . -106.21 -46.74 3.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.959 0.787 . . . . 0.0 109.22 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -173.21 -170.08 0.6 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.118 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -127.73 115.22 2.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.6 mm -79.4 110.55 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.23 160.53 28.02 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.487 1.116 0 C-N-CA 121.633 1.556 . . . . 0.0 108.961 173.837 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 3' ' ' ILE . 5.1 tp -79.19 76.23 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.322 1.058 . . . . 0.0 108.711 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.1 m -90.32 36.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.218 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.24 -171.55 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.727 -2.033 . . . . 0.0 106.843 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 68.8 m-80 -160.4 167.8 26.57 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.406 1.066 . . . . 0.0 111.122 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -61.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.344 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -59.69 5.06 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.101 -1.408 . . . . 0.0 109.013 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . . . -79.05 31.8 0.21 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.137 -2.301 . . . . 0.0 111.351 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.03 -130.09 0.65 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.486 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.0 m -142.58 109.64 5.56 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 123.97 0.453 . . . . 0.0 111.294 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -48.37 106.61 0.1 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.443 1.089 . . . . 0.0 111.225 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.28 -27.23 4.27 Favored Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.567 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.4 m -110.29 134.45 52.26 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.919 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -80.2 101.15 8.66 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.529 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -62.42 119.24 8.74 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.96 158.68 38.88 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.222 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 t -103.59 129.76 50.91 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.323 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -46.0 -20.84 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 125.855 1.972 . . . . 0.0 114.765 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -55.17 -29.81 58.58 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 123.859 0.724 . . . . 0.0 110.785 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.55 31.57 1.48 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.8 m -144.03 140.68 29.69 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.732 0.777 . . . . 0.0 111.574 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -74.49 135.74 42.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.374 -1.284 . . . . 0.0 107.682 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -91.14 -63.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.356 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -176.25 171.91 2.39 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.17 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.3 mt-10 -90.45 150.25 21.89 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 120.174 -0.611 . . . . 0.0 112.433 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.486 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.11 124.61 11.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.65 -5.0 15.12 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.8 t -85.39 123.45 30.87 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.656 ' H ' HD21 ' A' ' 33' ' ' ASN . 13.0 t70 -80.11 127.06 78.06 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.85 83.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.93 1.753 . . . . 0.0 110.155 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 30' ' ' ASP . 1.4 mmt-85 176.16 -39.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.966 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.656 HD21 ' H ' ' A' ' 30' ' ' ASP . 14.9 p30 -91.28 148.91 38.76 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 124.167 0.917 . . . . 0.0 110.945 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.14 47.29 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.58 2.187 . . . . 0.0 110.183 162.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -72.88 111.55 8.1 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -155.08 109.12 2.9 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.784 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 2.2 m -79.48 -42.66 1.59 Allowed Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 37' ' ' CYS . 10.0 Cg_endo -72.79 -176.32 2.28 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 C-N-CA 122.42 2.08 . . . . 0.0 110.643 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.11 -1.23 1.77 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.575 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -125.49 -168.02 1.78 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.213 0.946 . . . . 0.0 113.023 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 89.0 m -91.18 152.91 20.37 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.132 -1.395 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.597 ' CG ' HD12 ' A' ' 45' ' ' ILE . 7.3 t0 -113.8 76.36 3.11 Favored Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 123.652 0.595 . . . . 0.0 110.996 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.66 -26.98 81.58 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.447 2.098 . . . . 0.0 111.423 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 mtm-85 -60.51 -45.09 95.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.22 0.95 . . . . 0.0 109.744 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.597 HD12 ' CG ' ' A' ' 42' ' ' ASP . 2.4 mt -66.55 155.36 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 124.347 1.03 . . . . 0.0 108.614 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.34 -45.38 0.83 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.93 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.18 175.02 12.56 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 124.059 0.849 . . . . 0.0 111.16 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.01 108.96 1.63 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.27 90.49 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.25 156.6 59.85 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 N--CA 1.49 1.267 0 C-N-CA 122.116 1.877 . . . . 0.0 110.057 173.196 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 3' ' ' ILE . 7.6 tp -70.4 105.11 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.29 26.81 9.49 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -91.32 158.89 16.29 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 112.663 -2.062 . . . . 0.0 106.143 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -140.13 161.53 37.41 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -57.62 -34.95 69.84 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.124 0.964 . . . . 0.0 109.548 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' SG ' ' C ' ' A' ' 36' ' ' ALA . 8.1 t -75.61 -62.36 1.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.47 67.78 6.63 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 113.854 -1.521 . . . . 0.0 106.912 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.76 -109.45 2.88 Favored Glycine 0 N--CA 1.497 2.723 0 CA-C-N 114.259 -1.337 . . . . 0.0 115.066 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 m -167.07 107.46 0.62 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 124.648 0.852 . . . . 0.0 109.95 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.18 132.19 1.41 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.609 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' N ' ' HA3' ' A' ' 27' ' ' GLY . . . 84.46 -24.02 6.81 Favored Glycine 0 N--CA 1.493 2.457 0 CA-C-O 118.603 -1.11 . . . . 0.0 114.473 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.4 m -79.97 127.74 32.63 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.781 1.29 . . . . 0.0 109.921 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -77.76 91.56 4.1 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.536 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 16.4 m-85 -54.48 132.27 44.27 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.497 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -145.52 156.5 43.75 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.721 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.6 t -105.51 128.15 53.41 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 112.295 -2.23 . . . . 0.0 109.775 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.484 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.7 p-10 -39.16 -27.52 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.71 -29.22 64.52 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.199 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.93 36.27 0.73 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.1 m -141.36 133.78 28.25 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.489 0.662 . . . . 0.0 111.552 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -71.51 147.61 47.57 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.156 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 17' ' ' PHE . 58.8 t -104.23 -72.56 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.053 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -154.57 176.67 12.11 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.73 156.83 16.38 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -52.23 104.4 0.17 Allowed Glycine 0 N--CA 1.489 2.208 0 CA-C-N 112.909 -1.95 . . . . 0.0 109.657 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.49 -19.59 10.01 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.552 -0.824 . . . . 0.0 112.983 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.65 116.41 11.99 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.174 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.07 122.17 84.11 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -70.76 72.12 1.96 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 123.062 2.508 . . . . 0.0 112.342 -173.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -177.51 -48.02 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -87.5 144.43 35.56 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 124.135 0.897 . . . . 0.0 109.416 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.13 82.46 1.8 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.966 1.777 . . . . 0.0 109.085 167.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -69.39 91.67 0.56 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.482 ' C ' ' SG ' ' A' ' 8' ' ' CYS . . . -109.12 148.06 31.45 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.882 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 1.6 m -159.25 -51.24 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.88 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.322 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 18.7 Cg_endo -80.94 -158.66 0.1 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.997 2.465 . . . . 0.0 109.489 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -79.72 -94.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -160.5 135.49 7.75 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.2 m 60.12 126.3 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.716 1.26 . . . . 0.0 114.103 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.81 83.61 11.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.716 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -53.46 -24.8 29.5 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.568 2.178 . . . . 0.0 113.122 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.06 -48.01 79.6 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mt -74.12 150.3 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.932 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -111.03 -44.52 3.58 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.532 -1.667 . . . . 0.0 107.211 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -171.36 -171.23 0.91 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.718 1.261 . . . . 0.0 109.161 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.45 120.74 3.98 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.91 85.84 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.3 m -80.29 132.49 59.15 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.378 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.201 0 C-N-CA 121.945 1.764 . . . . 0.0 111.707 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tp -86.34 45.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 114.231 -1.349 . . . . 0.0 110.591 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.6 m -87.24 39.91 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.589 1.185 . . . . 0.0 111.495 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -79.76 171.09 15.59 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 112.931 -1.94 . . . . 0.0 107.92 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -157.95 172.94 17.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.53 1.144 . . . . 0.0 111.079 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 t -72.2 -22.86 61.21 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.069 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 9.1 t -74.42 -59.23 2.82 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.111 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.55 62.01 3.82 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.045 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.12 -95.64 1.22 Allowed Glycine 0 N--CA 1.502 3.051 0 N-CA-C 118.513 2.165 . . . . 0.0 118.513 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.4 ' N ' ' HB2' ' A' ' 29' ' ' SER . 0.0 OUTLIER -175.35 113.42 0.13 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 123.827 0.369 . . . . 0.0 111.69 -179.439 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HA ' ' C ' ' A' ' 27' ' ' GLY . 13.4 ttpt -71.62 93.49 1.24 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.321 1.057 . . . . 0.0 109.005 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.507 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 165.03 -39.26 0.29 Allowed Glycine 0 N--CA 1.485 1.962 0 CA-C-N 112.944 -1.935 . . . . 0.0 108.471 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.2 m -97.36 137.47 36.3 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.571 0.7 . . . . 0.0 112.451 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -85.07 105.17 15.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.64 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.791 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 56.9 m-85 -48.74 128.69 15.86 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.569 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.42 152.22 37.77 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.514 1.149 . . . . 0.0 111.959 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.2 t -104.53 130.37 52.49 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 112.082 -2.326 . . . . 0.0 111.955 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.93 -30.89 0.05 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 119.072 2.989 . . . . 0.0 119.072 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.07 -26.51 66.22 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.839 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.9 37.46 0.71 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 m -141.96 136.91 30.83 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.95 0.881 . . . . 0.0 111.862 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -70.49 150.05 46.56 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.975 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.7 t -112.11 -51.38 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.591 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.791 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -166.43 176.7 7.22 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 123.672 0.608 . . . . 0.0 109.942 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -106.03 142.68 35.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA3' ' H ' ' A' ' 13' ' ' GLY . . . -39.99 111.96 0.26 Allowed Glycine 0 N--CA 1.5 2.916 0 O-C-N 125.131 1.52 . . . . 0.0 111.434 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -126.31 -21.18 4.28 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.4 ' HB2' ' N ' ' A' ' 11' ' ' THR . 15.2 m -65.71 84.4 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.425 ' H ' HD21 ' A' ' 33' ' ' ASN . 12.6 t70 -83.03 133.86 47.46 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -50.76 -31.08 31.58 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.027 1.818 . . . . 0.0 112.937 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -75.06 -40.79 59.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 123.943 0.777 . . . . 0.0 110.713 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.425 HD21 ' H ' ' A' ' 30' ' ' ASP . 22.6 p30 -83.18 150.7 61.59 Favored Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.593 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.83 90.7 0.36 Allowed 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.165 1.91 . . . . 0.0 110.952 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 66.02 8.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.837 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.36 123.58 4.37 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.87 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.7 m -146.72 67.96 11.59 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.95 112.26 1.61 Allowed 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 121.972 1.782 . . . . 0.0 111.033 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -160.54 -37.02 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 123.79 0.681 . . . . 0.0 112.51 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -142.76 175.79 9.55 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.853 0.721 . . . . 0.0 112.075 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 68.7 m -119.8 145.48 46.56 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.569 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 45' ' ' ILE . 7.1 t0 -118.09 70.48 7.97 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.86 -23.41 76.78 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 C-N-CA 122.192 1.928 . . . . 0.0 112.217 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -42.62 99.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 124.405 1.066 . . . . 0.0 110.581 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 42' ' ' ASP . 10.6 tt -60.04 148.79 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.281 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.52 -40.37 3.06 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.035 -1.439 . . . . 0.0 107.678 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -174.46 -165.04 0.2 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.797 1.311 . . . . 0.0 109.102 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.39 122.93 4.78 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -79.12 102.85 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.2 m -91.06 125.32 59.06 Favored Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.097 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo . . . . . 0 N--CA 1.488 1.191 0 C-N-CA 122.03 1.82 . . . . 0.0 110.911 177.495 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 . . . . . 0 N--CA 1.502 2.126 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 3' ' ' ILE . 6.2 tp -87.59 60.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 122.409 1.099 . . . . 0.0 109.487 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.98 52.53 2.5 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.654 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.35 166.6 23.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.248 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -161.04 148.83 15.59 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.459 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -7.38 5.3 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.121 -1.399 . . . . 0.0 113.714 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 4.4 t -78.58 -63.31 1.44 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.97 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.2 -79.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 11' ' ' THR . . . 37.31 -103.51 0.02 OUTLIER Glycine 0 N--CA 1.503 3.112 0 O-C-N 123.658 0.599 . . . . 0.0 113.675 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -179.25 118.45 0.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -45.48 115.48 0.95 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 123.883 0.74 . . . . 0.0 111.509 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.8 -23.26 20.0 Favored Glycine 0 N--CA 1.499 2.835 0 O-C-N 124.393 1.058 . . . . 0.0 114.155 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -79.32 -176.96 5.47 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 118.014 0.907 . . . . 0.0 109.607 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -137.46 104.18 5.28 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.164 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.503 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 63.6 m-85 -57.82 131.26 49.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.47 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -145.24 154.49 42.44 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.238 1.018 . . . . 0.0 110.684 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 t -106.16 124.77 50.11 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 112.565 -2.107 . . . . 0.0 109.491 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.596 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 20.6 p-10 -39.04 -28.86 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.0 -28.17 64.17 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.218 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.33 35.22 0.72 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.2 m -140.01 135.45 32.7 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.615 0.721 . . . . 0.0 112.498 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -72.97 138.06 45.85 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.47 HG23 ' HA ' ' A' ' 17' ' ' PHE . 61.7 t -97.83 -52.73 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.422 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -173.03 -174.05 1.02 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 123.622 0.576 . . . . 0.0 111.007 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -114.17 142.6 46.04 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.65 110.06 1.7 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.45 14.02 23.79 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.7 t -145.45 115.65 7.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.556 0.693 . . . . 0.0 110.801 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.63 ' H ' HD21 ' A' ' 33' ' ' ASN . 10.6 t70 -79.68 141.36 55.84 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 113.569 -1.651 . . . . 0.0 106.716 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -44.25 -34.94 7.57 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 122.155 1.903 . . . . 0.0 113.152 173.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 tpp180 -73.98 -39.86 63.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 123.881 0.738 . . . . 0.0 112.593 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.63 HD21 ' H ' ' A' ' 30' ' ' ASP . 27.1 p30 -88.0 143.55 33.32 Favored Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.484 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.88 47.65 2.54 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 123.161 2.574 . . . . 0.0 112.881 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -98.51 27.17 4.95 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.139 0.971 . . . . 0.0 110.139 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.91 157.72 16.21 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.083 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.561 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.3 m -136.91 83.12 29.51 Favored Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.463 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.9 76.41 1.2 Allowed 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.219 1.946 . . . . 0.0 108.859 166.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -160.31 -30.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.644 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -94.96 132.27 39.98 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.985 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.0 m -113.84 131.44 56.25 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.836 1.335 . . . . 0.0 108.489 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -137.58 82.7 26.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 123.736 0.648 . . . . 0.0 111.087 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.51 -28.31 87.15 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.251 1.968 . . . . 0.0 112.751 168.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 mtm105 -64.18 -19.07 65.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.784 0.678 . . . . 0.0 111.91 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.13 144.07 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.596 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -103.04 -50.12 3.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.522 1.138 . . . . 0.0 108.46 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -169.44 -173.76 1.77 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.935 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.9 110.6 2.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.3 mm -79.07 102.21 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.8 m -95.45 133.63 25.56 Favored Pre-proline 0 N--CA 1.493 1.724 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.322 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 C-N-CA 122.052 1.834 . . . . 0.0 110.214 174.329 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 50.65 29.5 4.2 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 124.488 1.117 . . . . 0.0 111.643 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.07 136.84 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.985 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -142.71 35.84 1.43 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.246 1.022 . . . . 0.0 111.851 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.32 158.42 26.1 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 113.432 -1.713 . . . . 0.0 107.538 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -147.92 161.81 40.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 124.552 1.158 . . . . 0.0 110.831 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.21 -18.35 35.92 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.765 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 1.1 t -58.61 -59.2 5.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.2 -100.22 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.628 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 11' ' ' THR . . . 68.37 -99.13 0.56 Allowed Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.383 -0.823 . . . . 0.0 114.634 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 173.82 112.72 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HB2' ' N ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -61.3 107.53 0.78 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.507 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 131.2 -19.6 4.85 Favored Glycine 0 N--CA 1.493 2.441 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.3 m -103.65 143.34 32.9 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.019 0.437 . . . . 0.0 111.353 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -89.3 96.35 10.68 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.573 ' CZ ' ' HA2' ' A' ' 27' ' ' GLY . 3.5 m-85 -55.54 127.85 31.71 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.033 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.55 158.57 43.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.143 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 t -109.21 128.2 54.85 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 113.316 -1.766 . . . . 0.0 110.918 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.42 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 20.6 p-10 -41.89 -24.13 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 112.636 -2.075 . . . . 0.0 114.86 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -53.03 -31.94 44.03 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.923 0.764 . . . . 0.0 111.237 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.98 31.31 1.21 Allowed Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 m -143.88 143.31 31.23 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.869 0.842 . . . . 0.0 111.755 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -72.61 144.98 47.64 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.584 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.6 t -102.19 -54.93 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.173 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.494 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -174.59 168.27 3.77 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 123.992 0.808 . . . . 0.0 110.036 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -90.07 156.39 18.41 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -47.57 115.03 1.96 Allowed Glycine 0 N--CA 1.494 2.566 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.84 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -12.98 4.51 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 t -142.96 120.81 11.95 Favored 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 118.86 0.755 . . . . 0.0 110.659 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' N ' ' HB2' ' A' ' 12' ' ' LYS . 5.5 t70 -79.6 143.01 58.23 Favored Pre-proline 0 N--CA 1.49 1.545 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.091 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.19 -33.68 55.55 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.699 1.599 . . . . 0.0 111.87 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.57 -29.76 41.42 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.789 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -89.72 138.78 27.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.05 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -74.83 79.95 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.647 2.232 . . . . 0.0 110.331 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -138.68 38.58 2.21 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.857 0.837 . . . . 0.0 109.84 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.46 164.61 11.74 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 113.984 -1.462 . . . . 0.0 111.683 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.538 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.9 m -142.66 79.53 15.04 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.29 78.9 1.49 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.362 2.041 . . . . 0.0 110.026 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -149.09 -54.32 0.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.027 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -76.54 174.4 10.38 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.711 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.5 m -148.78 122.94 9.52 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.781 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.604 ' O ' HG22 ' A' ' 45' ' ' ILE . 7.8 t70 -117.26 78.02 10.18 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 124.113 0.883 . . . . 0.0 112.569 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.4 -19.99 38.13 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.192 1.928 . . . . 0.0 113.478 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -71.08 -40.63 71.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 123.742 0.651 . . . . 0.0 110.912 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 42' ' ' ASP . 12.4 tt -54.82 148.32 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 123.679 0.612 . . . . 0.0 110.421 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -126.11 -40.55 1.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 124.172 0.92 . . . . 0.0 110.598 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -172.92 -172.06 0.81 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.154 0.909 . . . . 0.0 109.985 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.43 116.33 3.0 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.9 mm -79.1 90.82 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.64 154.8 68.56 Favored Pre-proline 0 N--CA 1.493 1.675 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.536 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.56 -29.66 89.01 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.076 1.851 . . . . 0.0 110.446 173.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 52' ' ' LEU . 3.8 mm? -80.76 -32.27 35.6 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.888 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 116.266 -1.826 . . . . 0.0 109.325 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.048 0.452 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.51 -28.02 1.02 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.049 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 tp -84.74 61.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.06 36.35 0.77 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 114.336 -1.302 . . . . 0.0 113.089 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -90.71 174.2 7.61 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.345 -1.752 . . . . 0.0 108.749 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -161.44 166.0 27.93 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 124.217 0.948 . . . . 0.0 111.129 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.42 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 1.1 t -57.73 -9.84 1.39 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.567 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.4 t -89.09 -64.75 1.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.287 -1.324 . . . . 0.0 113.665 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.75 73.44 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 120.104 3.372 . . . . 0.0 120.104 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 11' ' ' THR . . . -20.93 -105.0 0.0 OUTLIER Glycine 0 N--CA 1.514 3.869 0 N-CA-C 119.398 2.519 . . . . 0.0 119.398 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -178.24 114.77 0.07 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 123.747 0.322 . . . . 0.0 111.681 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -45.16 111.93 0.38 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 124.19 0.931 . . . . 0.0 110.388 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.25 -35.7 2.77 Favored Glycine 0 N--CA 1.494 2.53 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.771 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.5 m -79.34 -178.38 6.21 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -137.71 106.8 6.01 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.594 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.536 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 61.7 m-85 -56.85 129.73 42.7 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.392 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.482 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -145.45 157.13 44.07 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.198 0.999 . . . . 0.0 111.294 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.8 t -109.04 126.15 52.84 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.175 -1.829 . . . . 0.0 110.866 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.589 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 20.7 p-10 -38.49 -33.08 0.09 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.03 -26.67 60.71 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.917 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.92 34.71 0.72 Allowed Glycine 0 N--CA 1.493 2.499 0 O-C-N 124.233 0.958 . . . . 0.0 111.777 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.4 m -141.49 137.58 32.19 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.657 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -71.92 140.18 49.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 17' ' ' PHE . 59.2 t -100.7 -51.96 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 123.723 0.639 . . . . 0.0 111.152 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.27 178.97 4.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 123.81 0.694 . . . . 0.0 110.839 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -104.44 150.05 24.89 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.55 111.77 1.54 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -118.22 -15.18 9.82 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.74 105.32 1.53 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.47 129.63 46.53 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 124.233 0.958 . . . . 0.0 109.341 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -73.63 60.02 4.2 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.489 2.126 . . . . 0.0 111.731 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.82 -27.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -90.43 155.07 46.53 Favored Pre-proline 0 N--CA 1.498 1.961 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.415 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -75.76 72.99 4.9 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.342 2.028 . . . . 0.0 111.065 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.19 98.51 0.11 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.225 0.536 . . . . 0.0 110.121 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.59 131.61 36.05 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.913 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.79 79.83 10.31 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 124.428 1.08 . . . . 0.0 112.311 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.82 0.58 6.23 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.685 2.256 . . . . 0.0 111.748 168.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -25.3 41.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.736 0.648 . . . . 0.0 110.819 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 54.45 -160.15 0.16 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.157 0.911 . . . . 0.0 111.59 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.3 m -55.4 127.69 30.75 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.704 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -127.24 75.16 77.15 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 124.055 0.847 . . . . 0.0 112.056 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.67 -18.48 33.43 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.962 1.775 . . . . 0.0 112.617 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ttp-105 -59.29 -44.97 92.45 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mt -68.56 154.01 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -109.36 -46.6 3.53 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.627 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -172.44 -173.4 1.04 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.524 1.14 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.56 115.69 3.09 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.4 mm -78.8 104.65 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 36.6 m -93.51 122.65 62.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.489 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.1 -61.24 0.16 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.762 1.641 . . . . 0.0 108.77 172.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 52' ' ' LEU . 4.0 mm? -122.66 -51.3 1.94 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.898 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.715 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 54.9 mtt85 -136.78 -54.14 0.72 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.701 HG23 ' HA ' ' A' ' 43' ' ' PRO . 4.7 tp -72.29 84.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 124.73 1.269 . . . . 0.0 107.625 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -92.89 47.47 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.385 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 p -89.83 176.66 6.74 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.743 -1.571 . . . . 0.0 108.441 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 9' ' ' ALA . 28.9 p-10 -157.77 154.65 28.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.168 0.918 . . . . 0.0 113.309 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 t -61.07 -31.25 70.92 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.778 -2.01 . . . . 0.0 112.418 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.7 t -63.33 -56.3 17.5 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.376 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -83.74 27.63 0.62 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 113.895 -1.502 . . . . 0.0 112.571 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.66 -135.71 0.06 OUTLIER Glycine 0 N--CA 1.497 2.731 0 O-C-N 124.129 0.893 . . . . 0.0 113.722 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.519 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 10.9 p -149.96 114.71 5.31 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 123.92 0.424 . . . . 0.0 112.052 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.12 103.46 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.821 0.701 . . . . 0.0 112.35 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.87 -31.72 3.64 Favored Glycine 0 N--CA 1.496 2.655 0 CA-C-N 114.336 -1.302 . . . . 0.0 113.86 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.9 m -85.91 158.77 19.84 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.968 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -112.31 91.68 3.74 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.471 1.107 . . . . 0.0 108.904 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -57.54 124.93 20.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.451 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.14 157.26 46.26 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.517 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.7 p -101.8 130.18 48.17 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.314 -1.766 . . . . 0.0 111.941 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 1.7 p30 -38.73 -32.27 0.08 Allowed 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -57.31 -28.76 63.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 123.687 0.617 . . . . 0.0 112.1 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.1 34.28 0.79 Allowed Glycine 0 N--CA 1.492 2.408 0 O-C-N 124.156 0.91 . . . . 0.0 111.0 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.2 m -140.43 137.46 33.97 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.19 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -70.81 142.84 51.29 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.39 -49.87 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 123.649 0.593 . . . . 0.0 110.481 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -175.74 -178.97 1.14 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.102 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -114.31 128.04 56.16 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.519 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -50.1 112.55 1.53 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 1.28 54.8 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.4 m -64.37 102.86 0.58 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.354 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.2 136.33 57.22 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 124.651 1.22 . . . . 0.0 112.104 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -67.39 87.46 0.33 Allowed 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 122.495 2.13 . . . . 0.0 110.002 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mtm105 166.85 -46.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.628 -1.623 . . . . 0.0 106.881 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -86.46 132.49 42.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.11 65.3 7.85 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.51 2.14 . . . . 0.0 110.621 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt 26.6 86.61 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 O-C-N 124.503 1.127 . . . . 0.0 113.806 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.04 87.91 4.81 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.619 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.0 m -148.86 147.88 25.73 Favored Pre-proline 0 N--CA 1.496 1.842 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.355 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.89 -75.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.167 0 C-N-CA 121.591 1.527 . . . . 0.0 109.683 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -161.15 -64.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.8 m120 56.54 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 125.411 1.694 . . . . 0.0 112.898 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.2 m -94.02 125.75 38.83 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.113 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -123.57 77.0 55.32 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 124.021 0.826 . . . . 0.0 110.725 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.701 ' HA ' HG23 ' A' ' 3' ' ' ILE . 5.9 Cg_exo -53.91 -30.32 57.77 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 122.309 2.006 . . . . 0.0 112.707 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -64.24 -43.75 93.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.162 0.914 . . . . 0.0 111.332 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.88 137.12 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 124.152 0.908 . . . . 0.0 109.316 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -116.42 -42.8 2.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.748 1.28 . . . . 0.0 109.085 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -170.13 -175.84 2.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.544 1.153 . . . . 0.0 109.92 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.22 114.58 2.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.4 mm -78.81 94.34 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.3 m -89.87 143.3 29.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.127 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.27 132.07 37.09 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 122.0 1.8 . . . . 0.0 110.715 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.63 -4.6 10.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 124.285 0.991 . . . . 0.0 111.262 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 116.683 -1.627 . . . . 0.0 111.369 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -72.34 -22.82 61.11 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.362 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 3' ' ' ILE . 7.0 tp -81.3 70.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.7 m -90.75 36.04 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.869 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 p -86.93 166.38 15.17 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 112.967 -1.924 . . . . 0.0 107.427 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -153.85 154.94 34.84 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 124.674 1.233 . . . . 0.0 109.046 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.471 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -59.34 -14.68 12.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 124.065 0.853 . . . . 0.0 112.257 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.0 t -90.39 -64.43 1.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.041 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.89 50.93 1.96 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 11' ' ' THR . . . -103.07 -88.21 2.04 Favored Glycine 0 N--CA 1.503 3.121 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.582 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.7 OUTLIER -169.08 108.68 0.45 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 124.641 0.848 . . . . 0.0 110.564 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HA ' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -50.8 112.14 0.66 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 123.763 0.664 . . . . 0.0 109.997 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 124.79 -30.51 4.62 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 124.483 1.114 . . . . 0.0 111.82 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.5 m -87.27 122.99 31.79 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -73.86 102.05 3.95 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.82 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.54 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 99.4 m-85 -51.66 126.49 17.8 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.53 153.61 41.3 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.429 1.109 . . . . 0.0 111.665 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.5 t -103.43 132.71 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.705 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 2.5 p30 -46.4 -23.58 0.38 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 113.111 -1.859 . . . . 0.0 114.449 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -58.99 -19.4 43.06 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.122 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.97 33.25 3.29 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.5 m -139.81 137.74 35.23 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.497 0.665 . . . . 0.0 112.232 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -72.26 142.47 48.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.2 t -102.56 -52.94 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.186 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.75 -179.77 3.42 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.823 0.702 . . . . 0.0 110.608 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -102.46 143.65 31.92 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -47.01 116.13 2.35 Favored Glycine 0 N--CA 1.498 2.819 0 O-C-N 125.353 1.658 . . . . 0.0 110.115 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.43 -29.81 5.03 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 p -68.43 100.16 1.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -101.74 129.12 27.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.61 -27.16 31.96 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.17 1.913 . . . . 0.0 113.219 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -38.86 51.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.721 0.638 . . . . 0.0 112.015 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.51 148.43 55.23 Favored Pre-proline 0 N--CA 1.495 1.796 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.082 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.14 76.88 4.0 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.502 2.135 . . . . 0.0 111.209 171.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.84 94.7 0.63 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.445 0.64 . . . . 0.0 109.637 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.7 83.12 5.7 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.43 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.9 m -102.56 151.31 38.22 Favored Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.327 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -67.5 153.77 75.58 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.118 1.879 . . . . 0.0 110.387 166.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -88.47 33.96 0.76 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.593 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -72.09 173.94 7.79 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.532 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 98.0 m -125.11 132.4 53.13 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.218 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 45' ' ' ILE . 12.6 t70 -113.79 84.38 8.38 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 123.747 0.654 . . . . 0.0 112.674 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -55.47 -21.88 32.14 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.352 2.035 . . . . 0.0 113.262 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -40.38 96.89 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.797 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 42' ' ' ASP . 11.4 tt -77.78 163.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 123.794 0.683 . . . . 0.0 110.667 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -121.67 -43.67 2.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 124.388 1.055 . . . . 0.0 108.289 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -171.75 -167.7 0.53 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 124.41 1.069 . . . . 0.0 109.758 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -128.01 120.61 3.48 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.6 100.75 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.4 m -92.51 145.63 30.88 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.147 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.59 112.0 2.04 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 122.064 1.842 . . . . 0.0 109.943 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 mt -137.41 -50.98 0.63 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 124.153 0.908 . . . . 0.0 109.743 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.171 0 O-C-N 124.421 1.076 . . . . 0.0 113.552 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.08 163.26 30.31 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 123.838 0.711 . . . . 0.0 110.001 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 43' ' ' PRO . 5.0 tp -72.46 80.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.841 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.49 43.25 1.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.649 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.508 HG21 ' CG2' ' A' ' 45' ' ' ILE . 5.0 t -75.93 167.63 21.52 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.407 -1.724 . . . . 0.0 108.199 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' A' ' 9' ' ' ALA . 31.9 p-10 -148.43 141.81 25.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 123.869 0.73 . . . . 0.0 109.433 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -23.63 49.12 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.024 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.12 -62.77 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.759 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.545 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -88.29 63.44 7.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 124.455 1.097 . . . . 0.0 110.497 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.48 -144.08 16.31 Favored Glycine 0 N--CA 1.494 2.563 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.292 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 p -136.68 107.23 6.51 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 123.905 0.415 . . . . 0.0 111.674 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -50.07 95.94 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.755 1.284 . . . . 0.0 110.661 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.86 -27.81 1.74 Allowed Glycine 0 N--CA 1.493 2.466 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.82 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.0 m -111.68 140.08 46.6 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.429 0.633 . . . . 0.0 112.4 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -89.79 97.96 11.49 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.209 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -56.43 125.34 21.58 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 156.98 48.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.807 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 t -104.51 130.31 52.47 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.993 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -39.84 -28.32 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 117.691 2.478 . . . . 0.0 117.691 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -55.99 -27.7 54.01 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.812 -0.755 . . . . 0.0 112.2 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.98 34.22 1.17 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 107.684 -2.166 . . . . 0.0 107.684 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.9 m -143.01 137.89 29.63 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.812 0.815 . . . . 0.0 111.172 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -70.12 152.41 44.35 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.699 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.7 -59.09 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 123.748 0.655 . . . . 0.0 111.677 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -176.19 177.96 1.47 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.868 0.73 . . . . 0.0 111.07 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.551 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -99.27 130.18 45.55 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.36 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.79 107.01 1.97 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.72 12.89 28.3 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -106.14 132.44 52.2 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.411 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -79.19 137.66 56.5 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.99 67.86 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.237 1.958 . . . . 0.0 111.924 169.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 170.09 -21.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.449 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -90.35 143.62 29.72 Favored Pre-proline 0 N--CA 1.493 1.716 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.072 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.3 55.44 5.66 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.528 2.152 . . . . 0.0 111.439 169.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.29 132.33 53.7 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.728 -1.189 . . . . 0.0 110.862 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.66 127.51 32.27 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.518 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.0 m -150.84 145.78 18.63 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 124.174 0.921 . . . . 0.0 110.54 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.65 151.09 83.43 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.721 1.614 . . . . 0.0 109.704 163.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.3 tpp85 -84.66 59.88 5.78 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.996 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -73.91 93.34 2.18 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.195 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.6 m -59.23 120.84 9.98 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.91 78.4 7.32 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.614 ' HA ' HG23 ' A' ' 3' ' ' ILE . 5.9 Cg_exo -54.48 -21.97 25.92 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 C-N-CA 122.554 2.169 . . . . 0.0 112.803 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -48.84 77.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.125 0.891 . . . . 0.0 109.136 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.508 ' CG2' HG21 ' A' ' 5' ' ' THR . 3.6 mt -58.18 143.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 123.931 0.769 . . . . 0.0 109.737 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.76 -37.38 0.82 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 112.607 -2.088 . . . . 0.0 111.036 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.01 178.19 9.42 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.196 0.935 . . . . 0.0 110.481 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.34 109.83 1.33 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.17 88.86 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -86.85 128.49 55.98 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -55.39 -30.58 73.72 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.069 1.846 . . . . 0.0 110.979 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.2 mt -124.34 125.1 43.77 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.12 0 O-C-N 124.167 0.917 . . . . 0.0 111.447 -179.851 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.551 0.691 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.1 ttt85 58.02 81.57 0.15 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.034 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 tp -87.44 45.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.329 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -84.56 46.68 1.26 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.478 1.132 . . . . 0.0 112.577 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.16 150.08 22.16 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.898 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -113.27 -165.76 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.752 1.283 . . . . 0.0 107.868 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 1.2 t -116.31 -29.39 6.23 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.376 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 t -56.32 -56.14 24.74 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.126 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.59 33.77 0.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.764 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.69 -113.88 0.14 Allowed Glycine 0 N--CA 1.494 2.556 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.457 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.5 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 1.4 p -154.88 111.82 3.31 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 123.933 0.431 . . . . 0.0 110.537 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -46.12 99.31 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.9 -23.57 5.88 Favored Glycine 0 N--CA 1.499 2.892 0 CA-C-N 114.99 -1.005 . . . . 0.0 114.902 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.1 m -86.31 143.14 28.04 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.837 0.818 . . . . 0.0 110.747 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -97.63 97.19 8.83 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.49 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 17.4 m-85 -62.24 122.39 15.5 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.97 162.85 31.27 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.023 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.8 t -108.84 131.44 54.99 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.462 -1.699 . . . . 0.0 111.5 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.556 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 4.4 p30 -45.14 -21.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 112.596 -2.093 . . . . 0.0 114.895 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -53.62 -30.33 42.25 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.896 0.747 . . . . 0.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.28 30.29 1.6 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.8 m -146.13 147.24 31.33 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.774 0.797 . . . . 0.0 112.124 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -69.86 158.68 35.06 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.04 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.482 HG11 ' NH1' ' A' ' 44' ' ' ARG . 39.2 t -129.98 -48.94 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 28.4 p -164.24 -175.85 4.16 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.143 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -130.48 137.01 49.56 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.239 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.5 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.32 115.41 5.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -114.49 26.12 10.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 109.63 21.14 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -88.16 137.19 31.25 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 124.379 1.049 . . . . 0.0 110.247 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -69.91 70.95 1.63 Allowed 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 121.969 1.779 . . . . 0.0 110.121 167.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 169.43 -30.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.682 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -90.08 141.47 27.92 Favored Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.215 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -75.12 68.29 5.88 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 122.734 2.289 . . . . 0.0 110.671 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.65 86.38 3.95 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.502 0.668 . . . . 0.0 110.061 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.43 103.07 9.1 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.198 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.3 m -104.82 150.62 38.86 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.25 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.87 158.18 57.68 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 122.317 2.012 . . . . 0.0 110.522 157.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.3 60.87 6.35 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.626 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -63.47 110.09 1.84 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.652 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 99.2 m -74.38 116.19 14.77 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.746 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.494 ' CG ' HD12 ' A' ' 45' ' ' ILE . 6.3 t70 -121.35 74.67 31.34 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.89 -25.77 78.44 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.413 2.076 . . . . 0.0 111.305 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.482 ' NH1' HG11 ' A' ' 24' ' ' VAL . 2.3 ttp-105 -59.99 -31.13 69.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.991 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.494 HD12 ' CG ' ' A' ' 42' ' ' ASP . 1.4 mt -77.12 156.96 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.556 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -116.83 -44.37 2.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.588 1.18 . . . . 0.0 109.687 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -173.92 178.93 2.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.305 1.003 . . . . 0.0 111.098 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.66 111.64 3.33 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.3 mt -79.24 89.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.0 m -86.27 134.65 38.06 Favored Pre-proline 0 N--CA 1.495 1.813 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.617 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -64.42 147.09 90.6 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.954 1.769 . . . . 0.0 110.931 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 tp -154.35 116.49 4.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 123.992 0.807 . . . . 0.0 109.362 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 116.734 -1.603 . . . . 0.0 110.196 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -154.79 47.7 0.56 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.332 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.6 tp -45.11 131.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.746 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -135.26 48.28 2.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.195 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -78.81 170.35 16.81 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.382 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -150.59 148.17 28.32 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 41.6 t -78.14 -20.98 50.99 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.181 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -60.57 -58.3 9.07 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.36 36.91 0.89 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.648 -1.615 . . . . 0.0 108.229 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.48 -110.13 0.07 OUTLIER Glycine 0 N--CA 1.495 2.601 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.646 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.536 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 5.3 t -162.35 123.96 2.68 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -65.3 91.94 0.12 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.073 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.83 -21.64 0.79 Allowed Glycine 0 N--CA 1.489 2.194 0 CA-C-N 113.443 -1.708 . . . . 0.0 111.779 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.5 m -127.02 138.23 53.21 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 119.301 -0.96 . . . . 0.0 113.069 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -83.48 102.3 12.0 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 113.548 -1.66 . . . . 0.0 108.501 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.613 ' HB2' ' SG ' ' A' ' 7' ' ' CYS . 6.5 m-85 -62.52 122.81 16.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.7 159.88 38.35 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.045 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 t -108.21 131.28 54.84 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.161 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -39.63 -28.3 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -56.54 -28.53 60.3 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.829 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.07 34.14 0.92 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.3 m -143.61 138.8 29.29 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.886 0.85 . . . . 0.0 112.079 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -71.9 138.91 48.5 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.001 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.32 -57.19 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.909 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -175.84 174.89 2.09 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.556 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.484 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 1.4 mt-10 -99.19 131.11 45.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.315 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.536 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -65.43 112.94 5.38 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -103.45 7.8 37.94 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.383 0.696 . . . . 0.0 112.733 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -80.87 100.04 8.64 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.559 -0.857 . . . . 0.0 112.583 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -90.44 133.43 32.99 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.91 -26.01 23.39 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.974 1.783 . . . . 0.0 112.134 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -86.41 -37.64 18.17 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.725 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -83.74 143.59 43.94 Favored Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.119 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -76.23 74.58 4.56 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 122.445 2.097 . . . . 0.0 109.91 167.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HE2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -64.55 97.89 0.23 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.78 127.2 31.93 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.529 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.439 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 60.8 m -147.09 149.2 34.64 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 124.266 0.979 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.37 142.85 67.66 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 N-CA-C 107.729 -1.681 . . . . 0.0 107.729 153.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -85.31 62.03 7.23 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.092 0.948 . . . . 0.0 108.878 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.09 107.7 0.77 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.625 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.2 m -55.63 118.14 4.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 124.193 0.933 . . . . 0.0 110.587 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -128.76 74.05 80.85 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 124.311 1.007 . . . . 0.0 113.061 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.45 -22.44 66.1 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 121.888 1.726 . . . . 0.0 110.627 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.478 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -55.64 -38.22 69.26 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 124.314 1.009 . . . . 0.0 110.099 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mt -66.67 146.52 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.02 -42.56 1.38 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.143 -1.39 . . . . 0.0 111.87 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.87 175.68 12.22 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 124.111 0.882 . . . . 0.0 110.571 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.18 108.81 1.5 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.353 -2.299 . . . . 0.0 107.353 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.5 mt -79.12 94.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.07 152.32 46.02 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.887 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -65.04 -65.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.785 1.656 . . . . 0.0 108.814 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.57 26.19 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.049 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 116.67 -1.633 . . . . 0.0 111.396 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -160.46 33.5 0.16 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.353 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 tp -57.03 133.4 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.611 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -146.9 49.22 1.13 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.784 1.278 . . . . 0.0 110.546 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -72.99 167.11 21.76 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 112.997 -1.91 . . . . 0.0 109.562 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -161.19 162.04 31.13 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.946 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.7 t -65.72 -23.48 66.76 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.932 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -58.32 -60.4 3.84 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.8 -106.6 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 112.899 -1.955 . . . . 0.0 105.738 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 11' ' ' THR . . . 79.09 -107.93 2.6 Favored Glycine 0 CA--C 1.549 2.174 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -179.13 97.61 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 123.291 0.636 . . . . 0.0 111.055 -179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.8 133.93 42.37 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.937 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.7 -28.6 12.77 Favored Glycine 0 N--CA 1.488 2.136 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.924 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.6 m -106.63 143.38 34.82 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.412 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.68 106.19 18.17 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.68 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 2.6 m-30 -55.59 131.33 46.04 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.09 159.41 43.32 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 124.669 1.231 . . . . 0.0 112.188 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 t -108.12 129.32 55.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 112.735 -2.029 . . . . 0.0 111.113 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.539 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 6.8 p-10 -43.37 -25.15 0.12 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-N 113.092 -1.867 . . . . 0.0 115.321 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -54.14 -30.2 48.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 123.897 0.748 . . . . 0.0 111.592 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.41 32.72 1.2 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 m -143.56 143.96 31.74 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.901 0.857 . . . . 0.0 111.759 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -72.86 149.16 43.76 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.435 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.2 t -110.5 -52.38 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.53 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -170.05 -173.01 1.44 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 123.53 0.519 . . . . 0.0 110.252 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.557 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 mt-10 -112.43 158.66 19.58 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.41 ' HA2' ' CE1' ' A' ' 16' ' ' TYR . . . -59.78 110.55 2.88 Favored Glycine 0 N--CA 1.494 2.561 0 CA-C-N 112.812 -1.994 . . . . 0.0 110.897 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -121.13 -39.06 2.73 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 p -72.11 102.42 3.01 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' H ' HD21 ' A' ' 33' ' ' ASN . 10.5 t70 -79.54 133.42 59.57 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.63 -29.83 20.36 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.975 1.783 . . . . 0.0 113.102 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.6 mtt180 -84.77 -34.86 22.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 123.863 0.727 . . . . 0.0 112.093 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.463 HD21 ' H ' ' A' ' 30' ' ' ASP . 32.9 p30 -81.16 142.88 51.72 Favored Pre-proline 0 N--CA 1.495 1.808 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.574 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.84 47.3 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.365 2.71 . . . . 0.0 112.37 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -96.1 95.16 7.98 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.498 0.666 . . . . 0.0 110.584 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.49 140.22 16.07 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.473 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.61 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.8 m -133.2 94.29 20.56 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -71.61 79.17 1.57 Allowed 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.099 1.866 . . . . 0.0 109.364 172.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -144.82 -59.41 0.36 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.263 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -77.69 136.01 38.14 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.004 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.1 m -112.13 126.36 55.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.972 1.42 . . . . 0.0 108.217 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -126.24 71.74 70.88 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 123.893 0.745 . . . . 0.0 112.497 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.15 -28.54 73.58 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.486 2.124 . . . . 0.0 112.643 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -63.15 -17.51 62.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.026 0.829 . . . . 0.0 112.147 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.664 HD11 ' HB3' ' A' ' 16' ' ' TYR . 4.6 tt -69.65 158.82 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 123.694 0.621 . . . . 0.0 109.671 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.539 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -124.16 -45.18 1.99 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.946 0.778 . . . . 0.0 109.47 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -173.94 -169.73 0.5 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 124.343 1.027 . . . . 0.0 110.181 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.52 116.06 3.11 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.9 mt -80.79 91.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.216 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.24 127.06 77.74 Favored Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.49 -30.26 23.8 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.901 1.734 . . . . 0.0 109.365 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.81 42.98 2.04 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.18 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 116.367 -1.778 . . . . 0.0 111.738 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mtm105 57.28 63.71 1.81 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 124.556 1.16 . . . . 0.0 110.987 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.7 tp -86.63 46.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.687 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 m -85.48 46.35 1.29 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.549 1.166 . . . . 0.0 112.513 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -90.21 174.12 7.78 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 112.961 -1.927 . . . . 0.0 108.45 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -161.39 165.58 28.67 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.028 0.83 . . . . 0.0 110.373 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.7 t -67.49 -3.28 8.15 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.7 t -91.12 -57.77 2.69 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -42.13 -69.26 0.14 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 4.43 -112.93 0.01 OUTLIER Glycine 0 N--CA 1.508 3.465 0 N-CA-C 117.556 1.782 . . . . 0.0 117.556 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 173.65 126.82 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -49.62 110.55 0.39 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 124.148 0.905 . . . . 0.0 110.01 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.94 -28.38 4.39 Favored Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.536 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.6 m -79.59 -176.48 5.34 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.199 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -139.22 101.39 4.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.857 0.723 . . . . 0.0 109.683 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.589 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 85.6 m-85 -57.45 131.92 51.57 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.42 155.86 44.5 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.222 1.01 . . . . 0.0 110.94 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 t -106.86 135.74 47.88 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.382 -2.19 . . . . 0.0 113.485 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -47.27 -24.47 0.74 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 111.575 -2.557 . . . . 0.0 113.573 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -56.0 -25.76 45.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 124.098 0.874 . . . . 0.0 111.797 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.27 32.17 2.43 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.7 m -145.66 148.34 32.96 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 112.449 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -70.98 153.49 42.61 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.339 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.7 t -115.99 -56.75 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.213 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.589 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -162.5 -178.92 6.56 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.702 0.626 . . . . 0.0 110.56 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.418 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -112.77 150.64 31.34 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.48 110.49 1.41 Allowed Glycine 0 N--CA 1.492 2.419 0 CA-C-N 112.951 -1.931 . . . . 0.0 109.653 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -114.03 -6.61 13.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.897 0.998 . . . . 0.0 113.437 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.97 89.66 4.14 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.95 130.39 44.85 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.28 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.0 74.49 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.609 2.206 . . . . 0.0 110.993 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 170.57 -39.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.591 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -80.95 155.99 72.52 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.104 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.86 78.51 2.47 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 122.128 1.885 . . . . 0.0 111.163 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.09 99.4 0.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.07 92.92 5.06 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.6 m -111.71 98.93 43.15 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.115 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.9 169.45 13.26 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 121.97 1.78 . . . . 0.0 110.452 168.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -83.69 25.51 0.77 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.352 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -63.95 134.85 55.85 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.644 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.22 136.66 34.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 125.501 1.75 . . . . 0.0 110.887 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -129.82 81.0 70.31 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 124.054 0.846 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -54.96 -27.92 56.67 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 122.189 1.926 . . . . 0.0 113.238 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -59.36 -46.9 87.36 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mt -64.77 148.46 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.97 -42.13 2.97 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.209 -1.814 . . . . 0.0 108.604 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -173.7 -168.74 0.45 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.638 1.211 . . . . 0.0 109.676 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.11 113.8 1.92 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 mm -79.5 111.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.6 m -102.71 157.44 33.72 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 123.557 0.536 . . . . 0.0 110.459 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.59 -34.71 41.01 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 121.909 1.739 . . . . 0.0 108.094 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.51 44.94 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.009 -1.451 . . . . 0.0 107.181 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.005 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.826 -179.853 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.4 mmt-85 -143.03 82.2 1.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 124.212 0.945 . . . . 0.0 109.458 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 3' ' ' ILE . 5.9 tp -72.72 89.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.599 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -97.05 55.8 1.34 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.693 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -87.72 179.49 6.49 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.507 -1.678 . . . . 0.0 107.993 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -160.27 -171.19 3.09 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 t -98.73 -30.95 12.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.043 0.84 . . . . 0.0 111.944 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.2 t -67.18 -60.82 2.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 123.995 0.81 . . . . 0.0 109.761 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.19 63.86 8.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 125.119 1.512 . . . . 0.0 108.772 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.65 -136.35 7.74 Favored Glycine 0 N--CA 1.491 2.348 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.812 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -144.25 108.63 4.83 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.86 94.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.346 1.029 . . . . 0.0 111.888 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.01 -26.2 2.5 Favored Glycine 0 N--CA 1.495 2.582 0 CA-C-N 113.754 -1.566 . . . . 0.0 113.169 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.7 m -87.66 158.88 18.73 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.005 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -116.18 95.66 5.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.515 1.134 . . . . 0.0 109.834 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -52.27 129.8 29.08 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.927 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.88 158.99 43.6 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.521 0.677 . . . . 0.0 111.76 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -107.38 132.71 52.86 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.473 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -44.58 -24.39 0.19 Allowed 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 112.887 -1.96 . . . . 0.0 114.997 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -54.42 -27.67 38.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.07 0.856 . . . . 0.0 111.45 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.06 32.84 1.77 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.6 m -144.93 140.78 28.5 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.505 0.669 . . . . 0.0 111.539 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.16 159.52 28.77 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.754 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.3 t -127.68 -46.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.72 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -167.38 -173.96 2.41 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.838 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.72 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -128.15 124.81 37.8 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.447 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.23 117.87 12.74 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 107.481 -2.248 . . . . 0.0 107.481 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.63 13.79 24.95 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.35 109.89 20.98 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.408 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.41 132.45 62.29 Favored Pre-proline 0 N--CA 1.494 1.725 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.21 75.66 0.48 Allowed 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.859 1.706 . . . . 0.0 110.149 173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 164.58 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.96 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.43 144.64 31.1 Favored Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.478 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.12 69.01 8.1 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.513 2.142 . . . . 0.0 111.309 168.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -71.08 89.41 0.82 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.91 121.63 25.67 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.715 -1.129 . . . . 0.0 113.675 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.4 m -160.42 162.47 23.51 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.079 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.62 159.77 35.31 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.692 1.594 . . . . 0.0 110.682 165.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.5 ttm105 -87.31 63.3 7.68 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -57.36 149.98 19.31 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.601 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.7 m -109.97 128.72 55.56 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.1 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CG ' HD12 ' A' ' 45' ' ' ILE . 5.7 t70 -123.66 75.51 55.26 Favored Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 124.059 0.849 . . . . 0.0 113.202 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.07 -21.47 65.58 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.485 2.123 . . . . 0.0 112.068 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -63.73 -39.07 93.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.039 0.837 . . . . 0.0 110.009 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.587 HD12 ' CG ' ' A' ' 42' ' ' ASP . 1.6 mt -69.29 154.31 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.42 1.075 . . . . 0.0 109.537 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.25 -44.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.354 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.49 -177.6 6.32 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 124.308 1.005 . . . . 0.0 110.212 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.68 110.57 1.26 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 107.169 -2.372 . . . . 0.0 107.169 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.1 mt -79.07 90.6 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -92.51 149.71 38.65 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.921 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.83 -18.89 44.17 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.206 1.938 . . . . 0.0 112.35 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 tp -79.66 138.87 37.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 123.951 0.782 . . . . 0.0 109.567 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 116.703 -1.618 . . . . 0.0 110.686 179.907 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -152.7 151.35 30.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.176 0.922 . . . . 0.0 109.763 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 43' ' ' PRO . 5.9 tp -69.31 87.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 124.22 0.95 . . . . 0.0 109.863 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.68 37.55 1.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.552 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 p -89.03 171.95 9.47 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 113.727 -1.578 . . . . 0.0 107.385 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -158.0 155.71 29.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.142 0.901 . . . . 0.0 111.883 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.42 -16.66 38.11 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.96 -1.473 . . . . 0.0 112.284 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -90.25 -69.27 0.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.472 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.82 58.85 3.97 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.94 -83.77 1.21 Allowed Glycine 0 N--CA 1.497 2.749 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.909 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.573 HG23 ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -174.24 111.78 0.16 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.83 119.72 4.14 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.072 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.9 -31.11 7.25 Favored Glycine 0 N--CA 1.495 2.63 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.416 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.573 ' HB2' HG23 ' A' ' 11' ' ' THR . 90.2 m -90.06 120.56 31.35 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.766 -1.173 . . . . 0.0 111.124 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -67.53 100.11 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.371 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.55 ' CE2' ' HA2' ' A' ' 27' ' ' GLY . 91.8 m-85 -48.96 131.03 18.84 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.29 156.37 42.45 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 122.147 0.975 . . . . 0.0 110.985 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.4 t -107.19 130.08 54.77 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 112.438 -2.165 . . . . 0.0 110.704 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 4.0 p-10 -39.04 -28.83 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 118.402 2.741 . . . . 0.0 118.402 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.43 -28.59 65.39 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.521 -0.872 . . . . 0.0 112.37 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.93 35.01 0.75 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 m -142.93 140.21 31.05 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.668 0.747 . . . . 0.0 111.845 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -70.63 153.37 42.92 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.081 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t -115.52 -57.91 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.114 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.533 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -162.08 -178.66 6.55 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 123.523 0.514 . . . . 0.0 110.717 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -97.42 138.62 34.59 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.55 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -54.47 113.8 3.75 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.14 -23.46 5.35 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.65 98.49 0.52 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 118.9 0.773 . . . . 0.0 111.504 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.73 127.23 30.63 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.482 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.53 -22.65 44.0 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.453 2.102 . . . . 0.0 113.772 -168.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.436 ' H ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -83.02 -41.71 18.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 123.895 0.747 . . . . 0.0 110.511 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.33 147.39 87.59 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -73.2 77.87 2.36 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.184 1.922 . . . . 0.0 110.607 174.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 81.43 2.29 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.045 0.926 . . . . 0.0 109.184 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.53 127.93 32.75 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.518 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -147.95 148.93 31.52 Favored Pre-proline 0 N--CA 1.495 1.783 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.07 161.26 37.82 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.818 1.679 . . . . 0.0 109.735 165.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -86.54 61.81 7.04 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.25 1.024 . . . . 0.0 109.367 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -76.69 -177.88 4.49 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.258 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 93.8 m -146.77 122.61 10.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -112.74 83.15 5.51 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 123.775 0.672 . . . . 0.0 112.724 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' HA ' HG23 ' A' ' 3' ' ' ILE . 4.5 Cg_exo -51.95 -31.44 43.55 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.573 2.182 . . . . 0.0 112.213 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -59.88 -50.69 72.79 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 124.406 1.066 . . . . 0.0 108.477 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -63.02 148.1 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.031 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -118.64 -43.19 2.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 124.527 1.142 . . . . 0.0 108.021 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -173.06 -167.75 0.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.719 1.262 . . . . 0.0 109.308 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.81 121.06 4.02 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.5 mt -83.0 95.03 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 123.947 0.44 . . . . 0.0 111.607 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 m -82.57 145.56 51.42 Favored Pre-proline 0 N--CA 1.503 2.2 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.41 86.54 0.34 Allowed 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 122.274 1.983 . . . . 0.0 110.77 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.75 -46.5 0.11 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.368 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 116.271 -1.823 . . . . 0.0 110.242 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.46 179.98 7.88 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.298 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tp -56.73 119.45 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.122 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -124.49 47.33 2.12 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.58 140.48 29.51 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.542 ' ND2' ' HA ' ' A' ' 40' ' ' ASN . 14.6 p-10 -160.35 163.04 33.55 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 124.028 0.83 . . . . 0.0 111.052 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 10.1 t -60.81 -16.8 44.75 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 1.9 t -91.55 -43.87 9.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.455 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -88.59 43.66 1.15 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -102.45 -118.18 4.39 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.066 -1.064 . . . . 0.0 114.056 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.5 m -160.6 126.4 3.97 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.86 103.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 123.706 0.629 . . . . 0.0 109.575 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.434 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 132.41 -25.31 3.84 Favored Glycine 0 N--CA 1.498 2.777 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.776 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.8 m -88.25 122.97 32.39 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 117.362 0.581 . . . . 0.0 110.174 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -76.75 99.43 5.11 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.491 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.59 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 82.7 m-85 -54.95 127.98 31.34 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.501 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -145.09 157.74 44.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.197 0.999 . . . . 0.0 110.839 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.8 t -103.99 131.32 51.36 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 112.592 -2.094 . . . . 0.0 110.97 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.1 p-10 -44.55 -24.87 0.22 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 125.519 1.762 . . . . 0.0 114.892 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -58.2 -20.95 45.47 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.766 0.666 . . . . 0.0 112.469 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.08 33.27 2.82 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.3 m -139.82 136.2 33.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.122 0.542 . . . . 0.0 112.119 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -70.89 148.66 47.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 45' ' ' ILE . 45.7 t -111.88 -50.88 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 123.779 0.674 . . . . 0.0 110.583 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.59 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -168.48 173.3 7.62 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 123.823 0.702 . . . . 0.0 109.778 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -96.99 152.19 18.97 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.624 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -48.02 118.46 4.46 Favored Glycine 0 N--CA 1.507 3.378 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -132.53 39.78 3.34 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.3 t -162.82 94.93 0.87 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.23 133.16 61.03 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -60.94 86.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 121.916 1.744 . . . . 0.0 109.419 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.62 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.219 -1.809 . . . . 0.0 106.961 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.76 135.49 28.93 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 124.154 0.909 . . . . 0.0 109.307 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -75.08 66.62 6.09 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.185 1.923 . . . . 0.0 109.439 167.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -53.03 127.36 23.7 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.81 135.8 37.17 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.371 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.3 m -145.74 155.89 52.29 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 124.526 1.141 . . . . 0.0 111.944 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.91 -46.07 3.64 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 122.193 1.929 . . . . 0.0 112.26 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -158.15 -2.0 0.09 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.542 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 58.1 m-20 51.79 48.32 23.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.002 0.814 . . . . 0.0 113.111 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 98.1 m -153.41 131.41 11.78 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.186 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -157.98 101.35 1.77 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 123.938 0.774 . . . . 0.0 110.93 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.59 -18.6 60.86 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 122.02 1.814 . . . . 0.0 112.652 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 ttm105 -66.53 -33.12 74.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 123.651 0.594 . . . . 0.0 110.351 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.605 HD11 HG11 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -83.74 157.11 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -114.03 -46.49 3.0 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.01 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -172.47 -172.93 0.97 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.327 1.017 . . . . 0.0 109.683 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -121.06 118.01 3.66 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.2 mm -79.03 95.47 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.54 142.35 29.41 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.291 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -65.39 133.55 35.27 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 122.062 1.841 . . . . 0.0 111.525 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mp -117.62 109.2 16.38 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.261 0.976 . . . . 0.0 108.402 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 116.376 -1.773 . . . . 0.0 111.172 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.035 0.445 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -144.34 125.58 14.66 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.403 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.5 tp -60.67 125.36 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 123.992 0.808 . . . . 0.0 110.517 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.13 47.59 2.46 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.23 143.95 36.68 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -150.76 178.13 9.42 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.491 1.139 . . . . 0.0 113.35 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.0 t -94.48 -45.02 7.61 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.262 -2.245 . . . . 0.0 108.589 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.24 -56.57 19.91 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.03 41.48 1.03 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.454 -1.703 . . . . 0.0 108.856 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' HB3' ' A' ' 29' ' ' SER . . . -78.7 -155.91 9.05 Favored Glycine 0 N--CA 1.491 2.348 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.518 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.515 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.1 m -141.02 96.17 2.96 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 115.697 -0.252 . . . . 0.0 110.566 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 5.8 mmtm -26.05 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 124.86 -34.89 3.3 Favored Glycine 0 N--CA 1.501 3.03 0 CA-C-N 114.932 -1.031 . . . . 0.0 114.822 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.3 m -84.4 120.61 26.48 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 101.7 5.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.375 1.047 . . . . 0.0 110.746 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.416 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 7.4 m-85 -58.99 122.57 14.04 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.65 157.47 46.56 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.404 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 t -103.18 130.61 50.43 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.64 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -46.2 -20.32 0.1 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 113.168 -1.833 . . . . 0.0 114.903 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -55.27 -28.65 54.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 123.638 0.586 . . . . 0.0 110.747 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.24 30.95 1.79 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.8 m -144.94 142.61 29.99 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.816 0.817 . . . . 0.0 112.09 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -69.35 149.69 48.15 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.808 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.5 t -112.38 -52.77 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 123.783 0.677 . . . . 0.0 110.986 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -168.21 176.9 5.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.083 0.864 . . . . 0.0 110.528 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.634 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -99.91 123.36 44.08 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -59.52 103.39 0.41 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -93.7 -8.23 41.45 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 118.075 2.62 . . . . 0.0 118.075 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.448 ' HB3' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -79.37 131.71 36.19 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.574 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.53 134.58 23.17 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.5 -27.5 19.08 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.034 1.823 . . . . 0.0 112.712 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -85.9 -34.17 21.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.957 0.786 . . . . 0.0 112.805 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -90.14 152.88 46.52 Favored Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.791 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -79.85 51.93 4.09 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.1 2.533 . . . . 0.0 112.978 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -74.05 94.65 2.42 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.795 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.48 155.57 48.31 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.765 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.427 ' H ' HD21 ' A' ' 40' ' ' ASN . 29.3 m -145.05 160.44 46.31 Favored Pre-proline 0 N--CA 1.499 1.989 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.11 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.02 -13.03 17.24 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.872 1.715 . . . . 0.0 113.241 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.12 75.32 1.44 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 124.035 0.834 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.427 HD21 ' H ' ' A' ' 37' ' ' CYS . 5.3 m120 -104.48 42.44 1.2 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.605 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.0 m -147.52 134.54 20.32 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.132 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -159.05 98.8 1.63 Allowed Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.24 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.22 -17.47 32.7 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.585 2.19 . . . . 0.0 113.677 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.6 ttp-105 -61.06 -35.28 76.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 123.705 0.628 . . . . 0.0 110.949 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -77.54 155.18 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.714 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.17 -41.44 1.77 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 112.414 -2.176 . . . . 0.0 110.064 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.17 177.94 10.0 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 124.162 0.913 . . . . 0.0 110.909 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.63 108.18 1.15 Allowed Glycine 0 N--CA 1.495 2.605 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.41 93.98 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.47 148.39 38.72 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-N 114.843 -1.072 . . . . 0.0 108.752 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -61.76 -57.68 0.51 Allowed 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.806 1.671 . . . . 0.0 110.32 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.5 pp -160.37 160.55 32.47 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.515 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 116.475 -1.726 . . . . 0.0 110.251 179.963 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 -80.85 25.59 0.44 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 123.996 0.81 . . . . 0.0 111.329 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 tp -86.42 49.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.643 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.4 45.45 1.12 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.668 1.223 . . . . 0.0 112.504 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.14 170.1 14.17 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 113.056 -1.884 . . . . 0.0 108.146 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -160.58 145.23 14.25 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.201 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 1.7 t -55.9 -19.9 13.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.554 1.159 . . . . 0.0 113.329 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -73.71 -67.82 0.56 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.182 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.45 -86.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 11' ' ' THR . . . 33.22 -108.04 0.03 OUTLIER Glycine 0 N--CA 1.506 3.363 0 N-CA-C 115.208 0.843 . . . . 0.0 115.208 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 177.28 121.74 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 124.912 1.007 . . . . 0.0 109.251 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.27 104.7 0.15 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 123.965 0.79 . . . . 0.0 109.863 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.02 -30.09 2.38 Favored Glycine 0 N--CA 1.491 2.313 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.076 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.45 125.57 41.03 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -82.74 113.81 20.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.345 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.634 ' HB3' HD11 ' A' ' 45' ' ' ILE . 92.2 m-85 -55.73 131.32 46.37 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.64 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.71 155.41 42.39 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.067 0.937 . . . . 0.0 111.204 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.5 t -107.92 133.51 52.15 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 112.683 -2.053 . . . . 0.0 112.851 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -38.96 -31.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 111.245 -2.707 . . . . 0.0 118.053 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.21 -28.15 66.39 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.362 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.82 37.17 0.68 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 m -144.56 142.06 29.92 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -69.89 152.12 44.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.677 -1.147 . . . . 0.0 107.951 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.7 -47.43 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 123.835 0.709 . . . . 0.0 110.541 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.603 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.04 -176.85 2.74 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 123.703 0.627 . . . . 0.0 110.683 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.5 mm-40 -111.15 147.54 34.69 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA2' ' CE1' ' A' ' 16' ' ' TYR . . . -49.52 113.7 1.91 Allowed Glycine 0 N--CA 1.491 2.33 0 O-C-N 125.652 1.845 . . . . 0.0 109.303 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -108.22 -37.21 6.08 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 t -77.9 95.48 4.77 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.509 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.5 t70 -85.55 123.06 73.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.98 86.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.326 2.017 . . . . 0.0 111.628 -167.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 30' ' ' ASP . 4.6 mtm-85 169.41 -34.89 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.671 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.509 HD21 ' H ' ' A' ' 30' ' ' ASP . 55.7 p30 -87.91 152.33 50.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 123.958 0.786 . . . . 0.0 112.62 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -79.52 42.64 1.34 Allowed 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 123.301 2.668 . . . . 0.0 112.929 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.96 38.16 1.25 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.55 132.36 56.21 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.255 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.457 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 4.5 m -137.06 68.99 57.12 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.96 -21.49 41.6 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.193 1.929 . . . . 0.0 112.338 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -83.37 19.9 1.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.791 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -118.93 118.33 31.23 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.741 0.651 . . . . 0.0 109.805 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.7 m -105.89 129.05 54.12 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.53 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -130.97 78.81 72.76 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 123.86 0.725 . . . . 0.0 110.938 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.42 -22.19 57.45 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.086 1.857 . . . . 0.0 113.78 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.495 ' HD3' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -67.07 -43.12 83.44 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -66.15 155.92 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.16 -43.18 2.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.099 0.875 . . . . 0.0 109.408 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -175.64 -165.07 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.36 1.038 . . . . 0.0 109.264 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -128.35 119.26 3.03 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.4 mm -79.0 110.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -99.3 151.52 37.45 Favored Pre-proline 0 N--CA 1.495 1.818 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.89 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.62 88.73 0.35 Allowed 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 121.944 1.763 . . . . 0.0 109.323 168.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.1 -59.4 2.02 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.285 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 116.688 -1.625 . . . . 0.0 110.906 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -91.6 51.0 1.79 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.094 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.601 HG22 ' OG1' ' A' ' 5' ' ' THR . 7.3 mm -76.14 89.65 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -85.94 27.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.601 ' OG1' HG22 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -91.03 164.78 13.84 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 9' ' ' ALA . 39.9 p-10 -160.87 150.6 17.32 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.585 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.3 t -65.37 -21.5 66.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.753 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -77.76 -68.6 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.162 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' A' ' 6' ' ' ASN . . . -90.32 52.8 2.31 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.556 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.74 -121.76 0.18 Allowed Glycine 0 N--CA 1.491 2.336 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.809 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.498 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -158.88 103.0 1.68 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -42.46 105.42 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.18 -30.06 4.42 Favored Glycine 0 N--CA 1.496 2.651 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.832 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.6 m -82.4 157.2 23.8 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.908 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -111.73 95.35 5.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.258 0.974 . . . . 0.0 111.703 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.6 129.0 34.84 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.639 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.12 160.39 41.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.024 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.4 t -109.6 129.8 55.56 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.408 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 7.2 p-10 -42.95 -24.35 0.06 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 112.962 -1.926 . . . . 0.0 115.366 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -53.24 -30.69 39.53 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.876 0.735 . . . . 0.0 111.292 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.16 31.78 1.25 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -144.86 144.43 31.11 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.759 0.79 . . . . 0.0 111.92 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -71.19 154.37 41.74 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.325 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.4 t -118.56 -52.43 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 123.613 0.57 . . . . 0.0 111.229 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -173.34 -169.51 0.53 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.027 0.829 . . . . 0.0 109.443 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.68 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -124.78 134.72 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.498 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -51.9 111.39 1.44 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.32 11.72 37.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.61 0.83 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.9 p -77.69 92.45 4.14 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.973 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -82.57 137.8 44.54 Favored Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.547 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.14 77.92 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 122.19 1.927 . . . . 0.0 111.309 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 161.58 -37.24 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.097 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -82.04 143.18 48.96 Favored Pre-proline 0 N--CA 1.498 1.954 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.333 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.97 91.22 0.53 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.847 1.698 . . . . 0.0 108.87 170.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 66.7 3.6 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.031 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.77 135.08 54.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.524 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 2.8 m -153.78 167.77 12.99 Favored Pre-proline 0 N--CA 1.497 1.918 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.083 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -68.99 70.08 1.19 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.073 1.848 . . . . 0.0 109.007 159.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.469 HH11 HH12 ' A' ' 44' ' ' ARG . 4.6 tpm_? -160.41 73.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -107.01 114.03 27.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.565 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 84.8 m 59.64 108.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 124.967 1.417 . . . . 0.0 111.615 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.15 88.31 5.65 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -47.1 -35.2 18.76 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 123.375 2.717 . . . . 0.0 114.434 170.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.469 HH12 HH11 ' A' ' 39' ' ' ARG . 0.5 OUTLIER -56.28 -43.74 79.11 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 124.223 0.952 . . . . 0.0 110.211 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.555 ' O ' HG21 ' A' ' 3' ' ' ILE . 2.2 mt -75.41 161.43 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.782 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.559 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -120.71 -44.6 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.0 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -173.52 -169.76 0.54 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 124.303 1.002 . . . . 0.0 109.754 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.84 117.07 2.92 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.8 mm -78.86 95.15 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.5 m -85.19 133.32 43.0 Favored Pre-proline 0 N--CA 1.493 1.713 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.301 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.9 95.9 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 122.133 1.889 . . . . 0.0 110.522 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.5 tp -108.84 57.21 0.61 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.002 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.309 0 CA-C-N 114.288 -1.324 . . . . 0.0 113.512 179.977 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.925 0.393 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -76.42 166.67 23.09 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.968 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.761 HD11 ' HA ' ' A' ' 46' ' ' ALA . 9.4 tp -89.99 38.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.646 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.8 m -94.21 43.15 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.985 -1.461 . . . . 0.0 112.299 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.72 176.01 7.6 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.675 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' A' ' 9' ' ' ALA . 10.4 p30 -158.86 141.17 14.0 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -65.28 -24.99 67.45 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.58 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -63.64 -54.2 39.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 124.249 0.968 . . . . 0.0 112.056 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.55 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -89.82 -77.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 113.811 -1.541 . . . . 0.0 115.135 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 11' ' ' THR . . . 39.43 -98.32 0.01 OUTLIER Glycine 0 N--CA 1.501 2.971 0 N-CA-C 115.433 0.933 . . . . 0.0 115.433 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 179.46 119.41 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 O-C-N 124.509 0.77 . . . . 0.0 111.575 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.23 130.25 8.02 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 123.669 0.605 . . . . 0.0 111.514 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.68 -29.66 10.65 Favored Glycine 0 N--CA 1.493 2.49 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.58 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.9 m -80.21 121.46 25.63 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.33 107.2 11.92 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.584 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 95.5 m-85 -58.43 129.01 40.02 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.76 156.99 43.96 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 124.229 0.956 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 t -106.04 136.05 46.42 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.572 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.608 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 10.8 p-10 -47.06 -23.48 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 112.074 -2.33 . . . . 0.0 113.503 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -58.11 -19.85 35.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 123.798 0.686 . . . . 0.0 111.849 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.66 33.24 3.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.6 m -143.88 139.93 29.49 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.687 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -68.65 154.93 41.01 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.443 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.25 -53.39 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.126 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -161.96 -178.32 6.37 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 123.567 0.542 . . . . 0.0 110.927 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 17.0 mm-40 -112.63 150.75 30.99 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.02 110.45 0.35 Allowed Glycine 0 N--CA 1.499 2.861 0 O-C-N 125.779 1.924 . . . . 0.0 112.459 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 -42.75 7.32 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 118.39 2.737 . . . . 0.0 118.39 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 t -57.86 102.81 0.11 Allowed 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 119.756 1.162 . . . . 0.0 113.883 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.55 139.9 22.98 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 124.931 1.395 . . . . 0.0 107.45 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -45.75 -30.61 6.75 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.627 2.218 . . . . 0.0 115.942 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -65.21 -36.93 85.69 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.743 HD22 ' H ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -81.61 142.49 49.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 119.226 -0.989 . . . . 0.0 108.561 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -75.52 40.52 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.147 1.898 . . . . 0.0 110.933 166.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.743 ' H ' HD22 ' A' ' 33' ' ' ASN . 2.6 mptp? 48.81 71.6 0.36 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.633 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.32 86.36 5.07 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.302 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.1 m -153.66 141.54 13.81 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.99 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.53 -166.28 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 121.936 1.757 . . . . 0.0 110.753 168.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -79.54 -76.56 0.21 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 m120 50.5 86.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 124.62 1.2 . . . . 0.0 113.052 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.8 m -66.95 128.37 36.09 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -113.71 80.97 5.32 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.59 -30.63 83.87 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 122.367 2.045 . . . . 0.0 112.603 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.481 ' HD3' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -61.48 -44.58 96.84 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.49 144.3 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.761 ' HA ' HD11 ' A' ' 3' ' ' ILE . . . -106.21 -46.74 3.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.959 0.787 . . . . 0.0 109.22 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -173.21 -170.08 0.6 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.118 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -127.73 115.22 2.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.6 mm -79.4 110.55 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.23 160.53 28.02 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.93 -42.85 34.27 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 121.633 1.556 . . . . 0.0 108.961 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 52' ' ' LEU . 10.8 mp -88.52 79.61 7.58 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 2.229 0 CA-C-O 115.723 -2.084 . . . . 0.0 113.629 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -137.63 -44.43 0.54 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.441 1.088 . . . . 0.0 108.835 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 3' ' ' ILE . 5.1 tp -79.19 76.23 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.322 1.058 . . . . 0.0 108.711 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.1 m -90.32 36.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.218 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.24 -171.55 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.727 -2.033 . . . . 0.0 106.843 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 68.8 m-80 -160.4 167.8 26.57 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.406 1.066 . . . . 0.0 111.122 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -61.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.344 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -59.69 5.06 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.101 -1.408 . . . . 0.0 109.013 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . . . -79.05 31.8 0.21 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.137 -2.301 . . . . 0.0 111.351 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.03 -130.09 0.65 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.486 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.0 m -142.58 109.64 5.56 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 123.97 0.453 . . . . 0.0 111.294 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -48.37 106.61 0.1 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.443 1.089 . . . . 0.0 111.225 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.28 -27.23 4.27 Favored Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.567 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.4 m -110.29 134.45 52.26 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.919 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -80.2 101.15 8.66 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.529 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -62.42 119.24 8.74 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.96 158.68 38.88 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.222 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 t -103.59 129.76 50.91 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.323 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -46.0 -20.84 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 125.855 1.972 . . . . 0.0 114.765 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -55.17 -29.81 58.58 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 123.859 0.724 . . . . 0.0 110.785 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.55 31.57 1.48 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.8 m -144.03 140.68 29.69 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.732 0.777 . . . . 0.0 111.574 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -74.49 135.74 42.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.374 -1.284 . . . . 0.0 107.682 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -91.14 -63.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.356 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -176.25 171.91 2.39 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.17 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.3 mt-10 -90.45 150.25 21.89 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 120.174 -0.611 . . . . 0.0 112.433 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.486 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.11 124.61 11.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.65 -5.0 15.12 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.8 t -85.39 123.45 30.87 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.656 ' H ' HD21 ' A' ' 33' ' ' ASN . 13.0 t70 -80.11 127.06 78.06 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.85 83.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.93 1.753 . . . . 0.0 110.155 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 30' ' ' ASP . 1.4 mmt-85 176.16 -39.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.966 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.656 HD21 ' H ' ' A' ' 30' ' ' ASP . 14.9 p30 -91.28 148.91 38.76 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 124.167 0.917 . . . . 0.0 110.945 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.14 47.29 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.58 2.187 . . . . 0.0 110.183 162.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -72.88 111.55 8.1 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -155.08 109.12 2.9 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.784 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 2.2 m -79.48 -42.66 1.59 Allowed Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 37' ' ' CYS . 10.0 Cg_endo -72.79 -176.32 2.28 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 C-N-CA 122.42 2.08 . . . . 0.0 110.643 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.11 -1.23 1.77 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.575 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -125.49 -168.02 1.78 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.213 0.946 . . . . 0.0 113.023 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 89.0 m -91.18 152.91 20.37 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.132 -1.395 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.597 ' CG ' HD12 ' A' ' 45' ' ' ILE . 7.3 t0 -113.8 76.36 3.11 Favored Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 123.652 0.595 . . . . 0.0 110.996 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.66 -26.98 81.58 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.447 2.098 . . . . 0.0 111.423 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 mtm-85 -60.51 -45.09 95.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.22 0.95 . . . . 0.0 109.744 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.597 HD12 ' CG ' ' A' ' 42' ' ' ASP . 2.4 mt -66.55 155.36 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 124.347 1.03 . . . . 0.0 108.614 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.34 -45.38 0.83 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.93 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.18 175.02 12.56 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 124.059 0.849 . . . . 0.0 111.16 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.01 108.96 1.63 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.27 90.49 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.25 156.6 59.85 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.62 -30.1 89.82 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.116 1.877 . . . . 0.0 110.057 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.6 tp -85.91 30.65 0.65 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.608 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 116.86 -1.543 . . . . 0.0 108.848 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.982 0.42 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.3 131.53 23.43 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.454 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 3' ' ' ILE . 7.6 tp -70.4 105.11 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.29 26.81 9.49 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -91.32 158.89 16.29 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 112.663 -2.062 . . . . 0.0 106.143 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -140.13 161.53 37.41 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -57.62 -34.95 69.84 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.124 0.964 . . . . 0.0 109.548 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' SG ' ' C ' ' A' ' 36' ' ' ALA . 8.1 t -75.61 -62.36 1.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.47 67.78 6.63 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 113.854 -1.521 . . . . 0.0 106.912 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.76 -109.45 2.88 Favored Glycine 0 N--CA 1.497 2.723 0 CA-C-N 114.259 -1.337 . . . . 0.0 115.066 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 m -167.07 107.46 0.62 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 124.648 0.852 . . . . 0.0 109.95 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.18 132.19 1.41 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.609 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' N ' ' HA3' ' A' ' 27' ' ' GLY . . . 84.46 -24.02 6.81 Favored Glycine 0 N--CA 1.493 2.457 0 CA-C-O 118.603 -1.11 . . . . 0.0 114.473 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.4 m -79.97 127.74 32.63 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.781 1.29 . . . . 0.0 109.921 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -77.76 91.56 4.1 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.536 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 16.4 m-85 -54.48 132.27 44.27 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.497 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -145.52 156.5 43.75 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.721 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.6 t -105.51 128.15 53.41 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 112.295 -2.23 . . . . 0.0 109.775 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.484 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.7 p-10 -39.16 -27.52 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.71 -29.22 64.52 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.199 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.93 36.27 0.73 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.1 m -141.36 133.78 28.25 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.489 0.662 . . . . 0.0 111.552 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -71.51 147.61 47.57 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.156 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 17' ' ' PHE . 58.8 t -104.23 -72.56 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.053 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -154.57 176.67 12.11 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.73 156.83 16.38 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -52.23 104.4 0.17 Allowed Glycine 0 N--CA 1.489 2.208 0 CA-C-N 112.909 -1.95 . . . . 0.0 109.657 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.49 -19.59 10.01 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.552 -0.824 . . . . 0.0 112.983 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.65 116.41 11.99 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.174 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.07 122.17 84.11 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -70.76 72.12 1.96 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 123.062 2.508 . . . . 0.0 112.342 -173.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -177.51 -48.02 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -87.5 144.43 35.56 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 124.135 0.897 . . . . 0.0 109.416 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.13 82.46 1.8 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.966 1.777 . . . . 0.0 109.085 167.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -69.39 91.67 0.56 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.482 ' C ' ' SG ' ' A' ' 8' ' ' CYS . . . -109.12 148.06 31.45 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.882 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.538 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 1.6 m -159.25 -51.24 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.88 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.322 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 18.7 Cg_endo -80.94 -158.66 0.1 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.997 2.465 . . . . 0.0 109.489 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -79.72 -94.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -160.5 135.49 7.75 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.2 m 60.12 126.3 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.716 1.26 . . . . 0.0 114.103 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.81 83.61 11.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.716 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -53.46 -24.8 29.5 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.568 2.178 . . . . 0.0 113.122 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.06 -48.01 79.6 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mt -74.12 150.3 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.932 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -111.03 -44.52 3.58 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.532 -1.667 . . . . 0.0 107.211 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -171.36 -171.23 0.91 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.718 1.261 . . . . 0.0 109.161 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.45 120.74 3.98 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.91 85.84 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.3 m -80.29 132.49 59.15 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.378 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.75 151.65 68.97 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.945 1.764 . . . . 0.0 111.707 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.477 HD13 ' H ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -139.46 153.83 47.63 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.37 1.044 . . . . 0.0 109.827 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' H ' HD13 ' A' ' 52' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.143 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.129 0.49 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.92 56.29 0.68 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tp -86.34 45.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 114.231 -1.349 . . . . 0.0 110.591 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.6 m -87.24 39.91 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.589 1.185 . . . . 0.0 111.495 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -79.76 171.09 15.59 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 112.931 -1.94 . . . . 0.0 107.92 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -157.95 172.94 17.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.53 1.144 . . . . 0.0 111.079 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 t -72.2 -22.86 61.21 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.069 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 9.1 t -74.42 -59.23 2.82 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.111 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.55 62.01 3.82 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.045 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.12 -95.64 1.22 Allowed Glycine 0 N--CA 1.502 3.051 0 N-CA-C 118.513 2.165 . . . . 0.0 118.513 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.4 ' N ' ' HB2' ' A' ' 29' ' ' SER . 0.0 OUTLIER -175.35 113.42 0.13 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 123.827 0.369 . . . . 0.0 111.69 -179.439 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HA ' ' C ' ' A' ' 27' ' ' GLY . 13.4 ttpt -71.62 93.49 1.24 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.321 1.057 . . . . 0.0 109.005 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.507 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 165.03 -39.26 0.29 Allowed Glycine 0 N--CA 1.485 1.962 0 CA-C-N 112.944 -1.935 . . . . 0.0 108.471 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.2 m -97.36 137.47 36.3 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.571 0.7 . . . . 0.0 112.451 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -85.07 105.17 15.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.64 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.791 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 56.9 m-85 -48.74 128.69 15.86 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.569 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.42 152.22 37.77 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.514 1.149 . . . . 0.0 111.959 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.2 t -104.53 130.37 52.49 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 112.082 -2.326 . . . . 0.0 111.955 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.93 -30.89 0.05 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 119.072 2.989 . . . . 0.0 119.072 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.07 -26.51 66.22 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.839 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.9 37.46 0.71 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 m -141.96 136.91 30.83 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.95 0.881 . . . . 0.0 111.862 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -70.49 150.05 46.56 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.975 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.7 t -112.11 -51.38 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.591 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.791 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -166.43 176.7 7.22 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 123.672 0.608 . . . . 0.0 109.942 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -106.03 142.68 35.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA3' ' H ' ' A' ' 13' ' ' GLY . . . -39.99 111.96 0.26 Allowed Glycine 0 N--CA 1.5 2.916 0 O-C-N 125.131 1.52 . . . . 0.0 111.434 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -126.31 -21.18 4.28 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.4 ' HB2' ' N ' ' A' ' 11' ' ' THR . 15.2 m -65.71 84.4 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.425 ' H ' HD21 ' A' ' 33' ' ' ASN . 12.6 t70 -83.03 133.86 47.46 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -50.76 -31.08 31.58 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.027 1.818 . . . . 0.0 112.937 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -75.06 -40.79 59.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 123.943 0.777 . . . . 0.0 110.713 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.425 HD21 ' H ' ' A' ' 30' ' ' ASP . 22.6 p30 -83.18 150.7 61.59 Favored Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.593 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.83 90.7 0.36 Allowed 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.165 1.91 . . . . 0.0 110.952 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 66.02 8.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.837 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.36 123.58 4.37 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.87 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.7 m -146.72 67.96 11.59 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.95 112.26 1.61 Allowed 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 121.972 1.782 . . . . 0.0 111.033 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -160.54 -37.02 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 123.79 0.681 . . . . 0.0 112.51 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -142.76 175.79 9.55 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.853 0.721 . . . . 0.0 112.075 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 68.7 m -119.8 145.48 46.56 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.569 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 45' ' ' ILE . 7.1 t0 -118.09 70.48 7.97 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.86 -23.41 76.78 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 C-N-CA 122.192 1.928 . . . . 0.0 112.217 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -42.62 99.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 124.405 1.066 . . . . 0.0 110.581 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 42' ' ' ASP . 10.6 tt -60.04 148.79 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.281 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.52 -40.37 3.06 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.035 -1.439 . . . . 0.0 107.678 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -174.46 -165.04 0.2 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.797 1.311 . . . . 0.0 109.102 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.39 122.93 4.78 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -79.12 102.85 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.2 m -91.06 125.32 59.06 Favored Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.097 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -64.18 148.24 91.23 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.03 1.82 . . . . 0.0 110.911 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.7 17.06 2.91 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 114.768 -2.539 . . . . 0.0 111.423 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.732 0.301 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 66.14 121.87 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 124.435 1.084 . . . . 0.0 112.872 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 3' ' ' ILE . 6.2 tp -87.59 60.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 122.409 1.099 . . . . 0.0 109.487 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.98 52.53 2.5 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.654 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.35 166.6 23.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.248 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -161.04 148.83 15.59 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.459 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -7.38 5.3 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.121 -1.399 . . . . 0.0 113.714 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 4.4 t -78.58 -63.31 1.44 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.97 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.2 -79.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 11' ' ' THR . . . 37.31 -103.51 0.02 OUTLIER Glycine 0 N--CA 1.503 3.112 0 O-C-N 123.658 0.599 . . . . 0.0 113.675 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -179.25 118.45 0.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -45.48 115.48 0.95 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 123.883 0.74 . . . . 0.0 111.509 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.8 -23.26 20.0 Favored Glycine 0 N--CA 1.499 2.835 0 O-C-N 124.393 1.058 . . . . 0.0 114.155 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -79.32 -176.96 5.47 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 118.014 0.907 . . . . 0.0 109.607 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -137.46 104.18 5.28 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.164 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.503 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 63.6 m-85 -57.82 131.26 49.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.47 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -145.24 154.49 42.44 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.238 1.018 . . . . 0.0 110.684 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 t -106.16 124.77 50.11 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 112.565 -2.107 . . . . 0.0 109.491 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.596 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 20.6 p-10 -39.04 -28.86 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.0 -28.17 64.17 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.218 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.33 35.22 0.72 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.2 m -140.01 135.45 32.7 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.615 0.721 . . . . 0.0 112.498 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -72.97 138.06 45.85 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.47 HG23 ' HA ' ' A' ' 17' ' ' PHE . 61.7 t -97.83 -52.73 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.422 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -173.03 -174.05 1.02 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 123.622 0.576 . . . . 0.0 111.007 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -114.17 142.6 46.04 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.65 110.06 1.7 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.45 14.02 23.79 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.7 t -145.45 115.65 7.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.556 0.693 . . . . 0.0 110.801 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.63 ' H ' HD21 ' A' ' 33' ' ' ASN . 10.6 t70 -79.68 141.36 55.84 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 113.569 -1.651 . . . . 0.0 106.716 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -44.25 -34.94 7.57 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 122.155 1.903 . . . . 0.0 113.152 173.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 tpp180 -73.98 -39.86 63.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 123.881 0.738 . . . . 0.0 112.593 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.63 HD21 ' H ' ' A' ' 30' ' ' ASP . 27.1 p30 -88.0 143.55 33.32 Favored Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.484 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.88 47.65 2.54 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 123.161 2.574 . . . . 0.0 112.881 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -98.51 27.17 4.95 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.139 0.971 . . . . 0.0 110.139 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.91 157.72 16.21 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.083 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.561 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.3 m -136.91 83.12 29.51 Favored Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.463 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.9 76.41 1.2 Allowed 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.219 1.946 . . . . 0.0 108.859 166.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -160.31 -30.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.644 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -94.96 132.27 39.98 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.985 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.0 m -113.84 131.44 56.25 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.836 1.335 . . . . 0.0 108.489 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -137.58 82.7 26.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 123.736 0.648 . . . . 0.0 111.087 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.51 -28.31 87.15 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.251 1.968 . . . . 0.0 112.751 168.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 mtm105 -64.18 -19.07 65.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.784 0.678 . . . . 0.0 111.91 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.13 144.07 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.596 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -103.04 -50.12 3.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.522 1.138 . . . . 0.0 108.46 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -169.44 -173.76 1.77 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.935 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.9 110.6 2.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.3 mm -79.07 102.21 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.8 m -95.45 133.63 25.56 Favored Pre-proline 0 N--CA 1.493 1.724 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.322 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.0 86.34 0.39 Allowed 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 122.052 1.834 . . . . 0.0 110.214 174.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.16 179.11 8.99 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.045 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 116.958 -1.496 . . . . 0.0 110.103 179.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 121.445 0.64 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.07 136.84 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.985 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -142.71 35.84 1.43 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.246 1.022 . . . . 0.0 111.851 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.32 158.42 26.1 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 113.432 -1.713 . . . . 0.0 107.538 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -147.92 161.81 40.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 124.552 1.158 . . . . 0.0 110.831 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.21 -18.35 35.92 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.765 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 1.1 t -58.61 -59.2 5.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.2 -100.22 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.628 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 11' ' ' THR . . . 68.37 -99.13 0.56 Allowed Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.383 -0.823 . . . . 0.0 114.634 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 173.82 112.72 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HB2' ' N ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -61.3 107.53 0.78 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.507 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 131.2 -19.6 4.85 Favored Glycine 0 N--CA 1.493 2.441 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.3 m -103.65 143.34 32.9 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.019 0.437 . . . . 0.0 111.353 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -89.3 96.35 10.68 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.573 ' CZ ' ' HA2' ' A' ' 27' ' ' GLY . 3.5 m-85 -55.54 127.85 31.71 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.033 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.55 158.57 43.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.143 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 t -109.21 128.2 54.85 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 113.316 -1.766 . . . . 0.0 110.918 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.42 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 20.6 p-10 -41.89 -24.13 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 112.636 -2.075 . . . . 0.0 114.86 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -53.03 -31.94 44.03 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.923 0.764 . . . . 0.0 111.237 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.98 31.31 1.21 Allowed Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 m -143.88 143.31 31.23 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.869 0.842 . . . . 0.0 111.755 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -72.61 144.98 47.64 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.584 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.6 t -102.19 -54.93 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.173 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.494 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -174.59 168.27 3.77 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 123.992 0.808 . . . . 0.0 110.036 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -90.07 156.39 18.41 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -47.57 115.03 1.96 Allowed Glycine 0 N--CA 1.494 2.566 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.84 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -12.98 4.51 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 t -142.96 120.81 11.95 Favored 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 118.86 0.755 . . . . 0.0 110.659 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' N ' ' HB2' ' A' ' 12' ' ' LYS . 5.5 t70 -79.6 143.01 58.23 Favored Pre-proline 0 N--CA 1.49 1.545 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.091 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.19 -33.68 55.55 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.699 1.599 . . . . 0.0 111.87 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.57 -29.76 41.42 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.789 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -89.72 138.78 27.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.05 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -74.83 79.95 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.647 2.232 . . . . 0.0 110.331 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -138.68 38.58 2.21 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.857 0.837 . . . . 0.0 109.84 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.46 164.61 11.74 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 113.984 -1.462 . . . . 0.0 111.683 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.9 m -142.66 79.53 15.04 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.29 78.9 1.49 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.362 2.041 . . . . 0.0 110.026 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -149.09 -54.32 0.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.027 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -76.54 174.4 10.38 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.711 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.5 m -148.78 122.94 9.52 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.781 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.604 ' O ' HG22 ' A' ' 45' ' ' ILE . 7.8 t70 -117.26 78.02 10.18 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 124.113 0.883 . . . . 0.0 112.569 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.4 -19.99 38.13 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.192 1.928 . . . . 0.0 113.478 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -71.08 -40.63 71.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 123.742 0.651 . . . . 0.0 110.912 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 42' ' ' ASP . 12.4 tt -54.82 148.32 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 123.679 0.612 . . . . 0.0 110.421 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -126.11 -40.55 1.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 124.172 0.92 . . . . 0.0 110.598 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -172.92 -172.06 0.81 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.154 0.909 . . . . 0.0 109.985 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.43 116.33 3.0 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.9 mm -79.1 90.82 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.64 154.8 68.56 Favored Pre-proline 0 N--CA 1.493 1.675 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.536 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.489 1.259 0 C-N-CA 122.076 1.851 . . . . 0.0 110.446 173.904 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.895 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 tp -84.74 61.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.06 36.35 0.77 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 114.336 -1.302 . . . . 0.0 113.089 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -90.71 174.2 7.61 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.345 -1.752 . . . . 0.0 108.749 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -161.44 166.0 27.93 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 124.217 0.948 . . . . 0.0 111.129 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.42 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 1.1 t -57.73 -9.84 1.39 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.567 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.4 t -89.09 -64.75 1.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.287 -1.324 . . . . 0.0 113.665 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.75 73.44 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 120.104 3.372 . . . . 0.0 120.104 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 11' ' ' THR . . . -20.93 -105.0 0.0 OUTLIER Glycine 0 N--CA 1.514 3.869 0 N-CA-C 119.398 2.519 . . . . 0.0 119.398 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -178.24 114.77 0.07 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 123.747 0.322 . . . . 0.0 111.681 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -45.16 111.93 0.38 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 124.19 0.931 . . . . 0.0 110.388 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.25 -35.7 2.77 Favored Glycine 0 N--CA 1.494 2.53 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.771 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.5 m -79.34 -178.38 6.21 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -137.71 106.8 6.01 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.594 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.536 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 61.7 m-85 -56.85 129.73 42.7 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.392 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.482 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -145.45 157.13 44.07 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.198 0.999 . . . . 0.0 111.294 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.8 t -109.04 126.15 52.84 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.175 -1.829 . . . . 0.0 110.866 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.589 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 20.7 p-10 -38.49 -33.08 0.09 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.03 -26.67 60.71 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.917 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.92 34.71 0.72 Allowed Glycine 0 N--CA 1.493 2.499 0 O-C-N 124.233 0.958 . . . . 0.0 111.777 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.4 m -141.49 137.58 32.19 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.657 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -71.92 140.18 49.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 17' ' ' PHE . 59.2 t -100.7 -51.96 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 123.723 0.639 . . . . 0.0 111.152 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.27 178.97 4.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 123.81 0.694 . . . . 0.0 110.839 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -104.44 150.05 24.89 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.55 111.77 1.54 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -118.22 -15.18 9.82 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.74 105.32 1.53 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.47 129.63 46.53 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 124.233 0.958 . . . . 0.0 109.341 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -73.63 60.02 4.2 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.489 2.126 . . . . 0.0 111.731 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.82 -27.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.468 HD21 ' HB3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -90.43 155.07 46.53 Favored Pre-proline 0 N--CA 1.498 1.961 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.415 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -75.76 72.99 4.9 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.342 2.028 . . . . 0.0 111.065 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.468 ' HB3' HD21 ' A' ' 33' ' ' ASN . 0.1 OUTLIER -62.19 98.51 0.11 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.225 0.536 . . . . 0.0 110.121 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.59 131.61 36.05 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.913 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.79 79.83 10.31 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 124.428 1.08 . . . . 0.0 112.311 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.82 0.58 6.23 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.685 2.256 . . . . 0.0 111.748 168.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -25.3 41.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.736 0.648 . . . . 0.0 110.819 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 54.45 -160.15 0.16 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.157 0.911 . . . . 0.0 111.59 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.3 m -55.4 127.69 30.75 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.704 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -127.24 75.16 77.15 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 124.055 0.847 . . . . 0.0 112.056 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.67 -18.48 33.43 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.962 1.775 . . . . 0.0 112.617 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ttp-105 -59.29 -44.97 92.45 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mt -68.56 154.01 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -109.36 -46.6 3.53 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.627 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -172.44 -173.4 1.04 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.524 1.14 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.56 115.69 3.09 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.4 mm -78.8 104.65 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 36.6 m -93.51 122.65 62.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.489 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.2 0 C-N-CA 121.762 1.641 . . . . 0.0 108.77 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 54.9 mtt85 . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.701 HG23 ' HA ' ' A' ' 43' ' ' PRO . 4.7 tp -72.29 84.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 124.73 1.269 . . . . 0.0 107.625 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -92.89 47.47 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.385 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 p -89.83 176.66 6.74 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.743 -1.571 . . . . 0.0 108.441 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 9' ' ' ALA . 28.9 p-10 -157.77 154.65 28.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.168 0.918 . . . . 0.0 113.309 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 t -61.07 -31.25 70.92 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.778 -2.01 . . . . 0.0 112.418 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.7 t -63.33 -56.3 17.5 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.376 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.464 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -83.74 27.63 0.62 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 113.895 -1.502 . . . . 0.0 112.571 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.66 -135.71 0.06 OUTLIER Glycine 0 N--CA 1.497 2.731 0 O-C-N 124.129 0.893 . . . . 0.0 113.722 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.519 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 10.9 p -149.96 114.71 5.31 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 123.92 0.424 . . . . 0.0 112.052 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.12 103.46 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.821 0.701 . . . . 0.0 112.35 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.87 -31.72 3.64 Favored Glycine 0 N--CA 1.496 2.655 0 CA-C-N 114.336 -1.302 . . . . 0.0 113.86 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.9 m -85.91 158.77 19.84 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.968 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -112.31 91.68 3.74 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.471 1.107 . . . . 0.0 108.904 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -57.54 124.93 20.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.451 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.14 157.26 46.26 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.517 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.7 p -101.8 130.18 48.17 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.314 -1.766 . . . . 0.0 111.941 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.421 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 1.7 p30 -38.73 -32.27 0.08 Allowed 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -57.31 -28.76 63.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 123.687 0.617 . . . . 0.0 112.1 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.1 34.28 0.79 Allowed Glycine 0 N--CA 1.492 2.408 0 O-C-N 124.156 0.91 . . . . 0.0 111.0 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.2 m -140.43 137.46 33.97 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.19 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -70.81 142.84 51.29 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.39 -49.87 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 123.649 0.593 . . . . 0.0 110.481 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -175.74 -178.97 1.14 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.102 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -114.31 128.04 56.16 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.519 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -50.1 112.55 1.53 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 1.28 54.8 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.4 m -64.37 102.86 0.58 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.354 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.2 136.33 57.22 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 124.651 1.22 . . . . 0.0 112.104 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -67.39 87.46 0.33 Allowed 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 122.495 2.13 . . . . 0.0 110.002 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mtm105 166.85 -46.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.628 -1.623 . . . . 0.0 106.881 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -86.46 132.49 42.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.11 65.3 7.85 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.51 2.14 . . . . 0.0 110.621 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt 26.6 86.61 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 O-C-N 124.503 1.127 . . . . 0.0 113.806 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.04 87.91 4.81 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.619 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.0 m -148.86 147.88 25.73 Favored Pre-proline 0 N--CA 1.496 1.842 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.355 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.89 -75.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.167 0 C-N-CA 121.591 1.527 . . . . 0.0 109.683 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -161.15 -64.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.8 m120 56.54 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 125.411 1.694 . . . . 0.0 112.898 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.2 m -94.02 125.75 38.83 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.113 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -123.57 77.0 55.32 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 124.021 0.826 . . . . 0.0 110.725 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.701 ' HA ' HG23 ' A' ' 3' ' ' ILE . 5.9 Cg_exo -53.91 -30.32 57.77 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 122.309 2.006 . . . . 0.0 112.707 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -64.24 -43.75 93.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.162 0.914 . . . . 0.0 111.332 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.88 137.12 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 124.152 0.908 . . . . 0.0 109.316 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -116.42 -42.8 2.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.748 1.28 . . . . 0.0 109.085 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -170.13 -175.84 2.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.544 1.153 . . . . 0.0 109.92 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.22 114.58 2.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.4 mm -78.81 94.34 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.3 m -89.87 143.3 29.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.127 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 C-N-CA 122.0 1.8 . . . . 0.0 110.715 176.256 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 3' ' ' ILE . 7.0 tp -81.3 70.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.7 m -90.75 36.04 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.869 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 p -86.93 166.38 15.17 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 112.967 -1.924 . . . . 0.0 107.427 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -153.85 154.94 34.84 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 124.674 1.233 . . . . 0.0 109.046 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.471 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -59.34 -14.68 12.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 124.065 0.853 . . . . 0.0 112.257 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.0 t -90.39 -64.43 1.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.041 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.89 50.93 1.96 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 11' ' ' THR . . . -103.07 -88.21 2.04 Favored Glycine 0 N--CA 1.503 3.121 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.582 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.7 OUTLIER -169.08 108.68 0.45 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 124.641 0.848 . . . . 0.0 110.564 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HA ' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -50.8 112.14 0.66 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 123.763 0.664 . . . . 0.0 109.997 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.421 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 124.79 -30.51 4.62 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 124.483 1.114 . . . . 0.0 111.82 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.5 m -87.27 122.99 31.79 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -73.86 102.05 3.95 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.82 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.54 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 99.4 m-85 -51.66 126.49 17.8 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.53 153.61 41.3 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.429 1.109 . . . . 0.0 111.665 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.5 t -103.43 132.71 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.705 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 2.5 p30 -46.4 -23.58 0.38 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 113.111 -1.859 . . . . 0.0 114.449 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -58.99 -19.4 43.06 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.122 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.97 33.25 3.29 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.5 m -139.81 137.74 35.23 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.497 0.665 . . . . 0.0 112.232 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -72.26 142.47 48.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.2 t -102.56 -52.94 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.186 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.75 -179.77 3.42 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.823 0.702 . . . . 0.0 110.608 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -102.46 143.65 31.92 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -47.01 116.13 2.35 Favored Glycine 0 N--CA 1.498 2.819 0 O-C-N 125.353 1.658 . . . . 0.0 110.115 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.43 -29.81 5.03 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 p -68.43 100.16 1.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -101.74 129.12 27.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.61 -27.16 31.96 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.17 1.913 . . . . 0.0 113.219 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -38.86 51.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.721 0.638 . . . . 0.0 112.015 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.51 148.43 55.23 Favored Pre-proline 0 N--CA 1.495 1.796 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.082 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.14 76.88 4.0 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.502 2.135 . . . . 0.0 111.209 171.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.84 94.7 0.63 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.445 0.64 . . . . 0.0 109.637 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.7 83.12 5.7 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.43 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.9 m -102.56 151.31 38.22 Favored Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.327 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -67.5 153.77 75.58 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.118 1.879 . . . . 0.0 110.387 166.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -88.47 33.96 0.76 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.593 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -72.09 173.94 7.79 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.532 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 98.0 m -125.11 132.4 53.13 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.218 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 45' ' ' ILE . 12.6 t70 -113.79 84.38 8.38 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 123.747 0.654 . . . . 0.0 112.674 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -55.47 -21.88 32.14 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.352 2.035 . . . . 0.0 113.262 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -40.38 96.89 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.797 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 42' ' ' ASP . 11.4 tt -77.78 163.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 123.794 0.683 . . . . 0.0 110.667 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -121.67 -43.67 2.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 124.388 1.055 . . . . 0.0 108.289 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -171.75 -167.7 0.53 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 124.41 1.069 . . . . 0.0 109.758 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -128.01 120.61 3.48 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.6 100.75 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.4 m -92.51 145.63 30.88 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.147 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.487 1.108 0 C-N-CA 122.064 1.842 . . . . 0.0 109.943 176.604 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 43' ' ' PRO . 5.0 tp -72.46 80.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.841 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.49 43.25 1.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.649 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.508 HG21 ' CG2' ' A' ' 45' ' ' ILE . 5.0 t -75.93 167.63 21.52 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.407 -1.724 . . . . 0.0 108.199 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' A' ' 9' ' ' ALA . 31.9 p-10 -148.43 141.81 25.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 123.869 0.73 . . . . 0.0 109.433 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -23.63 49.12 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.024 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.12 -62.77 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.759 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.545 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -88.29 63.44 7.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 124.455 1.097 . . . . 0.0 110.497 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.48 -144.08 16.31 Favored Glycine 0 N--CA 1.494 2.563 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.292 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 p -136.68 107.23 6.51 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 123.905 0.415 . . . . 0.0 111.674 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -50.07 95.94 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.755 1.284 . . . . 0.0 110.661 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.86 -27.81 1.74 Allowed Glycine 0 N--CA 1.493 2.466 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.82 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.0 m -111.68 140.08 46.6 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.429 0.633 . . . . 0.0 112.4 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -89.79 97.96 11.49 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.209 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -56.43 125.34 21.58 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 156.98 48.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.807 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 t -104.51 130.31 52.47 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.993 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -39.84 -28.32 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 117.691 2.478 . . . . 0.0 117.691 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -55.99 -27.7 54.01 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.812 -0.755 . . . . 0.0 112.2 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.98 34.22 1.17 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 107.684 -2.166 . . . . 0.0 107.684 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.9 m -143.01 137.89 29.63 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.812 0.815 . . . . 0.0 111.172 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -70.12 152.41 44.35 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.699 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.7 -59.09 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 123.748 0.655 . . . . 0.0 111.677 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -176.19 177.96 1.47 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.868 0.73 . . . . 0.0 111.07 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.551 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -99.27 130.18 45.55 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.36 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.79 107.01 1.97 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.72 12.89 28.3 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -106.14 132.44 52.2 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.19 137.66 56.5 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.99 67.86 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.237 1.958 . . . . 0.0 111.924 169.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 170.09 -21.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.449 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -90.35 143.62 29.72 Favored Pre-proline 0 N--CA 1.493 1.716 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.072 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.3 55.44 5.66 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.528 2.152 . . . . 0.0 111.439 169.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.29 132.33 53.7 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.728 -1.189 . . . . 0.0 110.862 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.66 127.51 32.27 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.518 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.0 m -150.84 145.78 18.63 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 124.174 0.921 . . . . 0.0 110.54 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.65 151.09 83.43 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.721 1.614 . . . . 0.0 109.704 163.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.3 tpp85 -84.66 59.88 5.78 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.996 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -73.91 93.34 2.18 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.195 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.6 m -59.23 120.84 9.98 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.91 78.4 7.32 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.614 ' HA ' HG23 ' A' ' 3' ' ' ILE . 5.9 Cg_exo -54.48 -21.97 25.92 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 C-N-CA 122.554 2.169 . . . . 0.0 112.803 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -48.84 77.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.125 0.891 . . . . 0.0 109.136 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.508 ' CG2' HG21 ' A' ' 5' ' ' THR . 3.6 mt -58.18 143.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 123.931 0.769 . . . . 0.0 109.737 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.76 -37.38 0.82 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 112.607 -2.088 . . . . 0.0 111.036 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.01 178.19 9.42 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.196 0.935 . . . . 0.0 110.481 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.34 109.83 1.33 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.17 88.86 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -86.85 128.49 55.98 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.49 1.31 0 C-N-CA 122.069 1.846 . . . . 0.0 110.979 -179.033 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.1 ttt85 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 121.642 0.734 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 tp -87.44 45.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.329 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -84.56 46.68 1.26 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.478 1.132 . . . . 0.0 112.577 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.16 150.08 22.16 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.898 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -113.27 -165.76 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.752 1.283 . . . . 0.0 107.868 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 1.2 t -116.31 -29.39 6.23 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.376 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 t -56.32 -56.14 24.74 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.126 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.59 33.77 0.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.764 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.69 -113.88 0.14 Allowed Glycine 0 N--CA 1.494 2.556 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.457 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.5 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 1.4 p -154.88 111.82 3.31 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 123.933 0.431 . . . . 0.0 110.537 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -46.12 99.31 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.9 -23.57 5.88 Favored Glycine 0 N--CA 1.499 2.892 0 CA-C-N 114.99 -1.005 . . . . 0.0 114.902 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.1 m -86.31 143.14 28.04 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.837 0.818 . . . . 0.0 110.747 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -97.63 97.19 8.83 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.49 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 17.4 m-85 -62.24 122.39 15.5 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.97 162.85 31.27 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.023 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.8 t -108.84 131.44 54.99 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.462 -1.699 . . . . 0.0 111.5 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.556 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 4.4 p30 -45.14 -21.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 112.596 -2.093 . . . . 0.0 114.895 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -53.62 -30.33 42.25 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.896 0.747 . . . . 0.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.28 30.29 1.6 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.8 m -146.13 147.24 31.33 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.774 0.797 . . . . 0.0 112.124 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -69.86 158.68 35.06 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.04 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.482 HG11 ' NH1' ' A' ' 44' ' ' ARG . 39.2 t -129.98 -48.94 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 28.4 p -164.24 -175.85 4.16 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.143 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -130.48 137.01 49.56 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.239 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.5 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.32 115.41 5.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -114.49 26.12 10.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 109.63 21.14 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -88.16 137.19 31.25 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 124.379 1.049 . . . . 0.0 110.247 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -69.91 70.95 1.63 Allowed 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 121.969 1.779 . . . . 0.0 110.121 167.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 169.43 -30.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.682 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -90.08 141.47 27.92 Favored Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.215 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -75.12 68.29 5.88 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 122.734 2.289 . . . . 0.0 110.671 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.65 86.38 3.95 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.502 0.668 . . . . 0.0 110.061 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.43 103.07 9.1 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.198 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.3 m -104.82 150.62 38.86 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.25 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.87 158.18 57.68 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 122.317 2.012 . . . . 0.0 110.522 157.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.499 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.3 60.87 6.35 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.626 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -63.47 110.09 1.84 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.652 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 99.2 m -74.38 116.19 14.77 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.746 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.494 ' CG ' HD12 ' A' ' 45' ' ' ILE . 6.3 t70 -121.35 74.67 31.34 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.89 -25.77 78.44 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.413 2.076 . . . . 0.0 111.305 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.482 ' NH1' HG11 ' A' ' 24' ' ' VAL . 2.3 ttp-105 -59.99 -31.13 69.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.991 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.494 HD12 ' CG ' ' A' ' 42' ' ' ASP . 1.4 mt -77.12 156.96 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.556 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -116.83 -44.37 2.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.588 1.18 . . . . 0.0 109.687 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -173.92 178.93 2.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.305 1.003 . . . . 0.0 111.098 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.66 111.64 3.33 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.3 mt -79.24 89.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.0 m -86.27 134.65 38.06 Favored Pre-proline 0 N--CA 1.495 1.813 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.617 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 C-N-CA 121.954 1.769 . . . . 0.0 110.931 175.782 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 121.574 0.702 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.6 tp -45.11 131.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.746 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -135.26 48.28 2.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.195 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -78.81 170.35 16.81 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.382 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -150.59 148.17 28.32 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 41.6 t -78.14 -20.98 50.99 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.181 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -60.57 -58.3 9.07 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.36 36.91 0.89 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.648 -1.615 . . . . 0.0 108.229 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.48 -110.13 0.07 OUTLIER Glycine 0 N--CA 1.495 2.601 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.646 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.536 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 5.3 t -162.35 123.96 2.68 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -65.3 91.94 0.12 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.073 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.83 -21.64 0.79 Allowed Glycine 0 N--CA 1.489 2.194 0 CA-C-N 113.443 -1.708 . . . . 0.0 111.779 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.5 m -127.02 138.23 53.21 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 119.301 -0.96 . . . . 0.0 113.069 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -83.48 102.3 12.0 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 113.548 -1.66 . . . . 0.0 108.501 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.613 ' HB2' ' SG ' ' A' ' 7' ' ' CYS . 6.5 m-85 -62.52 122.81 16.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.7 159.88 38.35 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.045 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 t -108.21 131.28 54.84 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.161 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -39.63 -28.3 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -56.54 -28.53 60.3 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.829 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.07 34.14 0.92 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.3 m -143.61 138.8 29.29 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.886 0.85 . . . . 0.0 112.079 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -71.9 138.91 48.5 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.001 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.32 -57.19 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.909 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -175.84 174.89 2.09 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.556 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.484 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 1.4 mt-10 -99.19 131.11 45.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.315 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.536 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -65.43 112.94 5.38 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -103.45 7.8 37.94 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.383 0.696 . . . . 0.0 112.733 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -80.87 100.04 8.64 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.559 -0.857 . . . . 0.0 112.583 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -90.44 133.43 32.99 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.91 -26.01 23.39 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.974 1.783 . . . . 0.0 112.134 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -86.41 -37.64 18.17 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.725 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -83.74 143.59 43.94 Favored Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.119 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -76.23 74.58 4.56 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 122.445 2.097 . . . . 0.0 109.91 167.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HE2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -64.55 97.89 0.23 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.78 127.2 31.93 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.529 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.439 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 60.8 m -147.09 149.2 34.64 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 124.266 0.979 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.37 142.85 67.66 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 N-CA-C 107.729 -1.681 . . . . 0.0 107.729 153.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -85.31 62.03 7.23 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.092 0.948 . . . . 0.0 108.878 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -61.09 107.7 0.77 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.625 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.2 m -55.63 118.14 4.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 124.193 0.933 . . . . 0.0 110.587 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -128.76 74.05 80.85 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 124.311 1.007 . . . . 0.0 113.061 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.45 -22.44 66.1 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 121.888 1.726 . . . . 0.0 110.627 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.478 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -55.64 -38.22 69.26 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 124.314 1.009 . . . . 0.0 110.099 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mt -66.67 146.52 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.02 -42.56 1.38 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.143 -1.39 . . . . 0.0 111.87 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.87 175.68 12.22 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 124.111 0.882 . . . . 0.0 110.571 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.18 108.81 1.5 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.353 -2.299 . . . . 0.0 107.353 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.5 mt -79.12 94.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.07 152.32 46.02 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.887 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 C--N 1.316 -1.144 0 C-N-CA 121.785 1.656 . . . . 0.0 108.814 -179.727 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 tp -57.03 133.4 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.611 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -146.9 49.22 1.13 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.784 1.278 . . . . 0.0 110.546 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -72.99 167.11 21.76 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 112.997 -1.91 . . . . 0.0 109.562 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -161.19 162.04 31.13 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.946 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.7 t -65.72 -23.48 66.76 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.932 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -58.32 -60.4 3.84 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.8 -106.6 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 112.899 -1.955 . . . . 0.0 105.738 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 11' ' ' THR . . . 79.09 -107.93 2.6 Favored Glycine 0 CA--C 1.549 2.174 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -179.13 97.61 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 123.291 0.636 . . . . 0.0 111.055 -179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.8 133.93 42.37 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.937 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.7 -28.6 12.77 Favored Glycine 0 N--CA 1.488 2.136 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.924 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.6 m -106.63 143.38 34.82 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.412 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.68 106.19 18.17 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.68 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 2.6 m-30 -55.59 131.33 46.04 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.09 159.41 43.32 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 124.669 1.231 . . . . 0.0 112.188 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 t -108.12 129.32 55.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 112.735 -2.029 . . . . 0.0 111.113 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.539 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 6.8 p-10 -43.37 -25.15 0.12 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-N 113.092 -1.867 . . . . 0.0 115.321 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -54.14 -30.2 48.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 123.897 0.748 . . . . 0.0 111.592 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.41 32.72 1.2 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 m -143.56 143.96 31.74 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.901 0.857 . . . . 0.0 111.759 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -72.86 149.16 43.76 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.435 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.2 t -110.5 -52.38 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.53 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -170.05 -173.01 1.44 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 123.53 0.519 . . . . 0.0 110.252 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.557 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 mt-10 -112.43 158.66 19.58 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.41 ' HA2' ' CE1' ' A' ' 16' ' ' TYR . . . -59.78 110.55 2.88 Favored Glycine 0 N--CA 1.494 2.561 0 CA-C-N 112.812 -1.994 . . . . 0.0 110.897 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -121.13 -39.06 2.73 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 p -72.11 102.42 3.01 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.463 ' H ' HD21 ' A' ' 33' ' ' ASN . 10.5 t70 -79.54 133.42 59.57 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.63 -29.83 20.36 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.975 1.783 . . . . 0.0 113.102 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.6 mtt180 -84.77 -34.86 22.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 123.863 0.727 . . . . 0.0 112.093 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.463 HD21 ' H ' ' A' ' 30' ' ' ASP . 32.9 p30 -81.16 142.88 51.72 Favored Pre-proline 0 N--CA 1.495 1.808 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.574 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.84 47.3 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.365 2.71 . . . . 0.0 112.37 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -96.1 95.16 7.98 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.498 0.666 . . . . 0.0 110.584 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.49 140.22 16.07 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.473 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.61 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.8 m -133.2 94.29 20.56 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -71.61 79.17 1.57 Allowed 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.099 1.866 . . . . 0.0 109.364 172.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -144.82 -59.41 0.36 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.263 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -77.69 136.01 38.14 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.004 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.1 m -112.13 126.36 55.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.972 1.42 . . . . 0.0 108.217 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -126.24 71.74 70.88 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 123.893 0.745 . . . . 0.0 112.497 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.15 -28.54 73.58 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.486 2.124 . . . . 0.0 112.643 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -63.15 -17.51 62.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.026 0.829 . . . . 0.0 112.147 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.664 HD11 ' HB3' ' A' ' 16' ' ' TYR . 4.6 tt -69.65 158.82 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 123.694 0.621 . . . . 0.0 109.671 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.539 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -124.16 -45.18 1.99 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.946 0.778 . . . . 0.0 109.47 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -173.94 -169.73 0.5 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 124.343 1.027 . . . . 0.0 110.181 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.52 116.06 3.11 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.9 mt -80.79 91.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.216 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.24 127.06 77.74 Favored Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 N--CA 1.489 1.245 0 C-N-CA 121.901 1.734 . . . . 0.0 109.365 177.009 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mtm105 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 121.703 0.763 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.7 tp -86.63 46.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.687 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 m -85.48 46.35 1.29 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.549 1.166 . . . . 0.0 112.513 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -90.21 174.12 7.78 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 112.961 -1.927 . . . . 0.0 108.45 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -161.39 165.58 28.67 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.028 0.83 . . . . 0.0 110.373 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.7 t -67.49 -3.28 8.15 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.7 t -91.12 -57.77 2.69 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -42.13 -69.26 0.14 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 4.43 -112.93 0.01 OUTLIER Glycine 0 N--CA 1.508 3.465 0 N-CA-C 117.556 1.782 . . . . 0.0 117.556 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 173.65 126.82 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -49.62 110.55 0.39 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 124.148 0.905 . . . . 0.0 110.01 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.94 -28.38 4.39 Favored Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.536 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.6 m -79.59 -176.48 5.34 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.199 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -139.22 101.39 4.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.857 0.723 . . . . 0.0 109.683 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.589 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 85.6 m-85 -57.45 131.92 51.57 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.42 155.86 44.5 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.222 1.01 . . . . 0.0 110.94 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 t -106.86 135.74 47.88 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.382 -2.19 . . . . 0.0 113.485 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -47.27 -24.47 0.74 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 111.575 -2.557 . . . . 0.0 113.573 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -56.0 -25.76 45.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 124.098 0.874 . . . . 0.0 111.797 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.27 32.17 2.43 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.7 m -145.66 148.34 32.96 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 112.449 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -70.98 153.49 42.61 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.339 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.7 t -115.99 -56.75 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.213 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.589 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -162.5 -178.92 6.56 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.702 0.626 . . . . 0.0 110.56 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.418 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -112.77 150.64 31.34 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.48 110.49 1.41 Allowed Glycine 0 N--CA 1.492 2.419 0 CA-C-N 112.951 -1.931 . . . . 0.0 109.653 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -114.03 -6.61 13.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.897 0.998 . . . . 0.0 113.437 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.97 89.66 4.14 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.95 130.39 44.85 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.28 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.0 74.49 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.609 2.206 . . . . 0.0 110.993 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 170.57 -39.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.591 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -80.95 155.99 72.52 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.104 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.86 78.51 2.47 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 122.128 1.885 . . . . 0.0 111.163 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.09 99.4 0.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.07 92.92 5.06 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.6 m -111.71 98.93 43.15 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.115 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.9 169.45 13.26 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 121.97 1.78 . . . . 0.0 110.452 168.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -83.69 25.51 0.77 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.352 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -63.95 134.85 55.85 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.644 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.22 136.66 34.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 125.501 1.75 . . . . 0.0 110.887 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -129.82 81.0 70.31 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 124.054 0.846 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -54.96 -27.92 56.67 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 122.189 1.926 . . . . 0.0 113.238 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -59.36 -46.9 87.36 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mt -64.77 148.46 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.97 -42.13 2.97 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.209 -1.814 . . . . 0.0 108.604 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -173.7 -168.74 0.45 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.638 1.211 . . . . 0.0 109.676 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.11 113.8 1.92 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 mm -79.5 111.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.6 m -102.71 157.44 33.72 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 123.557 0.536 . . . . 0.0 110.459 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.486 1.073 0 C-N-CA 121.909 1.739 . . . . 0.0 108.094 173.091 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.4 mmt-85 . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 3' ' ' ILE . 5.9 tp -72.72 89.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.599 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -97.05 55.8 1.34 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.693 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -87.72 179.49 6.49 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.507 -1.678 . . . . 0.0 107.993 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -160.27 -171.19 3.09 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 t -98.73 -30.95 12.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.043 0.84 . . . . 0.0 111.944 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.2 t -67.18 -60.82 2.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 123.995 0.81 . . . . 0.0 109.761 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.19 63.86 8.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 125.119 1.512 . . . . 0.0 108.772 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.65 -136.35 7.74 Favored Glycine 0 N--CA 1.491 2.348 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.812 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -144.25 108.63 4.83 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.86 94.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.346 1.029 . . . . 0.0 111.888 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.01 -26.2 2.5 Favored Glycine 0 N--CA 1.495 2.582 0 CA-C-N 113.754 -1.566 . . . . 0.0 113.169 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.7 m -87.66 158.88 18.73 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.005 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -116.18 95.66 5.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.515 1.134 . . . . 0.0 109.834 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -52.27 129.8 29.08 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.927 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.88 158.99 43.6 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.521 0.677 . . . . 0.0 111.76 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -107.38 132.71 52.86 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.473 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -44.58 -24.39 0.19 Allowed 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 112.887 -1.96 . . . . 0.0 114.997 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -54.42 -27.67 38.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.07 0.856 . . . . 0.0 111.45 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.06 32.84 1.77 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.6 m -144.93 140.78 28.5 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.505 0.669 . . . . 0.0 111.539 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.16 159.52 28.77 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.754 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.3 t -127.68 -46.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.72 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -167.38 -173.96 2.41 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.838 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.72 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -128.15 124.81 37.8 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.23 117.87 12.74 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 107.481 -2.248 . . . . 0.0 107.481 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.63 13.79 24.95 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.35 109.89 20.98 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.408 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.41 132.45 62.29 Favored Pre-proline 0 N--CA 1.494 1.725 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.21 75.66 0.48 Allowed 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.859 1.706 . . . . 0.0 110.149 173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 164.58 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.96 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -90.43 144.64 31.1 Favored Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.478 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.12 69.01 8.1 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.513 2.142 . . . . 0.0 111.309 168.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -71.08 89.41 0.82 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.91 121.63 25.67 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.715 -1.129 . . . . 0.0 113.675 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.4 m -160.42 162.47 23.51 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.079 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.62 159.77 35.31 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.692 1.594 . . . . 0.0 110.682 165.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.5 ttm105 -87.31 63.3 7.68 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -57.36 149.98 19.31 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.601 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.7 m -109.97 128.72 55.56 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.1 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CG ' HD12 ' A' ' 45' ' ' ILE . 5.7 t70 -123.66 75.51 55.26 Favored Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 124.059 0.849 . . . . 0.0 113.202 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.07 -21.47 65.58 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.485 2.123 . . . . 0.0 112.068 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -63.73 -39.07 93.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.039 0.837 . . . . 0.0 110.009 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.587 HD12 ' CG ' ' A' ' 42' ' ' ASP . 1.6 mt -69.29 154.31 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.42 1.075 . . . . 0.0 109.537 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.25 -44.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.354 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.49 -177.6 6.32 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 124.308 1.005 . . . . 0.0 110.212 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.68 110.57 1.26 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 107.169 -2.372 . . . . 0.0 107.169 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.1 mt -79.07 90.6 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -92.51 149.71 38.65 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.921 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.374 0 C-N-CA 122.206 1.938 . . . . 0.0 112.35 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 . . . . . 0 N--CA 1.497 1.908 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 43' ' ' PRO . 5.9 tp -69.31 87.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 124.22 0.95 . . . . 0.0 109.863 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.68 37.55 1.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.552 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 p -89.03 171.95 9.47 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 113.727 -1.578 . . . . 0.0 107.385 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -158.0 155.71 29.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.142 0.901 . . . . 0.0 111.883 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.42 -16.66 38.11 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.96 -1.473 . . . . 0.0 112.284 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -90.25 -69.27 0.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.472 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.82 58.85 3.97 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.94 -83.77 1.21 Allowed Glycine 0 N--CA 1.497 2.749 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.909 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.573 HG23 ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -174.24 111.78 0.16 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.83 119.72 4.14 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.072 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.9 -31.11 7.25 Favored Glycine 0 N--CA 1.495 2.63 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.416 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.573 ' HB2' HG23 ' A' ' 11' ' ' THR . 90.2 m -90.06 120.56 31.35 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.766 -1.173 . . . . 0.0 111.124 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -67.53 100.11 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.371 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.55 ' CE2' ' HA2' ' A' ' 27' ' ' GLY . 91.8 m-85 -48.96 131.03 18.84 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.29 156.37 42.45 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 122.147 0.975 . . . . 0.0 110.985 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.4 t -107.19 130.08 54.77 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 112.438 -2.165 . . . . 0.0 110.704 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 4.0 p-10 -39.04 -28.83 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 118.402 2.741 . . . . 0.0 118.402 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.43 -28.59 65.39 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.521 -0.872 . . . . 0.0 112.37 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.93 35.01 0.75 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 m -142.93 140.21 31.05 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.668 0.747 . . . . 0.0 111.845 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -70.63 153.37 42.92 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.081 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t -115.52 -57.91 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.114 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.533 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -162.08 -178.66 6.55 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 123.523 0.514 . . . . 0.0 110.717 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -97.42 138.62 34.59 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.55 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -54.47 113.8 3.75 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.14 -23.46 5.35 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.65 98.49 0.52 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 118.9 0.773 . . . . 0.0 111.504 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.73 127.23 30.63 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.482 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.53 -22.65 44.0 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.453 2.102 . . . . 0.0 113.772 -168.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.436 ' H ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -83.02 -41.71 18.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 123.895 0.747 . . . . 0.0 110.511 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.33 147.39 87.59 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -73.2 77.87 2.36 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.184 1.922 . . . . 0.0 110.607 174.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 81.43 2.29 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.045 0.926 . . . . 0.0 109.184 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.53 127.93 32.75 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.518 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -147.95 148.93 31.52 Favored Pre-proline 0 N--CA 1.495 1.783 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.07 161.26 37.82 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.818 1.679 . . . . 0.0 109.735 165.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -86.54 61.81 7.04 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.25 1.024 . . . . 0.0 109.367 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -76.69 -177.88 4.49 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.258 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 93.8 m -146.77 122.61 10.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -112.74 83.15 5.51 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 123.775 0.672 . . . . 0.0 112.724 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' HA ' HG23 ' A' ' 3' ' ' ILE . 4.5 Cg_exo -51.95 -31.44 43.55 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.573 2.182 . . . . 0.0 112.213 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -59.88 -50.69 72.79 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 124.406 1.066 . . . . 0.0 108.477 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -63.02 148.1 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.031 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -118.64 -43.19 2.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 124.527 1.142 . . . . 0.0 108.021 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -173.06 -167.75 0.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.719 1.262 . . . . 0.0 109.308 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.81 121.06 4.02 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.5 mt -83.0 95.03 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 123.947 0.44 . . . . 0.0 111.607 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 m -82.57 145.56 51.42 Favored Pre-proline 0 N--CA 1.503 2.2 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 C-N-CA 122.274 1.983 . . . . 0.0 110.77 177.216 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tp -56.73 119.45 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.122 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -124.49 47.33 2.12 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.58 140.48 29.51 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.542 ' ND2' ' HA ' ' A' ' 40' ' ' ASN . 14.6 p-10 -160.35 163.04 33.55 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 124.028 0.83 . . . . 0.0 111.052 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 10.1 t -60.81 -16.8 44.75 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 1.9 t -91.55 -43.87 9.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.455 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -88.59 43.66 1.15 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -102.45 -118.18 4.39 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.066 -1.064 . . . . 0.0 114.056 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.5 m -160.6 126.4 3.97 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.86 103.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 123.706 0.629 . . . . 0.0 109.575 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.434 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 132.41 -25.31 3.84 Favored Glycine 0 N--CA 1.498 2.777 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.776 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.8 m -88.25 122.97 32.39 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 117.362 0.581 . . . . 0.0 110.174 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -76.75 99.43 5.11 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.491 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.59 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 82.7 m-85 -54.95 127.98 31.34 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.501 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -145.09 157.74 44.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.197 0.999 . . . . 0.0 110.839 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.8 t -103.99 131.32 51.36 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 112.592 -2.094 . . . . 0.0 110.97 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.1 p-10 -44.55 -24.87 0.22 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 125.519 1.762 . . . . 0.0 114.892 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -58.2 -20.95 45.47 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.766 0.666 . . . . 0.0 112.469 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.08 33.27 2.82 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.3 m -139.82 136.2 33.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.122 0.542 . . . . 0.0 112.119 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -70.89 148.66 47.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 45' ' ' ILE . 45.7 t -111.88 -50.88 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 123.779 0.674 . . . . 0.0 110.583 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.59 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -168.48 173.3 7.62 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 123.823 0.702 . . . . 0.0 109.778 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -96.99 152.19 18.97 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.624 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -48.02 118.46 4.46 Favored Glycine 0 N--CA 1.507 3.378 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -132.53 39.78 3.34 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.3 t -162.82 94.93 0.87 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.619 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.3 t70 -79.23 133.16 61.03 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -60.94 86.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 121.916 1.744 . . . . 0.0 109.419 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.62 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.219 -1.809 . . . . 0.0 106.961 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.619 HD21 ' H ' ' A' ' 30' ' ' ASP . 1.8 p30 -90.76 135.49 28.93 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 124.154 0.909 . . . . 0.0 109.307 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -75.08 66.62 6.09 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.185 1.923 . . . . 0.0 109.439 167.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -53.03 127.36 23.7 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.81 135.8 37.17 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.371 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.3 m -145.74 155.89 52.29 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 124.526 1.141 . . . . 0.0 111.944 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.91 -46.07 3.64 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 122.193 1.929 . . . . 0.0 112.26 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -158.15 -2.0 0.09 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.542 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 58.1 m-20 51.79 48.32 23.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.002 0.814 . . . . 0.0 113.111 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 98.1 m -153.41 131.41 11.78 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.186 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -157.98 101.35 1.77 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 123.938 0.774 . . . . 0.0 110.93 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.59 -18.6 60.86 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 122.02 1.814 . . . . 0.0 112.652 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 ttm105 -66.53 -33.12 74.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 123.651 0.594 . . . . 0.0 110.351 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.605 HD11 HG11 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -83.74 157.11 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -114.03 -46.49 3.0 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.01 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -172.47 -172.93 0.97 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.327 1.017 . . . . 0.0 109.683 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -121.06 118.01 3.66 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.2 mm -79.03 95.47 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.54 142.35 29.41 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.291 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo . . . . . 0 N--CA 1.489 1.219 0 C-N-CA 122.062 1.841 . . . . 0.0 111.525 177.288 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.5 tp -60.67 125.36 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 123.992 0.808 . . . . 0.0 110.517 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.13 47.59 2.46 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.23 143.95 36.68 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.508 HD22 ' H ' ' A' ' 8' ' ' CYS . 3.8 t30 -150.76 178.13 9.42 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.491 1.139 . . . . 0.0 113.35 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.0 t -94.48 -45.02 7.61 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.262 -2.245 . . . . 0.0 108.589 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.508 ' H ' HD22 ' A' ' 6' ' ' ASN . 37.5 t -60.24 -56.57 19.91 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.03 41.48 1.03 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.454 -1.703 . . . . 0.0 108.856 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' HB3' ' A' ' 29' ' ' SER . . . -78.7 -155.91 9.05 Favored Glycine 0 N--CA 1.491 2.348 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.518 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.515 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.1 m -141.02 96.17 2.96 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 115.697 -0.252 . . . . 0.0 110.566 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 5.8 mmtm -26.05 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 124.86 -34.89 3.3 Favored Glycine 0 N--CA 1.501 3.03 0 CA-C-N 114.932 -1.031 . . . . 0.0 114.822 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.3 m -84.4 120.61 26.48 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 101.7 5.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.375 1.047 . . . . 0.0 110.746 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.416 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 7.4 m-85 -58.99 122.57 14.04 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.65 157.47 46.56 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.404 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 t -103.18 130.61 50.43 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.64 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -46.2 -20.32 0.1 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 113.168 -1.833 . . . . 0.0 114.903 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -55.27 -28.65 54.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 123.638 0.586 . . . . 0.0 110.747 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.24 30.95 1.79 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.8 m -144.94 142.61 29.99 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.816 0.817 . . . . 0.0 112.09 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -69.35 149.69 48.15 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.808 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.5 t -112.38 -52.77 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 123.783 0.677 . . . . 0.0 110.986 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -168.21 176.9 5.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.083 0.864 . . . . 0.0 110.528 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.634 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -99.91 123.36 44.08 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -59.52 103.39 0.41 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -93.7 -8.23 41.45 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 118.075 2.62 . . . . 0.0 118.075 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.448 ' HB3' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -79.37 131.71 36.19 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.574 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.53 134.58 23.17 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.5 -27.5 19.08 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.034 1.823 . . . . 0.0 112.712 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -85.9 -34.17 21.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.957 0.786 . . . . 0.0 112.805 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -90.14 152.88 46.52 Favored Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.791 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -79.85 51.93 4.09 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.1 2.533 . . . . 0.0 112.978 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -74.05 94.65 2.42 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.795 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.48 155.57 48.31 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.765 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.427 ' H ' HD21 ' A' ' 40' ' ' ASN . 29.3 m -145.05 160.44 46.31 Favored Pre-proline 0 N--CA 1.499 1.989 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.11 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.02 -13.03 17.24 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.872 1.715 . . . . 0.0 113.241 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.12 75.32 1.44 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 124.035 0.834 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.427 HD21 ' H ' ' A' ' 37' ' ' CYS . 5.3 m120 -104.48 42.44 1.2 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.605 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.0 m -147.52 134.54 20.32 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.132 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -159.05 98.8 1.63 Allowed Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.24 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.22 -17.47 32.7 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.585 2.19 . . . . 0.0 113.677 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.6 ttp-105 -61.06 -35.28 76.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 123.705 0.628 . . . . 0.0 110.949 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -77.54 155.18 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.714 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.17 -41.44 1.77 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 112.414 -2.176 . . . . 0.0 110.064 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.17 177.94 10.0 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 124.162 0.913 . . . . 0.0 110.909 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.63 108.18 1.15 Allowed Glycine 0 N--CA 1.495 2.605 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.41 93.98 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.47 148.39 38.72 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-N 114.843 -1.072 . . . . 0.0 108.752 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo . . . . . 0 N--CA 1.488 1.201 0 C-N-CA 121.806 1.671 . . . . 0.0 110.32 176.65 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 120.908 0.385 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 tp -86.42 49.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.643 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.4 45.45 1.12 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.668 1.223 . . . . 0.0 112.504 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.14 170.1 14.17 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 113.056 -1.884 . . . . 0.0 108.146 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -160.58 145.23 14.25 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.201 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 1.7 t -55.9 -19.9 13.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.554 1.159 . . . . 0.0 113.329 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -73.71 -67.82 0.56 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.182 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.45 -86.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 11' ' ' THR . . . 33.22 -108.04 0.03 OUTLIER Glycine 0 N--CA 1.506 3.363 0 N-CA-C 115.208 0.843 . . . . 0.0 115.208 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 177.28 121.74 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 124.912 1.007 . . . . 0.0 109.251 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.27 104.7 0.15 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 123.965 0.79 . . . . 0.0 109.863 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.02 -30.09 2.38 Favored Glycine 0 N--CA 1.491 2.313 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.076 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.45 125.57 41.03 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -82.74 113.81 20.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.345 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.634 ' HB3' HD11 ' A' ' 45' ' ' ILE . 92.2 m-85 -55.73 131.32 46.37 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.64 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.71 155.41 42.39 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.067 0.937 . . . . 0.0 111.204 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.5 t -107.92 133.51 52.15 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 112.683 -2.053 . . . . 0.0 112.851 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -38.96 -31.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 111.245 -2.707 . . . . 0.0 118.053 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.21 -28.15 66.39 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.362 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.82 37.17 0.68 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 m -144.56 142.06 29.92 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -69.89 152.12 44.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.677 -1.147 . . . . 0.0 107.951 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.7 -47.43 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 123.835 0.709 . . . . 0.0 110.541 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.603 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.04 -176.85 2.74 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 123.703 0.627 . . . . 0.0 110.683 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.5 mm-40 -111.15 147.54 34.69 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA2' ' CE1' ' A' ' 16' ' ' TYR . . . -49.52 113.7 1.91 Allowed Glycine 0 N--CA 1.491 2.33 0 O-C-N 125.652 1.845 . . . . 0.0 109.303 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -108.22 -37.21 6.08 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 t -77.9 95.48 4.77 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.509 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.5 t70 -85.55 123.06 73.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.98 86.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.326 2.017 . . . . 0.0 111.628 -167.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 30' ' ' ASP . 4.6 mtm-85 169.41 -34.89 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.671 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.509 HD21 ' H ' ' A' ' 30' ' ' ASP . 55.7 p30 -87.91 152.33 50.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 123.958 0.786 . . . . 0.0 112.62 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -79.52 42.64 1.34 Allowed 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 123.301 2.668 . . . . 0.0 112.929 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.96 38.16 1.25 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.55 132.36 56.21 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.255 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.457 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 4.5 m -137.06 68.99 57.12 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.96 -21.49 41.6 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.193 1.929 . . . . 0.0 112.338 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -83.37 19.9 1.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.791 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -118.93 118.33 31.23 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.741 0.651 . . . . 0.0 109.805 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.7 m -105.89 129.05 54.12 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.53 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -130.97 78.81 72.76 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 123.86 0.725 . . . . 0.0 110.938 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.42 -22.19 57.45 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.086 1.857 . . . . 0.0 113.78 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.495 ' H ' ' HD3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -67.07 -43.12 83.44 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -66.15 155.92 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.16 -43.18 2.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.099 0.875 . . . . 0.0 109.408 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -175.64 -165.07 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.36 1.038 . . . . 0.0 109.264 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -128.35 119.26 3.03 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.4 mm -79.0 110.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -99.3 151.52 37.45 Favored Pre-proline 0 N--CA 1.495 1.818 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.89 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.486 1.049 0 C-N-CA 121.944 1.763 . . . . 0.0 109.323 168.502 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.798 0.809 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.601 HG22 ' OG1' ' A' ' 5' ' ' THR . 7.3 mm -76.14 89.65 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -85.94 27.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.601 ' OG1' HG22 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -91.03 164.78 13.84 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 9' ' ' ALA . 39.9 p-10 -160.87 150.6 17.32 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.585 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.3 t -65.37 -21.5 66.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.753 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -77.76 -68.6 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.162 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' A' ' 6' ' ' ASN . . . -90.32 52.8 2.31 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.556 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.74 -121.76 0.18 Allowed Glycine 0 N--CA 1.491 2.336 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.809 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.498 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -158.88 103.0 1.68 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -42.46 105.42 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.18 -30.06 4.42 Favored Glycine 0 N--CA 1.496 2.651 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.832 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.6 m -82.4 157.2 23.8 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.908 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -111.73 95.35 5.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.258 0.974 . . . . 0.0 111.703 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.6 129.0 34.84 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.639 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.12 160.39 41.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.024 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.4 t -109.6 129.8 55.56 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.408 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.559 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 7.2 p-10 -42.95 -24.35 0.06 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 112.962 -1.926 . . . . 0.0 115.366 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -53.24 -30.69 39.53 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.876 0.735 . . . . 0.0 111.292 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.16 31.78 1.25 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -144.86 144.43 31.11 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.759 0.79 . . . . 0.0 111.92 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -71.19 154.37 41.74 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.325 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.4 t -118.56 -52.43 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 123.613 0.57 . . . . 0.0 111.229 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -173.34 -169.51 0.53 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.027 0.829 . . . . 0.0 109.443 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.68 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -124.78 134.72 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.498 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -51.9 111.39 1.44 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.32 11.72 37.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.61 0.83 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.9 p -77.69 92.45 4.14 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.973 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -82.57 137.8 44.54 Favored Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.547 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.14 77.92 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 122.19 1.927 . . . . 0.0 111.309 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 161.58 -37.24 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.097 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -82.04 143.18 48.96 Favored Pre-proline 0 N--CA 1.498 1.954 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.333 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.97 91.22 0.53 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.847 1.698 . . . . 0.0 108.87 170.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 66.7 3.6 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.031 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.77 135.08 54.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.524 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 2.8 m -153.78 167.77 12.99 Favored Pre-proline 0 N--CA 1.497 1.918 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.083 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -68.99 70.08 1.19 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.073 1.848 . . . . 0.0 109.007 159.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.469 HH11 HH12 ' A' ' 44' ' ' ARG . 4.6 tpm_? -160.41 73.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -107.01 114.03 27.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.565 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 84.8 m 59.64 108.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 124.967 1.417 . . . . 0.0 111.615 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.15 88.31 5.65 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -47.1 -35.2 18.76 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 123.375 2.717 . . . . 0.0 114.434 170.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.469 HH12 HH11 ' A' ' 39' ' ' ARG . 0.5 OUTLIER -56.28 -43.74 79.11 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 124.223 0.952 . . . . 0.0 110.211 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.555 ' O ' HG21 ' A' ' 3' ' ' ILE . 2.2 mt -75.41 161.43 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.782 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.559 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -120.71 -44.6 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.0 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -173.52 -169.76 0.54 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 124.303 1.002 . . . . 0.0 109.754 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.84 117.07 2.92 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.8 mm -78.86 95.15 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.5 m -85.19 133.32 43.0 Favored Pre-proline 0 N--CA 1.493 1.713 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.301 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.488 1.151 0 C-N-CA 122.133 1.889 . . . . 0.0 110.522 178.02 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.028 0.442 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.761 HD11 ' HA ' ' A' ' 46' ' ' ALA . 9.4 tp -89.99 38.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.646 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.8 m -94.21 43.15 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.985 -1.461 . . . . 0.0 112.299 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.72 176.01 7.6 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.675 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' A' ' 9' ' ' ALA . 10.4 p30 -158.86 141.17 14.0 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -65.28 -24.99 67.45 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.58 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -63.64 -54.2 39.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 124.249 0.968 . . . . 0.0 112.056 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.55 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -89.82 -77.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 113.811 -1.541 . . . . 0.0 115.135 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 11' ' ' THR . . . 39.43 -98.32 0.01 OUTLIER Glycine 0 N--CA 1.501 2.971 0 N-CA-C 115.433 0.933 . . . . 0.0 115.433 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 179.46 119.41 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 O-C-N 124.509 0.77 . . . . 0.0 111.575 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.23 130.25 8.02 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 123.669 0.605 . . . . 0.0 111.514 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.68 -29.66 10.65 Favored Glycine 0 N--CA 1.493 2.49 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.58 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.9 m -80.21 121.46 25.63 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.33 107.2 11.92 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.584 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 95.5 m-85 -58.43 129.01 40.02 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.76 156.99 43.96 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 124.229 0.956 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 t -106.04 136.05 46.42 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.572 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.608 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 10.8 p-10 -47.06 -23.48 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 112.074 -2.33 . . . . 0.0 113.503 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -58.11 -19.85 35.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 123.798 0.686 . . . . 0.0 111.849 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.66 33.24 3.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.6 m -143.88 139.93 29.49 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.687 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -68.65 154.93 41.01 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.443 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.25 -53.39 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.126 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -161.96 -178.32 6.37 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 123.567 0.542 . . . . 0.0 110.927 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.419 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 17.0 mm-40 -112.63 150.75 30.99 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.02 110.45 0.35 Allowed Glycine 0 N--CA 1.499 2.861 0 O-C-N 125.779 1.924 . . . . 0.0 112.459 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 -42.75 7.32 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 118.39 2.737 . . . . 0.0 118.39 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 t -57.86 102.81 0.11 Allowed 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 119.756 1.162 . . . . 0.0 113.883 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.55 139.9 22.98 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 124.931 1.395 . . . . 0.0 107.45 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -45.75 -30.61 6.75 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.627 2.218 . . . . 0.0 115.942 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -65.21 -36.93 85.69 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.743 HD22 ' H ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -81.61 142.49 49.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 119.226 -0.989 . . . . 0.0 108.561 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -75.52 40.52 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.147 1.898 . . . . 0.0 110.933 166.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.743 ' H ' HD22 ' A' ' 33' ' ' ASN . 2.6 mptp? 48.81 71.6 0.36 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.633 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.32 86.36 5.07 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.302 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.1 m -153.66 141.54 13.81 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.99 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.53 -166.28 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 121.936 1.757 . . . . 0.0 110.753 168.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -79.54 -76.56 0.21 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 m120 50.5 86.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 124.62 1.2 . . . . 0.0 113.052 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.8 m -66.95 128.37 36.09 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -113.71 80.97 5.32 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.59 -30.63 83.87 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 122.367 2.045 . . . . 0.0 112.603 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.481 ' H ' ' HD3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -61.48 -44.58 96.84 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.49 144.3 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.761 ' HA ' HD11 ' A' ' 3' ' ' ILE . . . -106.21 -46.74 3.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.959 0.787 . . . . 0.0 109.22 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -173.21 -170.08 0.6 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.118 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -127.73 115.22 2.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.6 mm -79.4 110.55 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.23 160.53 28.02 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.487 1.116 0 C-N-CA 121.633 1.556 . . . . 0.0 108.961 173.837 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 3' ' ' ILE . 5.1 tp -79.19 76.23 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.322 1.058 . . . . 0.0 108.711 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.1 m -90.32 36.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.218 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.24 -171.55 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.727 -2.033 . . . . 0.0 106.843 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 68.8 m-80 -160.4 167.8 26.57 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.406 1.066 . . . . 0.0 111.122 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -61.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.344 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -59.69 5.06 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.101 -1.408 . . . . 0.0 109.013 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . . . -79.05 31.8 0.21 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.137 -2.301 . . . . 0.0 111.351 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.03 -130.09 0.65 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.486 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.0 m -142.58 109.64 5.56 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 123.97 0.453 . . . . 0.0 111.294 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -48.37 106.61 0.1 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.443 1.089 . . . . 0.0 111.225 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.28 -27.23 4.27 Favored Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.567 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.4 m -110.29 134.45 52.26 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.919 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -80.2 101.15 8.66 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.529 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -62.42 119.24 8.74 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.96 158.68 38.88 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.222 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 t -103.59 129.76 50.91 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.323 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -46.0 -20.84 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 125.855 1.972 . . . . 0.0 114.765 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -55.17 -29.81 58.58 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 123.859 0.724 . . . . 0.0 110.785 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.55 31.57 1.48 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.8 m -144.03 140.68 29.69 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.732 0.777 . . . . 0.0 111.574 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -74.49 135.74 42.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.374 -1.284 . . . . 0.0 107.682 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -91.14 -63.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.356 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -176.25 171.91 2.39 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.17 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.3 mt-10 -90.45 150.25 21.89 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 120.174 -0.611 . . . . 0.0 112.433 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.486 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.11 124.61 11.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.65 -5.0 15.12 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.8 t -85.39 123.45 30.87 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.656 ' H ' HD21 ' A' ' 33' ' ' ASN . 13.0 t70 -80.11 127.06 78.06 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.85 83.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.93 1.753 . . . . 0.0 110.155 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 30' ' ' ASP . 1.4 mmt-85 176.16 -39.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.966 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.656 HD21 ' H ' ' A' ' 30' ' ' ASP . 14.9 p30 -91.28 148.91 38.76 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 124.167 0.917 . . . . 0.0 110.945 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.14 47.29 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.58 2.187 . . . . 0.0 110.183 162.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -72.88 111.55 8.1 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -155.08 109.12 2.9 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.784 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 2.2 m -79.48 -42.66 1.59 Allowed Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 37' ' ' CYS . 10.0 Cg_endo -72.79 -176.32 2.28 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 C-N-CA 122.42 2.08 . . . . 0.0 110.643 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.11 -1.23 1.77 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.575 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -125.49 -168.02 1.78 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.213 0.946 . . . . 0.0 113.023 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 89.0 m -91.18 152.91 20.37 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.132 -1.395 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.597 ' CG ' HD12 ' A' ' 45' ' ' ILE . 7.3 t0 -113.8 76.36 3.11 Favored Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 123.652 0.595 . . . . 0.0 110.996 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.66 -26.98 81.58 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.447 2.098 . . . . 0.0 111.423 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 mtm-85 -60.51 -45.09 95.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.22 0.95 . . . . 0.0 109.744 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.597 HD12 ' CG ' ' A' ' 42' ' ' ASP . 2.4 mt -66.55 155.36 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 124.347 1.03 . . . . 0.0 108.614 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.34 -45.38 0.83 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.93 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.18 175.02 12.56 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 124.059 0.849 . . . . 0.0 111.16 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.01 108.96 1.63 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.27 90.49 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.25 156.6 59.85 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 N--CA 1.49 1.267 0 C-N-CA 122.116 1.877 . . . . 0.0 110.057 173.196 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 3' ' ' ILE . 7.6 tp -70.4 105.11 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.29 26.81 9.49 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -91.32 158.89 16.29 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 112.663 -2.062 . . . . 0.0 106.143 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -140.13 161.53 37.41 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -57.62 -34.95 69.84 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.124 0.964 . . . . 0.0 109.548 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' SG ' ' C ' ' A' ' 36' ' ' ALA . 8.1 t -75.61 -62.36 1.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.47 67.78 6.63 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 113.854 -1.521 . . . . 0.0 106.912 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.76 -109.45 2.88 Favored Glycine 0 N--CA 1.497 2.723 0 CA-C-N 114.259 -1.337 . . . . 0.0 115.066 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 m -167.07 107.46 0.62 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 124.648 0.852 . . . . 0.0 109.95 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.18 132.19 1.41 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.609 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' N ' ' HA3' ' A' ' 27' ' ' GLY . . . 84.46 -24.02 6.81 Favored Glycine 0 N--CA 1.493 2.457 0 CA-C-O 118.603 -1.11 . . . . 0.0 114.473 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.4 m -79.97 127.74 32.63 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.781 1.29 . . . . 0.0 109.921 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -77.76 91.56 4.1 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.536 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 16.4 m-85 -54.48 132.27 44.27 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.497 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -145.52 156.5 43.75 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.721 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.6 t -105.51 128.15 53.41 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 112.295 -2.23 . . . . 0.0 109.775 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.484 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.7 p-10 -39.16 -27.52 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.71 -29.22 64.52 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.199 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.93 36.27 0.73 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.1 m -141.36 133.78 28.25 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.489 0.662 . . . . 0.0 111.552 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -71.51 147.61 47.57 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.156 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 17' ' ' PHE . 58.8 t -104.23 -72.56 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.053 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -154.57 176.67 12.11 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.73 156.83 16.38 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -52.23 104.4 0.17 Allowed Glycine 0 N--CA 1.489 2.208 0 CA-C-N 112.909 -1.95 . . . . 0.0 109.657 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.49 -19.59 10.01 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.552 -0.824 . . . . 0.0 112.983 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.65 116.41 11.99 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.174 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.07 122.17 84.11 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -70.76 72.12 1.96 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 123.062 2.508 . . . . 0.0 112.342 -173.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -177.51 -48.02 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -87.5 144.43 35.56 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 124.135 0.897 . . . . 0.0 109.416 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.13 82.46 1.8 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.966 1.777 . . . . 0.0 109.085 167.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -69.39 91.67 0.56 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.482 ' C ' ' SG ' ' A' ' 8' ' ' CYS . . . -109.12 148.06 31.45 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.882 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 1.6 m -159.25 -51.24 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.88 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.322 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 18.7 Cg_endo -80.94 -158.66 0.1 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.997 2.465 . . . . 0.0 109.489 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -79.72 -94.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -160.5 135.49 7.75 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.2 m 60.12 126.3 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.716 1.26 . . . . 0.0 114.103 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.81 83.61 11.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.716 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -53.46 -24.8 29.5 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.568 2.178 . . . . 0.0 113.122 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.06 -48.01 79.6 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mt -74.12 150.3 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.932 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -111.03 -44.52 3.58 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.532 -1.667 . . . . 0.0 107.211 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -171.36 -171.23 0.91 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.718 1.261 . . . . 0.0 109.161 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.45 120.74 3.98 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.91 85.84 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.3 m -80.29 132.49 59.15 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.378 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.201 0 C-N-CA 121.945 1.764 . . . . 0.0 111.707 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tp -86.34 45.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 114.231 -1.349 . . . . 0.0 110.591 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.6 m -87.24 39.91 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.589 1.185 . . . . 0.0 111.495 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -79.76 171.09 15.59 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 112.931 -1.94 . . . . 0.0 107.92 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -157.95 172.94 17.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.53 1.144 . . . . 0.0 111.079 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 t -72.2 -22.86 61.21 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.069 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 9.1 t -74.42 -59.23 2.82 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.111 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.55 62.01 3.82 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.045 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.12 -95.64 1.22 Allowed Glycine 0 N--CA 1.502 3.051 0 N-CA-C 118.513 2.165 . . . . 0.0 118.513 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.4 ' N ' ' HB2' ' A' ' 29' ' ' SER . 0.0 OUTLIER -175.35 113.42 0.13 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 123.827 0.369 . . . . 0.0 111.69 -179.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HA ' ' C ' ' A' ' 27' ' ' GLY . 13.4 ttpt -71.62 93.49 1.24 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.321 1.057 . . . . 0.0 109.005 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.507 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 165.03 -39.26 0.29 Allowed Glycine 0 N--CA 1.485 1.962 0 CA-C-N 112.944 -1.935 . . . . 0.0 108.471 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.2 m -97.36 137.47 36.3 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.571 0.7 . . . . 0.0 112.451 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -85.07 105.17 15.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.64 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.791 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 56.9 m-85 -48.74 128.69 15.86 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.569 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.42 152.22 37.77 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.514 1.149 . . . . 0.0 111.959 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.2 t -104.53 130.37 52.49 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 112.082 -2.326 . . . . 0.0 111.955 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.93 -30.89 0.05 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 119.072 2.989 . . . . 0.0 119.072 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.07 -26.51 66.22 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.839 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.9 37.46 0.71 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 m -141.96 136.91 30.83 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.95 0.881 . . . . 0.0 111.862 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -70.49 150.05 46.56 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.975 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.7 t -112.11 -51.38 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.591 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.791 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -166.43 176.7 7.22 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 123.672 0.608 . . . . 0.0 109.942 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -106.03 142.68 35.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA3' ' H ' ' A' ' 13' ' ' GLY . . . -39.99 111.96 0.26 Allowed Glycine 0 N--CA 1.5 2.916 0 O-C-N 125.131 1.52 . . . . 0.0 111.434 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -126.31 -21.18 4.28 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.4 ' HB2' ' N ' ' A' ' 11' ' ' THR . 15.2 m -65.71 84.4 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.425 ' H ' HD21 ' A' ' 33' ' ' ASN . 12.6 t70 -83.03 133.86 47.46 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -50.76 -31.08 31.58 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.027 1.818 . . . . 0.0 112.937 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -75.06 -40.79 59.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 123.943 0.777 . . . . 0.0 110.713 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.425 HD21 ' H ' ' A' ' 30' ' ' ASP . 22.6 p30 -83.18 150.7 61.59 Favored Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.593 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.83 90.7 0.36 Allowed 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.165 1.91 . . . . 0.0 110.952 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 66.02 8.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.837 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.36 123.58 4.37 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.87 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.7 m -146.72 67.96 11.59 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.95 112.26 1.61 Allowed 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 121.972 1.782 . . . . 0.0 111.033 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -160.54 -37.02 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 123.79 0.681 . . . . 0.0 112.51 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -142.76 175.79 9.55 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.853 0.721 . . . . 0.0 112.075 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 68.7 m -119.8 145.48 46.56 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.569 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 45' ' ' ILE . 7.1 t0 -118.09 70.48 7.97 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.86 -23.41 76.78 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 C-N-CA 122.192 1.928 . . . . 0.0 112.217 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -42.62 99.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 124.405 1.066 . . . . 0.0 110.581 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 42' ' ' ASP . 10.6 tt -60.04 148.79 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.281 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.52 -40.37 3.06 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.035 -1.439 . . . . 0.0 107.678 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -174.46 -165.04 0.2 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.797 1.311 . . . . 0.0 109.102 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.39 122.93 4.78 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -79.12 102.85 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.2 m -91.06 125.32 59.06 Favored Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.097 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo . . . . . 0 N--CA 1.488 1.191 0 C-N-CA 122.03 1.82 . . . . 0.0 110.911 177.495 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 . . . . . 0 N--CA 1.502 2.126 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 3' ' ' ILE . 6.2 tp -87.59 60.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 122.409 1.099 . . . . 0.0 109.487 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.98 52.53 2.5 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.654 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.35 166.6 23.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.248 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -161.04 148.83 15.59 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.459 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -7.38 5.3 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.121 -1.399 . . . . 0.0 113.714 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 4.4 t -78.58 -63.31 1.44 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.97 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.2 -79.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 11' ' ' THR . . . 37.31 -103.51 0.02 OUTLIER Glycine 0 N--CA 1.503 3.112 0 O-C-N 123.658 0.599 . . . . 0.0 113.675 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -179.25 118.45 0.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -45.48 115.48 0.95 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 123.883 0.74 . . . . 0.0 111.509 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.8 -23.26 20.0 Favored Glycine 0 N--CA 1.499 2.835 0 O-C-N 124.393 1.058 . . . . 0.0 114.155 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -79.32 -176.96 5.47 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 118.014 0.907 . . . . 0.0 109.607 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -137.46 104.18 5.28 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.164 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.503 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 63.6 m-85 -57.82 131.26 49.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.47 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -145.24 154.49 42.44 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.238 1.018 . . . . 0.0 110.684 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 t -106.16 124.77 50.11 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 112.565 -2.107 . . . . 0.0 109.491 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.596 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 20.6 p-10 -39.04 -28.86 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.0 -28.17 64.17 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.218 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.33 35.22 0.72 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.2 m -140.01 135.45 32.7 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.615 0.721 . . . . 0.0 112.498 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -72.97 138.06 45.85 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.47 HG23 ' HA ' ' A' ' 17' ' ' PHE . 61.7 t -97.83 -52.73 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.422 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -173.03 -174.05 1.02 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 123.622 0.576 . . . . 0.0 111.007 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -114.17 142.6 46.04 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.65 110.06 1.7 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.45 14.02 23.79 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.7 t -145.45 115.65 7.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.556 0.693 . . . . 0.0 110.801 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.63 ' H ' HD21 ' A' ' 33' ' ' ASN . 10.6 t70 -79.68 141.36 55.84 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 113.569 -1.651 . . . . 0.0 106.716 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -44.25 -34.94 7.57 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 122.155 1.903 . . . . 0.0 113.152 173.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 tpp180 -73.98 -39.86 63.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 123.881 0.738 . . . . 0.0 112.593 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.63 HD21 ' H ' ' A' ' 30' ' ' ASP . 27.1 p30 -88.0 143.55 33.32 Favored Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.484 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.88 47.65 2.54 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 123.161 2.574 . . . . 0.0 112.881 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -98.51 27.17 4.95 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.139 0.971 . . . . 0.0 110.139 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.91 157.72 16.21 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.083 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.561 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.3 m -136.91 83.12 29.51 Favored Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.463 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.9 76.41 1.2 Allowed 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.219 1.946 . . . . 0.0 108.859 166.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -160.31 -30.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.644 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -94.96 132.27 39.98 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.985 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.0 m -113.84 131.44 56.25 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.836 1.335 . . . . 0.0 108.489 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -137.58 82.7 26.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 123.736 0.648 . . . . 0.0 111.087 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.51 -28.31 87.15 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.251 1.968 . . . . 0.0 112.751 168.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 mtm105 -64.18 -19.07 65.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.784 0.678 . . . . 0.0 111.91 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.13 144.07 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.596 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -103.04 -50.12 3.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.522 1.138 . . . . 0.0 108.46 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -169.44 -173.76 1.77 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.935 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.9 110.6 2.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.3 mm -79.07 102.21 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.8 m -95.45 133.63 25.56 Favored Pre-proline 0 N--CA 1.493 1.724 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.322 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 C-N-CA 122.052 1.834 . . . . 0.0 110.214 174.329 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 50.65 29.5 4.2 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 124.488 1.117 . . . . 0.0 111.643 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.07 136.84 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.985 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -142.71 35.84 1.43 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.246 1.022 . . . . 0.0 111.851 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.32 158.42 26.1 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 113.432 -1.713 . . . . 0.0 107.538 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -147.92 161.81 40.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 124.552 1.158 . . . . 0.0 110.831 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.21 -18.35 35.92 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.765 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 1.1 t -58.61 -59.2 5.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.2 -100.22 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.628 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 11' ' ' THR . . . 68.37 -99.13 0.56 Allowed Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.383 -0.823 . . . . 0.0 114.634 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 173.82 112.72 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HB2' ' N ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -61.3 107.53 0.78 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.507 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 131.2 -19.6 4.85 Favored Glycine 0 N--CA 1.493 2.441 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.3 m -103.65 143.34 32.9 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.019 0.437 . . . . 0.0 111.353 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -89.3 96.35 10.68 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.573 ' CZ ' ' HA2' ' A' ' 27' ' ' GLY . 3.5 m-85 -55.54 127.85 31.71 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.033 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.55 158.57 43.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.143 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 t -109.21 128.2 54.85 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 113.316 -1.766 . . . . 0.0 110.918 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.42 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 20.6 p-10 -41.89 -24.13 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 112.636 -2.075 . . . . 0.0 114.86 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -53.03 -31.94 44.03 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.923 0.764 . . . . 0.0 111.237 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.98 31.31 1.21 Allowed Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 m -143.88 143.31 31.23 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.869 0.842 . . . . 0.0 111.755 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -72.61 144.98 47.64 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.584 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.6 t -102.19 -54.93 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.173 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.494 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -174.59 168.27 3.77 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 123.992 0.808 . . . . 0.0 110.036 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -90.07 156.39 18.41 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -47.57 115.03 1.96 Allowed Glycine 0 N--CA 1.494 2.566 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.84 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -12.98 4.51 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 t -142.96 120.81 11.95 Favored 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 118.86 0.755 . . . . 0.0 110.659 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' N ' ' HB2' ' A' ' 12' ' ' LYS . 5.5 t70 -79.6 143.01 58.23 Favored Pre-proline 0 N--CA 1.49 1.545 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.091 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.19 -33.68 55.55 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.699 1.599 . . . . 0.0 111.87 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.57 -29.76 41.42 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.789 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -89.72 138.78 27.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.05 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -74.83 79.95 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.647 2.232 . . . . 0.0 110.331 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -138.68 38.58 2.21 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.857 0.837 . . . . 0.0 109.84 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.46 164.61 11.74 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 113.984 -1.462 . . . . 0.0 111.683 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.538 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.9 m -142.66 79.53 15.04 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.29 78.9 1.49 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.362 2.041 . . . . 0.0 110.026 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -149.09 -54.32 0.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.027 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -76.54 174.4 10.38 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.711 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 80.5 m -148.78 122.94 9.52 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.781 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.604 ' O ' HG22 ' A' ' 45' ' ' ILE . 7.8 t70 -117.26 78.02 10.18 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 124.113 0.883 . . . . 0.0 112.569 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.4 -19.99 38.13 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.192 1.928 . . . . 0.0 113.478 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -71.08 -40.63 71.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 123.742 0.651 . . . . 0.0 110.912 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 42' ' ' ASP . 12.4 tt -54.82 148.32 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 123.679 0.612 . . . . 0.0 110.421 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -126.11 -40.55 1.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 124.172 0.92 . . . . 0.0 110.598 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -172.92 -172.06 0.81 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.154 0.909 . . . . 0.0 109.985 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.43 116.33 3.0 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.9 mm -79.1 90.82 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.64 154.8 68.56 Favored Pre-proline 0 N--CA 1.493 1.675 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.536 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.56 -29.66 89.01 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.076 1.851 . . . . 0.0 110.446 173.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.8 mm? -80.76 -32.27 35.6 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.888 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 116.266 -1.826 . . . . 0.0 109.325 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.048 0.452 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.51 -28.02 1.02 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.049 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 tp -84.74 61.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.06 36.35 0.77 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 114.336 -1.302 . . . . 0.0 113.089 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -90.71 174.2 7.61 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.345 -1.752 . . . . 0.0 108.749 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -161.44 166.0 27.93 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 124.217 0.948 . . . . 0.0 111.129 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.42 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 1.1 t -57.73 -9.84 1.39 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.567 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.4 t -89.09 -64.75 1.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.287 -1.324 . . . . 0.0 113.665 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.75 73.44 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 120.104 3.372 . . . . 0.0 120.104 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 11' ' ' THR . . . -20.93 -105.0 0.0 OUTLIER Glycine 0 N--CA 1.514 3.869 0 N-CA-C 119.398 2.519 . . . . 0.0 119.398 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -178.24 114.77 0.07 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 123.747 0.322 . . . . 0.0 111.681 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -45.16 111.93 0.38 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 124.19 0.931 . . . . 0.0 110.388 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.25 -35.7 2.77 Favored Glycine 0 N--CA 1.494 2.53 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.771 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.5 m -79.34 -178.38 6.21 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -137.71 106.8 6.01 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.594 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.536 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 61.7 m-85 -56.85 129.73 42.7 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.392 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.482 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -145.45 157.13 44.07 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.198 0.999 . . . . 0.0 111.294 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.8 t -109.04 126.15 52.84 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.175 -1.829 . . . . 0.0 110.866 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.589 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 20.7 p-10 -38.49 -33.08 0.09 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.03 -26.67 60.71 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.917 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.92 34.71 0.72 Allowed Glycine 0 N--CA 1.493 2.499 0 O-C-N 124.233 0.958 . . . . 0.0 111.777 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.4 m -141.49 137.58 32.19 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.657 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -71.92 140.18 49.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 17' ' ' PHE . 59.2 t -100.7 -51.96 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 123.723 0.639 . . . . 0.0 111.152 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.27 178.97 4.12 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 123.81 0.694 . . . . 0.0 110.839 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -104.44 150.05 24.89 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.55 111.77 1.54 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -118.22 -15.18 9.82 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.74 105.32 1.53 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.47 129.63 46.53 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 124.233 0.958 . . . . 0.0 109.341 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -73.63 60.02 4.2 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.489 2.126 . . . . 0.0 111.731 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.82 -27.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.468 HD21 ' HB3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -90.43 155.07 46.53 Favored Pre-proline 0 N--CA 1.498 1.961 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.415 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -75.76 72.99 4.9 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.342 2.028 . . . . 0.0 111.065 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.468 ' HB3' HD21 ' A' ' 33' ' ' ASN . 0.1 OUTLIER -62.19 98.51 0.11 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.225 0.536 . . . . 0.0 110.121 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.59 131.61 36.05 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.913 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.79 79.83 10.31 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 124.428 1.08 . . . . 0.0 112.311 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.82 0.58 6.23 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.685 2.256 . . . . 0.0 111.748 168.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -25.3 41.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 123.736 0.648 . . . . 0.0 110.819 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 54.45 -160.15 0.16 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.157 0.911 . . . . 0.0 111.59 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.3 m -55.4 127.69 30.75 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.704 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -127.24 75.16 77.15 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 124.055 0.847 . . . . 0.0 112.056 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.67 -18.48 33.43 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.962 1.775 . . . . 0.0 112.617 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ttp-105 -59.29 -44.97 92.45 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mt -68.56 154.01 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -109.36 -46.6 3.53 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.627 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -172.44 -173.4 1.04 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.524 1.14 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.56 115.69 3.09 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.4 mm -78.8 104.65 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 36.6 m -93.51 122.65 62.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.489 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.1 -61.24 0.16 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.762 1.641 . . . . 0.0 108.77 172.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 52' ' ' LEU . 4.0 mm? -122.66 -51.3 1.94 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.898 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.715 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 54.9 mtt85 -136.78 -54.14 0.72 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.701 HG23 ' HA ' ' A' ' 43' ' ' PRO . 4.7 tp -72.29 84.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 124.73 1.269 . . . . 0.0 107.625 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -92.89 47.47 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.385 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 p -89.83 176.66 6.74 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.743 -1.571 . . . . 0.0 108.441 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 9' ' ' ALA . 28.9 p-10 -157.77 154.65 28.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.168 0.918 . . . . 0.0 113.309 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 t -61.07 -31.25 70.92 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.778 -2.01 . . . . 0.0 112.418 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.7 t -63.33 -56.3 17.5 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.376 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -83.74 27.63 0.62 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 113.895 -1.502 . . . . 0.0 112.571 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.66 -135.71 0.06 OUTLIER Glycine 0 N--CA 1.497 2.731 0 O-C-N 124.129 0.893 . . . . 0.0 113.722 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.519 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 10.9 p -149.96 114.71 5.31 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 123.92 0.424 . . . . 0.0 112.052 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.12 103.46 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.821 0.701 . . . . 0.0 112.35 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.87 -31.72 3.64 Favored Glycine 0 N--CA 1.496 2.655 0 CA-C-N 114.336 -1.302 . . . . 0.0 113.86 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.9 m -85.91 158.77 19.84 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.968 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -112.31 91.68 3.74 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.471 1.107 . . . . 0.0 108.904 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -57.54 124.93 20.73 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.451 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.14 157.26 46.26 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.517 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.7 p -101.8 130.18 48.17 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.314 -1.766 . . . . 0.0 111.941 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 1.7 p30 -38.73 -32.27 0.08 Allowed 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -57.31 -28.76 63.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 123.687 0.617 . . . . 0.0 112.1 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.1 34.28 0.79 Allowed Glycine 0 N--CA 1.492 2.408 0 O-C-N 124.156 0.91 . . . . 0.0 111.0 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.2 m -140.43 137.46 33.97 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.19 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -70.81 142.84 51.29 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.39 -49.87 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 123.649 0.593 . . . . 0.0 110.481 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -175.74 -178.97 1.14 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.102 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -114.31 128.04 56.16 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.519 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -50.1 112.55 1.53 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 1.28 54.8 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.4 m -64.37 102.86 0.58 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.354 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.2 136.33 57.22 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 124.651 1.22 . . . . 0.0 112.104 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -67.39 87.46 0.33 Allowed 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 122.495 2.13 . . . . 0.0 110.002 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mtm105 166.85 -46.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.628 -1.623 . . . . 0.0 106.881 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -86.46 132.49 42.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.11 65.3 7.85 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.51 2.14 . . . . 0.0 110.621 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt 26.6 86.61 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 O-C-N 124.503 1.127 . . . . 0.0 113.806 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.04 87.91 4.81 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.619 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.0 m -148.86 147.88 25.73 Favored Pre-proline 0 N--CA 1.496 1.842 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.355 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.89 -75.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.167 0 C-N-CA 121.591 1.527 . . . . 0.0 109.683 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -161.15 -64.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.8 m120 56.54 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 125.411 1.694 . . . . 0.0 112.898 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.2 m -94.02 125.75 38.83 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.113 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -123.57 77.0 55.32 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 124.021 0.826 . . . . 0.0 110.725 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.701 ' HA ' HG23 ' A' ' 3' ' ' ILE . 5.9 Cg_exo -53.91 -30.32 57.77 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 122.309 2.006 . . . . 0.0 112.707 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -64.24 -43.75 93.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.162 0.914 . . . . 0.0 111.332 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.88 137.12 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 124.152 0.908 . . . . 0.0 109.316 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -116.42 -42.8 2.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.748 1.28 . . . . 0.0 109.085 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -170.13 -175.84 2.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.544 1.153 . . . . 0.0 109.92 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.22 114.58 2.72 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.4 mm -78.81 94.34 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.3 m -89.87 143.3 29.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.127 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.27 132.07 37.09 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 122.0 1.8 . . . . 0.0 110.715 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.63 -4.6 10.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 124.285 0.991 . . . . 0.0 111.262 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 116.683 -1.627 . . . . 0.0 111.369 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -72.34 -22.82 61.11 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.362 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 3' ' ' ILE . 7.0 tp -81.3 70.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.7 m -90.75 36.04 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.869 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 p -86.93 166.38 15.17 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 112.967 -1.924 . . . . 0.0 107.427 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -153.85 154.94 34.84 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 124.674 1.233 . . . . 0.0 109.046 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.471 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -59.34 -14.68 12.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 124.065 0.853 . . . . 0.0 112.257 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.0 t -90.39 -64.43 1.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.041 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.89 50.93 1.96 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 11' ' ' THR . . . -103.07 -88.21 2.04 Favored Glycine 0 N--CA 1.503 3.121 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.582 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.7 OUTLIER -169.08 108.68 0.45 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 124.641 0.848 . . . . 0.0 110.564 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HA ' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -50.8 112.14 0.66 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 123.763 0.664 . . . . 0.0 109.997 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 124.79 -30.51 4.62 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 124.483 1.114 . . . . 0.0 111.82 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.5 m -87.27 122.99 31.79 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -73.86 102.05 3.95 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.82 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.54 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 99.4 m-85 -51.66 126.49 17.8 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.53 153.61 41.3 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.429 1.109 . . . . 0.0 111.665 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.5 t -103.43 132.71 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.705 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 2.5 p30 -46.4 -23.58 0.38 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 113.111 -1.859 . . . . 0.0 114.449 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -58.99 -19.4 43.06 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.122 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.97 33.25 3.29 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.5 m -139.81 137.74 35.23 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.497 0.665 . . . . 0.0 112.232 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -72.26 142.47 48.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.2 t -102.56 -52.94 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.186 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.54 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.75 -179.77 3.42 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.823 0.702 . . . . 0.0 110.608 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -102.46 143.65 31.92 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -47.01 116.13 2.35 Favored Glycine 0 N--CA 1.498 2.819 0 O-C-N 125.353 1.658 . . . . 0.0 110.115 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.43 -29.81 5.03 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 p -68.43 100.16 1.05 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -101.74 129.12 27.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.61 -27.16 31.96 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.17 1.913 . . . . 0.0 113.219 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -38.86 51.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 123.721 0.638 . . . . 0.0 112.015 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.51 148.43 55.23 Favored Pre-proline 0 N--CA 1.495 1.796 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.082 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.14 76.88 4.0 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.502 2.135 . . . . 0.0 111.209 171.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.84 94.7 0.63 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.445 0.64 . . . . 0.0 109.637 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.7 83.12 5.7 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.43 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.9 m -102.56 151.31 38.22 Favored Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.327 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -67.5 153.77 75.58 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.118 1.879 . . . . 0.0 110.387 166.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -88.47 33.96 0.76 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.593 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -72.09 173.94 7.79 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.532 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 98.0 m -125.11 132.4 53.13 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.218 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 45' ' ' ILE . 12.6 t70 -113.79 84.38 8.38 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 123.747 0.654 . . . . 0.0 112.674 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -55.47 -21.88 32.14 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.352 2.035 . . . . 0.0 113.262 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -40.38 96.89 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.797 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 42' ' ' ASP . 11.4 tt -77.78 163.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 123.794 0.683 . . . . 0.0 110.667 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -121.67 -43.67 2.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 124.388 1.055 . . . . 0.0 108.289 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -171.75 -167.7 0.53 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 124.41 1.069 . . . . 0.0 109.758 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -128.01 120.61 3.48 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.6 100.75 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.4 m -92.51 145.63 30.88 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.147 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.59 112.0 2.04 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 122.064 1.842 . . . . 0.0 109.943 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 mt -137.41 -50.98 0.63 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 124.153 0.908 . . . . 0.0 109.743 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.171 0 O-C-N 124.421 1.076 . . . . 0.0 113.552 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.08 163.26 30.31 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 123.838 0.711 . . . . 0.0 110.001 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 43' ' ' PRO . 5.0 tp -72.46 80.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.841 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.49 43.25 1.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.649 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.508 HG21 ' CG2' ' A' ' 45' ' ' ILE . 5.0 t -75.93 167.63 21.52 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.407 -1.724 . . . . 0.0 108.199 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' A' ' 9' ' ' ALA . 31.9 p-10 -148.43 141.81 25.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 123.869 0.73 . . . . 0.0 109.433 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -23.63 49.12 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.024 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.12 -62.77 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.759 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.545 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -88.29 63.44 7.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 124.455 1.097 . . . . 0.0 110.497 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.48 -144.08 16.31 Favored Glycine 0 N--CA 1.494 2.563 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.292 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 p -136.68 107.23 6.51 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 123.905 0.415 . . . . 0.0 111.674 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -50.07 95.94 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.755 1.284 . . . . 0.0 110.661 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.86 -27.81 1.74 Allowed Glycine 0 N--CA 1.493 2.466 0 CA-C-N 114.053 -1.43 . . . . 0.0 111.82 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.0 m -111.68 140.08 46.6 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.429 0.633 . . . . 0.0 112.4 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -89.79 97.96 11.49 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.209 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -56.43 125.34 21.58 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 156.98 48.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.807 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 t -104.51 130.31 52.47 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.993 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -39.84 -28.32 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 117.691 2.478 . . . . 0.0 117.691 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -55.99 -27.7 54.01 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.812 -0.755 . . . . 0.0 112.2 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.98 34.22 1.17 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 107.684 -2.166 . . . . 0.0 107.684 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.9 m -143.01 137.89 29.63 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.812 0.815 . . . . 0.0 111.172 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -70.12 152.41 44.35 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.699 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.7 -59.09 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 123.748 0.655 . . . . 0.0 111.677 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -176.19 177.96 1.47 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.868 0.73 . . . . 0.0 111.07 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.551 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -99.27 130.18 45.55 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.36 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.79 107.01 1.97 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.72 12.89 28.3 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -106.14 132.44 52.2 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.19 137.66 56.5 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.99 67.86 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.237 1.958 . . . . 0.0 111.924 169.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 170.09 -21.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.449 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -90.35 143.62 29.72 Favored Pre-proline 0 N--CA 1.493 1.716 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.072 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.3 55.44 5.66 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.528 2.152 . . . . 0.0 111.439 169.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.29 132.33 53.7 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.728 -1.189 . . . . 0.0 110.862 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.66 127.51 32.27 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.518 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.0 m -150.84 145.78 18.63 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 124.174 0.921 . . . . 0.0 110.54 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.65 151.09 83.43 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.721 1.614 . . . . 0.0 109.704 163.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.3 tpp85 -84.66 59.88 5.78 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.996 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -73.91 93.34 2.18 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.195 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 84.6 m -59.23 120.84 9.98 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.91 78.4 7.32 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.614 ' HA ' HG23 ' A' ' 3' ' ' ILE . 5.9 Cg_exo -54.48 -21.97 25.92 Favored 'Trans proline' 0 N--CA 1.486 1.075 0 C-N-CA 122.554 2.169 . . . . 0.0 112.803 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -48.84 77.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.125 0.891 . . . . 0.0 109.136 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.508 ' CG2' HG21 ' A' ' 5' ' ' THR . 3.6 mt -58.18 143.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 123.931 0.769 . . . . 0.0 109.737 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.76 -37.38 0.82 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 112.607 -2.088 . . . . 0.0 111.036 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.01 178.19 9.42 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 124.196 0.935 . . . . 0.0 110.481 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.34 109.83 1.33 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 81.1 mt -79.17 88.86 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -86.85 128.49 55.98 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -55.39 -30.58 73.72 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.069 1.846 . . . . 0.0 110.979 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.2 mt -124.34 125.1 43.77 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.12 0 O-C-N 124.167 0.917 . . . . 0.0 111.447 -179.851 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.551 0.691 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.1 ttt85 58.02 81.57 0.15 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.034 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 tp -87.44 45.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.329 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -84.56 46.68 1.26 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.478 1.132 . . . . 0.0 112.577 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.16 150.08 22.16 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.898 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -113.27 -165.76 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.752 1.283 . . . . 0.0 107.868 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 1.2 t -116.31 -29.39 6.23 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.376 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 t -56.32 -56.14 24.74 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.126 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.59 33.77 0.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.764 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.69 -113.88 0.14 Allowed Glycine 0 N--CA 1.494 2.556 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.457 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.5 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 1.4 p -154.88 111.82 3.31 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 123.933 0.431 . . . . 0.0 110.537 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -46.12 99.31 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.9 -23.57 5.88 Favored Glycine 0 N--CA 1.499 2.892 0 CA-C-N 114.99 -1.005 . . . . 0.0 114.902 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.1 m -86.31 143.14 28.04 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.837 0.818 . . . . 0.0 110.747 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -97.63 97.19 8.83 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.49 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 17.4 m-85 -62.24 122.39 15.5 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.97 162.85 31.27 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.023 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.8 t -108.84 131.44 54.99 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.462 -1.699 . . . . 0.0 111.5 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.556 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 4.4 p30 -45.14 -21.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 112.596 -2.093 . . . . 0.0 114.895 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -53.62 -30.33 42.25 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.896 0.747 . . . . 0.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.28 30.29 1.6 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.8 m -146.13 147.24 31.33 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.774 0.797 . . . . 0.0 112.124 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -69.86 158.68 35.06 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.04 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.482 HG11 ' NH1' ' A' ' 44' ' ' ARG . 39.2 t -129.98 -48.94 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 28.4 p -164.24 -175.85 4.16 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.143 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -130.48 137.01 49.56 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.239 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.5 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.32 115.41 5.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -114.49 26.12 10.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 109.63 21.14 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -88.16 137.19 31.25 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 124.379 1.049 . . . . 0.0 110.247 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -69.91 70.95 1.63 Allowed 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 121.969 1.779 . . . . 0.0 110.121 167.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 169.43 -30.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.682 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -90.08 141.47 27.92 Favored Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.215 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -75.12 68.29 5.88 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 122.734 2.289 . . . . 0.0 110.671 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.65 86.38 3.95 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.502 0.668 . . . . 0.0 110.061 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.43 103.07 9.1 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.198 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.3 m -104.82 150.62 38.86 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.25 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.87 158.18 57.68 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 122.317 2.012 . . . . 0.0 110.522 157.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.3 60.87 6.35 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.626 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -63.47 110.09 1.84 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.652 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 99.2 m -74.38 116.19 14.77 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.746 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.494 ' CG ' HD12 ' A' ' 45' ' ' ILE . 6.3 t70 -121.35 74.67 31.34 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.89 -25.77 78.44 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.413 2.076 . . . . 0.0 111.305 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.482 ' NH1' HG11 ' A' ' 24' ' ' VAL . 2.3 ttp-105 -59.99 -31.13 69.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.991 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.494 HD12 ' CG ' ' A' ' 42' ' ' ASP . 1.4 mt -77.12 156.96 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.556 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -116.83 -44.37 2.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.588 1.18 . . . . 0.0 109.687 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -173.92 178.93 2.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.305 1.003 . . . . 0.0 111.098 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.66 111.64 3.33 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.3 mt -79.24 89.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.0 m -86.27 134.65 38.06 Favored Pre-proline 0 N--CA 1.495 1.813 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.617 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -64.42 147.09 90.6 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.954 1.769 . . . . 0.0 110.931 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 tp -154.35 116.49 4.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 123.992 0.807 . . . . 0.0 109.362 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 116.734 -1.603 . . . . 0.0 110.196 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -154.79 47.7 0.56 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.332 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.6 tp -45.11 131.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.746 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -135.26 48.28 2.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.195 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -78.81 170.35 16.81 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.382 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -150.59 148.17 28.32 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 16' ' ' TYR . 41.6 t -78.14 -20.98 50.99 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.181 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -60.57 -58.3 9.07 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.36 36.91 0.89 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.648 -1.615 . . . . 0.0 108.229 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.48 -110.13 0.07 OUTLIER Glycine 0 N--CA 1.495 2.601 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.646 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.536 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 5.3 t -162.35 123.96 2.68 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -65.3 91.94 0.12 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.073 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.83 -21.64 0.79 Allowed Glycine 0 N--CA 1.489 2.194 0 CA-C-N 113.443 -1.708 . . . . 0.0 111.779 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.5 m -127.02 138.23 53.21 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 119.301 -0.96 . . . . 0.0 113.069 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -83.48 102.3 12.0 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 113.548 -1.66 . . . . 0.0 108.501 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.613 ' HB2' ' SG ' ' A' ' 7' ' ' CYS . 6.5 m-85 -62.52 122.81 16.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.7 159.88 38.35 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.045 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 t -108.21 131.28 54.84 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.161 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -39.63 -28.3 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -56.54 -28.53 60.3 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.829 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.07 34.14 0.92 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.3 m -143.61 138.8 29.29 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.886 0.85 . . . . 0.0 112.079 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -71.9 138.91 48.5 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.001 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.32 -57.19 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.909 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -175.84 174.89 2.09 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.556 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.484 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 1.4 mt-10 -99.19 131.11 45.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.315 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.536 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -65.43 112.94 5.38 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -103.45 7.8 37.94 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.383 0.696 . . . . 0.0 112.733 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -80.87 100.04 8.64 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.559 -0.857 . . . . 0.0 112.583 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -90.44 133.43 32.99 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.91 -26.01 23.39 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.974 1.783 . . . . 0.0 112.134 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -86.41 -37.64 18.17 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.725 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -83.74 143.59 43.94 Favored Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.119 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -76.23 74.58 4.56 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 122.445 2.097 . . . . 0.0 109.91 167.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HE2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -64.55 97.89 0.23 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.78 127.2 31.93 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.529 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.439 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 60.8 m -147.09 149.2 34.64 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 124.266 0.979 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.37 142.85 67.66 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 N-CA-C 107.729 -1.681 . . . . 0.0 107.729 153.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -85.31 62.03 7.23 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.092 0.948 . . . . 0.0 108.878 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -61.09 107.7 0.77 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.625 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.2 m -55.63 118.14 4.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 124.193 0.933 . . . . 0.0 110.587 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -128.76 74.05 80.85 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 124.311 1.007 . . . . 0.0 113.061 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.45 -22.44 66.1 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 121.888 1.726 . . . . 0.0 110.627 170.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.478 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -55.64 -38.22 69.26 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 124.314 1.009 . . . . 0.0 110.099 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mt -66.67 146.52 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.02 -42.56 1.38 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.143 -1.39 . . . . 0.0 111.87 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.87 175.68 12.22 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 124.111 0.882 . . . . 0.0 110.571 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.18 108.81 1.5 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.353 -2.299 . . . . 0.0 107.353 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.5 mt -79.12 94.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.07 152.32 46.02 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.887 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -65.04 -65.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.785 1.656 . . . . 0.0 108.814 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.57 26.19 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.049 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 116.67 -1.633 . . . . 0.0 111.396 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -160.46 33.5 0.16 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.353 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 tp -57.03 133.4 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.611 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -146.9 49.22 1.13 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.784 1.278 . . . . 0.0 110.546 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -72.99 167.11 21.76 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 112.997 -1.91 . . . . 0.0 109.562 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -161.19 162.04 31.13 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.946 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.7 t -65.72 -23.48 66.76 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.932 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -58.32 -60.4 3.84 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.8 -106.6 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 112.899 -1.955 . . . . 0.0 105.738 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 11' ' ' THR . . . 79.09 -107.93 2.6 Favored Glycine 0 CA--C 1.549 2.174 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -179.13 97.61 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 123.291 0.636 . . . . 0.0 111.055 -179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.8 133.93 42.37 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.937 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.7 -28.6 12.77 Favored Glycine 0 N--CA 1.488 2.136 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.924 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.6 m -106.63 143.38 34.82 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.412 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.68 106.19 18.17 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.68 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 2.6 m-30 -55.59 131.33 46.04 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.09 159.41 43.32 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 124.669 1.231 . . . . 0.0 112.188 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 t -108.12 129.32 55.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 112.735 -2.029 . . . . 0.0 111.113 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.539 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 6.8 p-10 -43.37 -25.15 0.12 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-N 113.092 -1.867 . . . . 0.0 115.321 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -54.14 -30.2 48.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 123.897 0.748 . . . . 0.0 111.592 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.41 32.72 1.2 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 m -143.56 143.96 31.74 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.901 0.857 . . . . 0.0 111.759 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -72.86 149.16 43.76 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.435 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.2 t -110.5 -52.38 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.53 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -170.05 -173.01 1.44 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 123.53 0.519 . . . . 0.0 110.252 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.557 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 mt-10 -112.43 158.66 19.58 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.41 ' HA2' ' CE1' ' A' ' 16' ' ' TYR . . . -59.78 110.55 2.88 Favored Glycine 0 N--CA 1.494 2.561 0 CA-C-N 112.812 -1.994 . . . . 0.0 110.897 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -121.13 -39.06 2.73 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 p -72.11 102.42 3.01 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' H ' HD21 ' A' ' 33' ' ' ASN . 10.5 t70 -79.54 133.42 59.57 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.63 -29.83 20.36 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.975 1.783 . . . . 0.0 113.102 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.6 mtt180 -84.77 -34.86 22.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 123.863 0.727 . . . . 0.0 112.093 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.463 HD21 ' H ' ' A' ' 30' ' ' ASP . 32.9 p30 -81.16 142.88 51.72 Favored Pre-proline 0 N--CA 1.495 1.808 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.574 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.84 47.3 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.365 2.71 . . . . 0.0 112.37 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -96.1 95.16 7.98 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.498 0.666 . . . . 0.0 110.584 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.49 140.22 16.07 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.473 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.61 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.8 m -133.2 94.29 20.56 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -71.61 79.17 1.57 Allowed 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.099 1.866 . . . . 0.0 109.364 172.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -144.82 -59.41 0.36 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.263 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -77.69 136.01 38.14 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.004 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.1 m -112.13 126.36 55.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.972 1.42 . . . . 0.0 108.217 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -126.24 71.74 70.88 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 123.893 0.745 . . . . 0.0 112.497 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.15 -28.54 73.58 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.486 2.124 . . . . 0.0 112.643 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -63.15 -17.51 62.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.026 0.829 . . . . 0.0 112.147 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.664 HD11 ' HB3' ' A' ' 16' ' ' TYR . 4.6 tt -69.65 158.82 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 123.694 0.621 . . . . 0.0 109.671 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.539 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -124.16 -45.18 1.99 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.946 0.778 . . . . 0.0 109.47 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -173.94 -169.73 0.5 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 124.343 1.027 . . . . 0.0 110.181 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -120.52 116.06 3.11 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.9 mt -80.79 91.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.216 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.24 127.06 77.74 Favored Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.49 -30.26 23.8 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.901 1.734 . . . . 0.0 109.365 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.81 42.98 2.04 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.18 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 116.367 -1.778 . . . . 0.0 111.738 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 mtm105 57.28 63.71 1.81 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 124.556 1.16 . . . . 0.0 110.987 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.7 tp -86.63 46.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.687 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 m -85.48 46.35 1.29 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.549 1.166 . . . . 0.0 112.513 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -90.21 174.12 7.78 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 112.961 -1.927 . . . . 0.0 108.45 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -161.39 165.58 28.67 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.028 0.83 . . . . 0.0 110.373 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.7 t -67.49 -3.28 8.15 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.7 t -91.12 -57.77 2.69 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -42.13 -69.26 0.14 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 4.43 -112.93 0.01 OUTLIER Glycine 0 N--CA 1.508 3.465 0 N-CA-C 117.556 1.782 . . . . 0.0 117.556 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 173.65 126.82 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -49.62 110.55 0.39 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 124.148 0.905 . . . . 0.0 110.01 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.94 -28.38 4.39 Favored Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.536 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.6 m -79.59 -176.48 5.34 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.199 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -139.22 101.39 4.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.857 0.723 . . . . 0.0 109.683 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.589 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 85.6 m-85 -57.45 131.92 51.57 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.42 155.86 44.5 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.222 1.01 . . . . 0.0 110.94 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 t -106.86 135.74 47.88 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.382 -2.19 . . . . 0.0 113.485 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -47.27 -24.47 0.74 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 111.575 -2.557 . . . . 0.0 113.573 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -56.0 -25.76 45.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 124.098 0.874 . . . . 0.0 111.797 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.27 32.17 2.43 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.7 m -145.66 148.34 32.96 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 112.449 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -70.98 153.49 42.61 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.339 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.7 t -115.99 -56.75 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.213 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.589 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -162.5 -178.92 6.56 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.702 0.626 . . . . 0.0 110.56 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.418 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -112.77 150.64 31.34 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.48 110.49 1.41 Allowed Glycine 0 N--CA 1.492 2.419 0 CA-C-N 112.951 -1.931 . . . . 0.0 109.653 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -114.03 -6.61 13.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.897 0.998 . . . . 0.0 113.437 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.97 89.66 4.14 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.95 130.39 44.85 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.28 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.0 74.49 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.609 2.206 . . . . 0.0 110.993 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 170.57 -39.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.591 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -80.95 155.99 72.52 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.104 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.86 78.51 2.47 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 122.128 1.885 . . . . 0.0 111.163 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.09 99.4 0.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.07 92.92 5.06 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.6 m -111.71 98.93 43.15 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.115 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.9 169.45 13.26 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 121.97 1.78 . . . . 0.0 110.452 168.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -83.69 25.51 0.77 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.352 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -63.95 134.85 55.85 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.644 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.22 136.66 34.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 125.501 1.75 . . . . 0.0 110.887 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -129.82 81.0 70.31 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 124.054 0.846 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -54.96 -27.92 56.67 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 122.189 1.926 . . . . 0.0 113.238 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -59.36 -46.9 87.36 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mt -64.77 148.46 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.97 -42.13 2.97 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.209 -1.814 . . . . 0.0 108.604 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -173.7 -168.74 0.45 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.638 1.211 . . . . 0.0 109.676 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.11 113.8 1.92 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 mm -79.5 111.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 14.6 m -102.71 157.44 33.72 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 123.557 0.536 . . . . 0.0 110.459 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.59 -34.71 41.01 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 121.909 1.739 . . . . 0.0 108.094 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.51 44.94 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.009 -1.451 . . . . 0.0 107.181 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.005 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.826 -179.853 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.4 mmt-85 -143.03 82.2 1.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 124.212 0.945 . . . . 0.0 109.458 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 3' ' ' ILE . 5.9 tp -72.72 89.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.599 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -97.05 55.8 1.34 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.693 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -87.72 179.49 6.49 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.507 -1.678 . . . . 0.0 107.993 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -160.27 -171.19 3.09 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 t -98.73 -30.95 12.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.043 0.84 . . . . 0.0 111.944 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.2 t -67.18 -60.82 2.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 123.995 0.81 . . . . 0.0 109.761 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.19 63.86 8.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 125.119 1.512 . . . . 0.0 108.772 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.65 -136.35 7.74 Favored Glycine 0 N--CA 1.491 2.348 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.812 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -144.25 108.63 4.83 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.86 94.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.346 1.029 . . . . 0.0 111.888 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.01 -26.2 2.5 Favored Glycine 0 N--CA 1.495 2.582 0 CA-C-N 113.754 -1.566 . . . . 0.0 113.169 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.7 m -87.66 158.88 18.73 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.005 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -116.18 95.66 5.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.515 1.134 . . . . 0.0 109.834 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -52.27 129.8 29.08 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.927 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.88 158.99 43.6 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.521 0.677 . . . . 0.0 111.76 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -107.38 132.71 52.86 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.473 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -44.58 -24.39 0.19 Allowed 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 112.887 -1.96 . . . . 0.0 114.997 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -54.42 -27.67 38.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.07 0.856 . . . . 0.0 111.45 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.06 32.84 1.77 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.6 m -144.93 140.78 28.5 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.505 0.669 . . . . 0.0 111.539 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.16 159.52 28.77 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.754 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.3 t -127.68 -46.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.72 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -167.38 -173.96 2.41 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.838 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.72 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -128.15 124.81 37.8 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.23 117.87 12.74 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 107.481 -2.248 . . . . 0.0 107.481 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.63 13.79 24.95 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.35 109.89 20.98 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.408 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.41 132.45 62.29 Favored Pre-proline 0 N--CA 1.494 1.725 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.21 75.66 0.48 Allowed 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.859 1.706 . . . . 0.0 110.149 173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 164.58 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.96 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -90.43 144.64 31.1 Favored Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.478 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.12 69.01 8.1 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.513 2.142 . . . . 0.0 111.309 168.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -71.08 89.41 0.82 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.91 121.63 25.67 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.715 -1.129 . . . . 0.0 113.675 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.4 m -160.42 162.47 23.51 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.079 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.62 159.77 35.31 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.692 1.594 . . . . 0.0 110.682 165.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.5 ttm105 -87.31 63.3 7.68 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -57.36 149.98 19.31 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.601 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.7 m -109.97 128.72 55.56 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.1 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CG ' HD12 ' A' ' 45' ' ' ILE . 5.7 t70 -123.66 75.51 55.26 Favored Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 124.059 0.849 . . . . 0.0 113.202 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.07 -21.47 65.58 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.485 2.123 . . . . 0.0 112.068 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -63.73 -39.07 93.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.039 0.837 . . . . 0.0 110.009 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.587 HD12 ' CG ' ' A' ' 42' ' ' ASP . 1.6 mt -69.29 154.31 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 124.42 1.075 . . . . 0.0 109.537 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.25 -44.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.354 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.49 -177.6 6.32 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 124.308 1.005 . . . . 0.0 110.212 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.68 110.57 1.26 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 107.169 -2.372 . . . . 0.0 107.169 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.1 mt -79.07 90.6 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -92.51 149.71 38.65 Favored Pre-proline 0 N--CA 1.496 1.825 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.921 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.83 -18.89 44.17 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.206 1.938 . . . . 0.0 112.35 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 tp -79.66 138.87 37.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 123.951 0.782 . . . . 0.0 109.567 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 116.703 -1.618 . . . . 0.0 110.686 179.907 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -152.7 151.35 30.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.176 0.922 . . . . 0.0 109.763 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 43' ' ' PRO . 5.9 tp -69.31 87.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 124.22 0.95 . . . . 0.0 109.863 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.68 37.55 1.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.552 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 p -89.03 171.95 9.47 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 113.727 -1.578 . . . . 0.0 107.385 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -158.0 155.71 29.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.142 0.901 . . . . 0.0 111.883 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.42 -16.66 38.11 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.96 -1.473 . . . . 0.0 112.284 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -90.25 -69.27 0.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.472 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.82 58.85 3.97 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.94 -83.77 1.21 Allowed Glycine 0 N--CA 1.497 2.749 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.909 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.573 HG23 ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -174.24 111.78 0.16 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.83 119.72 4.14 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.072 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.9 -31.11 7.25 Favored Glycine 0 N--CA 1.495 2.63 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.416 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.573 ' HB2' HG23 ' A' ' 11' ' ' THR . 90.2 m -90.06 120.56 31.35 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.766 -1.173 . . . . 0.0 111.124 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -67.53 100.11 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.371 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.55 ' CE2' ' HA2' ' A' ' 27' ' ' GLY . 91.8 m-85 -48.96 131.03 18.84 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.29 156.37 42.45 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 122.147 0.975 . . . . 0.0 110.985 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.4 t -107.19 130.08 54.77 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 112.438 -2.165 . . . . 0.0 110.704 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 4.0 p-10 -39.04 -28.83 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 118.402 2.741 . . . . 0.0 118.402 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.43 -28.59 65.39 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.521 -0.872 . . . . 0.0 112.37 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.93 35.01 0.75 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 m -142.93 140.21 31.05 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.668 0.747 . . . . 0.0 111.845 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -70.63 153.37 42.92 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.081 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t -115.52 -57.91 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.114 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.533 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -162.08 -178.66 6.55 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 123.523 0.514 . . . . 0.0 110.717 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -97.42 138.62 34.59 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.55 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -54.47 113.8 3.75 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.14 -23.46 5.35 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.65 98.49 0.52 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 118.9 0.773 . . . . 0.0 111.504 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.73 127.23 30.63 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.482 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.53 -22.65 44.0 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.453 2.102 . . . . 0.0 113.772 -168.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.436 ' H ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -83.02 -41.71 18.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 123.895 0.747 . . . . 0.0 110.511 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.33 147.39 87.59 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -73.2 77.87 2.36 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.184 1.922 . . . . 0.0 110.607 174.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 81.43 2.29 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.045 0.926 . . . . 0.0 109.184 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.53 127.93 32.75 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.518 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -147.95 148.93 31.52 Favored Pre-proline 0 N--CA 1.495 1.783 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.07 161.26 37.82 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.818 1.679 . . . . 0.0 109.735 165.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -86.54 61.81 7.04 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.25 1.024 . . . . 0.0 109.367 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -76.69 -177.88 4.49 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.258 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 93.8 m -146.77 122.61 10.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -112.74 83.15 5.51 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 123.775 0.672 . . . . 0.0 112.724 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' HA ' HG23 ' A' ' 3' ' ' ILE . 4.5 Cg_exo -51.95 -31.44 43.55 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.573 2.182 . . . . 0.0 112.213 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -59.88 -50.69 72.79 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 124.406 1.066 . . . . 0.0 108.477 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -63.02 148.1 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.031 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -118.64 -43.19 2.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 124.527 1.142 . . . . 0.0 108.021 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -173.06 -167.75 0.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.719 1.262 . . . . 0.0 109.308 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.81 121.06 4.02 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.5 mt -83.0 95.03 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 123.947 0.44 . . . . 0.0 111.607 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 m -82.57 145.56 51.42 Favored Pre-proline 0 N--CA 1.503 2.2 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.41 86.54 0.34 Allowed 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 122.274 1.983 . . . . 0.0 110.77 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.75 -46.5 0.11 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.368 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 116.271 -1.823 . . . . 0.0 110.242 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.46 179.98 7.88 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.298 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tp -56.73 119.45 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.122 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -124.49 47.33 2.12 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.58 140.48 29.51 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.542 ' ND2' ' HA ' ' A' ' 40' ' ' ASN . 14.6 p-10 -160.35 163.04 33.55 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 124.028 0.83 . . . . 0.0 111.052 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HA ' ' CD1' ' A' ' 16' ' ' TYR . 10.1 t -60.81 -16.8 44.75 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 1.9 t -91.55 -43.87 9.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.455 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -88.59 43.66 1.15 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' HA3' ' CE1' ' A' ' 16' ' ' TYR . . . -102.45 -118.18 4.39 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.066 -1.064 . . . . 0.0 114.056 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.5 m -160.6 126.4 3.97 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.86 103.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 123.706 0.629 . . . . 0.0 109.575 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.434 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 132.41 -25.31 3.84 Favored Glycine 0 N--CA 1.498 2.777 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.776 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.8 m -88.25 122.97 32.39 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 117.362 0.581 . . . . 0.0 110.174 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -76.75 99.43 5.11 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.491 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.59 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 82.7 m-85 -54.95 127.98 31.34 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.501 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -145.09 157.74 44.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.197 0.999 . . . . 0.0 110.839 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.8 t -103.99 131.32 51.36 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 112.592 -2.094 . . . . 0.0 110.97 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.1 p-10 -44.55 -24.87 0.22 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 125.519 1.762 . . . . 0.0 114.892 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -58.2 -20.95 45.47 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.766 0.666 . . . . 0.0 112.469 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.08 33.27 2.82 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.3 m -139.82 136.2 33.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.122 0.542 . . . . 0.0 112.119 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -70.89 148.66 47.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 45' ' ' ILE . 45.7 t -111.88 -50.88 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 123.779 0.674 . . . . 0.0 110.583 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.59 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -168.48 173.3 7.62 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 123.823 0.702 . . . . 0.0 109.778 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -96.99 152.19 18.97 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.624 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . -48.02 118.46 4.46 Favored Glycine 0 N--CA 1.507 3.378 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -132.53 39.78 3.34 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.3 t -162.82 94.93 0.87 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.619 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.3 t70 -79.23 133.16 61.03 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -60.94 86.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 121.916 1.744 . . . . 0.0 109.419 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.62 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.219 -1.809 . . . . 0.0 106.961 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.619 HD21 ' H ' ' A' ' 30' ' ' ASP . 1.8 p30 -90.76 135.49 28.93 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 124.154 0.909 . . . . 0.0 109.307 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -75.08 66.62 6.09 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.185 1.923 . . . . 0.0 109.439 167.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -53.03 127.36 23.7 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.81 135.8 37.17 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.371 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.3 m -145.74 155.89 52.29 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 124.526 1.141 . . . . 0.0 111.944 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.91 -46.07 3.64 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 122.193 1.929 . . . . 0.0 112.26 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -158.15 -2.0 0.09 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.542 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 58.1 m-20 51.79 48.32 23.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.002 0.814 . . . . 0.0 113.111 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 98.1 m -153.41 131.41 11.78 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.186 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -157.98 101.35 1.77 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 123.938 0.774 . . . . 0.0 110.93 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.59 -18.6 60.86 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 122.02 1.814 . . . . 0.0 112.652 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 ttm105 -66.53 -33.12 74.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 123.651 0.594 . . . . 0.0 110.351 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.605 HD11 HG11 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -83.74 157.11 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -114.03 -46.49 3.0 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.01 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -172.47 -172.93 0.97 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.327 1.017 . . . . 0.0 109.683 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -121.06 118.01 3.66 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.2 mm -79.03 95.47 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.54 142.35 29.41 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.291 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -65.39 133.55 35.27 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 122.062 1.841 . . . . 0.0 111.525 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mp -117.62 109.2 16.38 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.261 0.976 . . . . 0.0 108.402 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 116.376 -1.773 . . . . 0.0 111.172 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.035 0.445 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -144.34 125.58 14.66 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.403 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.5 tp -60.67 125.36 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 123.992 0.808 . . . . 0.0 110.517 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.13 47.59 2.46 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.23 143.95 36.68 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.508 HD22 ' H ' ' A' ' 8' ' ' CYS . 3.8 t30 -150.76 178.13 9.42 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.491 1.139 . . . . 0.0 113.35 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.0 t -94.48 -45.02 7.61 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.262 -2.245 . . . . 0.0 108.589 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.508 ' H ' HD22 ' A' ' 6' ' ' ASN . 37.5 t -60.24 -56.57 19.91 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.03 41.48 1.03 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.454 -1.703 . . . . 0.0 108.856 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' HB3' ' A' ' 29' ' ' SER . . . -78.7 -155.91 9.05 Favored Glycine 0 N--CA 1.491 2.348 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.518 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.515 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.1 m -141.02 96.17 2.96 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 115.697 -0.252 . . . . 0.0 110.566 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 5.8 mmtm -26.05 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 124.86 -34.89 3.3 Favored Glycine 0 N--CA 1.501 3.03 0 CA-C-N 114.932 -1.031 . . . . 0.0 114.822 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.3 m -84.4 120.61 26.48 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 101.7 5.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.375 1.047 . . . . 0.0 110.746 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.416 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 7.4 m-85 -58.99 122.57 14.04 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.65 157.47 46.56 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.404 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 t -103.18 130.61 50.43 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.64 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -46.2 -20.32 0.1 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 113.168 -1.833 . . . . 0.0 114.903 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -55.27 -28.65 54.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 123.638 0.586 . . . . 0.0 110.747 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.24 30.95 1.79 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.8 m -144.94 142.61 29.99 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.816 0.817 . . . . 0.0 112.09 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -69.35 149.69 48.15 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.808 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.5 t -112.38 -52.77 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 123.783 0.677 . . . . 0.0 110.986 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -168.21 176.9 5.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.083 0.864 . . . . 0.0 110.528 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.634 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -99.91 123.36 44.08 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -59.52 103.39 0.41 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -93.7 -8.23 41.45 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 118.075 2.62 . . . . 0.0 118.075 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.448 ' HB3' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -79.37 131.71 36.19 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.574 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.53 134.58 23.17 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.5 -27.5 19.08 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.034 1.823 . . . . 0.0 112.712 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -85.9 -34.17 21.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.957 0.786 . . . . 0.0 112.805 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -90.14 152.88 46.52 Favored Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.791 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -79.85 51.93 4.09 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.1 2.533 . . . . 0.0 112.978 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -74.05 94.65 2.42 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.795 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.48 155.57 48.31 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.765 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.427 ' H ' HD21 ' A' ' 40' ' ' ASN . 29.3 m -145.05 160.44 46.31 Favored Pre-proline 0 N--CA 1.499 1.989 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.11 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.02 -13.03 17.24 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.872 1.715 . . . . 0.0 113.241 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.12 75.32 1.44 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 124.035 0.834 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.427 HD21 ' H ' ' A' ' 37' ' ' CYS . 5.3 m120 -104.48 42.44 1.2 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.605 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.0 m -147.52 134.54 20.32 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.132 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -159.05 98.8 1.63 Allowed Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.24 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.22 -17.47 32.7 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.585 2.19 . . . . 0.0 113.677 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.6 ttp-105 -61.06 -35.28 76.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 123.705 0.628 . . . . 0.0 110.949 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -77.54 155.18 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.714 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.17 -41.44 1.77 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 112.414 -2.176 . . . . 0.0 110.064 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.17 177.94 10.0 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 124.162 0.913 . . . . 0.0 110.909 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.63 108.18 1.15 Allowed Glycine 0 N--CA 1.495 2.605 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.41 93.98 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.47 148.39 38.72 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-N 114.843 -1.072 . . . . 0.0 108.752 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -61.76 -57.68 0.51 Allowed 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.806 1.671 . . . . 0.0 110.32 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.5 pp -160.37 160.55 32.47 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.515 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 116.475 -1.726 . . . . 0.0 110.251 179.963 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 -80.85 25.59 0.44 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 123.996 0.81 . . . . 0.0 111.329 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 tp -86.42 49.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.643 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.4 45.45 1.12 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.668 1.223 . . . . 0.0 112.504 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.14 170.1 14.17 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 113.056 -1.884 . . . . 0.0 108.146 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -160.58 145.23 14.25 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.201 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 1.7 t -55.9 -19.9 13.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.554 1.159 . . . . 0.0 113.329 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -73.71 -67.82 0.56 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.182 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.45 -86.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 11' ' ' THR . . . 33.22 -108.04 0.03 OUTLIER Glycine 0 N--CA 1.506 3.363 0 N-CA-C 115.208 0.843 . . . . 0.0 115.208 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 177.28 121.74 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 124.912 1.007 . . . . 0.0 109.251 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.27 104.7 0.15 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 123.965 0.79 . . . . 0.0 109.863 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.02 -30.09 2.38 Favored Glycine 0 N--CA 1.491 2.313 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.076 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.45 125.57 41.03 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -82.74 113.81 20.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.345 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.634 ' HB3' HD11 ' A' ' 45' ' ' ILE . 92.2 m-85 -55.73 131.32 46.37 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.64 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.71 155.41 42.39 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.067 0.937 . . . . 0.0 111.204 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.5 t -107.92 133.51 52.15 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 112.683 -2.053 . . . . 0.0 112.851 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -38.96 -31.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 111.245 -2.707 . . . . 0.0 118.053 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.21 -28.15 66.39 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.362 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.82 37.17 0.68 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 m -144.56 142.06 29.92 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -69.89 152.12 44.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.677 -1.147 . . . . 0.0 107.951 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.7 -47.43 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 123.835 0.709 . . . . 0.0 110.541 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.603 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -169.04 -176.85 2.74 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 123.703 0.627 . . . . 0.0 110.683 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.5 mm-40 -111.15 147.54 34.69 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA2' ' CE1' ' A' ' 16' ' ' TYR . . . -49.52 113.7 1.91 Allowed Glycine 0 N--CA 1.491 2.33 0 O-C-N 125.652 1.845 . . . . 0.0 109.303 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -108.22 -37.21 6.08 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 t -77.9 95.48 4.77 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.509 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.5 t70 -85.55 123.06 73.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.98 86.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.326 2.017 . . . . 0.0 111.628 -167.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 30' ' ' ASP . 4.6 mtm-85 169.41 -34.89 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.671 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.509 HD21 ' H ' ' A' ' 30' ' ' ASP . 55.7 p30 -87.91 152.33 50.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 123.958 0.786 . . . . 0.0 112.62 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -79.52 42.64 1.34 Allowed 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 123.301 2.668 . . . . 0.0 112.929 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.96 38.16 1.25 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.55 132.36 56.21 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.255 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.457 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 4.5 m -137.06 68.99 57.12 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.96 -21.49 41.6 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.193 1.929 . . . . 0.0 112.338 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -83.37 19.9 1.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.791 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -118.93 118.33 31.23 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.741 0.651 . . . . 0.0 109.805 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 95.7 m -105.89 129.05 54.12 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.53 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -130.97 78.81 72.76 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 123.86 0.725 . . . . 0.0 110.938 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.42 -22.19 57.45 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.086 1.857 . . . . 0.0 113.78 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.495 ' H ' ' HD3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -67.07 -43.12 83.44 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -66.15 155.92 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.16 -43.18 2.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.099 0.875 . . . . 0.0 109.408 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -175.64 -165.07 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.36 1.038 . . . . 0.0 109.264 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -128.35 119.26 3.03 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.4 mm -79.0 110.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -99.3 151.52 37.45 Favored Pre-proline 0 N--CA 1.495 1.818 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.89 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.62 88.73 0.35 Allowed 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 121.944 1.763 . . . . 0.0 109.323 168.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.1 -59.4 2.02 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.285 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 116.688 -1.625 . . . . 0.0 110.906 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -91.6 51.0 1.79 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.094 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.601 HG22 ' OG1' ' A' ' 5' ' ' THR . 7.3 mm -76.14 89.65 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 1.6 m -85.94 27.4 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.601 ' OG1' HG22 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -91.03 164.78 13.84 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 9' ' ' ALA . 39.9 p-10 -160.87 150.6 17.32 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.585 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.3 t -65.37 -21.5 66.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.753 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -77.76 -68.6 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.162 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' A' ' 6' ' ' ASN . . . -90.32 52.8 2.31 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.556 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.74 -121.76 0.18 Allowed Glycine 0 N--CA 1.491 2.336 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.809 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.498 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -158.88 103.0 1.68 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -42.46 105.42 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.18 -30.06 4.42 Favored Glycine 0 N--CA 1.496 2.651 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.832 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.6 m -82.4 157.2 23.8 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.908 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -111.73 95.35 5.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.258 0.974 . . . . 0.0 111.703 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.6 129.0 34.84 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.639 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.12 160.39 41.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.024 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.4 t -109.6 129.8 55.56 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.408 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 7.2 p-10 -42.95 -24.35 0.06 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 112.962 -1.926 . . . . 0.0 115.366 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -53.24 -30.69 39.53 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.876 0.735 . . . . 0.0 111.292 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.16 31.78 1.25 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -144.86 144.43 31.11 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.759 0.79 . . . . 0.0 111.92 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -71.19 154.37 41.74 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.325 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.4 t -118.56 -52.43 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 123.613 0.57 . . . . 0.0 111.229 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -173.34 -169.51 0.53 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.027 0.829 . . . . 0.0 109.443 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.68 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -124.78 134.72 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.498 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -51.9 111.39 1.44 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.32 11.72 37.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.61 0.83 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.9 p -77.69 92.45 4.14 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.973 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -82.57 137.8 44.54 Favored Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.547 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.14 77.92 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 122.19 1.927 . . . . 0.0 111.309 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 161.58 -37.24 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.097 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -82.04 143.18 48.96 Favored Pre-proline 0 N--CA 1.498 1.954 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.333 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.97 91.22 0.53 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.847 1.698 . . . . 0.0 108.87 170.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 66.7 3.6 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.031 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.77 135.08 54.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.524 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 2.8 m -153.78 167.77 12.99 Favored Pre-proline 0 N--CA 1.497 1.918 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.083 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -68.99 70.08 1.19 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.073 1.848 . . . . 0.0 109.007 159.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.469 HH11 HH12 ' A' ' 44' ' ' ARG . 4.6 tpm_? -160.41 73.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -107.01 114.03 27.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.565 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 84.8 m 59.64 108.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 124.967 1.417 . . . . 0.0 111.615 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.15 88.31 5.65 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -47.1 -35.2 18.76 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 123.375 2.717 . . . . 0.0 114.434 170.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.469 HH12 HH11 ' A' ' 39' ' ' ARG . 0.5 OUTLIER -56.28 -43.74 79.11 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 124.223 0.952 . . . . 0.0 110.211 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.555 ' O ' HG21 ' A' ' 3' ' ' ILE . 2.2 mt -75.41 161.43 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.782 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.559 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -120.71 -44.6 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.0 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -173.52 -169.76 0.54 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 124.303 1.002 . . . . 0.0 109.754 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.84 117.07 2.92 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.8 mm -78.86 95.15 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.5 m -85.19 133.32 43.0 Favored Pre-proline 0 N--CA 1.493 1.713 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.301 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.9 95.9 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 122.133 1.889 . . . . 0.0 110.522 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.5 tp -108.84 57.21 0.61 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.002 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.309 0 CA-C-N 114.288 -1.324 . . . . 0.0 113.512 179.977 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.925 0.393 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -76.42 166.67 23.09 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.968 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.761 HD11 ' HA ' ' A' ' 46' ' ' ALA . 9.4 tp -89.99 38.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.646 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.8 m -94.21 43.15 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.985 -1.461 . . . . 0.0 112.299 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.72 176.01 7.6 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.675 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' A' ' 9' ' ' ALA . 10.4 p30 -158.86 141.17 14.0 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -65.28 -24.99 67.45 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.58 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -63.64 -54.2 39.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 124.249 0.968 . . . . 0.0 112.056 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.55 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -89.82 -77.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 113.811 -1.541 . . . . 0.0 115.135 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 11' ' ' THR . . . 39.43 -98.32 0.01 OUTLIER Glycine 0 N--CA 1.501 2.971 0 N-CA-C 115.433 0.933 . . . . 0.0 115.433 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 179.46 119.41 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 O-C-N 124.509 0.77 . . . . 0.0 111.575 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.23 130.25 8.02 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 123.669 0.605 . . . . 0.0 111.514 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.68 -29.66 10.65 Favored Glycine 0 N--CA 1.493 2.49 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.58 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.9 m -80.21 121.46 25.63 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.33 107.2 11.92 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.584 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.612 ' CD2' ' SG ' ' A' ' 25' ' ' CYS . 95.5 m-85 -58.43 129.01 40.02 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.76 156.99 43.96 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 124.229 0.956 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 t -106.04 136.05 46.42 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.572 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.608 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 10.8 p-10 -47.06 -23.48 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 112.074 -2.33 . . . . 0.0 113.503 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -58.11 -19.85 35.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 123.798 0.686 . . . . 0.0 111.849 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.66 33.24 3.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.6 m -143.88 139.93 29.49 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.687 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -68.65 154.93 41.01 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.443 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.25 -53.39 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.126 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.612 ' SG ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -161.96 -178.32 6.37 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 123.567 0.542 . . . . 0.0 110.927 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 17.0 mm-40 -112.63 150.75 30.99 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.02 110.45 0.35 Allowed Glycine 0 N--CA 1.499 2.861 0 O-C-N 125.779 1.924 . . . . 0.0 112.459 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 -42.75 7.32 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 118.39 2.737 . . . . 0.0 118.39 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 t -57.86 102.81 0.11 Allowed 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 119.756 1.162 . . . . 0.0 113.883 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.55 139.9 22.98 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 124.931 1.395 . . . . 0.0 107.45 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -45.75 -30.61 6.75 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.627 2.218 . . . . 0.0 115.942 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -65.21 -36.93 85.69 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.743 HD22 ' H ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -81.61 142.49 49.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 119.226 -0.989 . . . . 0.0 108.561 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -75.52 40.52 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.147 1.898 . . . . 0.0 110.933 166.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.743 ' H ' HD22 ' A' ' 33' ' ' ASN . 2.6 mptp? 48.81 71.6 0.36 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.633 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.32 86.36 5.07 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.302 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.1 m -153.66 141.54 13.81 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.99 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.53 -166.28 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 121.936 1.757 . . . . 0.0 110.753 168.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -79.54 -76.56 0.21 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 m120 50.5 86.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 124.62 1.2 . . . . 0.0 113.052 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.8 m -66.95 128.37 36.09 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -113.71 80.97 5.32 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.59 -30.63 83.87 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 122.367 2.045 . . . . 0.0 112.603 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.481 ' H ' ' HD3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -61.48 -44.58 96.84 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.49 144.3 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.761 ' HA ' HD11 ' A' ' 3' ' ' ILE . . . -106.21 -46.74 3.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.959 0.787 . . . . 0.0 109.22 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -173.21 -170.08 0.6 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.118 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -127.73 115.22 2.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.6 mm -79.4 110.55 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.23 160.53 28.02 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.93 -42.85 34.27 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 121.633 1.556 . . . . 0.0 108.961 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 52' ' ' LEU . 10.8 mp -88.52 79.61 7.58 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 2.229 0 CA-C-O 115.723 -2.084 . . . . 0.0 113.629 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -137.63 -44.43 0.54 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 124.441 1.088 . . . . 0.0 108.835 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 3' ' ' ILE . 5.1 tp -79.19 76.23 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.322 1.058 . . . . 0.0 108.711 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.1 m -90.32 36.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.218 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.24 -171.55 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.727 -2.033 . . . . 0.0 106.843 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 68.8 m-80 -160.4 167.8 26.57 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.406 1.066 . . . . 0.0 111.122 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -61.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.344 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -59.23 -59.69 5.06 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.101 -1.408 . . . . 0.0 109.013 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . . . -79.05 31.8 0.21 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.137 -2.301 . . . . 0.0 111.351 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.03 -130.09 0.65 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.486 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 99.0 m -142.58 109.64 5.56 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 123.97 0.453 . . . . 0.0 111.294 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -48.37 106.61 0.1 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.443 1.089 . . . . 0.0 111.225 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.28 -27.23 4.27 Favored Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.567 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.4 m -110.29 134.45 52.26 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.919 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -80.2 101.15 8.66 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.529 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -62.42 119.24 8.74 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.96 158.68 38.88 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.222 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 t -103.59 129.76 50.91 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.323 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -46.0 -20.84 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 125.855 1.972 . . . . 0.0 114.765 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -55.17 -29.81 58.58 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 123.859 0.724 . . . . 0.0 110.785 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.55 31.57 1.48 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.8 m -144.03 140.68 29.69 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.732 0.777 . . . . 0.0 111.574 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -74.49 135.74 42.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.374 -1.284 . . . . 0.0 107.682 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -91.14 -63.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.356 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -176.25 171.91 2.39 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.17 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 2.3 mt-10 -90.45 150.25 21.89 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 120.174 -0.611 . . . . 0.0 112.433 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.486 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.11 124.61 11.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.65 -5.0 15.12 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.8 t -85.39 123.45 30.87 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.656 ' H ' HD21 ' A' ' 33' ' ' ASN . 13.0 t70 -80.11 127.06 78.06 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.85 83.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.93 1.753 . . . . 0.0 110.155 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 30' ' ' ASP . 1.4 mmt-85 176.16 -39.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.966 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.656 HD21 ' H ' ' A' ' 30' ' ' ASP . 14.9 p30 -91.28 148.91 38.76 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 124.167 0.917 . . . . 0.0 110.945 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.14 47.29 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.58 2.187 . . . . 0.0 110.183 162.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -72.88 111.55 8.1 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . . . -155.08 109.12 2.9 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.784 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 2.2 m -79.48 -42.66 1.59 Allowed Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 37' ' ' CYS . 10.0 Cg_endo -72.79 -176.32 2.28 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 C-N-CA 122.42 2.08 . . . . 0.0 110.643 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.11 -1.23 1.77 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.575 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -125.49 -168.02 1.78 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.213 0.946 . . . . 0.0 113.023 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 89.0 m -91.18 152.91 20.37 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 114.132 -1.395 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.597 ' CG ' HD12 ' A' ' 45' ' ' ILE . 7.3 t0 -113.8 76.36 3.11 Favored Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 123.652 0.595 . . . . 0.0 110.996 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.66 -26.98 81.58 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.447 2.098 . . . . 0.0 111.423 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.5 mtm-85 -60.51 -45.09 95.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.22 0.95 . . . . 0.0 109.744 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.597 HD12 ' CG ' ' A' ' 42' ' ' ASP . 2.4 mt -66.55 155.36 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 124.347 1.03 . . . . 0.0 108.614 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.34 -45.38 0.83 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.93 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.18 175.02 12.56 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 124.059 0.849 . . . . 0.0 111.16 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.01 108.96 1.63 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mm -79.27 90.49 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.25 156.6 59.85 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.62 -30.1 89.82 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.116 1.877 . . . . 0.0 110.057 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.6 tp -85.91 30.65 0.65 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.608 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 116.86 -1.543 . . . . 0.0 108.848 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.982 0.42 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.3 131.53 23.43 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.454 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 3' ' ' ILE . 7.6 tp -70.4 105.11 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.29 26.81 9.49 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -91.32 158.89 16.29 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 112.663 -2.062 . . . . 0.0 106.143 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -140.13 161.53 37.41 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -57.62 -34.95 69.84 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.124 0.964 . . . . 0.0 109.548 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' SG ' ' C ' ' A' ' 36' ' ' ALA . 8.1 t -75.61 -62.36 1.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.47 67.78 6.63 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 113.854 -1.521 . . . . 0.0 106.912 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.76 -109.45 2.88 Favored Glycine 0 N--CA 1.497 2.723 0 CA-C-N 114.259 -1.337 . . . . 0.0 115.066 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 m -167.07 107.46 0.62 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 124.648 0.852 . . . . 0.0 109.95 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.18 132.19 1.41 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.609 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' N ' ' HA3' ' A' ' 27' ' ' GLY . . . 84.46 -24.02 6.81 Favored Glycine 0 N--CA 1.493 2.457 0 CA-C-O 118.603 -1.11 . . . . 0.0 114.473 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.4 m -79.97 127.74 32.63 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.781 1.29 . . . . 0.0 109.921 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -77.76 91.56 4.1 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.536 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 16.4 m-85 -54.48 132.27 44.27 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.497 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -145.52 156.5 43.75 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.721 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.6 t -105.51 128.15 53.41 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 112.295 -2.23 . . . . 0.0 109.775 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.484 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 5.7 p-10 -39.16 -27.52 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.71 -29.22 64.52 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.199 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.93 36.27 0.73 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.1 m -141.36 133.78 28.25 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.489 0.662 . . . . 0.0 111.552 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -71.51 147.61 47.57 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.156 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 17' ' ' PHE . 58.8 t -104.23 -72.56 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.053 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -154.57 176.67 12.11 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.73 156.83 16.38 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -52.23 104.4 0.17 Allowed Glycine 0 N--CA 1.489 2.208 0 CA-C-N 112.909 -1.95 . . . . 0.0 109.657 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.49 -19.59 10.01 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.552 -0.824 . . . . 0.0 112.983 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.65 116.41 11.99 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.174 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.07 122.17 84.11 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -70.76 72.12 1.96 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 123.062 2.508 . . . . 0.0 112.342 -173.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -177.51 -48.02 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -87.5 144.43 35.56 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 124.135 0.897 . . . . 0.0 109.416 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.13 82.46 1.8 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.966 1.777 . . . . 0.0 109.085 167.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -69.39 91.67 0.56 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.482 ' C ' ' SG ' ' A' ' 8' ' ' CYS . . . -109.12 148.06 31.45 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.882 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.538 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 1.6 m -159.25 -51.24 0.01 OUTLIER Pre-proline 0 N--CA 1.497 1.88 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.322 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 18.7 Cg_endo -80.94 -158.66 0.1 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.997 2.465 . . . . 0.0 109.489 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -79.72 -94.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -160.5 135.49 7.75 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.2 m 60.12 126.3 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.716 1.26 . . . . 0.0 114.103 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.81 83.61 11.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.716 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -53.46 -24.8 29.5 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.568 2.178 . . . . 0.0 113.122 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.06 -48.01 79.6 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mt -74.12 150.3 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.932 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -111.03 -44.52 3.58 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.532 -1.667 . . . . 0.0 107.211 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -171.36 -171.23 0.91 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.718 1.261 . . . . 0.0 109.161 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.45 120.74 3.98 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.91 85.84 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.3 m -80.29 132.49 59.15 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.378 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.75 151.65 68.97 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.945 1.764 . . . . 0.0 111.707 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.477 HD13 ' H ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -139.46 153.83 47.63 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.37 1.044 . . . . 0.0 109.827 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' H ' HD13 ' A' ' 52' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.143 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.129 0.49 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.92 56.29 0.68 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tp -86.34 45.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 114.231 -1.349 . . . . 0.0 110.591 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.6 m -87.24 39.91 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.589 1.185 . . . . 0.0 111.495 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -79.76 171.09 15.59 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 112.931 -1.94 . . . . 0.0 107.92 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -157.95 172.94 17.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.53 1.144 . . . . 0.0 111.079 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 t -72.2 -22.86 61.21 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.069 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 9.1 t -74.42 -59.23 2.82 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.111 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.55 62.01 3.82 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.045 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.12 -95.64 1.22 Allowed Glycine 0 N--CA 1.502 3.051 0 N-CA-C 118.513 2.165 . . . . 0.0 118.513 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.4 ' N ' ' HB2' ' A' ' 29' ' ' SER . 0.0 OUTLIER -175.35 113.42 0.13 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 123.827 0.369 . . . . 0.0 111.69 -179.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HA ' ' C ' ' A' ' 27' ' ' GLY . 13.4 ttpt -71.62 93.49 1.24 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.321 1.057 . . . . 0.0 109.005 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.507 ' H ' ' HA3' ' A' ' 27' ' ' GLY . . . 165.03 -39.26 0.29 Allowed Glycine 0 N--CA 1.485 1.962 0 CA-C-N 112.944 -1.935 . . . . 0.0 108.471 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.2 m -97.36 137.47 36.3 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.571 0.7 . . . . 0.0 112.451 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -85.07 105.17 15.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.64 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.791 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 56.9 m-85 -48.74 128.69 15.86 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.569 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.42 152.22 37.77 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.514 1.149 . . . . 0.0 111.959 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.2 t -104.53 130.37 52.49 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 112.082 -2.326 . . . . 0.0 111.955 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.93 -30.89 0.05 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 119.072 2.989 . . . . 0.0 119.072 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.07 -26.51 66.22 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.839 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.9 37.46 0.71 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 m -141.96 136.91 30.83 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.95 0.881 . . . . 0.0 111.862 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -70.49 150.05 46.56 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.975 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.7 t -112.11 -51.38 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.591 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.791 ' SG ' ' CD1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -166.43 176.7 7.22 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 123.672 0.608 . . . . 0.0 109.942 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -106.03 142.68 35.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA3' ' H ' ' A' ' 13' ' ' GLY . . . -39.99 111.96 0.26 Allowed Glycine 0 N--CA 1.5 2.916 0 O-C-N 125.131 1.52 . . . . 0.0 111.434 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -126.31 -21.18 4.28 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.4 ' HB2' ' N ' ' A' ' 11' ' ' THR . 15.2 m -65.71 84.4 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.425 ' H ' HD21 ' A' ' 33' ' ' ASN . 12.6 t70 -83.03 133.86 47.46 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -50.76 -31.08 31.58 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.027 1.818 . . . . 0.0 112.937 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -75.06 -40.79 59.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 123.943 0.777 . . . . 0.0 110.713 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.425 HD21 ' H ' ' A' ' 30' ' ' ASP . 22.6 p30 -83.18 150.7 61.59 Favored Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.593 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.83 90.7 0.36 Allowed 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.165 1.91 . . . . 0.0 110.952 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 66.02 8.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.837 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.36 123.58 4.37 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.87 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.7 m -146.72 67.96 11.59 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.95 112.26 1.61 Allowed 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 121.972 1.782 . . . . 0.0 111.033 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -160.54 -37.02 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 123.79 0.681 . . . . 0.0 112.51 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -142.76 175.79 9.55 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.853 0.721 . . . . 0.0 112.075 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 68.7 m -119.8 145.48 46.56 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.569 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 45' ' ' ILE . 7.1 t0 -118.09 70.48 7.97 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.86 -23.41 76.78 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 C-N-CA 122.192 1.928 . . . . 0.0 112.217 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -42.62 99.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 124.405 1.066 . . . . 0.0 110.581 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 42' ' ' ASP . 10.6 tt -60.04 148.79 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.281 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.52 -40.37 3.06 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.035 -1.439 . . . . 0.0 107.678 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -174.46 -165.04 0.2 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.797 1.311 . . . . 0.0 109.102 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.39 122.93 4.78 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -79.12 102.85 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.2 m -91.06 125.32 59.06 Favored Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.097 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -64.18 148.24 91.23 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.03 1.82 . . . . 0.0 110.911 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.7 17.06 2.91 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 114.768 -2.539 . . . . 0.0 111.423 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.732 0.301 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 66.14 121.87 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 124.435 1.084 . . . . 0.0 112.872 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 3' ' ' ILE . 6.2 tp -87.59 60.44 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 122.409 1.099 . . . . 0.0 109.487 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.98 52.53 2.5 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.654 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.35 166.6 23.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.248 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -161.04 148.83 15.59 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.459 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -7.38 5.3 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.121 -1.399 . . . . 0.0 113.714 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 4.4 t -78.58 -63.31 1.44 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.97 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.2 -79.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 11' ' ' THR . . . 37.31 -103.51 0.02 OUTLIER Glycine 0 N--CA 1.503 3.112 0 O-C-N 123.658 0.599 . . . . 0.0 113.675 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -179.25 118.45 0.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -45.48 115.48 0.95 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 123.883 0.74 . . . . 0.0 111.509 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.8 -23.26 20.0 Favored Glycine 0 N--CA 1.499 2.835 0 O-C-N 124.393 1.058 . . . . 0.0 114.155 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -79.32 -176.96 5.47 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 118.014 0.907 . . . . 0.0 109.607 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -137.46 104.18 5.28 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.164 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.503 ' CD1' ' SG ' ' A' ' 25' ' ' CYS . 63.6 m-85 -57.82 131.26 49.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.47 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -145.24 154.49 42.44 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.238 1.018 . . . . 0.0 110.684 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 t -106.16 124.77 50.11 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 112.565 -2.107 . . . . 0.0 109.491 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.596 ' H ' ' HB2' ' A' ' 46' ' ' ALA . 20.6 p-10 -39.04 -28.86 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.0 -28.17 64.17 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.218 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.33 35.22 0.72 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.2 m -140.01 135.45 32.7 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.615 0.721 . . . . 0.0 112.498 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -72.97 138.06 45.85 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.47 HG23 ' HA ' ' A' ' 17' ' ' PHE . 61.7 t -97.83 -52.73 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.422 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -173.03 -174.05 1.02 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 123.622 0.576 . . . . 0.0 111.007 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -114.17 142.6 46.04 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.65 110.06 1.7 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.45 14.02 23.79 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.7 t -145.45 115.65 7.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.556 0.693 . . . . 0.0 110.801 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.63 ' H ' HD21 ' A' ' 33' ' ' ASN . 10.6 t70 -79.68 141.36 55.84 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 113.569 -1.651 . . . . 0.0 106.716 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -44.25 -34.94 7.57 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 122.155 1.903 . . . . 0.0 113.152 173.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 tpp180 -73.98 -39.86 63.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 123.881 0.738 . . . . 0.0 112.593 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.63 HD21 ' H ' ' A' ' 30' ' ' ASP . 27.1 p30 -88.0 143.55 33.32 Favored Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.484 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.88 47.65 2.54 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 123.161 2.574 . . . . 0.0 112.881 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -98.51 27.17 4.95 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.139 0.971 . . . . 0.0 110.139 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.91 157.72 16.21 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.083 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.561 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.3 m -136.91 83.12 29.51 Favored Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.463 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.9 76.41 1.2 Allowed 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.219 1.946 . . . . 0.0 108.859 166.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -160.31 -30.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.644 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -94.96 132.27 39.98 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.985 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.0 m -113.84 131.44 56.25 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.836 1.335 . . . . 0.0 108.489 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -137.58 82.7 26.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 123.736 0.648 . . . . 0.0 111.087 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.51 -28.31 87.15 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.251 1.968 . . . . 0.0 112.751 168.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 mtm105 -64.18 -19.07 65.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.784 0.678 . . . . 0.0 111.91 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.13 144.07 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.596 ' HB2' ' H ' ' A' ' 19' ' ' ASP . . . -103.04 -50.12 3.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.522 1.138 . . . . 0.0 108.46 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -169.44 -173.76 1.77 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.935 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.9 110.6 2.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.3 mm -79.07 102.21 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.8 m -95.45 133.63 25.56 Favored Pre-proline 0 N--CA 1.493 1.724 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.322 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.0 86.34 0.39 Allowed 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 122.052 1.834 . . . . 0.0 110.214 174.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.16 179.11 8.99 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.045 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 116.958 -1.496 . . . . 0.0 110.103 179.922 . . . . . . . . 0 0 . 1 stop_ save_